text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY The application of various mass spectrometric techniques to structure elucidation of three classes of biologically important natural products will be studied.  The first group encompasses novel marine sterols, which differ primarily from terrestrial sterols in the nature of their unusual (elongated or branched) side chains.  This feature appears to be of importance in cell membrane function and a detailed knowledge of the mass spectral fragmentation pattern of such sterol types is needed for structural elucidation of novel and as yet unidentified sterols of marine organisms.  Much of this work requires synthesis of requisite sterol reference compounds or synthetic verification of postulated structure.  The second group of natural products deals with the unusual phospholipids isolated from marine organisms.  Much less is known about the mass spectrometric behavior of this biologically important class of natural products as compared to sterols, and we intend to explore this field in detail by comparing different ionization techniques (electron impact vs. field desorption vs. chemical ionization vs. fast atom bombardment) since each is likely to provide special structural information on specific portions of the phospholipid molecule.  Since the novel marine phospholipids are particularly unusual in the context of their unprecedented fatty acid components (usually polyunsaturated), work is also envisaged on the mass spectrometric location of such double bonds in long-chain fatty acids.  Finally, we intend to develop mass spectral procedures (notably through the use of chemical ionization mass spectrometry with hydrogen gas) in the porphyrin field with the aim of accomplishing an as yet largely unrealized goal, namely the location of chemical substituents in the four different pyrrole rings of the prophyrin molecule solely through the use of mass spectrometry.  If successful, this should not only make an important contribution to porphyrin chemistry, but should also help greatly in drug metabolism studies involving cytochrome P-450.  ",MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY,3275644,R01GM028352,"['marine biology ', ' sterols ', ' steroid analog ', ' steroids ', ' gas chromatography ', ' chemical models ', ' marine animal oil ', ' cyclopropanes ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' mass spectrometry ', ' ion cyclotron resonance spectrometry ', ' organic chemicals ', ' chemical structure function ', ' stereochemistry ', ' chemical information system ', ' biochemistry ', ' alkylation ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,1985,271077,0.19310761683173586
"STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY The goal of the proposed research is to evaluate and develop techniques for the application of the triple quadrupole mass spectrometer in the determination of molecular structure.  In triple quadrupole mass spectrometry (TQMS), ions from the source are selected by mass in the first quadrupole and then undergo fragmenting or reactive collision(s) with neutral molecules in the non mass-selective center quadrupole.  The ionic collision products are then mass-analysed by the third quadrupole before detection.  This is a form mass spectrometry (MS/MS).  With TQMS or MS/MS, one can obtain a spectrum for every ""parent"" ion produced in the source. This three-dimensional collection of spectra contains much more information about the sample than the oridinary mass spectrum.  It is a goal of this proposal to deduce the structural information contained in these spectra by comparison of the daughter spectra with those from a large number of compounds with known and varied structure.  The proposed research includes four areas:  1) a continuation of our effort to identify the structural information contained in the variations in daughter spectra with changes in ion internal energy, ion kinetic energy, and collision gas pressure and to identify reasonable and reproducible ""standard"" conditions for the collection of spectra for a data base library, 2) the development of searching and ranking procedures which will produce lists of compounds in the data base that produce ions that give daughter spectra similar to those of the unknown compound.  3) The development of algorithms to identify from the lists of compounds, those common substructures which might be part of the unknown compound and from them produce a list of possible structures, and 4) make certain improvements in the instrumentation and data base management software to facilitate the above goals.  Efficient organic structural analysis is a major need among synthetic, environmental and pharaceutical chemists as well as toxicologists and pathologists.  ",STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY,3275550,R01GM028254,"['ionization ', ' hydrocarbons ', ' computer graphics /printing ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' organic chemicals ', ' chemical structure ', ' chemical group ', ' chemical information system ', ' ']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,1985,76349,0.17640336262322331
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY The specific aim of the proposed research is to continue to develop the analytical capability of 252Cf-plasma desorption mass spectrometry for biomedical research involving large biomolecules (m/z greater than 5000). Part of the plan is to change the method of sample preparation so that the formation of molecular ions from the substrate will be less dependent on matrix effects and at the same time will improve sensitivity to the picomole level.  The new method of sample preparation will utilize adsorption of proteins (insulin and cytochrome-C) onto polymeric surfaces from liquid solutions.  The interaction will be analyzed using phase equilibrium thermodynamics to evaluate equilibrium constants, DeltaH, and DeltaS for adsorption.  These same surfaces will become samples for 252Cf-PDMS analysis.  Fractional coverage will be determined by 252Cf-PDMS.  A general study of polymer-protein surface thermodynamics will be carried out using 252Cf-PDMS as an analytical method.  Two important protein systems, interferon and hemoglobin, have been targeted as the next model compounds for extending the mass range and capabilities of 252Cf-PDMS.  Some feasibility studies will be carried out to determine whether 252Cf-PDMS might be used to study antibody-antigen interactions and receptor sites on cell surfaces.  The studies of protein-polymer interactions have relevance to the genesis of atherosclerosis.  Specific interactions between proteins and receptor sites are fundamental to the immune response in humans and in understanding the role of proteins such as insulin in triggering a response within a cell when it attaches to a receptor site.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273558,R01GM026096,"['peptides ', ' insulin ', ' oligonucleotides ', ' interferons ', ' hemoglobin ', ' cytochrome c ', ' artificial intelligence ', ' mass spectrometry ', ' blood proteins ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1985,151747,0.12897674402232315
"MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY The application of various mass spectrometric techniques to structure elucidation of three classes of biologically important natural products will be studied.  The first group encompasses novel marine sterols, which differ primarily from terrestrial sterols in the nature of their unusual (elongated or branched) side chains.  This feature appears to be of importance in cell membrane function and a detailed knowledge of the mass spectral fragmentation pattern of such sterol types is needed for structural elucidation of novel and as yet unidentified sterols of marine organisms.  Much of this work requires synthesis of requisite sterol reference compounds or synthetic verification of postulated structure.  The second group of natural products deals with the unusual phospholipids isolated from marine organisms.  Much less is known about the mass spectrometric behavior of this biologically important class of natural products as compared to sterols, and we intend to explore this field in detail by comparing different ionization techniques (electron impact vs. field desorption vs. chemical ionization vs. fast atom bombardment) since each is likely to provide special structural information on specific portions of the phospholipid molecule.  Since the novel marine phospholipids are particularly unusual in the context of their unprecedented fatty acid components (usually polyunsaturated), work is also envisaged on the mass spectrometric location of such double bonds in long-chain fatty acids.  Finally, we intend to develop mass spectral procedures (notably through the use of chemical ionization mass spectrometry with hydrogen gas) in the porphyrin field with the aim of accomplishing an as yet largely unrealized goal, namely the location of chemical substituents in the four different pyrrole rings of the prophyrin molecule solely through the use of mass spectrometry.  If successful, this should not only make an important contribution to porphyrin chemistry, but should also help greatly in drug metabolism studies involving cytochrome P-450.  ",MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY,3275645,R01GM028352,"['marine biology ', ' sterols ', ' steroid analog ', ' steroids ', ' gas chromatography ', ' chemical models ', ' marine animal oil ', ' cyclopropanes ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' mass spectrometry ', ' ion cyclotron resonance spectrometry ', ' organic chemicals ', ' chemical structure function ', ' stereochemistry ', ' chemical information system ', ' biochemistry ', ' alkylation ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,1986,281369,0.19310761683173586
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY The specific aim of the proposed research is to continue to develop the analytical capability of 252Cf-plasma desorption mass spectrometry for biomedical research involving large biomolecules (m/z greater than 5000). Part of the plan is to change the method of sample preparation so that the formation of molecular ions from the substrate will be less dependent on matrix effects and at the same time will improve sensitivity to the picomole level.  The new method of sample preparation will utilize adsorption of proteins (insulin and cytochrome-C) onto polymeric surfaces from liquid solutions.  The interaction will be analyzed using phase equilibrium thermodynamics to evaluate equilibrium constants, DeltaH, and DeltaS for adsorption.  These same surfaces will become samples for 252Cf-PDMS analysis.  Fractional coverage will be determined by 252Cf-PDMS.  A general study of polymer-protein surface thermodynamics will be carried out using 252Cf-PDMS as an analytical method.  Two important protein systems, interferon and hemoglobin, have been targeted as the next model compounds for extending the mass range and capabilities of 252Cf-PDMS.  Some feasibility studies will be carried out to determine whether 252Cf-PDMS might be used to study antibody-antigen interactions and receptor sites on cell surfaces.  The studies of protein-polymer interactions have relevance to the genesis of atherosclerosis.  Specific interactions between proteins and receptor sites are fundamental to the immune response in humans and in understanding the role of proteins such as insulin in triggering a response within a cell when it attaches to a receptor site.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273562,R01GM026096,"['peptides ', ' insulin ', ' oligonucleotides ', ' interferons ', ' hemoglobin ', ' cytochrome c ', ' artificial intelligence ', ' mass spectrometry ', ' blood proteins ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1986,133245,0.12897674402232315
"STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY The goal of this research is to develop the full capability of tandem mass spectrometry for routine organic structure determination.  In tandem mass spectrometry, or MS/MS, ions from the source are selected by the first mass analyzer and then undergo fragmenting collision with neutral molecules in a collision region.  The ionic products of the collision process are then mass analyzed by a second mass filter and ion detector.  The special potential offered by MS/MS for structure determination comes from the individual fragmentation spectrum available for each ion in the normal mass spectrum.  Each ion species in the source is related to some substructure of the original molecule and the identity of each of these species can be deduced from its fragmentation spectrum.  The direct correlation of ion fragmentation spectra with precursor substructures is only one of many types of structural information available in the overall MS/MS molecular fragmentation map.  To make this potentially powerful technique generally useful, it is necessary to extend the knowledge base to known relationships between MS/MS spectral features and substructures, to obtain the molecular structure from the identified substructures, and to automate the entire process from instrument control to final structure output.  To accomplish this, we propose to utilize a tandem quadrupole mass spectrometer (TWMS) MS/MS instrument, spectrum and structure databases designed for MS/MS applications, and spectrum matching functions linked to these databases.  These existing and available functions will be combined with an intelligent controller and expert systems for matching, generating, and organizing structures.  The goal is an automated system for the determination of molecular structure.  This system will be used in semi-automatic mode to extend the spectra/substructure knowledge base.  In measurement mode, the intelligent controller will direct the measurement process to acquire the data most likely to resolve the remaining structural uncertainties.  This project combines the fields of organic mass spectrometry, instrumentation, and artificial intelligence.  It is relevant to health-related research because of its potential to determine complex structures (and therefore the complete identity) of previously unknown compounds, detect particular sought substructures in various materials or mixtures, and do so using only micrograms of sample.  ",STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY,3275547,R01GM028254,"['ionization ', ' hydrocarbons ', ' computer graphics /printing ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' organic chemicals ', ' chemical structure ', ' chemical group ', ' chemical information system ', ' ']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,1986,103750,0.2764275865230478
"STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY The goal of this research is to develop the full capability of tandem mass spectrometry for routine organic structure determination.  In tandem mass spectrometry, or MS/MS, ions from the source are selected by the first mass analyzer and then undergo fragmenting collision with neutral molecules in a collision region.  The ionic products of the collision process are then mass analyzed by a second mass filter and ion detector.  The special potential offered by MS/MS for structure determination comes from the individual fragmentation spectrum available for each ion in the normal mass spectrum.  Each ion species in the source is related to some substructure of the original molecule and the identity of each of these species can be deduced from its fragmentation spectrum.  The direct correlation of ion fragmentation spectra with precursor substructures is only one of many types of structural information available in the overall MS/MS molecular fragmentation map.  To make this potentially powerful technique generally useful, it is necessary to extend the knowledge base to known relationships between MS/MS spectral features and substructures, to obtain the molecular structure from the identified substructures, and to automate the entire process from instrument control to final structure output.  To accomplish this, we propose to utilize a tandem quadrupole mass spectrometer (TWMS) MS/MS instrument, spectrum and structure databases designed for MS/MS applications, and spectrum matching functions linked to these databases.  These existing and available functions will be combined with an intelligent controller and expert systems for matching, generating, and organizing structures.  The goal is an automated system for the determination of molecular structure.  This system will be used in semi-automatic mode to extend the spectra/substructure knowledge base.  In measurement mode, the intelligent controller will direct the measurement process to acquire the data most likely to resolve the remaining structural uncertainties.  This project combines the fields of organic mass spectrometry, instrumentation, and artificial intelligence.  It is relevant to health-related research because of its potential to determine complex structures (and therefore the complete identity) of previously unknown compounds, detect particular sought substructures in various materials or mixtures, and do so using only micrograms of sample.  ",STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY,3275551,R01GM028254,"['ionization ', ' hydrocarbons ', ' computer graphics /printing ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' organic chemicals ', ' chemical structure ', ' chemical group ', ' chemical information system ', ' ']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,1987,76585,0.2764275865230478
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY The specific aim of the proposed research is to continue to develop the analytical capability of 252Cf-plasma desorption mass spectrometry for biomedical research involving large biomolecules (m/z greater than 5000). Part of the plan is to change the method of sample preparation so that the formation of molecular ions from the substrate will be less dependent on matrix effects and at the same time will improve sensitivity to the picomole level.  The new method of sample preparation will utilize adsorption of proteins (insulin and cytochrome-C) onto polymeric surfaces from liquid solutions.  The interaction will be analyzed using phase equilibrium thermodynamics to evaluate equilibrium constants, DeltaH, and DeltaS for adsorption.  These same surfaces will become samples for 252Cf-PDMS analysis.  Fractional coverage will be determined by 252Cf-PDMS.  A general study of polymer-protein surface thermodynamics will be carried out using 252Cf-PDMS as an analytical method.  Two important protein systems, interferon and hemoglobin, have been targeted as the next model compounds for extending the mass range and capabilities of 252Cf-PDMS.  Some feasibility studies will be carried out to determine whether 252Cf-PDMS might be used to study antibody-antigen interactions and receptor sites on cell surfaces.  The studies of protein-polymer interactions have relevance to the genesis of atherosclerosis.  Specific interactions between proteins and receptor sites are fundamental to the immune response in humans and in understanding the role of proteins such as insulin in triggering a response within a cell when it attaches to a receptor site.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273563,R01GM026096,"['peptides ', ' insulin ', ' oligonucleotides ', ' interferons ', ' hemoglobin ', ' cytochrome c ', ' artificial intelligence ', ' mass spectrometry ', ' blood proteins ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1987,191633,0.12897674402232315
"MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY The application of various mass spectrometric techniques to structure elucidation of three classes of biologically important natural products will be studied.  The first group encompasses novel marine sterols, which differ primarily from terrestrial sterols in the nature of their unusual (elongated or branched) side chains.  This feature appears to be of importance in cell membrane function and a detailed knowledge of the mass spectral fragmentation pattern of such sterol types is needed for structural elucidation of novel and as yet unidentified sterols of marine organisms.  Much of this work requires synthesis of requisite sterol reference compounds or synthetic verification of postulated structure.  The second group of natural products deals with the unusual phospholipids isolated from marine organisms.  Much less is known about the mass spectrometric behavior of this biologically important class of natural products as compared to sterols, and we intend to explore this field in detail by comparing different ionization techniques (electron impact vs. field desorption vs. chemical ionization vs. fast atom bombardment) since each is likely to provide special structural information on specific portions of the phospholipid molecule.  Since the novel marine phospholipids are particularly unusual in the context of their unprecedented fatty acid components (usually polyunsaturated), work is also envisaged on the mass spectrometric location of such double bonds in long-chain fatty acids.  Finally, we intend to develop mass spectral procedures (notably through the use of chemical ionization mass spectrometry with hydrogen gas) in the porphyrin field with the aim of accomplishing an as yet largely unrealized goal, namely the location of chemical substituents in the four different pyrrole rings of the prophyrin molecule solely through the use of mass spectrometry.  If successful, this should not only make an important contribution to porphyrin chemistry, but should also help greatly in drug metabolism studies involving cytochrome P-450.  ",MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY,3275646,R01GM028352,"['marine biology ', ' sterols ', ' steroid analog ', ' steroids ', ' gas chromatography ', ' chemical models ', ' marine animal oil ', ' deuterium ', ' cyclopropanes ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' mass spectrometry ', ' ion cyclotron resonance spectrometry ', ' organic chemicals ', ' chemical structure function ', ' stereochemistry ', ' chemical information system ', ' biochemistry ', ' alkylation ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,1987,322043,0.19310761683173586
"COMPUTER-ASSISTED STRUCTURE ELUCIDATION The characterization of the structure of a biomolecule on the its  chemical and spectral properties is of widespread importance in the biomedical sciences.  Because of its complexity, structure characterization is overall a time-consuming activity that has been largely left to experts in the field.  The goal of this research is to substantially increase the productivity of those experts.  Given the expert's proficiency in readily picking out the correct structure of an unknown from among a limited number of alternative structures, a much more expeditious assignment of structure would be achieved if the expert could begin the structure characterization problem with such a conceptually manageable number of plausible alternatives.  Thus, the goal of the research is to create artificial intelligence based computer software capable of directly reducing the collective spectral properties (infrared, proton and carbon-13 nuclear magnetic resonance, ultraviolet and mass spectral data) of the unknown to a conceptually manageable number of stereochemically defined structures, each of which is compatible with the observed spectral data.  The expert is still a required player, but is spared what is actually the time-intensive component of the ""manual"" process, that of producing the limited number of alternatives.  Key features of the software to be created include, (1) programs for both spectrum interpretation and structure generation, (2) provision to accept any structural information known to the expert and (3) the capability to treat real-world structure characterization problems without regard to the class of structures to which the unknown belongs.  The last named feature requires a system that is not spectral library dependent.  ",COMPUTER-ASSISTED STRUCTURE ELUCIDATION,3293871,R01GM037963,"['electronic spectra ', ' computer simulation ', ' artificial intelligence ', ' ultraviolet spectrometry ', ' nuclear magnetic resonance spectroscopy ', ' mass spectrometry ', ' infrared spectrometry ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,1987,136301,0.048843889799610435
"MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY The application of various mass spectrometric techniques to structure elucidation of three classes of biologically important natural products will be studied.  The first group encompasses novel marine sterols, which differ primarily from terrestrial sterols in the nature of their unusual (elongated or branched) side chains.  This feature appears to be of importance in cell membrane function and a detailed knowledge of the mass spectral fragmentation pattern of such sterol types is needed for structural elucidation of novel and as yet unidentified sterols of marine organisms.  Much of this work requires synthesis of requisite sterol reference compounds or synthetic verification of postulated structure.  The second group of natural products deals with the unusual phospholipids isolated from marine organisms.  Much less is known about the mass spectrometric behavior of this biologically important class of natural products as compared to sterols, and we intend to explore this field in detail by comparing different ionization techniques (electron impact vs. field desorption vs. chemical ionization vs. fast atom bombardment) since each is likely to provide special structural information on specific portions of the phospholipid molecule.  Since the novel marine phospholipids are particularly unusual in the context of their unprecedented fatty acid components (usually polyunsaturated), work is also envisaged on the mass spectrometric location of such double bonds in long-chain fatty acids.  Finally, we intend to develop mass spectral procedures (notably through the use of chemical ionization mass spectrometry with hydrogen gas) in the porphyrin field with the aim of accomplishing an as yet largely unrealized goal, namely the location of chemical substituents in the four different pyrrole rings of the prophyrin molecule solely through the use of mass spectrometry.  If successful, this should not only make an important contribution to porphyrin chemistry, but should also help greatly in drug metabolism studies involving cytochrome P-450.  ",MASS SPECTROMETRY IN ORGANIC AND BIOCHEMISTRY,3275647,R01GM028352,"['marine biology ', ' sterols ', ' steroid analog ', ' steroids ', ' gas chromatography ', ' chemical models ', ' marine animal oil ', ' deuterium ', ' cyclopropanes ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' mass spectrometry ', ' ion cyclotron resonance spectrometry ', ' organic chemicals ', ' chemical structure function ', ' stereochemistry ', ' chemical information system ', ' biochemistry ', ' alkylation ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,1988,311233,0.19310761683173586
"COMPUTER-ASSISTED STRUCTURE ELUCIDATION The characterization of the structure of a biomolecule on the its  chemical and spectral properties is of widespread importance in the biomedical sciences.  Because of its complexity, structure characterization is overall a time-consuming activity that has been largely left to experts in the field.  The goal of this research is to substantially increase the productivity of those experts.  Given the expert's proficiency in readily picking out the correct structure of an unknown from among a limited number of alternative structures, a much more expeditious assignment of structure would be achieved if the expert could begin the structure characterization problem with such a conceptually manageable number of plausible alternatives.  Thus, the goal of the research is to create artificial intelligence based computer software capable of directly reducing the collective spectral properties (infrared, proton and carbon-13 nuclear magnetic resonance, ultraviolet and mass spectral data) of the unknown to a conceptually manageable number of stereochemically defined structures, each of which is compatible with the observed spectral data.  The expert is still a required player, but is spared what is actually the time-intensive component of the ""manual"" process, that of producing the limited number of alternatives.  Key features of the software to be created include, (1) programs for both spectrum interpretation and structure generation, (2) provision to accept any structural information known to the expert and (3) the capability to treat real-world structure characterization problems without regard to the class of structures to which the unknown belongs.  The last named feature requires a system that is not spectral library dependent.  ",COMPUTER-ASSISTED STRUCTURE ELUCIDATION,3293872,R01GM037963,"['electronic spectra ', ' computer simulation ', ' artificial intelligence ', ' ultraviolet spectrometry ', ' nuclear magnetic resonance spectroscopy ', ' mass spectrometry ', ' infrared spectrometry ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,1988,138167,0.048843889799610435
"STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY The goal of this research is to develop the full capability of tandem mass spectrometry for routine organic structure determination.  In tandem mass spectrometry, or MS/MS, ions from the source are selected by the first mass analyzer and then undergo fragmenting collision with neutral molecules in a collision region.  The ionic products of the collision process are then mass analyzed by a second mass filter and ion detector.  The special potential offered by MS/MS for structure determination comes from the individual fragmentation spectrum available for each ion in the normal mass spectrum.  Each ion species in the source is related to some substructure of the original molecule and the identity of each of these species can be deduced from its fragmentation spectrum.  The direct correlation of ion fragmentation spectra with precursor substructures is only one of many types of structural information available in the overall MS/MS molecular fragmentation map.  To make this potentially powerful technique generally useful, it is necessary to extend the knowledge base to known relationships between MS/MS spectral features and substructures, to obtain the molecular structure from the identified substructures, and to automate the entire process from instrument control to final structure output.  To accomplish this, we propose to utilize a tandem quadrupole mass spectrometer (TWMS) MS/MS instrument, spectrum and structure databases designed for MS/MS applications, and spectrum matching functions linked to these databases.  These existing and available functions will be combined with an intelligent controller and expert systems for matching, generating, and organizing structures.  The goal is an automated system for the determination of molecular structure.  This system will be used in semi-automatic mode to extend the spectra/substructure knowledge base.  In measurement mode, the intelligent controller will direct the measurement process to acquire the data most likely to resolve the remaining structural uncertainties.  This project combines the fields of organic mass spectrometry, instrumentation, and artificial intelligence.  It is relevant to health-related research because of its potential to determine complex structures (and therefore the complete identity) of previously unknown compounds, detect particular sought substructures in various materials or mixtures, and do so using only micrograms of sample.  ",STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY,3275552,R01GM028254,"['ionization ', ' hydrocarbons ', ' computer graphics /printing ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' organic chemicals ', ' chemical structure ', ' chemical group ', ' chemical information system ', ' ']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,1988,83472,0.2764275865230478
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY Biopolymers are key components of living organisms.  The use of 252-Cf-plasma desorption mass spectrometry (252Cf-PDMS) to improve their characterization and detection and study chemical activity can have a significant impact on elucidating structure-function, early detection of disease and the question of biocompatibility of organic implants.  One of the long term objectives of the proposed research is to develop 252Cf-PDMS to the level where it is routinely used for obtaining molecular weights of biomolecules in the molecular weight range from 1000-100,000 u with unit accuracy and pmol sensitivity.  A second long term objective is to develop the use of modified surfaces for selective adsorption as a new dimension in analytical biomedical mass spectrometry.  A third long term objective is to better utilize the fragmentation patterns inherent in the 252Cf-PD mass spectra of biopolymers to determine their sequence.  An additional long term objective is to use 252Cf- PDMS to study plasma protein adsorption on biocompatible surfaces. One of the specific aims of the proposed research is to improve the current 252Cf-PD TOF technology for obtaining mass spectra of high molecular weight species.  A second specific aim is to explore the use of different surfaces to selectively adsorb proteins and polyanionic biopolymers from aqueous solution in a manner that they can be readily desorbed as molecular ions in vacuum.  A third specific aim is to develop a protocol for studying protein adsorption on different polymer substrates with the objective of addressing the question of biocompatibility.  The experimental design and methods for accomplishing the first of the long range objectives and specific aims include the development of a new detector that will give enhanced sensitivity for high molecular weight ions, and the use of energy selection and pulsed fields for background reduction.  For the utilization of surfaces for selective adsorption, four systems for surface modification will be studied.  The first is based on the use of silanol chemistry on thin Si wafers.  The second is based on surface modification of polyethylene terephthalate.  The third is based on the electrochemical doping of electropolymerized poly-3-methyl- thiophene.  For studying protein adsorption and biocompatibility, albumin and fibrinogen will be used as model plasma proteins.  Thin films of different polymers will be prepared by spin casting and a combination of direct protein analysis and 252Cf-PDMS will be used to study the biocompatibility problem.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273559,R01GM026096,"['thiophenes ', ' silanes ', ' radiotracer ', ' binding proteins ', ' albumins ', ' artificial intelligence ', ' mass spectrometry ', ' chemical structure function ', ' blood proteins ', ' fibrinogen ', ' clinical biomedical equipment ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1988,202587,0.19932946274909838
"COMPUTER-ASSISTED STRUCTURE ELUCIDATION The characterization of the structure of a biomolecule on the its  chemical and spectral properties is of widespread importance in the biomedical sciences.  Because of its complexity, structure characterization is overall a time-consuming activity that has been largely left to experts in the field.  The goal of this research is to substantially increase the productivity of those experts.  Given the expert's proficiency in readily picking out the correct structure of an unknown from among a limited number of alternative structures, a much more expeditious assignment of structure would be achieved if the expert could begin the structure characterization problem with such a conceptually manageable number of plausible alternatives.  Thus, the goal of the research is to create artificial intelligence based computer software capable of directly reducing the collective spectral properties (infrared, proton and carbon-13 nuclear magnetic resonance, ultraviolet and mass spectral data) of the unknown to a conceptually manageable number of stereochemically defined structures, each of which is compatible with the observed spectral data.  The expert is still a required player, but is spared what is actually the time-intensive component of the ""manual"" process, that of producing the limited number of alternatives.  Key features of the software to be created include, (1) programs for both spectrum interpretation and structure generation, (2) provision to accept any structural information known to the expert and (3) the capability to treat real-world structure characterization problems without regard to the class of structures to which the unknown belongs.  The last named feature requires a system that is not spectral library dependent.  ",COMPUTER-ASSISTED STRUCTURE ELUCIDATION,3293873,R01GM037963,"['electronic spectra ', ' computer simulation ', ' artificial intelligence ', ' ultraviolet spectrometry ', ' nuclear magnetic resonance spectroscopy ', ' mass spectrometry ', ' infrared spectrometry ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,1989,142563,0.048843889799610435
"A TOOL TO HELP DIAGNOSE FUNDUSCOPIC DISEASE We propose to create a computer assisted aid to ophthalmic diagnosis. Our product will be an optical storage medium that contains both an expert system for diagnosis of fundus disease, and color fundus photographs of each disease entity that will be presented to the operator in confirmation of the diagnosis.  The availability of mass storage media for micro-computers plus our special skills in expert systems makes it possible to design a system that will present such a large amount of information to the non-expert physician.  We anticipate that this approach can be expanded to much of ophthalmology, and is adaptable to other problems in medical diagnosis. Both patients and medical providers should benefit greatly.  ",A TOOL TO HELP DIAGNOSE FUNDUSCOPIC DISEASE,3497048,R43EY008329,"['eye fundus photography ', ' retina disorder ', ' fundus oculi ', ' diagnosis design /evaluation ', ' computer graphics /printing ', ' artificial intelligence ', ' computer assisted diagnosis ', ' clinical biomedical equipment ', ' ']",NEI,BAHILL INTELLIGENT COMPUTER SYSTEMS,R43,1989,50000,0.12776903231825387
"STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY The goal of this research is to develop the full capability of tandem mass spectrometry for routine organic structure determination.  In tandem mass spectrometry, or MS/MS, ions from the source are selected by the first mass analyzer and then undergo fragmenting collision with neutral molecules in a collision region.  The ionic products of the collision process are then mass analyzed by a second mass filter and ion detector.  The special potential offered by MS/MS for structure determination comes from the individual fragmentation spectrum available for each ion in the normal mass spectrum.  Each ion species in the source is related to some substructure of the original molecule and the identity of each of these species can be deduced from its fragmentation spectrum.  The direct correlation of ion fragmentation spectra with precursor substructures is only one of many types of structural information available in the overall MS/MS molecular fragmentation map.  To make this potentially powerful technique generally useful, it is necessary to extend the knowledge base to known relationships between MS/MS spectral features and substructures, to obtain the molecular structure from the identified substructures, and to automate the entire process from instrument control to final structure output.  To accomplish this, we propose to utilize a tandem quadrupole mass spectrometer (TWMS) MS/MS instrument, spectrum and structure databases designed for MS/MS applications, and spectrum matching functions linked to these databases.  These existing and available functions will be combined with an intelligent controller and expert systems for matching, generating, and organizing structures.  The goal is an automated system for the determination of molecular structure.  This system will be used in semi-automatic mode to extend the spectra/substructure knowledge base.  In measurement mode, the intelligent controller will direct the measurement process to acquire the data most likely to resolve the remaining structural uncertainties.  This project combines the fields of organic mass spectrometry, instrumentation, and artificial intelligence.  It is relevant to health-related research because of its potential to determine complex structures (and therefore the complete identity) of previously unknown compounds, detect particular sought substructures in various materials or mixtures, and do so using only micrograms of sample.  ",STRUCTURE DETERMINATION BY TRIPLE QUAD MASS SPECTROMETRY,3275549,R01GM028254,"['ionization ', ' hydrocarbons ', ' computer graphics /printing ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' organic chemicals ', ' chemical structure ', ' chemical group ', ' chemical information system ', ' ']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,1989,58336,0.2764275865230478
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY Biopolymers are key components of living organisms.  The use of 252-Cf-plasma desorption mass spectrometry (252Cf-PDMS) to improve their characterization and detection and study chemical activity can have a significant impact on elucidating structure-function, early detection of disease and the question of biocompatibility of organic implants.  One of the long term objectives of the proposed research is to develop 252Cf-PDMS to the level where it is routinely used for obtaining molecular weights of biomolecules in the molecular weight range from 1000-100,000 u with unit accuracy and pmol sensitivity.  A second long term objective is to develop the use of modified surfaces for selective adsorption as a new dimension in analytical biomedical mass spectrometry.  A third long term objective is to better utilize the fragmentation patterns inherent in the 252Cf-PD mass spectra of biopolymers to determine their sequence.  An additional long term objective is to use 252Cf- PDMS to study plasma protein adsorption on biocompatible surfaces. One of the specific aims of the proposed research is to improve the current 252Cf-PD TOF technology for obtaining mass spectra of high molecular weight species.  A second specific aim is to explore the use of different surfaces to selectively adsorb proteins and polyanionic biopolymers from aqueous solution in a manner that they can be readily desorbed as molecular ions in vacuum.  A third specific aim is to develop a protocol for studying protein adsorption on different polymer substrates with the objective of addressing the question of biocompatibility.  The experimental design and methods for accomplishing the first of the long range objectives and specific aims include the development of a new detector that will give enhanced sensitivity for high molecular weight ions, and the use of energy selection and pulsed fields for background reduction.  For the utilization of surfaces for selective adsorption, four systems for surface modification will be studied.  The first is based on the use of silanol chemistry on thin Si wafers.  The second is based on surface modification of polyethylene terephthalate.  The third is based on the electrochemical doping of electropolymerized poly-3-methyl- thiophene.  For studying protein adsorption and biocompatibility, albumin and fibrinogen will be used as model plasma proteins.  Thin films of different polymers will be prepared by spin casting and a combination of direct protein analysis and 252Cf-PDMS will be used to study the biocompatibility problem.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273564,R01GM026096,"['thiophenes ', ' silanes ', ' radiotracer ', ' binding proteins ', ' albumins ', ' artificial intelligence ', ' mass spectrometry ', ' chemical structure function ', ' blood proteins ', ' fibrinogen ', ' clinical biomedical equipment ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1989,182924,0.19932946274909838
"INTELLIGENT MASS STORAGE SUBSYSTEM This proposal requests equipment that will expand the on-line data storage capabilities of existing computer hardware.  Thirteen PHS grants and contracts within the Division of Epidemiology, School of Public Health, University of Minnesota will share this resource.  The ability of these thirteen projects to process and analyze data will be seriously impaired without this addition of an intelligent on-line data storage system.  ",INTELLIGENT MASS STORAGE SUBSYSTEM,3520194,S10RR004708,"['information systems ', ' online computer ', ' artificial intelligence ', ' biomedical equipment purchase ', ' ']",NCRR,UNIVERSITY OF MINNESOTA,S10,1989,148000,0.1232765740197312
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY Biopolymers are key components of living organisms.  The use of 252-Cf-plasma desorption mass spectrometry (252Cf-PDMS) to improve their characterization and detection and study chemical activity can have a significant impact on elucidating structure-function, early detection of disease and the question of biocompatibility of organic implants.  One of the long term objectives of the proposed research is to develop 252Cf-PDMS to the level where it is routinely used for obtaining molecular weights of biomolecules in the molecular weight range from 1000-100,000 u with unit accuracy and pmol sensitivity.  A second long term objective is to develop the use of modified surfaces for selective adsorption as a new dimension in analytical biomedical mass spectrometry.  A third long term objective is to better utilize the fragmentation patterns inherent in the 252Cf-PD mass spectra of biopolymers to determine their sequence.  An additional long term objective is to use 252Cf- PDMS to study plasma protein adsorption on biocompatible surfaces. One of the specific aims of the proposed research is to improve the current 252Cf-PD TOF technology for obtaining mass spectra of high molecular weight species.  A second specific aim is to explore the use of different surfaces to selectively adsorb proteins and polyanionic biopolymers from aqueous solution in a manner that they can be readily desorbed as molecular ions in vacuum.  A third specific aim is to develop a protocol for studying protein adsorption on different polymer substrates with the objective of addressing the question of biocompatibility.  The experimental design and methods for accomplishing the first of the long range objectives and specific aims include the development of a new detector that will give enhanced sensitivity for high molecular weight ions, and the use of energy selection and pulsed fields for background reduction.  For the utilization of surfaces for selective adsorption, four systems for surface modification will be studied.  The first is based on the use of silanol chemistry on thin Si wafers.  The second is based on surface modification of polyethylene terephthalate.  The third is based on the electrochemical doping of electropolymerized poly-3-methyl- thiophene.  For studying protein adsorption and biocompatibility, albumin and fibrinogen will be used as model plasma proteins.  Thin films of different polymers will be prepared by spin casting and a combination of direct protein analysis and 252Cf-PDMS will be used to study the biocompatibility problem.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273565,R01GM026096,"['thiophenes ', ' silanes ', ' radiotracer ', ' binding proteins ', ' albumins ', ' artificial intelligence ', ' mass spectrometry ', ' chemical structure function ', ' blood proteins ', ' fibrinogen ', ' clinical biomedical equipment ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1990,189911,0.19932946274909838
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY Biopolymers are key components of living organisms.  The use of 252-Cf-plasma desorption mass spectrometry (252Cf-PDMS) to improve their characterization and detection and study chemical activity can have a significant impact on elucidating structure-function, early detection of disease and the question of biocompatibility of organic implants.  One of the long term objectives of the proposed research is to develop 252Cf-PDMS to the level where it is routinely used for obtaining molecular weights of biomolecules in the molecular weight range from 1000-100,000 u with unit accuracy and pmol sensitivity.  A second long term objective is to develop the use of modified surfaces for selective adsorption as a new dimension in analytical biomedical mass spectrometry.  A third long term objective is to better utilize the fragmentation patterns inherent in the 252Cf-PD mass spectra of biopolymers to determine their sequence.  An additional long term objective is to use 252Cf- PDMS to study plasma protein adsorption on biocompatible surfaces. One of the specific aims of the proposed research is to improve the current 252Cf-PD TOF technology for obtaining mass spectra of high molecular weight species.  A second specific aim is to explore the use of different surfaces to selectively adsorb proteins and polyanionic biopolymers from aqueous solution in a manner that they can be readily desorbed as molecular ions in vacuum.  A third specific aim is to develop a protocol for studying protein adsorption on different polymer substrates with the objective of addressing the question of biocompatibility.  The experimental design and methods for accomplishing the first of the long range objectives and specific aims include the development of a new detector that will give enhanced sensitivity for high molecular weight ions, and the use of energy selection and pulsed fields for background reduction.  For the utilization of surfaces for selective adsorption, four systems for surface modification will be studied.  The first is based on the use of silanol chemistry on thin Si wafers.  The second is based on surface modification of polyethylene terephthalate.  The third is based on the electrochemical doping of electropolymerized poly-3-methyl- thiophene.  For studying protein adsorption and biocompatibility, albumin and fibrinogen will be used as model plasma proteins.  Thin films of different polymers will be prepared by spin casting and a combination of direct protein analysis and 252Cf-PDMS will be used to study the biocompatibility problem.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273566,R01GM026096,"['thiophenes ', ' silanes ', ' radiotracer ', ' binding proteins ', ' albumins ', ' artificial intelligence ', ' mass spectrometry ', ' chemical structure function ', ' blood proteins ', ' fibrinogen ', ' clinical biomedical equipment ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1991,197507,0.19932946274909838
"BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY Biopolymers are key components of living organisms.  The use of 252-Cf-plasma desorption mass spectrometry (252Cf-PDMS) to improve their characterization and detection and study chemical activity can have a significant impact on elucidating structure-function, early detection of disease and the question of biocompatibility of organic implants.  One of the long term objectives of the proposed research is to develop 252Cf-PDMS to the level where it is routinely used for obtaining molecular weights of biomolecules in the molecular weight range from 1000-100,000 u with unit accuracy and pmol sensitivity.  A second long term objective is to develop the use of modified surfaces for selective adsorption as a new dimension in analytical biomedical mass spectrometry.  A third long term objective is to better utilize the fragmentation patterns inherent in the 252Cf-PD mass spectra of biopolymers to determine their sequence.  An additional long term objective is to use 252Cf- PDMS to study plasma protein adsorption on biocompatible surfaces. One of the specific aims of the proposed research is to improve the current 252Cf-PD TOF technology for obtaining mass spectra of high molecular weight species.  A second specific aim is to explore the use of different surfaces to selectively adsorb proteins and polyanionic biopolymers from aqueous solution in a manner that they can be readily desorbed as molecular ions in vacuum.  A third specific aim is to develop a protocol for studying protein adsorption on different polymer substrates with the objective of addressing the question of biocompatibility.  The experimental design and methods for accomplishing the first of the long range objectives and specific aims include the development of a new detector that will give enhanced sensitivity for high molecular weight ions, and the use of energy selection and pulsed fields for background reduction.  For the utilization of surfaces for selective adsorption, four systems for surface modification will be studied.  The first is based on the use of silanol chemistry on thin Si wafers.  The second is based on surface modification of polyethylene terephthalate.  The third is based on the electrochemical doping of electropolymerized poly-3-methyl- thiophene.  For studying protein adsorption and biocompatibility, albumin and fibrinogen will be used as model plasma proteins.  Thin films of different polymers will be prepared by spin casting and a combination of direct protein analysis and 252Cf-PDMS will be used to study the biocompatibility problem.  ",BIOMEDICAL USE OF PLASMA DESORPTION MASS SPECTROMETRY,3273567,R01GM026096,"['thiophenes ', ' silanes ', ' radiotracer ', ' binding proteins ', ' albumins ', ' artificial intelligence ', ' mass spectrometry ', ' chemical structure function ', ' blood proteins ', ' fibrinogen ', ' clinical biomedical equipment ', ' ']",NIGMS,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,R01,1992,205407,0.19932946274909838
INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS  ,INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,2456536,R01RR006217,"['biomedical equipment development ', ' posttranslational modifications ', ' computer system hardware ', ' histocompatibility antigens ', ' computer system design /evaluation ', ' mass spectrometry ', ' artificial intelligence ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,1997,478059,0.31777445081373207
"DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY The goal of the proposed research is to develop computer-aided diagnosis         (CAD) schemes in order to improve the diagnostic accuracy of breast cancer       in mammography. Four specific aims are included: (l) development of              computer programs for the detection and characterization of                      microcalcifications, (2) development of computer programs for detection          and characterization of masses, (3) implementation of the CAD algorithms         in a dedicated workstation to perform a pilot preclinical testing of the         accuracy of the CAD programs, and (4) evaluation of the effects of the CAD       schemes on radiologists' performance. The proposed CAD schemes will aid          radiologists in screening mammograms for suspicious lesions and provide          estimate of the likelihood of malignancy for the detected lesions. The           information is expected to reduce the miss rate and to improve the               positive predictive value of the mammographic findings.                                                                                                           A data base of clinical mammograms which include malignant and benign            microcalcifications and masses will be established. Physical measures            which characterize the significant image features of the lesions will be         developed. Based on these measures, linear discriminant classifiers or           neural network classifiers will be optimized using a genetic algorithm           approach to classify true and false signals and to estimate the likelihood       of malignancy for each type of lesions.                                                                                                                           For automated detection and classification of microcalcifications, we will       investigate the usefulness of multiresolution analysis for enhancement of        the signal-to-noise ratio of the microcalcifications and for improvement         of feature extraction techniques. Physical characteristics such as size,         shape, frequency spectrum, spatial distribution, clustering properties,          and texture features will be extracted and analyzed with the classifiers.                                                                                         For automated detection and classification of masses, we will improve the        background correction and signal segmentation techniques, and develop            effective false-positive reduction methods. Adaptive filtering, edge             enhancement, and clustering segmentation methods will be developed for           extraction of the mass margins. Physical characteristics such as size,           density, edge sharpness, calcifications, shape, lobulation, spiculation,         and multiresolution wavelet texture features will be extracted from the          masses and analyzed with the classifiers.                                                                                                                         The algorithms will be implemented in a dedicated CAD workstation and            preclinical testing will be conducted. The performance of the programs in        a clinical setting will be assessed. The algorithms will be revised and          improved based on the information obtained with the preclinical testing.         The study is a vital step for the development of a clinically reliable CAD       scheme.                                                                                                                                                           Observer performance studies using receiver operating characteristic (ROC)       methodology will be conducted to evaluate the effects of the CAD schemes         on radiologists'performance.                                                      ",DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY,2376830,R01CA048129,"['digital imaging ', ' computational neuroscience ', ' image processing ', ' breast neoplasms ', ' mammography ', ' breast neoplasm /cancer diagnosis ', ' mathematical model ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer program /software ', ' artificial intelligence ', ' computer assisted medical decision making ', ' computer assisted diagnosis ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,1997,388428,0.12480439134279321
"INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS DESCRIPTION:  (Applicant's abstract) The development of true microscale          interfaces for protein mass spectrometry based on silicon chip                   micromachining is proposed.  The devices would integrate electrospray            ionization with a variety of protein isolation, digestion, and/or separation     steps into a single monolithic structure that can be mass produced in much       the same way as computer chips are made.  The silicon chip devices would be      coupled to state-of-the-art tandem mass spectrometer systems capable of          providing detailed structural information on protein samples.  Functional        utility of the systems will be increased by the development of automated         data collection procedures capable of analyzing incoming spectra and             adjusting analysis parameters in real time.  In addition to optimizing           general factors such as relative collison energy and resolution, spectra         would be evaluated in the context of the problem to be solved.  A fast,          multiprocessor computer will provide realtime access to a knowledge base and     spectra will be analyzed according to a user defined set of rules.  This         expert system approach will be applied to a number of different kinds of         applications including the rapid determination of protein variants and           posttranslational modifications, the definition of specific protein protein      interactions, and the identification of MHC complex peptides.  A fundamental     goal of the proposed research is to create a system in which both hardware       and analytical expertise can be readily transferred to other labs and other      researchers in the form of inexpensive, disposable interfaces and problem        specific data collection and analysis programs.  The development of such         tools will greatly facilitate work to define the human proteome.                  ",INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,2797088,R01RR006217,"['biomedical equipment development ', ' mass spectrometry ', ' artificial intelligence ', ' computer system design /evaluation ', ' posttranslational modification ', ' histocompatibility antigen ', ' computer system hardware ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,1998,472789,0.20590595072390444
"DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY The goal of the proposed research is to develop computer-aided diagnosis         (CAD) schemes in order to improve the diagnostic accuracy of breast cancer       in mammography. Four specific aims are included: (l) development of              computer programs for the detection and characterization of                      microcalcifications, (2) development of computer programs for detection          and characterization of masses, (3) implementation of the CAD algorithms         in a dedicated workstation to perform a pilot preclinical testing of the         accuracy of the CAD programs, and (4) evaluation of the effects of the CAD       schemes on radiologists' performance. The proposed CAD schemes will aid          radiologists in screening mammograms for suspicious lesions and provide          estimate of the likelihood of malignancy for the detected lesions. The           information is expected to reduce the miss rate and to improve the               positive predictive value of the mammographic findings.                                                                                                           A data base of clinical mammograms which include malignant and benign            microcalcifications and masses will be established. Physical measures            which characterize the significant image features of the lesions will be         developed. Based on these measures, linear discriminant classifiers or           neural network classifiers will be optimized using a genetic algorithm           approach to classify true and false signals and to estimate the likelihood       of malignancy for each type of lesions.                                                                                                                           For automated detection and classification of microcalcifications, we will       investigate the usefulness of multiresolution analysis for enhancement of        the signal-to-noise ratio of the microcalcifications and for improvement         of feature extraction techniques. Physical characteristics such as size,         shape, frequency spectrum, spatial distribution, clustering properties,          and texture features will be extracted and analyzed with the classifiers.                                                                                         For automated detection and classification of masses, we will improve the        background correction and signal segmentation techniques, and develop            effective false-positive reduction methods. Adaptive filtering, edge             enhancement, and clustering segmentation methods will be developed for           extraction of the mass margins. Physical characteristics such as size,           density, edge sharpness, calcifications, shape, lobulation, spiculation,         and multiresolution wavelet texture features will be extracted from the          masses and analyzed with the classifiers.                                                                                                                         The algorithms will be implemented in a dedicated CAD workstation and            preclinical testing will be conducted. The performance of the programs in        a clinical setting will be assessed. The algorithms will be revised and          improved based on the information obtained with the preclinical testing.         The study is a vital step for the development of a clinically reliable CAD       scheme.                                                                                                                                                           Observer performance studies using receiver operating characteristic (ROC)       methodology will be conducted to evaluate the effects of the CAD schemes         on radiologists'performance.                                                      ",DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY,2667915,R01CA048129,"['digital imaging ', ' computational neuroscience ', ' image processing ', ' breast neoplasms ', ' mammography ', ' breast neoplasm /cancer diagnosis ', ' mathematical model ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer program /software ', ' artificial intelligence ', ' computer assisted medical decision making ', ' computer assisted diagnosis ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,1998,412299,0.12480439134279321
"DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY The goal of the proposed research is to develop computer-aided diagnosis         (CAD) schemes in order to improve the diagnostic accuracy of breast cancer       in mammography. Four specific aims are included: (l) development of              computer programs for the detection and characterization of                      microcalcifications, (2) development of computer programs for detection          and characterization of masses, (3) implementation of the CAD algorithms         in a dedicated workstation to perform a pilot preclinical testing of the         accuracy of the CAD programs, and (4) evaluation of the effects of the CAD       schemes on radiologists' performance. The proposed CAD schemes will aid          radiologists in screening mammograms for suspicious lesions and provide          estimate of the likelihood of malignancy for the detected lesions. The           information is expected to reduce the miss rate and to improve the               positive predictive value of the mammographic findings.                                                                                                           A data base of clinical mammograms which include malignant and benign            microcalcifications and masses will be established. Physical measures            which characterize the significant image features of the lesions will be         developed. Based on these measures, linear discriminant classifiers or           neural network classifiers will be optimized using a genetic algorithm           approach to classify true and false signals and to estimate the likelihood       of malignancy for each type of lesions.                                                                                                                           For automated detection and classification of microcalcifications, we will       investigate the usefulness of multiresolution analysis for enhancement of        the signal-to-noise ratio of the microcalcifications and for improvement         of feature extraction techniques. Physical characteristics such as size,         shape, frequency spectrum, spatial distribution, clustering properties,          and texture features will be extracted and analyzed with the classifiers.                                                                                         For automated detection and classification of masses, we will improve the        background correction and signal segmentation techniques, and develop            effective false-positive reduction methods. Adaptive filtering, edge             enhancement, and clustering segmentation methods will be developed for           extraction of the mass margins. Physical characteristics such as size,           density, edge sharpness, calcifications, shape, lobulation, spiculation,         and multiresolution wavelet texture features will be extracted from the          masses and analyzed with the classifiers.                                                                                                                         The algorithms will be implemented in a dedicated CAD workstation and            preclinical testing will be conducted. The performance of the programs in        a clinical setting will be assessed. The algorithms will be revised and          improved based on the information obtained with the preclinical testing.         The study is a vital step for the development of a clinically reliable CAD       scheme.                                                                                                                                                           Observer performance studies using receiver operating characteristic (ROC)       methodology will be conducted to evaluate the effects of the CAD schemes         on radiologists'performance.                                                      ",DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY,2882358,R01CA048129,"['computer assisted diagnosis ', ' computer assisted medical decision making ', ' artificial intelligence ', ' computer program /software ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' mathematical model ', ' breast neoplasm /cancer diagnosis ', ' mammography ', ' breast neoplasm ', ' image processing ', ' computational neuroscience ', ' digital imaging ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,1999,434986,0.12480439134279321
"INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS DESCRIPTION:  (Applicant's abstract) The development of true microscale          interfaces for protein mass spectrometry based on silicon chip                   micromachining is proposed.  The devices would integrate electrospray            ionization with a variety of protein isolation, digestion, and/or separation     steps into a single monolithic structure that can be mass produced in much       the same way as computer chips are made.  The silicon chip devices would be      coupled to state-of-the-art tandem mass spectrometer systems capable of          providing detailed structural information on protein samples.  Functional        utility of the systems will be increased by the development of automated         data collection procedures capable of analyzing incoming spectra and             adjusting analysis parameters in real time.  In addition to optimizing           general factors such as relative collison energy and resolution, spectra         would be evaluated in the context of the problem to be solved.  A fast,          multiprocessor computer will provide realtime access to a knowledge base and     spectra will be analyzed according to a user defined set of rules.  This         expert system approach will be applied to a number of different kinds of         applications including the rapid determination of protein variants and           posttranslational modifications, the definition of specific protein protein      interactions, and the identification of MHC complex peptides.  A fundamental     goal of the proposed research is to create a system in which both hardware       and analytical expertise can be readily transferred to other labs and other      researchers in the form of inexpensive, disposable interfaces and problem        specific data collection and analysis programs.  The development of such         tools will greatly facilitate work to define the human proteome.                  ",INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,6078269,R01RR006217,"['biomedical equipment development ', ' mass spectrometry ', ' artificial intelligence ', ' computer system design /evaluation ', ' posttranslational modification ', ' histocompatibility antigen ', ' microprocessor /microchip ', ' protein protein interaction ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,1999,475971,0.20590595072390444
"DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY The goal of the proposed research is to develop computer-aided diagnosis         (CAD) schemes in order to improve the diagnostic accuracy of breast cancer       in mammography. Four specific aims are included: (l) development of              computer programs for the detection and characterization of                      microcalcifications, (2) development of computer programs for detection          and characterization of masses, (3) implementation of the CAD algorithms         in a dedicated workstation to perform a pilot preclinical testing of the         accuracy of the CAD programs, and (4) evaluation of the effects of the CAD       schemes on radiologists' performance. The proposed CAD schemes will aid          radiologists in screening mammograms for suspicious lesions and provide          estimate of the likelihood of malignancy for the detected lesions. The           information is expected to reduce the miss rate and to improve the               positive predictive value of the mammographic findings.                                                                                                           A data base of clinical mammograms which include malignant and benign            microcalcifications and masses will be established. Physical measures            which characterize the significant image features of the lesions will be         developed. Based on these measures, linear discriminant classifiers or           neural network classifiers will be optimized using a genetic algorithm           approach to classify true and false signals and to estimate the likelihood       of malignancy for each type of lesions.                                                                                                                           For automated detection and classification of microcalcifications, we will       investigate the usefulness of multiresolution analysis for enhancement of        the signal-to-noise ratio of the microcalcifications and for improvement         of feature extraction techniques. Physical characteristics such as size,         shape, frequency spectrum, spatial distribution, clustering properties,          and texture features will be extracted and analyzed with the classifiers.                                                                                         For automated detection and classification of masses, we will improve the        background correction and signal segmentation techniques, and develop            effective false-positive reduction methods. Adaptive filtering, edge             enhancement, and clustering segmentation methods will be developed for           extraction of the mass margins. Physical characteristics such as size,           density, edge sharpness, calcifications, shape, lobulation, spiculation,         and multiresolution wavelet texture features will be extracted from the          masses and analyzed with the classifiers.                                                                                                                         The algorithms will be implemented in a dedicated CAD workstation and            preclinical testing will be conducted. The performance of the programs in        a clinical setting will be assessed. The algorithms will be revised and          improved based on the information obtained with the preclinical testing.         The study is a vital step for the development of a clinically reliable CAD       scheme.                                                                                                                                                           Observer performance studies using receiver operating characteristic (ROC)       methodology will be conducted to evaluate the effects of the CAD schemes         on radiologists'performance.                                                      ",DEVELOPMENT OF COMPUTER BASED TECHNIQUES IN MAMMOGRAPHY,6164055,R01CA048129,"['bioimaging /biomedical imaging ', ' digital imaging ', ' computational neuroscience ', ' image processing ', ' breast neoplasms ', ' mammography ', ' breast neoplasm /cancer diagnosis ', ' mathematical model ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer program /software ', ' artificial intelligence ', ' computer assisted medical decision making ', ' computer assisted diagnosis ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2000,452383,0.12480439134279321
"INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS  APPLICANT'S DESCRIPTION: The proposed research will develop a new technology         for highly automated and highly sensitive analytical systems for the protein         components of complex biological systems. The technology will combine                multi-step sample processes in silicon chip formats with highly sophisticated        tandem mass spectrometry analyses. Micromachining methods that have already          been successful in producing chambers, channels, check valves, filters and           electrospray emitters will be extended to include active valves and                  micro-pumps. The methodologies needed to place chemical systems within the           chip-based structures to perform affinity isolations, enzyme digestions, and         chromatographic and/or electrophoretic separations will be developed. By             combining these operations in a single microscale device, the sample losses in       going from one step to the next will be avoided. These chip-based sample             preparation systems will be interfaced to ion trap mass analyzers capable of         multiple stages of tandem MS analysis. Control of both the on-chip processes         and the MS analysis will be accomplished using a single expert system program.       This program has the capability of analyzing data in real time and changing the      course of the analysis according to a predefined set of rules. The net result        will be a much more efficient and comprehensive method of collecting data, thus      minimizing the amount of time and sample needed. Applications of the new             technology will focus on the characterization of protein posttranslational           modifications with initial emphasis on sites of phosphorylation. The principal       goal of this research is to package very sophisticated analytical tools and          expertise in a form that can be readily exported to other laboratories.              ",INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,6333670,R01RR006217,"['biomedical equipment development ', ' analytical method ', ' artificial intelligence ', ' computer system design /evaluation ', ' phosphorylation ', ' liquid chromatography ', ' posttranslational modification ', ' technology /technique development ', ' electrospray ionization mass spectrometry ', ' microprocessor /microchip ', ' protein protein interaction ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,2001,455361,0.17407722831421657
"COMPUTERIZED MAMMOGRAPHIC LESION DESCRIPTION   DESCRIPTION (Verbatim from Applicant's Abstract): Mammography is recognized as       an important means to reduce breast cancer mortality. However, its accuracy is       limited, both in sensitivity (some cancers are missed) and specificity (many         non-cancer cases are referred for invasive procedures). This proposal aims at        improving the effectiveness of breast cancer screening by the discovery of           measurements that can be taken from digital mammograms, and the design of            classifiers that result in an automatic computer-generated description of            suspicious areas. In particular, classifiers for the standardized lexicon for        mass shape, mass margin and mass density, as well as breast composition will be      designed.                                                                                                                                                                 These automaticaily generated descriptions are aimed at increasing the               specificity of mammography by providing the radiologist with a probability of        rnalignancy for the lesion. The descriptions should also be helpful in               conjunction with computer programs that detect suspicious areas, by rejecting        those detected areas that do not likely represent cancer (false positive             reduction). In addition, automatic description of a marnmographic iesion will        reduce reader variability and may heip in training radiologists to use the           standardized lexicon.                                                                                                                                                     This project will first develop a segmentation program, that finds the border        of a mammographic mass. The approach will be a multi-stage knowledge guided          system. Measurements to be taken from digital mammograms make use of this            border, and include some that have been reported in the literature as well as        newly proposed measurements. As the classification problem for mammographic          masses is very difficult, hybrid classifiers will be constructed that take           advantage of specific abilities of multiple classifiers. A rule based system         will be developed to arrive at an aggregate decision for each of the BIRADS          descriptions. Finally, these descriptions will be used in a classifier to            determine the likelihood of malignancy.                                                                                                                                   The outcome of this project would be the tools to develop an aid to non-expert       mammographers to define the characteristics of mammographic masses and help in       decisions to biopsy a mammographic lesion, but can also be applied to help           enhance sensitivity through computer assisted diagnosis, and in educational          tools.                                                                                                                                                                    ",COMPUTERIZED MAMMOGRAPHIC LESION DESCRIPTION,6260256,R21CA082639,"['computer assisted diagnosis ', ' artificial intelligence ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' information display ', ' mammography ', ' breast neoplasm ', ' image processing ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF SOUTH FLORIDA,R21,2001,145000,0.05970379861762269
"INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS  APPLICANT'S DESCRIPTION: The proposed research will develop a new technology         for highly automated and highly sensitive analytical systems for the protein         components of complex biological systems. The technology will combine                multi-step sample processes in silicon chip formats with highly sophisticated        tandem mass spectrometry analyses. Micromachining methods that have already          been successful in producing chambers, channels, check valves, filters and           electrospray emitters will be extended to include active valves and                  micro-pumps. The methodologies needed to place chemical systems within the           chip-based structures to perform affinity isolations, enzyme digestions, and         chromatographic and/or electrophoretic separations will be developed. By             combining these operations in a single microscale device, the sample losses in       going from one step to the next will be avoided. These chip-based sample             preparation systems will be interfaced to ion trap mass analyzers capable of         multiple stages of tandem MS analysis. Control of both the on-chip processes         and the MS analysis will be accomplished using a single expert system program.       This program has the capability of analyzing data in real time and changing the      course of the analysis according to a predefined set of rules. The net result        will be a much more efficient and comprehensive method of collecting data, thus      minimizing the amount of time and sample needed. Applications of the new             technology will focus on the characterization of protein posttranslational           modifications with initial emphasis on sites of phosphorylation. The principal       goal of this research is to package very sophisticated analytical tools and          expertise in a form that can be readily exported to other laboratories.              ",INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,6540576,R01RR006217,"['biomedical equipment development ', ' analytical method ', ' artificial intelligence ', ' computer system design /evaluation ', ' phosphorylation ', ' liquid chromatography ', ' posttranslational modification ', ' technology /technique development ', ' electrospray ionization mass spectrometry ', ' microprocessor /microchip ', ' protein protein interaction ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,2002,449674,0.17407722831421657
"COMPUTERIZED MAMMOGRAPHIC LESION DESCRIPTION   DESCRIPTION (Verbatim from Applicant's Abstract): Mammography is recognized as       an important means to reduce breast cancer mortality. However, its accuracy is       limited, both in sensitivity (some cancers are missed) and specificity (many         non-cancer cases are referred for invasive procedures). This proposal aims at        improving the effectiveness of breast cancer screening by the discovery of           measurements that can be taken from digital mammograms, and the design of            classifiers that result in an automatic computer-generated description of            suspicious areas. In particular, classifiers for the standardized lexicon for        mass shape, mass margin and mass density, as well as breast composition will be      designed.                                                                                                                                                                 These automaticaily generated descriptions are aimed at increasing the               specificity of mammography by providing the radiologist with a probability of        rnalignancy for the lesion. The descriptions should also be helpful in               conjunction with computer programs that detect suspicious areas, by rejecting        those detected areas that do not likely represent cancer (false positive             reduction). In addition, automatic description of a marnmographic iesion will        reduce reader variability and may heip in training radiologists to use the           standardized lexicon.                                                                                                                                                     This project will first develop a segmentation program, that finds the border        of a mammographic mass. The approach will be a multi-stage knowledge guided          system. Measurements to be taken from digital mammograms make use of this            border, and include some that have been reported in the literature as well as        newly proposed measurements. As the classification problem for mammographic          masses is very difficult, hybrid classifiers will be constructed that take           advantage of specific abilities of multiple classifiers. A rule based system         will be developed to arrive at an aggregate decision for each of the BIRADS          descriptions. Finally, these descriptions will be used in a classifier to            determine the likelihood of malignancy.                                                                                                                                   The outcome of this project would be the tools to develop an aid to non-expert       mammographers to define the characteristics of mammographic masses and help in       decisions to biopsy a mammographic lesion, but can also be applied to help           enhance sensitivity through computer assisted diagnosis, and in educational          tools.                                                                                                                                                                    ",COMPUTERIZED MAMMOGRAPHIC LESION DESCRIPTION,6514127,R21CA082639,"['computer assisted diagnosis ', ' artificial intelligence ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' information display ', ' mammography ', ' breast neoplasm ', ' image processing ', ' human data ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF SOUTH FLORIDA,R21,2002,145000,0.05970379861762269
"Digital Mammography: Advanced Computer-Aided Breast Can* DESCRIPTION (provided by applicant): The major goals of the proposed research are (1) to develop a computer-aided diagnosis (CAD) system for full field digital mammography (FFDM) using advanced computer vision techniques and (2) to evaluate the effects of CAD on interpretation of DMs. Previous CAD methods for lesion (mass and microcalcification) detection and characterization have been designed for digitized film mammograms and have generally been based on image features extracted from a single view. Our proposed approach is distinctly different from the previous approaches in that image information from two-view mammograms and bilateral mammograms will be fused using machine intelligence techniques. This fundamental change will expand the amount of information utilized in CAD and is expected to improve lesion detection and characterization. New computer vision techniques will be specifically designed for FFDM in order to exploit the advantages offered by digital detectors. This will produce a CAD system that is integrated with and takes full advantage of the latest imaging technologies to further improve the health care of women. We hypothesize that these advanced multiple-image information fusion techniques will lead to a more effective CAD system for FFDMs in comparison to a single-image approach, and that the CAD system will significantly improve radiologists' accuracy in the four most important areas of mammography: (i) detection of masses, (ii) classification of masses, (iii) detection of microcalcifications, and (iv) classification of microcalcifications. A database of digital mammograms (DMs) with malignant and benign lesions and a set of normal cases will be collected. We will first adapt our current film-based CAD algorithms to DMs in each of the four areas, taking into account the differences in the imaging characteristics between DMs and digitized mammograms. New computer vision techniques will then be developed to improve upon the current methods and to exploit the potential advantages of the high contrast sensitivity, high detective quantum efficiency, wide dynamic range, and the linear response to x-ray intensity of digital detectors. Novel regional registration methods for identifying corresponding lesions on CC and MLO views and for comparing the density symmetry on bilateral mammograms will be developed. Innovative fuzzy classification schemes will be designed to fuse multiple-image information and one-view information to reduce false positives and to improve detection sensitivity. Multiple-view morphological and texture features of a lesion will be merged using neural networks or other statistical classifiers for characterization of malignant and benign lesions. To test the hypotheses, we will (1) compare the performance of the multiple-image fusion CAD algorithm for DMs in each area to that of the corresponding one-view algorithm, (2) compare the detection accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies, and (3) compare the classification accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies. It is expected that this research will not only lead to an effective CAD system for FFDM, the multiple-image fusion approach and the new computer vision techniques will also advance CAD technology for mammography in general. ",Digital Mammography: Advanced Computer-Aided Breast Can*,6574171,R01CA095153,"['computer assisted diagnosis ', ' calcification ', ' artificial intelligence ', ' computer system design /evaluation ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' information system ', ' mathematics ', ' neoplasm /cancer diagnosis ', ' mammography ', ' breast neoplasm ', ' neoplastic growth ', ' digital imaging ', ' human data ', ' clinical research ', ' data management ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2003,482072,0.1208857510117614
"INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS  APPLICANT'S DESCRIPTION: The proposed research will develop a new technology         for highly automated and highly sensitive analytical systems for the protein         components of complex biological systems. The technology will combine                multi-step sample processes in silicon chip formats with highly sophisticated        tandem mass spectrometry analyses. Micromachining methods that have already          been successful in producing chambers, channels, check valves, filters and           electrospray emitters will be extended to include active valves and                  micro-pumps. The methodologies needed to place chemical systems within the           chip-based structures to perform affinity isolations, enzyme digestions, and         chromatographic and/or electrophoretic separations will be developed. By             combining these operations in a single microscale device, the sample losses in       going from one step to the next will be avoided. These chip-based sample             preparation systems will be interfaced to ion trap mass analyzers capable of         multiple stages of tandem MS analysis. Control of both the on-chip processes         and the MS analysis will be accomplished using a single expert system program.       This program has the capability of analyzing data in real time and changing the      course of the analysis according to a predefined set of rules. The net result        will be a much more efficient and comprehensive method of collecting data, thus      minimizing the amount of time and sample needed. Applications of the new             technology will focus on the characterization of protein posttranslational           modifications with initial emphasis on sites of phosphorylation. The principal       goal of this research is to package very sophisticated analytical tools and          expertise in a form that can be readily exported to other laboratories.              ",INTEGRATED STRUCTURES FOR PROTEIN MASS SPECTRAL ANALYSIS,6639848,R01RR006217,"['biomedical equipment development ', ' analytical method ', ' artificial intelligence ', ' computer system design /evaluation ', ' phosphorylation ', ' liquid chromatography ', ' posttranslational modification ', ' technology /technique development ', ' electrospray ionization mass spectrometry ', ' microprocessor /microchip ', ' protein protein interaction ', ' ']",NCRR,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,R01,2003,463130,0.17407722831421657
"Intelligent Aids for Proteomic Data Mining DESCRIPTION (provided by applicant): Primary purpose of this proposal is to provide the applicant with the means and structures for achieving two goals; (1) to develop intelligent computational aids for mining proteomic data accumulating from high throughput techniques like SELDI-TOF mass spectrometry; and (2) the long-term goal is to gain independence as a biomedical informatics researcher by developing methodological expertise in Bayesian methods and proteomic technologies. Applicant will obtain further instruction in probabilistic methods of data analysis; and she will receive education on proteomic technologies that are driving today's proteome research. Training will be provided through formal coursework, directed readings, seminars and conferences in addition to research directed by excellent mentors.  Applicant's research project involves a novel combination of techniques for use in proteomic data analysis. Previous research has included the use of techniques such as genetic algorithms and neural networks for analysis of proteomic data. These techniques were not explicitly designed to take into account background and prior knowledge. Hypothesis of this project is that background knowledge and machine learning techniques can positively influence the selection of appropriate biomarkers from proteomic data, enabling efficient and accurate analysis of massive datasets arising from proteomic profiling studies. Therefore, this project will satisfy four aims: (1) development of a wrapper-based machine learning tool; (2) augment the tool with prior knowledge such as heuristic rules and relationships in the data; (3) use these features along with de-identified patient information as input to classification systems; and (4) evaluate existing techniques for interpreting tandem mass spectrometry (MS-MS or MS/MS) data, and propose, implement and evaluate a Bayesian method for identification of peptides and proteins indicated by the MS-MS spectrum. ",Intelligent Aids for Proteomic Data Mining,6811846,K25GM071951,"['biomarker ', ' biotechnology ', ' mass spectrometry ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis design /evaluation ', ' genetic disorder diagnosis ', ' computer assisted sequence analysis ', ' human data ', ' data management ', ' proteomics ', ' bioinformatics ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K25,2004,122697,0.14164761923269487
"Digital Mammography: Advanced Computer-Aided Breast Can* DESCRIPTION (provided by applicant): The major goals of the proposed research are (1) to develop a computer-aided diagnosis (CAD) system for full field digital mammography (FFDM) using advanced computer vision techniques and (2) to evaluate the effects of CAD on interpretation of DMs. Previous CAD methods for lesion (mass and microcalcification) detection and characterization have been designed for digitized film mammograms and have generally been based on image features extracted from a single view. Our proposed approach is distinctly different from the previous approaches in that image information from two-view mammograms and bilateral mammograms will be fused using machine intelligence techniques. This fundamental change will expand the amount of information utilized in CAD and is expected to improve lesion detection and characterization. New computer vision techniques will be specifically designed for FFDM in order to exploit the advantages offered by digital detectors. This will produce a CAD system that is integrated with and takes full advantage of the latest imaging technologies to further improve the health care of women. We hypothesize that these advanced multiple-image information fusion techniques will lead to a more effective CAD system for FFDMs in comparison to a single-image approach, and that the CAD system will significantly improve radiologists' accuracy in the four most important areas of mammography: (i) detection of masses, (ii) classification of masses, (iii) detection of microcalcifications, and (iv) classification of microcalcifications. A database of digital mammograms (DMs) with malignant and benign lesions and a set of normal cases will be collected. We will first adapt our current film-based CAD algorithms to DMs in each of the four areas, taking into account the differences in the imaging characteristics between DMs and digitized mammograms. New computer vision techniques will then be developed to improve upon the current methods and to exploit the potential advantages of the high contrast sensitivity, high detective quantum efficiency, wide dynamic range, and the linear response to x-ray intensity of digital detectors. Novel regional registration methods for identifying corresponding lesions on CC and MLO views and for comparing the density symmetry on bilateral mammograms will be developed. Innovative fuzzy classification schemes will be designed to fuse multiple-image information and one-view information to reduce false positives and to improve detection sensitivity. Multiple-view morphological and texture features of a lesion will be merged using neural networks or other statistical classifiers for characterization of malignant and benign lesions. To test the hypotheses, we will (1) compare the performance of the multiple-image fusion CAD algorithm for DMs in each area to that of the corresponding one-view algorithm, (2) compare the detection accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies, and (3) compare the classification accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies. It is expected that this research will not only lead to an effective CAD system for FFDM, the multiple-image fusion approach and the new computer vision techniques will also advance CAD technology for mammography in general. ",Digital Mammography: Advanced Computer-Aided Breast Can*,6753540,R01CA095153,"['computer assisted diagnosis ', ' calcification ', ' artificial intelligence ', ' computer system design /evaluation ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' information system ', ' mathematics ', ' neoplasm /cancer diagnosis ', ' mammography ', ' breast neoplasm ', ' neoplastic growth ', ' digital imaging ', ' human data ', ' clinical research ', ' data management ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2004,492610,0.1208857510117614
"Intelligent Aids for Proteomic Data Mining DESCRIPTION (provided by applicant): Primary purpose of this proposal is to provide the applicant with the means and structures for achieving two goals; (1) to develop intelligent computational aids for mining proteomic data accumulating from high throughput techniques like SELDI-TOF mass spectrometry; and (2) the long-term goal is to gain independence as a biomedical informatics researcher by developing methodological expertise in Bayesian methods and proteomic technologies. Applicant will obtain further instruction in probabilistic methods of data analysis; and she will receive education on proteomic technologies that are driving today's proteome research. Training will be provided through formal coursework, directed readings, seminars and conferences in addition to research directed by excellent mentors.  Applicant's research project involves a novel combination of techniques for use in proteomic data analysis. Previous research has included the use of techniques such as genetic algorithms and neural networks for analysis of proteomic data. These techniques were not explicitly designed to take into account background and prior knowledge. Hypothesis of this project is that background knowledge and machine learning techniques can positively influence the selection of appropriate biomarkers from proteomic data, enabling efficient and accurate analysis of massive datasets arising from proteomic profiling studies. Therefore, this project will satisfy four aims: (1) development of a wrapper-based machine learning tool; (2) augment the tool with prior knowledge such as heuristic rules and relationships in the data; (3) use these features along with de-identified patient information as input to classification systems; and (4) evaluate existing techniques for interpreting tandem mass spectrometry (MS-MS or MS/MS) data, and propose, implement and evaluate a Bayesian method for identification of peptides and proteins indicated by the MS-MS spectrum. ",Intelligent Aids for Proteomic Data Mining,6915489,K25GM071951,"['biomarker ', ' biotechnology ', ' mass spectrometry ', ' computer system design /evaluation ', ' computer program /software ', ' diagnosis design /evaluation ', ' genetic disorder diagnosis ', ' computer assisted sequence analysis ', ' human data ', ' data management ', ' proteomics ', ' bioinformatics ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K25,2005,123942,0.14164761923269487
"Digital Mammography: Advanced Computer-Aided Breast Can* DESCRIPTION (provided by applicant): The major goals of the proposed research are (1) to develop a computer-aided diagnosis (CAD) system for full field digital mammography (FFDM) using advanced computer vision techniques and (2) to evaluate the effects of CAD on interpretation of DMs. Previous CAD methods for lesion (mass and microcalcification) detection and characterization have been designed for digitized film mammograms and have generally been based on image features extracted from a single view. Our proposed approach is distinctly different from the previous approaches in that image information from two-view mammograms and bilateral mammograms will be fused using machine intelligence techniques. This fundamental change will expand the amount of information utilized in CAD and is expected to improve lesion detection and characterization. New computer vision techniques will be specifically designed for FFDM in order to exploit the advantages offered by digital detectors. This will produce a CAD system that is integrated with and takes full advantage of the latest imaging technologies to further improve the health care of women. We hypothesize that these advanced multiple-image information fusion techniques will lead to a more effective CAD system for FFDMs in comparison to a single-image approach, and that the CAD system will significantly improve radiologists' accuracy in the four most important areas of mammography: (i) detection of masses, (ii) classification of masses, (iii) detection of microcalcifications, and (iv) classification of microcalcifications. A database of digital mammograms (DMs) with malignant and benign lesions and a set of normal cases will be collected. We will first adapt our current film-based CAD algorithms to DMs in each of the four areas, taking into account the differences in the imaging characteristics between DMs and digitized mammograms. New computer vision techniques will then be developed to improve upon the current methods and to exploit the potential advantages of the high contrast sensitivity, high detective quantum efficiency, wide dynamic range, and the linear response to x-ray intensity of digital detectors. Novel regional registration methods for identifying corresponding lesions on CC and MLO views and for comparing the density symmetry on bilateral mammograms will be developed. Innovative fuzzy classification schemes will be designed to fuse multiple-image information and one-view information to reduce false positives and to improve detection sensitivity. Multiple-view morphological and texture features of a lesion will be merged using neural networks or other statistical classifiers for characterization of malignant and benign lesions. To test the hypotheses, we will (1) compare the performance of the multiple-image fusion CAD algorithm for DMs in each area to that of the corresponding one-view algorithm, (2) compare the detection accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies, and (3) compare the classification accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies. It is expected that this research will not only lead to an effective CAD system for FFDM, the multiple-image fusion approach and the new computer vision techniques will also advance CAD technology for mammography in general. ",Digital Mammography: Advanced Computer-Aided Breast Can*,6903375,R01CA095153,"['computer assisted diagnosis ', ' calcification ', ' artificial intelligence ', ' computer system design /evaluation ', ' diagnosis quality /standard ', ' diagnosis design /evaluation ', ' information system ', ' mathematics ', ' neoplasm /cancer diagnosis ', ' mammography ', ' breast neoplasm ', ' neoplastic growth ', ' digital imaging ', ' human data ', ' clinical research ', ' data management ', ' bioimaging /biomedical imaging ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2005,519009,0.1208857510117614
"High-throughput annotation of glycan mass spectra     DESCRIPTION (provided by applicant): The correct functioning of many proteins depends on glycosylation, the addition of sugar molecules (glycans) to selected amino acids in the protein. For example, cancer cells have different glycosylation patterns than ordinary cells, and there is strong evidence that glycoproteins on the surface of egg cells play an essential role in sperm binding. Despite the importance of glycosylation, there are as yet no reliable, high-throughput methods for determining the identity and location of glycans. Glycan identification is currently a manual procedure for experts, involving a combination of chemical assays and mass spectrometry. The automation of the process would have a significant impact on our understanding of this important biological process. The proposed project aims to invent chemical procedures, algorithms, and software for high-throughput analysis of glycan mass spectrometry data. The goal is to bring glycan analysis up to the level of peptide analysis within 3 years. In contrast to peptide analysis, which can leverage genomics data, glycan analysis requires the incorporation of expert knowledge of synthetic pathways, in order to limit the huge number of theoretical combinations of monosaccharides to the much smaller number that are actually synthesized in nature. The project will have to develop novel representations for the evolving expert knowledge, because an exhaustive list- analogous to the human genome- is not currently known. Along with expert knowledge, the project will develop and validate machine learning and statistical techniques for glycan identification. In particular, the project will develop methods for internally calibrating spectra, and will learn fragmentation patterns that can statistically distinguish different types of glycosidic linkages.         ",High-throughput annotation of glycan mass spectra,6916805,R01GM074128,"['biomedical automation ', ' chemical structure ', ' chemical synthesis ', ' mass spectrometry ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' glycosylation ', ' mathematics ', ' polysaccharide ', ' technology /technique development ', ' structural biology ', ' matrix assisted laser desorption ionization ', ' high throughput technology ', ' bioinformatics ', ' computational biology ', ' ']",NIGMS,PALO ALTO RESEARCH CENTER,R01,2005,353067,0.11564226398340649
"Digital Mammography: Advanced Computer-Aided Breast Can* DESCRIPTION (provided by applicant): The major goals of the proposed research are (1) to develop a computer-aided diagnosis (CAD) system for full field digital mammography (FFDM) using advanced computer vision techniques and (2) to evaluate the effects of CAD on interpretation of DMs. Previous CAD methods for lesion (mass and microcalcification) detection and characterization have been designed for digitized film mammograms and have generally been based on image features extracted from a single view. Our proposed approach is distinctly different from the previous approaches in that image information from two-view mammograms and bilateral mammograms will be fused using machine intelligence techniques. This fundamental change will expand the amount of information utilized in CAD and is expected to improve lesion detection and characterization. New computer vision techniques will be specifically designed for FFDM in order to exploit the advantages offered by digital detectors. This will produce a CAD system that is integrated with and takes full advantage of the latest imaging technologies to further improve the health care of women. We hypothesize that these advanced multiple-image information fusion techniques will lead to a more effective CAD system for FFDMs in comparison to a single-image approach, and that the CAD system will significantly improve radiologists' accuracy in the four most important areas of mammography: (i) detection of masses, (ii) classification of masses, (iii) detection of microcalcifications, and (iv) classification of microcalcifications. A database of digital mammograms (DMs) with malignant and benign lesions and a set of normal cases will be collected. We will first adapt our current film-based CAD algorithms to DMs in each of the four areas, taking into account the differences in the imaging characteristics between DMs and digitized mammograms. New computer vision techniques will then be developed to improve upon the current methods and to exploit the potential advantages of the high contrast sensitivity, high detective quantum efficiency, wide dynamic range, and the linear response to x-ray intensity of digital detectors. Novel regional registration methods for identifying corresponding lesions on CC and MLO views and for comparing the density symmetry on bilateral mammograms will be developed. Innovative fuzzy classification schemes will be designed to fuse multiple-image information and one-view information to reduce false positives and to improve detection sensitivity. Multiple-view morphological and texture features of a lesion will be merged using neural networks or other statistical classifiers for characterization of malignant and benign lesions. To test the hypotheses, we will (1) compare the performance of the multiple-image fusion CAD algorithm for DMs in each area to that of the corresponding one-view algorithm, (2) compare the detection accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies, and (3) compare the classification accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies. It is expected that this research will not only lead to an effective CAD system for FFDM, the multiple-image fusion approach and the new computer vision techniques will also advance CAD technology for mammography in general. ",Digital Mammography: Advanced Computer-Aided Breast Can*,7088818,R01CA095153,"['bioimaging /biomedical imaging ', ' data management ', ' clinical research ', ' human data ', ' digital imaging ', ' neoplastic growth ', ' breast neoplasms ', ' mammography ', ' neoplasm /cancer diagnosis ', ' mathematics ', ' information systems ', ' diagnosis design /evaluation ', ' diagnosis quality /standard ', ' computer system design /evaluation ', ' artificial intelligence ', ' calcification ', ' computer assisted diagnosis ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2006,565364,0.1208857510117614
"Intelligent Aids for Proteomic Data Mining DESCRIPTION (provided by applicant): Primary purpose of this proposal is to provide the applicant with the means and structures for achieving two goals; (1) to develop intelligent computational aids for mining proteomic data accumulating from high throughput techniques like SELDI-TOF mass spectrometry; and (2) the long-term goal is to gain independence as a biomedical informatics researcher by developing methodological expertise in Bayesian methods and proteomic technologies. Applicant will obtain further instruction in probabilistic methods of data analysis; and she will receive education on proteomic technologies that are driving today's proteome research. Training will be provided through formal coursework, directed readings, seminars and conferences in addition to research directed by excellent mentors.  Applicant's research project involves a novel combination of techniques for use in proteomic data analysis. Previous research has included the use of techniques such as genetic algorithms and neural networks for analysis of proteomic data. These techniques were not explicitly designed to take into account background and prior knowledge. Hypothesis of this project is that background knowledge and machine learning techniques can positively influence the selection of appropriate biomarkers from proteomic data, enabling efficient and accurate analysis of massive datasets arising from proteomic profiling studies. Therefore, this project will satisfy four aims: (1) development of a wrapper-based machine learning tool; (2) augment the tool with prior knowledge such as heuristic rules and relationships in the data; (3) use these features along with de-identified patient information as input to classification systems; and (4) evaluate existing techniques for interpreting tandem mass spectrometry (MS-MS or MS/MS) data, and propose, implement and evaluate a Bayesian method for identification of peptides and proteins indicated by the MS-MS spectrum. ",Intelligent Aids for Proteomic Data Mining,7089794,K25GM071951,"['bioinformatics ', ' proteomics ', ' data management ', ' human data ', ' computer assisted sequence analysis ', ' genetic disorder diagnosis ', ' diagnosis design /evaluation ', ' computer program /software ', ' computer system design /evaluation ', ' mass spectrometry ', ' biotechnology ', ' biomarker ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K25,2006,127449,0.14164761923269487
"High-throughput annotation of glycan mass spectra     DESCRIPTION (provided by applicant): The correct functioning of many proteins depends on glycosylation, the addition of sugar molecules (glycans) to selected amino acids in the protein. For example, cancer cells have different glycosylation patterns than ordinary cells, and there is strong evidence that glycoproteins on the surface of egg cells play an essential role in sperm binding. Despite the importance of glycosylation, there are as yet no reliable, high-throughput methods for determining the identity and location of glycans. Glycan identification is currently a manual procedure for experts, involving a combination of chemical assays and mass spectrometry. The automation of the process would have a significant impact on our understanding of this important biological process. The proposed project aims to invent chemical procedures, algorithms, and software for high-throughput analysis of glycan mass spectrometry data. The goal is to bring glycan analysis up to the level of peptide analysis within 3 years. In contrast to peptide analysis, which can leverage genomics data, glycan analysis requires the incorporation of expert knowledge of synthetic pathways, in order to limit the huge number of theoretical combinations of monosaccharides to the much smaller number that are actually synthesized in nature. The project will have to develop novel representations for the evolving expert knowledge, because an exhaustive list- analogous to the human genome- is not currently known. Along with expert knowledge, the project will develop and validate machine learning and statistical techniques for glycan identification. In particular, the project will develop methods for internally calibrating spectra, and will learn fragmentation patterns that can statistically distinguish different types of glycosidic linkages.         ",High-throughput annotation of glycan mass spectra,7071180,R01GM074128,"['biomedical automation ', ' chemical structure ', ' chemical synthesis ', ' mass spectrometry ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' glycosylation ', ' mathematics ', ' polysaccharide ', ' technology /technique development ', ' structural biology ', ' matrix assisted laser desorption ionization ', ' high throughput technology ', ' bioinformatics ', ' computational biology ', ' ']",NIGMS,PALO ALTO RESEARCH CENTER,R01,2006,324279,0.11564226398340649
"High-throughput annotation of glycan mass spectra     DESCRIPTION (provided by applicant): The correct functioning of many proteins depends on glycosylation, the addition of sugar molecules (glycans) to selected amino acids in the protein. For example, cancer cells have different glycosylation patterns than ordinary cells, and there is strong evidence that glycoproteins on the surface of egg cells play an essential role in sperm binding. Despite the importance of glycosylation, there are as yet no reliable, high-throughput methods for determining the identity and location of glycans. Glycan identification is currently a manual procedure for experts, involving a combination of chemical assays and mass spectrometry. The automation of the process would have a significant impact on our understanding of this important biological process. The proposed project aims to invent chemical procedures, algorithms, and software for high-throughput analysis of glycan mass spectrometry data. The goal is to bring glycan analysis up to the level of peptide analysis within 3 years. In contrast to peptide analysis, which can leverage genomics data, glycan analysis requires the incorporation of expert knowledge of synthetic pathways, in order to limit the huge number of theoretical combinations of monosaccharides to the much smaller number that are actually synthesized in nature. The project will have to develop novel representations for the evolving expert knowledge, because an exhaustive list- analogous to the human genome- is not currently known. Along with expert knowledge, the project will develop and validate machine learning and statistical techniques for glycan identification. In particular, the project will develop methods for internally calibrating spectra, and will learn fragmentation patterns that can statistically distinguish different types of glycosidic linkages.         ",High-throughput annotation of glycan mass spectra,7239477,R01GM074128,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Disclosure ', ' Information Disclosure ', ' Disease ', ' disease/disorder ', ' Disorder ', ' immune function ', ' Cellular Immune Function ', ' Address ', ' Data ', ' Range ', ' Resolution ', ' Title ', ' Process ', ' Modification ', ' Development ', ' developmental ', ' Facility Construction Funding Category ', ' Expert Systems ', ' Intelligent systems ', ' Pathway interactions ', ' pathway ', ' Human Genome ', ' human whole genome ', ' Age ', ' Glycoproteins ', ' glycosylation ', ' Metabolic Glycosylation ', ' Goals ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Algorithms ', ' Site ', ' Area ', ' Surface ', ' Specific qualifier value ', ' Specified ', ' Biological ', ' Link ', ' Chemicals ', ' Training ', ' Isomerism ', ' isomer ', ' Learning ', ' Libraries ', ' Numbers ', ' sugar ', ' enzyme activity ', ' Mammals ', ' Mammalia ', ' Manuals ', ' Amino Acids ', ' aminoacid ', ' Methods ', ' Monosaccharides ', ' Biological Process ', ' Biological Function ', ' Occupations ', ' Professional Postions ', ' Jobs ', ' Organism ', ' living system ', ' Peptides ', ' Play ', ' Polymers ', ' Polysaccharides ', ' Glycans ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Proteins ', ' gene product ', ' Nature ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Technology ', ' Work ', ' Automation ', ' Pattern ', ' Score ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Class ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' Speed (motion) ', ' Speed ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' C element ', ' Cartoons ', ' Cells ', ' glycosyltransferase ', ' Glycoside Transferases ', ' EC 2.4 ', ' Sampling ', ' Specialist ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Communities ', ' egg ', ' prototype ', ' ']",NIGMS,PALO ALTO RESEARCH CENTER,R01,2007,318904,0.11564226398340649
"Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses    DESCRIPTION (provided by applicant): Digital tomosynthesis mammography (DTM) is a new modality that holds the promise of improving mammographic sensitivity of breast cancer detection and diagnosis, especially for dense breasts. The main goals of the proposed research are (1) to develop a computer-aided detection (CADd) system for breast masses in DTM, (2) to develop a computer-aided diagnosis (CADx) system for classification of malignant and benign masses in DTM, and (3) to evaluate the effects of CAD (either CADd or CADx) on radiologists' interpretation of DTMs. Previous CAD systems are developed for regular projection mammograms (PMs).The proposed CAD system makes use of the 3-dimensional (3D) information in DTM to improve mass detection and characterization. The innovations in the proposed project include: (1) development of new computer-vision techniques to exploit the 3D volumetric information in DTMs, (2) evaluation of the dependence of CAD performance on reconstruction algorithms, and (3) comparison of computerized mass detection and characterization in DTMs, projection view mammograms (PVs) (the non-reconstructed mammograms taken at multiple angles during tomosynthesis imaging), and PMs. We hypothesize that detection and characterization of masses on DTMs will be more accurate than corresponding tasks on regular PMs, and that the CAD systems can improve radiologists' accuracy. 3D breast phantoms with test objects will be designed and imaged with a prototype DTM system. The dependence of DTM image quality on reconstruction algorithms and their parameters, and on image acquisition techniques will be studied. The appropriate reconstruction techniques will be selected based on phantom and patient studies. A database of DTMs and corresponding PMs with malignant and benign masses and a set of normal cases will be collected with patient informed consent. CAD systems for detection and classification of masses will be developed. Two approaches will be compared: one uses the reconstructed DTM slices and the other uses the PVs as input to the CAD systems. For the DTMs, new techniques for 3D preprocessing, image segmentation, feature extraction, and feature classification will be designed. For the PVs, our previous techniques developed for regular PMs will be adapted to these low- dose images, and information fusion methods using techniques such as neural networks or support vector machines will be developed to merge the multiple-PV information. To test our hypotheses, we will compare the CAD system performances from these two approaches and that from the corresponding regular PMs, and conduct observer ROC studies to evaluate effects of the CAD systems on radiologists' performance. CAD will be an important tool that can help accelerate the implementation of DTM in clinical practice. DTM with CAD is expected to help fully utilize the potential of this new modality to improve breast cancer detection.           ",Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses,7498781,R33CA120234,"['relational database management systems ', ' Data Base Management Systems ', ' Database Management Systems ', ' Diagnosis ', ' Computer aided diagnosis ', ' Computer-Assisted Diagnosis ', ' Dose ', ' TimeLine ', ' mammary cancer detection ', ' Breast cancer screening ', ' Breast Cancer Detection ', ' Detection ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Collection ', ' Slice ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Depth ', ' Benign ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Image Reconstructions ', ' Informed Consent ', ' Evaluation ', ' Training ', ' Lesion ', ' Breast Nodule ', ' Breast Lump ', ' Mass in breast ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Mammogram ', ' Mammography ', ' Methods ', ' RDST ', ' radiologist ', ' Imaging Phantoms ', ' Patients ', ' Staging ', ' tool ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Dependence ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' 3-D ', ' 3-Dimensional ', ' experience ', ' Performance ', ' neural network ', ' Biological Neural Networks ', ' Breast ', ' Modality ', ' Abbreviations ', ' Digital Mammography ', ' Systematics ', ' Classification ', ' reconstruction ', ' digital ', ' computerized ', ' computer aided ', ' Computer Assisted ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' imaging Segmentation ', ' graphic user interface ', ' Graphical interface ', ' graphical user interface ', ' prototype ', ' computer vision ', ' Computer Vision Systems ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R33,2007,389685,0.07479768660762637
"Information-Theoretic Based CAD in Mammography DESCRIPTION (provided by applicant):    The purpose of the study is to develop and evaluate a novel computer-assisted decision (CAD) scheme for improving the clinical detection of breast masses in screening mammograms. The CAD scheme combines information-theoretic similarity metrics with knowledge-based decision algorithms. It will help radiologists scrutinize mammograms providing evidence-based decision support. Given a query mammographic region, the CAD system will interrogate a database of archived mammograms, examine similar eases, and assign a likelihood measure regarding the presence of a potentially malignant mass.  The study proposes the formulation of information-theoretic metrics to quantify the similarity of two mammographic regions. The similarity metrics are based on Sharmon's entropy; a measure of complexity (or information) contained in an image. Theoretically, if two mammographic regions depict similar structures, they should contain diagnostic information for each other. The amount of relevant diagnostic information can be measured by entropy-based similarity metrics that are computed directly from the images without requiring segmentation or feature extraction. Using the similarity metrics and an image databank of mammographic cases with known truth, a knowledge-bussed CAD scheme will be implemented for the detection of masses in screening mammograms. Preliminary studies have established that standard mutual information (MI) is an effective similarity metric for the task.  The specific aims of the study are: (1) To fully exploit information-theoretic metrics that measure the similar content of two mammographic regions, (2) To optimize their contributions in an evidence-based decision algorithm for the early detection of potentially malignant masses, and (3) To perform preliminary clinical evaluation of the CAD system.  As digital image libraries are an upcoming trend in radiology, the proposed CAD system will take advantage of continuously deposited mammograms with established ground truth. The system aims to reduce the interpretation error associated with screening mammograms and/or the false positives generated by cuing CAD schemes, Overall, the study aims to improve the sensitivity while maintaining or improving the specificity of screening mammography for masses. ",Information-Theoretic Based CAD in Mammography,7162911,R01CA101911,"['Cues ', ' Diagnosis ', ' Purpose ', ' Detection ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' Scheme ', ' trend ', ' Image ', ' imaging ', ' Standards of Weights and Measures ', ' base ', ' concept ', ' Computer Interface ', ' improved ', ' Algorithms ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Information Theory ', ' Screening procedure ', ' screenings ', ' screening ', ' Knowledge Base (Computer) ', ' Libraries ', ' Mass in breast ', ' Breast Nodule ', ' Breast Lump ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Mammography ', ' Mammogram ', ' radiologist ', ' RDST ', ' Physicians ', ' Deposition ', ' Deposit ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Diagnostic ', ' Archives ', ' Entropy ', ' Knowledge ', ' Specificity ', ' statistics ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Drug Formulations ', ' Formulation ', ' digital imaging ', ' computer imaging ', ' Early Diagnosis ', ' early detection ', ' knowledge base ', ' knowledgebase ', ' Structure ', ' novel ', ' Metric ', ' Measures ', ' Uncertainty ', ' doubt ', ' Classification ', ' Systematics ', ' Computer Assisted ', ' computer aided ', ' ']",NCI,DUKE UNIVERSITY,R01,2007,230712,0.15429392872498382
"Novel Machine Learning Methods for Analysis of MALDI-TOF Mass Spectrometry Data    DESCRIPTION (provided by applicant):       Hepatocellular carcinoma (HCC) is a common cancer worldwide with as many as 500,000 new cases each year. Between 1981 to 1998, the 5-year patient survival rate with HCC only rose from 2% to 5%. This poor survival rate is in part related to the diagnosis of HCC at advanced stages, where effective therapies are lacking. Early detection of HCC improves patient survival. Patients with cirrhosis are typically the ones to develop HCC. Hence, monitoring cirrhotic patients can potentially decrease the cancer-related mortality rate. The poor sensitivity and specificity of currently available tools has prevented widespread implementation of HCC surveillance. Therefore, additional serum markers that provide higher sensitivity and specificity are needed to improve the detection rate of early HCC. The goal of this collaborative project is to identify a panel of serum biomarkers for early diagnosis of HCC. The long-term goal is to find and validate markers that would help identify HCC at a treatable stage in high-risk population of cirrhotic patients. This project will lead to the development of innovative mass spectral data preprocessing and biomarker selection methods that for the identification of candidate biomarkers specific to HCC by using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (MS) of low-molecular-weight (LMW) enriched sera. The specific aims of the project are the following: Aim 1: To develop algorithms for improved MALDI-TOF mass spectral data preprocessing including outlier screening, binning, smoothing, baseline correction, normalization, peak detection, and peak calibration. The proposed algorithms will enable us to reduce run-to-run variability in replicate spectra of a standard serum and to enhance the prediction accuracy in distinguishing HCC patients from cirrhotic patients or healthy individuals. Aim 2: To develop a novel algorithm that is superior to currently used biomarker selection methods by combining two popular machine learning methods, particle swarm optimization (PSO) and support vector machines (SVMs). The proposed algorithm will be used to identify HCC-specific markers from the preprocessed MALDI-TOF spectra. To avoid confounding effects, peaks will be removed prior to biomarker selection if they are associated with viral infection or covariates such as age, gender, smoking status, drinking status, and residency (urban or rural). From the remaining peaks, a small set of candidate biomarkers that accurately distinguishes HCC patients from cirrhotic patients will be identified. The capability of the algorithm to identify a small set of markers with high sensitivity and specificity is critical for establishment of clinical tests. Additionally, the algorithm will identify markers that distinguish various pairs (normal vs. cirrhosis, normal vs. HCC, cirrhosis vs. early-stage HCC, and cirrhosis vs. late-stage HCC). This will enable us to isolate HCC- specific markers and identify disease progression markers. Furthermore, the peptides represented by the selected candidate biomarkers will be identified. Finally, the performance of the algorithm will be compared with existing methods.           ",Novel Machine Learning Methods for Analysis of MALDI-TOF Mass Spectrometry Data,7265522,R03CA119313,"['Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Diagnosis ', ' prevent ', ' preventing ', ' Data ', ' Detection ', ' Analytical Biochemistry ', ' Collection ', ' MALDI-TOF Mass Spectrometry ', ' Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry ', ' Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS ', ' Newly Diagnosed ', ' Smoking Status ', ' Monitor ', ' Preparation ', ' Rate ', ' Development ', ' developmental ', ' Cirrhosis ', ' Serum Markers ', ' Standards of Weights and Measures ', ' Age ', ' base ', ' Goals ', ' improved ', ' Primary carcinoma of the liver cells ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Algorithms ', ' Clinical ', ' Variant ', ' Variation ', ' Logistic Regressions ', ' Ensure ', ' Screening procedure ', ' screenings ', ' screening ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Rural ', ' Disease Progression ', ' Methods ', ' Molecular Weight ', ' Mortality Vital Statistics ', ' Mortality ', ' oncology ', ' Oncology Cancer ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Patient Monitoring ', ' Patients ', ' Peptides ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Figs - dietary ', ' Figs ', ' Research ', ' Residencies ', ' Risk ', ' Rosa ', ' Rose ', ' Running ', ' Sensitivity and Specificity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Survival Rate ', ' Testing ', ' Time ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Spectrometry ', ' Viral ', ' Biological Markers ', ' Biologic Marker ', ' Early Diagnosis ', ' early detection ', ' particle ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' drinking ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' Gender ', ' Generations ', ' Measures ', ' Code ', ' Coding System ', ' Liquid Chromatography ', ' Modeling ', ' Sampling ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' mass spectrometer ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCI,GEORGETOWN UNIVERSITY,R03,2007,77600,0.12884144199284772
"A Proteomic Approach to Biomarker Discovery in Prion Disease    DESCRIPTION (provided by applicant): Transmissible spongiform encephalopathies (TSEs) are a unique family of neurodegenerative diseases of the central nervous system that are always fatal. Of the various forms of prion disease, those with the most impact upon human and animal health are Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (BSE), scrapie and chronic wasting disease (CWD). The outbreaks of BSE and variant CJD (vCJD) in the United Kingdom and worldwide, including the United States, has prompted the need for rapid, reliable and inexpensive screening methods that detect TSE infection in humans and live animals. Current diagnostic tests for prion disease have, thus far, focused on detection of the causal agent of the disease, the abnormal prion protein, or individual proteins that correlate with the neurological disease. These tests are inadequate because they are post-mortem, low throughput and not sufficiently sensitive to detect infection early in the pre-clinical period. Clearly, there is an urgent need for the development of a reliable, sensitive, and specific ante-mortem diagnostic test for the pre-clinical identification of TSE-infected animals or individuals. Herein we propose the development of a new highly-sensitive mass spectrometry (MS)-based analytical platform in combination with a suite of bioinformatics tools to identify a panel of biomarkers of prion disease in body fluids collected from live animals infected with prion disease during the preclinical incubation period. The guiding hypotheses of the proposed research are: (1) The pathophysiological changes associated with prion infection will result in an altered protein profile of the cerebrospinal fluids (CSF) and/or serum proteome. (2) The combination of accurate mass measurements, isotopic labeling strategy for quantitative analyses, tandem mass spectrometry, and a suite of machine-learning algorithms will provide a unique and integrated platform to identify and characterize these diagnostic protein markers with unprecedented sensitivity and specificity. (3) Characterization of these diagnostic protein biomarkers will provide a basis for the development of an ante-mortem antibody-based screening test for prion diseases in suspected animals. To investigate these hypotheses, we propose the following specific aims: (1) To identify a panel of candidate biomarkers in the CSF and serum of animals infected with prion diseases using MS and classification algorithms. (2) To determine the identities of the candidate biomarkers by tandem MS and to obtain global quantitative changes of putative biomarkers via isotopic labeling. (3) To validate the biomarkers in blind diagnostic trials. Collectively, the proposed study will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample and it will also further our understanding of prion disease progression and pathology. This proposal explores a novel proteomic approach combining high sensitivity mass spectrometric profiling and sequencing with a set of bioinformatics tools to discover, identify, and quantify biomarkers that are indicative of prion infection. These putative biomarkers may also serve as targets for therapeutic intervention. Collectively, the proposed research will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample, enhancing our ability to secure food and blood supplies, and it will also further our understanding of prion disease progression and pathology.          ",A Proteomic Approach to Biomarker Discovery in Prion Disease,7313388,R21AI072588,"['Prions ', ' Prion Proteins ', ' PrP Proteins ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Diagnostic ', ' Research ', ' Scrapie ', ' Rida ', ' Sensitivity and Specificity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' United Kingdom ', ' United States ', ' Wasting Syndrome ', ' Wasting Disease ', ' Spectrometry ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Biological Markers ', ' Biologic Marker ', ' Body Fluids ', ' Early Diagnosis ', ' early detection ', ' tandem mass spectrometry ', ' cohort ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Secure ', ' novel ', ' new technology ', ' novel technologies ', ' Proteome ', ' Cerebrospinal Fluid ', ' spinal fluid ', ' cerebral spinal fluid ', ' Therapeutic Intervention ', ' intervention therapy ', ' Bovine Spongiform Encephalopathy ', ' Mad Cow Disease ', ' Bovine Spongiform Encephalitis ', ' Diagnostic tests ', ' Sampling ', ' Proteomics ', ' Classification ', ' Systematics ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Vascular blood supply ', ' vascular supply ', ' blood supply ', ' Neuraxis ', ' Central Nervous System ', ' CNS Nervous System ', ' blind ', ' Control Groups ', ' Chronic Wasting Disease ', ' Bioinformatics ', ' Bio-Informatics ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Disease Outbreaks ', ' Outbreaks ', ' Detection ', ' Diagnostic Trial ', ' Predictive Value ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Family ', ' Prion Diseases ', ' spongiform encephalopathy ', ' spongiform degeneration ', ' Transmissible Spongiform Encephalopathies ', ' Transmissible Dementias ', ' Prion-Induced Disorder ', ' Prion Protein Diseases ', ' Prion Disease Pathway ', ' Food ', ' Formaldehyde ', ' Oxomethane ', ' Methyl Aldehyde ', ' Methanal ', ' Formic Aldehyde ', ' pre-clinical ', ' preclinical ', ' base ', ' Label ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Chronic ', ' Variant ', ' Variation ', ' Immunoassay ', ' Infection ', ' Screening procedure ', ' screenings ', ' screening ', ' Creutzfeldt-Jakob Syndrome ', ' Subacute Spongiform Encephalopathy ', ' Jakob-Creutzfeldt Disease ', ' Creutzfeldt-Jakob Disease ', ' Creutzfeldt-Jacob Disease ', ' CJDs (Creutzfeldt-Jakob Disease) ', ' CJD ', ' Serum ', ' Blood Serum ', ' Individual ', ' Numbers ', ' Measurement ', ' Disease Progression ', ' Methods ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Animals ', ' Pathology ', ' Antibodies ', ' ']",NIAID,UNIVERSITY OF WISCONSIN-MADISON,R21,2007,223880,0.10936234579879688
"Intelligent Aids for Proteomic Data Mining DESCRIPTION (provided by applicant): Primary purpose of this proposal is to provide the applicant with the means and structures for achieving two goals; (1) to develop intelligent computational aids for mining proteomic data accumulating from high throughput techniques like SELDI-TOF mass spectrometry; and (2) the long-term goal is to gain independence as a biomedical informatics researcher by developing methodological expertise in Bayesian methods and proteomic technologies. Applicant will obtain further instruction in probabilistic methods of data analysis; and she will receive education on proteomic technologies that are driving today's proteome research. Training will be provided through formal coursework, directed readings, seminars and conferences in addition to research directed by excellent mentors.  Applicant's research project involves a novel combination of techniques for use in proteomic data analysis. Previous research has included the use of techniques such as genetic algorithms and neural networks for analysis of proteomic data. These techniques were not explicitly designed to take into account background and prior knowledge. Hypothesis of this project is that background knowledge and machine learning techniques can positively influence the selection of appropriate biomarkers from proteomic data, enabling efficient and accurate analysis of massive datasets arising from proteomic profiling studies. Therefore, this project will satisfy four aims: (1) development of a wrapper-based machine learning tool; (2) augment the tool with prior knowledge such as heuristic rules and relationships in the data; (3) use these features along with de-identified patient information as input to classification systems; and (4) evaluate existing techniques for interpreting tandem mass spectrometry (MS-MS or MS/MS) data, and propose, implement and evaluate a Bayesian method for identification of peptides and proteins indicated by the MS-MS spectrum. ",Intelligent Aids for Proteomic Data Mining,7254755,K25GM071951,"['Data Analyses ', ' Data Analysis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Purpose ', ' data mining ', ' datamining ', ' Educational aspects ', ' Education ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Genetic Programming ', ' Genetic Algorithm ', ' Development ', ' developmental ', ' analytical method ', ' base ', ' Goals ', ' Link ', ' Training ', ' Learning ', ' Bayesian Method ', ' Mentors ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mining ', ' Patients ', ' Peptides ', ' Problem Solving ', ' tool ', ' Proteins ', ' gene product ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Spectrometry ', ' Automobile Driving ', ' driving ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Class ', ' Biological Markers ', ' Biologic Marker ', ' heuristics ', ' Biological Neural Networks ', ' neural network ', ' tandem mass spectrometry ', ' Structure ', ' novel ', ' Prevention ', ' Today ', ' Proteome ', ' symposium ', ' conference ', ' Pathway Analysis ', ' Network Analysis ', ' Proteomics ', ' Classification ', ' Systematics ', ' Accounting ', ' Instruction ', ' biomedical informatics ', ' biomed informatics ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K25,2007,130068,0.14164761923269487
"Digital Mammography: Advanced Computer-Aided Breast Can* DESCRIPTION (provided by applicant): The major goals of the proposed research are (1) to develop a computer-aided diagnosis (CAD) system for full field digital mammography (FFDM) using advanced computer vision techniques and (2) to evaluate the effects of CAD on interpretation of DMs. Previous CAD methods for lesion (mass and microcalcification) detection and characterization have been designed for digitized film mammograms and have generally been based on image features extracted from a single view. Our proposed approach is distinctly different from the previous approaches in that image information from two-view mammograms and bilateral mammograms will be fused using machine intelligence techniques. This fundamental change will expand the amount of information utilized in CAD and is expected to improve lesion detection and characterization. New computer vision techniques will be specifically designed for FFDM in order to exploit the advantages offered by digital detectors. This will produce a CAD system that is integrated with and takes full advantage of the latest imaging technologies to further improve the health care of women. We hypothesize that these advanced multiple-image information fusion techniques will lead to a more effective CAD system for FFDMs in comparison to a single-image approach, and that the CAD system will significantly improve radiologists' accuracy in the four most important areas of mammography: (i) detection of masses, (ii) classification of masses, (iii) detection of microcalcifications, and (iv) classification of microcalcifications. A database of digital mammograms (DMs) with malignant and benign lesions and a set of normal cases will be collected. We will first adapt our current film-based CAD algorithms to DMs in each of the four areas, taking into account the differences in the imaging characteristics between DMs and digitized mammograms. New computer vision techniques will then be developed to improve upon the current methods and to exploit the potential advantages of the high contrast sensitivity, high detective quantum efficiency, wide dynamic range, and the linear response to x-ray intensity of digital detectors. Novel regional registration methods for identifying corresponding lesions on CC and MLO views and for comparing the density symmetry on bilateral mammograms will be developed. Innovative fuzzy classification schemes will be designed to fuse multiple-image information and one-view information to reduce false positives and to improve detection sensitivity. Multiple-view morphological and texture features of a lesion will be merged using neural networks or other statistical classifiers for characterization of malignant and benign lesions. To test the hypotheses, we will (1) compare the performance of the multiple-image fusion CAD algorithm for DMs in each area to that of the corresponding one-view algorithm, (2) compare the detection accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies, and (3) compare the classification accuracy of masses and microcalcifications on DMs with and without CAD by observer ROC studies. It is expected that this research will not only lead to an effective CAD system for FFDM, the multiple-image fusion approach and the new computer vision techniques will also advance CAD technology for mammography in general. ",Digital Mammography: Advanced Computer-Aided Breast Can*,7215135,R01CA095153,"['Database Management Systems ', ' relational database management systems ', ' Data Base Management Systems ', ' Computer-Assisted Diagnosis ', ' Computer aided diagnosis ', ' TimeLine ', ' Data Set ', ' Dataset ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Range ', ' Classification Scheme ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' base ', ' density ', ' method development ', ' Goals ', ' detector ', ' improved ', ' Algorithms ', ' Area ', ' Benign ', ' Malignant - descriptor ', ' Malignant ', ' Training ', ' Lesion ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Bilateral ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Mammography ', ' Mammogram ', ' Methods ', ' radiologist ', ' RDST ', ' Staging ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Archives ', ' programs ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Localized ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Woman ', ' Texture ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Test Result ', ' Breast Microcalcification ', ' Microcalcification ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' Breast ', ' Budgets ', ' novel ', ' Measures ', ' Digital Mammography ', ' Film ', ' Healthcare ', ' health care ', ' response ', ' Classification ', ' Systematics ', ' Accounting ', ' digital ', ' computerized ', ' Computer Assisted ', ' computer aided ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' quantum ', ' Imaging technology ', ' innovation ', ' innovative ', ' innovate ', ' Computer Vision Systems ', ' computer vision ', ' Contrast Sensitivity ', ' Visual Contrast Sensitivity ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2007,580689,0.1208857510117614
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Project summary: Mass spectrometry, the core technology in the field of proteomics, promises to enable scientists to identify and quantify the entire complement of molecules that comprise a complex biological sample. In the biological and health sciences, mass spectrometry is commonly used in a nigh-throughput fashion to identify proteins in a mixture. Currently, the primary bottleneck in this type of experiment is computational. Existing algorithms for interpreting mass spectra are slow and fail to identify a large proportion of the given spectra. We propose to apply techniques and tools from the field of machine learning to the analysis of mass spectrometry data. We will build computational models of peptide fragmentation within the mass spectrometer, as well as larger-scale models of the entire mass spectrometry process. Using these models, we will design and validate algorithms for identifying the set of proteins that best explain an observed set of spectra. Software implementations for all of the methods will be made publicly available in a user-friendly form. In practical terms, this software will enable scientists to more easily, efficiently and accurately analyze and understand their mass spectrometry data. Relevance: The applications of mass spectrometry and its promises for improvements of human health are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens.           ",Machine learning analysis of tandem mass spectra,7194479,R01EB007057,"['Complex Mixtures ', ' small molecule ', ' FOLH1 gene ', ' PSM ', ' NAALAD1 ', ' FOLH1 ', ' FOLH ', ' Data ', ' Health Sciences ', ' Protein Biochemistry ', ' Protein/Amino Acid Biochemistry ', ' Collection ', ' Preparation ', ' Rate ', ' Principal Investigator ', ' Molecular ', ' Process ', ' Set protein ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Source Code ', ' improved ', ' Procedures ', ' Hand ', ' Health ', ' Altretamine ', ' s-Triazine, 2,4,6-tris(dimethylamino)- ', ' N,n,n\',N""N""-hexamethyl-1,3,5,-triazine-2,4,6,-triamine ', ' N,N,N\',N\',N"",N""-hexamethyl-1,3,5-triazine-2,4,6-triamine ', ' Hexamethylmelamine ', ' Hexaloids ', ' Hemel ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Area ', ' Biological ', ' Biochemical ', ' prognostic ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Peptide Fragments ', ' Peptides ', ' Staging ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' tool ', ' Proteins ', ' gene product ', ' Receiver Operating Characteristics ', ' Diagnostic ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Running ', ' Blast Cell ', ' Hemohistioblast ', ' Hemocytoblast ', ' Hematohistioblast ', ' Ferrata cell ', ' Blasts ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Scientist ', ' Time ', ' Work ', ' Authorship ', ' Spectrometry ', ' Hour ', ' day ', ' Complex ', ' Score ', ' Techniques ', ' interest ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' expectation ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Devices ', ' Carbonyl Cyanide m-Chlorophenyl Hydrazone ', ' Propanedinitrile, ((3-chlorophenyl)hydrazono)- ', ' Carbonyl Cyanide meta-Chlorophenyl Hydrazone ', ' CCCP ', ' Abbreviations ', ' Today ', ' Dissociation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model design ', ' Complement ', ' Complement Proteins ', ' disease phenotype ', ' mass spectrometer ', ' computer based statistical methods ', ' Bayesian Networks ', ' markov model ', ' design ', ' designing ', ' user-friendly ', ' task analysis ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' ']",NIBIB,UNIVERSITY OF WASHINGTON,R01,2007,623873,0.31162898417224394
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Project summary: Mass spectrometry, the core technology in the field of proteomics, promises to enable scientists to identify and quantify the entire complement of molecules that comprise a complex biological sample. In the biological and health sciences, mass spectrometry is commonly used in a nigh-throughput fashion to identify proteins in a mixture. Currently, the primary bottleneck in this type of experiment is computational. Existing algorithms for interpreting mass spectra are slow and fail to identify a large proportion of the given spectra. We propose to apply techniques and tools from the field of machine learning to the analysis of mass spectrometry data. We will build computational models of peptide fragmentation within the mass spectrometer, as well as larger-scale models of the entire mass spectrometry process. Using these models, we will design and validate algorithms for identifying the set of proteins that best explain an observed set of spectra. Software implementations for all of the methods will be made publicly available in a user-friendly form. In practical terms, this software will enable scientists to more easily, efficiently and accurately analyze and understand their mass spectrometry data. Relevance: The applications of mass spectrometry and its promises for improvements of human health are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens.           ",Machine learning analysis of tandem mass spectra,7365198,R01EB007057,"['Complex Mixtures ', ' small molecule ', ' FOLH1 gene ', ' PSM ', ' NAALAD1 ', ' FOLH1 ', ' FOLH ', ' Data ', ' Health Sciences ', ' Protein Biochemistry ', ' Protein/Amino Acid Biochemistry ', ' Collection ', ' Preparation ', ' Rate ', ' Principal Investigator ', ' Molecular ', ' Process ', ' Set protein ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Source Code ', ' improved ', ' Procedures ', ' Hand ', ' Health ', ' Altretamine ', ' s-Triazine, 2,4,6-tris(dimethylamino)- ', ' N,n,n\',N""N""-hexamethyl-1,3,5,-triazine-2,4,6,-triamine ', ' N,N,N\',N\',N"",N""-hexamethyl-1,3,5-triazine-2,4,6-triamine ', ' Hexamethylmelamine ', ' Hexaloids ', ' Hemel ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Area ', ' Biological ', ' Biochemical ', ' prognostic ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Peptide Fragments ', ' Peptides ', ' Staging ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' tool ', ' Proteins ', ' gene product ', ' Receiver Operating Characteristics ', ' Diagnostic ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Running ', ' Blast Cell ', ' Hemohistioblast ', ' Hemocytoblast ', ' Hematohistioblast ', ' Ferrata cell ', ' Blasts ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Scientist ', ' Time ', ' Work ', ' Authorship ', ' Hour ', ' day ', ' Complex ', ' Score ', ' Techniques ', ' interest ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' expectation ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Devices ', ' Carbonyl Cyanide m-Chlorophenyl Hydrazone ', ' Propanedinitrile, ((3-chlorophenyl)hydrazono)- ', ' Carbonyl Cyanide meta-Chlorophenyl Hydrazone ', ' CCCP ', ' Abbreviations ', ' Today ', ' Dissociation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model design ', ' Complement ', ' Complement Proteins ', ' disease phenotype ', ' mass spectrometer ', ' computer based statistical methods ', ' Bayesian Networks ', ' markov model ', ' design ', ' designing ', ' user-friendly ', ' task analysis ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' ']",NIBIB,UNIVERSITY OF WASHINGTON,R01,2008,602497,0.31162898417224394
"Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses    DESCRIPTION (provided by applicant): Digital tomosynthesis mammography (DTM) is a new modality that holds the promise of improving mammographic sensitivity of breast cancer detection and diagnosis, especially for dense breasts. The main goals of the proposed research are (1) to develop a computer-aided detection (CADd) system for breast masses in DTM, (2) to develop a computer-aided diagnosis (CADx) system for classification of malignant and benign masses in DTM, and (3) to evaluate the effects of CAD (either CADd or CADx) on radiologists' interpretation of DTMs. Previous CAD systems are developed for regular projection mammograms (PMs).The proposed CAD system makes use of the 3-dimensional (3D) information in DTM to improve mass detection and characterization. The innovations in the proposed project include: (1) development of new computer-vision techniques to exploit the 3D volumetric information in DTMs, (2) evaluation of the dependence of CAD performance on reconstruction algorithms, and (3) comparison of computerized mass detection and characterization in DTMs, projection view mammograms (PVs) (the non-reconstructed mammograms taken at multiple angles during tomosynthesis imaging), and PMs. We hypothesize that detection and characterization of masses on DTMs will be more accurate than corresponding tasks on regular PMs, and that the CAD systems can improve radiologists' accuracy. 3D breast phantoms with test objects will be designed and imaged with a prototype DTM system. The dependence of DTM image quality on reconstruction algorithms and their parameters, and on image acquisition techniques will be studied. The appropriate reconstruction techniques will be selected based on phantom and patient studies. A database of DTMs and corresponding PMs with malignant and benign masses and a set of normal cases will be collected with patient informed consent. CAD systems for detection and classification of masses will be developed. Two approaches will be compared: one uses the reconstructed DTM slices and the other uses the PVs as input to the CAD systems. For the DTMs, new techniques for 3D preprocessing, image segmentation, feature extraction, and feature classification will be designed. For the PVs, our previous techniques developed for regular PMs will be adapted to these low- dose images, and information fusion methods using techniques such as neural networks or support vector machines will be developed to merge the multiple-PV information. To test our hypotheses, we will compare the CAD system performances from these two approaches and that from the corresponding regular PMs, and conduct observer ROC studies to evaluate effects of the CAD systems on radiologists' performance. CAD will be an important tool that can help accelerate the implementation of DTM in clinical practice. DTM with CAD is expected to help fully utilize the potential of this new modality to improve breast cancer detection.           ",Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses,7500088,R33CA120234,"['Training ', ' Lesion ', ' Mass in breast ', ' Breast Nodule ', ' Breast Lump ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Mammography ', ' Mammogram ', ' Methods ', ' radiologist ', ' RDST ', ' Imaging Phantoms ', ' Patients ', ' Staging ', ' tool ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Dependence ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' 3-Dimensional ', ' 3-D ', ' experience ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' Breast ', ' Modality ', ' Abbreviations ', ' Classification ', ' Systematics ', ' reconstruction ', ' digital ', ' computerized ', ' Computer Assisted ', ' computer aided ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' imaging Segmentation ', ' graphical user interface ', ' graphic user interface ', ' Graphical interface ', ' prototype ', ' Computer Vision Systems ', ' computer vision ', ' Database Management Systems ', ' relational database management systems ', ' Data Base Management Systems ', ' Diagnosis ', ' Computer-Assisted Diagnosis ', ' Computer aided diagnosis ', ' Dose ', ' TimeLine ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Collection ', ' Slice ', ' Process ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Depth ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Specific qualifier value ', ' Specified ', ' Phase ', ' Image Reconstructions ', ' Informed Consent ', ' Evaluation ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R33,2008,379995,0.07479768660762637
"Improving Breast Cancer Detection and Diagnosis with CAD    DESCRIPTION (provided by applicant): Computer-aided detection (CAD) of breast cancer is rapidly becoming a well accepted clinical practice. Studies have found that radiologists' attitude toward and acceptance of CAD-cued micro-calcification clusters and masses were substantially different. Due to the high sensitivity, radiologists heavily rely on CAD-cued results while searching for micro-calcifications. However, the lower CAD sensitivity for mass detection (including a fraction of subtle masses being cued only on one view) and the higher false-positive detection (FP) rates reduce radiologists' confidence in CAD-cued masses. As a result, radiologists frequently discard CAD-cued subtle masses in the clinical practice. To improve CAD performance and increase radiologists' confidence in using CAD-cued masses in their decision making, we propose two observer-focused innovative approaches to develop and optimize CAD schemes. By maintaining a comparable FP rate to current commercial CAD systems, the new approaches aim to either increase the number of masses being cued on both ipsilateral (CC and MLO) views or cue more subtle masses by eliminating a fraction of other regions that can be easily identified and classified by radiologists without using CAD. To test these approaches, we propose three specific tasks. First, we will develop a unique multi-view based CAD scheme. To more sensitively detect and better match subtle mass regions, we introduce a concept of limited viewing of specific regions into the arena of CAD development. After detecting a matching strip on the ipsolateral view, the scheme applies a second highly sensitive detection scheme only to this strip to identify matched regions. To control for and reduce FP rates, the scheme limits the number of possible matched candidates to less than one per image. Second, we will develop an integrated CAD scheme that includes a combined score for both detection and classification. To improve direct use of features computed by the detection module in the classification task, we will apply a new dual active contour algorithm that should improve mass region segmentation. We will separately optimize two machine learning classifiers to generate a detection score (the likelihood of being a true-positive mass) and a classification score (the likelihood of each detected mass for malignancy) for each segmented region. We will then develop a fusion method to combine these two scores and generate a new summary index that is more heavily weighted for subtle masses. Using this scheme, we can change the current mass detection based cuing method to a new cancer-based cueing method. Third, we will conduct a pilot observer performance study to investigate radiologists' performance under three CADcueing modes (using the current commercial single-image based, the new multi-view based, and the new integrated CAD schemes). The reading results will be compared and analyzed using both ROC and JAFROC methodologies. We note that the approach is substantially different than focusing on incremental improvements in image based detection schemes in that the observer's actual use (or not) of the CADcued regions drives our objectives in this project, resulting in a targeted development effort.          ",Improving Breast Cancer Detection and Diagnosis with CAD,7522346,R01CA077850,"['Cues ', ' Decision Making ', ' Diagnosis ', ' Institution ', ' Purpose ', ' Environment ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Detection ', ' Cancer Detection ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scheme ', ' Rate ', ' Process ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Eye ', ' Eyeball ', ' Image ', ' imaging ', ' calcification ', ' base ', ' concept ', ' improved ', ' Hybrids ', ' Algorithms ', ' Area ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Specific qualifier value ', ' Specified ', ' indexing ', ' Lesion ', ' Numbers ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' radiologist ', ' RDST ', ' Perception ', ' Play ', ' Reading ', ' Diagnostic ', ' Research ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Time ', ' Attention ', ' Attitude ', ' Investigation ', ' Weight ', ' Work ', ' Ipsilateral ', ' Score ', ' System ', ' LOINC Axis 4 System ', ' Performance ', ' Breast ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Reporting ', ' desire ', ' Classification ', ' Systematics ', ' Computer Assisted ', ' computer aided ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' innovation ', ' innovative ', ' innovate ', ' ']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2008,247081,0.24752795390064436
"A Proteomic Approach to Biomarker Discovery in Prion Disease    DESCRIPTION (provided by applicant): Transmissible spongiform encephalopathies (TSEs) are a unique family of neurodegenerative diseases of the central nervous system that are always fatal. Of the various forms of prion disease, those with the most impact upon human and animal health are Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (BSE), scrapie and chronic wasting disease (CWD). The outbreaks of BSE and variant CJD (vCJD) in the United Kingdom and worldwide, including the United States, has prompted the need for rapid, reliable and inexpensive screening methods that detect TSE infection in humans and live animals. Current diagnostic tests for prion disease have, thus far, focused on detection of the causal agent of the disease, the abnormal prion protein, or individual proteins that correlate with the neurological disease. These tests are inadequate because they are post-mortem, low throughput and not sufficiently sensitive to detect infection early in the pre-clinical period. Clearly, there is an urgent need for the development of a reliable, sensitive, and specific ante-mortem diagnostic test for the pre-clinical identification of TSE-infected animals or individuals. Herein we propose the development of a new highly-sensitive mass spectrometry (MS)-based analytical platform in combination with a suite of bioinformatics tools to identify a panel of biomarkers of prion disease in body fluids collected from live animals infected with prion disease during the preclinical incubation period. The guiding hypotheses of the proposed research are: (1) The pathophysiological changes associated with prion infection will result in an altered protein profile of the cerebrospinal fluids (CSF) and/or serum proteome. (2) The combination of accurate mass measurements, isotopic labeling strategy for quantitative analyses, tandem mass spectrometry, and a suite of machine-learning algorithms will provide a unique and integrated platform to identify and characterize these diagnostic protein markers with unprecedented sensitivity and specificity. (3) Characterization of these diagnostic protein biomarkers will provide a basis for the development of an ante-mortem antibody-based screening test for prion diseases in suspected animals. To investigate these hypotheses, we propose the following specific aims: (1) To identify a panel of candidate biomarkers in the CSF and serum of animals infected with prion diseases using MS and classification algorithms. (2) To determine the identities of the candidate biomarkers by tandem MS and to obtain global quantitative changes of putative biomarkers via isotopic labeling. (3) To validate the biomarkers in blind diagnostic trials. Collectively, the proposed study will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample and it will also further our understanding of prion disease progression and pathology. This proposal explores a novel proteomic approach combining high sensitivity mass spectrometric profiling and sequencing with a set of bioinformatics tools to discover, identify, and quantify biomarkers that are indicative of prion infection. These putative biomarkers may also serve as targets for therapeutic intervention. Collectively, the proposed research will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample, enhancing our ability to secure food and blood supplies, and it will also further our understanding of prion disease progression and pathology.          ",A Proteomic Approach to Biomarker Discovery in Prion Disease,7501971,R21AI072588,"['Chronic Wasting Disease ', ' Bioinformatics ', ' Bio-Informatics ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Disease Outbreaks ', ' Outbreaks ', ' Detection ', ' Diagnostic Trial ', ' Predictive Value ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Family ', ' Prion Diseases ', ' spongiform encephalopathy ', ' spongiform degeneration ', ' Transmissible Spongiform Encephalopathies ', ' Transmissible Dementias ', ' Prion-Induced Disorder ', ' Prion Protein Diseases ', ' Prion Disease Pathway ', ' Food ', ' Formaldehyde ', ' Oxomethane ', ' Methyl Aldehyde ', ' Methanal ', ' Formic Aldehyde ', ' pre-clinical ', ' preclinical ', ' base ', ' Label ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Chronic ', ' Variant ', ' Variation ', ' Immunoassay ', ' Infection ', ' Screening procedure ', ' screenings ', ' screening ', ' Creutzfeldt-Jakob Syndrome ', ' Subacute Spongiform Encephalopathy ', ' Jakob-Creutzfeldt Disease ', ' Creutzfeldt-Jakob Disease ', ' Creutzfeldt-Jacob Disease ', ' CJDs (Creutzfeldt-Jakob Disease) ', ' CJD ', ' Serum ', ' Blood Serum ', ' Individual ', ' Numbers ', ' Measurement ', ' Disease Progression ', ' Methods ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Animals ', ' Pathology ', ' Antibodies ', ' Prions ', ' Prion Proteins ', ' PrP Proteins ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Diagnostic ', ' Research ', ' Scrapie ', ' Rida ', ' Sensitivity and Specificity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' United Kingdom ', ' United States ', ' Wasting Syndrome ', ' Wasting Disease ', ' Spectrometry ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Biological Markers ', ' Biologic Marker ', ' Body Fluids ', ' Early Diagnosis ', ' early detection ', ' tandem mass spectrometry ', ' cohort ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Secure ', ' novel ', ' new technology ', ' novel technologies ', ' Proteome ', ' Cerebrospinal Fluid ', ' spinal fluid ', ' cerebral spinal fluid ', ' Therapeutic Intervention ', ' intervention therapy ', ' Bovine Spongiform Encephalopathy ', ' Mad Cow Disease ', ' Bovine Spongiform Encephalitis ', ' Diagnostic tests ', ' Sampling ', ' Proteomics ', ' Classification ', ' Systematics ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Vascular blood supply ', ' vascular supply ', ' blood supply ', ' Neuraxis ', ' Central Nervous System ', ' CNS Nervous System ', ' blind ', ' Control Groups ', ' ']",NIAID,UNIVERSITY OF WISCONSIN-MADISON,R21,2008,136830,0.10936234579879688
"High-throughput annotation of glycan mass spectra     DESCRIPTION (provided by applicant): The correct functioning of many proteins depends on glycosylation, the addition of sugar molecules (glycans) to selected amino acids in the protein. For example, cancer cells have different glycosylation patterns than ordinary cells, and there is strong evidence that glycoproteins on the surface of egg cells play an essential role in sperm binding. Despite the importance of glycosylation, there are as yet no reliable, high-throughput methods for determining the identity and location of glycans. Glycan identification is currently a manual procedure for experts, involving a combination of chemical assays and mass spectrometry. The automation of the process would have a significant impact on our understanding of this important biological process. The proposed project aims to invent chemical procedures, algorithms, and software for high-throughput analysis of glycan mass spectrometry data. The goal is to bring glycan analysis up to the level of peptide analysis within 3 years. In contrast to peptide analysis, which can leverage genomics data, glycan analysis requires the incorporation of expert knowledge of synthetic pathways, in order to limit the huge number of theoretical combinations of monosaccharides to the much smaller number that are actually synthesized in nature. The project will have to develop novel representations for the evolving expert knowledge, because an exhaustive list- analogous to the human genome- is not currently known. Along with expert knowledge, the project will develop and validate machine learning and statistical techniques for glycan identification. In particular, the project will develop methods for internally calibrating spectra, and will learn fragmentation patterns that can statistically distinguish different types of glycosidic linkages.         ",High-throughput annotation of glycan mass spectra,7431760,R01GM074128,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Disclosure ', ' Information Disclosure ', ' Disease ', ' disease/disorder ', ' Disorder ', ' immune function ', ' Cellular Immune Function ', ' Address ', ' Data ', ' Range ', ' Modification ', ' Development ', ' developmental ', ' Facility Construction Funding Category ', ' Expert Systems ', ' Intelligent systems ', ' Pathway interactions ', ' pathway ', ' Human Genome ', ' human whole genome ', ' Age ', ' Glycoproteins ', ' glycosylation ', ' Metabolic Glycosylation ', ' Goals ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Algorithms ', ' Site ', ' Area ', ' Surface ', ' Specific qualifier value ', ' Specified ', ' Biological ', ' Link ', ' Chemicals ', ' Training ', ' Isomerism ', ' isomer ', ' Learning ', ' Libraries ', ' Numbers ', ' sugar ', ' enzyme activity ', ' Mammals ', ' Mammalia ', ' Manuals ', ' Amino Acids ', ' aminoacid ', ' Methods ', ' Monosaccharides ', ' Biological Process ', ' Biological Function ', ' Occupations ', ' Professional Postions ', ' Jobs ', ' Organism ', ' living system ', ' Peptides ', ' Play ', ' Polymers ', ' Polysaccharides ', ' Glycans ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Proteins ', ' gene product ', ' Nature ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Technology ', ' Work ', ' Automation ', ' Pattern ', ' Score ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Class ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' Speed (motion) ', ' Speed ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' C element ', ' Cartoons ', ' Cells ', ' glycosyltransferase ', ' Glycoside Transferases ', ' EC 2.4 ', ' Sampling ', ' Specialist ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Communities ', ' egg ', ' prototype ', ' Resolution ', ' Title ', ' Process ', ' ']",NIGMS,PALO ALTO RESEARCH CENTER,R01,2008,329296,0.11564226398340649
"Intelligent Aids for Proteomic Data Mining DESCRIPTION (provided by applicant): Primary purpose of this proposal is to provide the applicant with the means and structures for achieving two goals; (1) to develop intelligent computational aids for mining proteomic data accumulating from high throughput techniques like SELDI-TOF mass spectrometry; and (2) the long-term goal is to gain independence as a biomedical informatics researcher by developing methodological expertise in Bayesian methods and proteomic technologies. Applicant will obtain further instruction in probabilistic methods of data analysis; and she will receive education on proteomic technologies that are driving today's proteome research. Training will be provided through formal coursework, directed readings, seminars and conferences in addition to research directed by excellent mentors.  Applicant's research project involves a novel combination of techniques for use in proteomic data analysis. Previous research has included the use of techniques such as genetic algorithms and neural networks for analysis of proteomic data. These techniques were not explicitly designed to take into account background and prior knowledge. Hypothesis of this project is that background knowledge and machine learning techniques can positively influence the selection of appropriate biomarkers from proteomic data, enabling efficient and accurate analysis of massive datasets arising from proteomic profiling studies. Therefore, this project will satisfy four aims: (1) development of a wrapper-based machine learning tool; (2) augment the tool with prior knowledge such as heuristic rules and relationships in the data; (3) use these features along with de-identified patient information as input to classification systems; and (4) evaluate existing techniques for interpreting tandem mass spectrometry (MS-MS or MS/MS) data, and propose, implement and evaluate a Bayesian method for identification of peptides and proteins indicated by the MS-MS spectrum. ",Intelligent Aids for Proteomic Data Mining,7460715,K25GM071951,"['data mining ', ' datamining ', ' Educational aspects ', ' Education ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Genetic Programming ', ' Genetic Algorithm ', ' Development ', ' developmental ', ' analytical method ', ' base ', ' Goals ', ' Link ', ' Training ', ' Learning ', ' Bayesian Method ', ' Mentors ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mining ', ' Patients ', ' Peptides ', ' Problem Solving ', ' tool ', ' Proteins ', ' gene product ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Spectrometry ', ' Automobile Driving ', ' driving ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Class ', ' Biological Markers ', ' Biologic Marker ', ' heuristics ', ' Biological Neural Networks ', ' neural network ', ' tandem mass spectrometry ', ' Structure ', ' novel ', ' Prevention ', ' Today ', ' Proteome ', ' symposium ', ' conference ', ' Pathway Analysis ', ' Network Analysis ', ' Proteomics ', ' Classification ', ' Systematics ', ' Accounting ', ' Instruction ', ' biomedical informatics ', ' biomed informatics ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Data Analyses ', ' Data Analysis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Purpose ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K25,2008,132674,0.14164761923269487
"Information-Theoretic Based CAD in Mammography DESCRIPTION (provided by applicant):    The purpose of the study is to develop and evaluate a novel computer-assisted decision (CAD) scheme for improving the clinical detection of breast masses in screening mammograms. The CAD scheme combines information-theoretic similarity metrics with knowledge-based decision algorithms. It will help radiologists scrutinize mammograms providing evidence-based decision support. Given a query mammographic region, the CAD system will interrogate a database of archived mammograms, examine similar eases, and assign a likelihood measure regarding the presence of a potentially malignant mass.  The study proposes the formulation of information-theoretic metrics to quantify the similarity of two mammographic regions. The similarity metrics are based on Sharmon's entropy; a measure of complexity (or information) contained in an image. Theoretically, if two mammographic regions depict similar structures, they should contain diagnostic information for each other. The amount of relevant diagnostic information can be measured by entropy-based similarity metrics that are computed directly from the images without requiring segmentation or feature extraction. Using the similarity metrics and an image databank of mammographic cases with known truth, a knowledge-bussed CAD scheme will be implemented for the detection of masses in screening mammograms. Preliminary studies have established that standard mutual information (MI) is an effective similarity metric for the task.  The specific aims of the study are: (1) To fully exploit information-theoretic metrics that measure the similar content of two mammographic regions, (2) To optimize their contributions in an evidence-based decision algorithm for the early detection of potentially malignant masses, and (3) To perform preliminary clinical evaluation of the CAD system.  As digital image libraries are an upcoming trend in radiology, the proposed CAD system will take advantage of continuously deposited mammograms with established ground truth. The system aims to reduce the interpretation error associated with screening mammograms and/or the false positives generated by cuing CAD schemes, Overall, the study aims to improve the sensitivity while maintaining or improving the specificity of screening mammography for masses. ",Information-Theoretic Based CAD in Mammography,7336275,R01CA101911,"['Cues ', ' Diagnosis ', ' Purpose ', ' Detection ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' Scheme ', ' trend ', ' Image ', ' imaging ', ' Standards of Weights and Measures ', ' base ', ' concept ', ' Computer Interface ', ' improved ', ' Algorithms ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Information Theory ', ' Screening procedure ', ' screenings ', ' screening ', ' Knowledge Base (Computer) ', ' Libraries ', ' Mass in breast ', ' Breast Nodule ', ' Breast Lump ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Mammography ', ' Mammogram ', ' radiologist ', ' RDST ', ' Physicians ', ' Deposition ', ' Deposit ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Diagnostic ', ' Archives ', ' Entropy ', ' Knowledge ', ' Specificity ', ' statistics ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Drug Formulations ', ' Formulation ', ' digital imaging ', ' computer imaging ', ' Early Diagnosis ', ' early detection ', ' knowledge base ', ' knowledgebase ', ' Structure ', ' novel ', ' Metric ', ' Measures ', ' Uncertainty ', ' doubt ', ' Classification ', ' Systematics ', ' Computer Assisted ', ' computer aided ', ' ']",NCI,DUKE UNIVERSITY,R01,2008,230712,0.15429392872498382
"Peptide Biomarker Discovery by Mass Spectrometry for Early Detection of Liver Can    DESCRIPTION (provided by applicant):  Mass spectrometry (MS) has the promise to provide a noninvasive screening mechanism on easily accessible fluids such as plasma, serum, and urine. The characterization of peptides in these biological fluids is one of the promising strategies for biomarker discovery. However, peptide profiles obtained through current mass spectrometric methods are characterized by their high dimensionality and complex patterns with substantial amount of noise. The presence of biological variability and disease heterogeneity in human samples from diverse populations adds to the complexity of the problem. Thus, in addition to innovative analytical methods desired for sample preparation, peptide identification, and validation, robust computational methods are needed for optimal selection of useful peptidic markers. This collaborative project brings together experts in bioinformatics, biostatistics, proteomics, and mass spectrometry to develop analytical tools that address the above challenges. The specific aims are the following: (1) To develop fuzzy logic based methods to detect and calibrate MS peaks. Our peak detection method will identify peaks in a way that is consistent with peaks detected manually by MS experts. Peaks will be calibrated to accommodate isotopic distributions and machine drifts. (2) To investigate machine learning- based peak selection methods that take into account biological variability and disease heterogeneity of the human population. Spike-in and simulation studies will be conducted to obtain spectra whose true inputs are known. The spectra from these studies will be used to optimize our peak detection/calibration and selection methods, and compare the methods with other existing solutions. The optimized analytical tools will be applied to find and validate markers that detect hepatocellular carcinoma (HCC) at a treatable stage. Serum samples collected from cirrhotic and HCC patients as well as healthy controls in Egypt, United States, and Thailand will be used in this study. Mass spectra will be generated using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS of enriched low molecular weight (LMW) serum fractions of the samples. From these spectra, the most useful panel of peaks will be identified using the proposed peak detection, calibration, and selection methods. The selected peaks will be sequenced to identify the peptides they represent. Finally, the identity of the peptides and their ability to detect HCC will be examined using isotope dilution by synthesizing 13C-labeled peptide standards. The synergetic interaction of diverse disciplines contributes to the intellectual merit of this project, leading to analytical tools that will make scientific knowledge discovery more efficient. Analytical tools developed in this project will be useful for other biomarker discovery studies, where the analysis of high-dimensional mass spectral data is needed. The tools will be freely available (open source) to mass spectrometry users. PUBLIC HEALTH RELEVANCE:  Development of a diagnostic test would be of great benefit for detection of hepatocellular carcinoma (HCC) at a treatable stage. In particular, defining clinically applicable biomarkers that detect early-stage HCC in a high-risk population of cirrhotic patients has potentially far-reaching consequences for disease management and patient health. This project is important because most HCC patients present with advanced-stage disease and poor prognosis. There is a pressing need to identify biomarkers of HCC that could be used for early detection and more accurate classification of disease. This project will lead to the development of analytical tools to find and validate early-diagnosis candidate peptide biomarkers from high- dimensional MALDI-TOF spectra of low-molecular-weight serum fractions. In addition to screening high-risk populations for early signs of disease, the resulting biomarkers could be used to design and test improved treatment strategies.          ",Peptide Biomarker Discovery by Mass Spectrometry for Early Detection of Liver Can,7531854,R21CA130837,"['Bioinformatics ', ' Bio-Informatics ', ' Commit ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Egypt ', ' Address ', ' Data ', ' Detection ', ' Early Detection Research Network ', ' National Detection Research Network ', ' EDRN ', ' Information Resources ', ' knowledge resources ', ' knowledge resource ', ' information resource ', ' Resolution ', ' Subgroup ', ' Comprehensive Cancer Center ', ' MALDI-TOF Mass Spectrometry ', ' Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry ', ' Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS ', ' Newly Diagnosed ', ' Validation ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Cirrhosis ', ' Fuzzy Logic ', ' Standards of Weights and Measures ', ' analytical method ', ' base ', ' Goals ', ' Label ', ' improved ', ' Health ', ' Primary carcinoma of the liver cells ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Clinical ', ' Biological ', ' Ensure ', ' Screening procedure ', ' screenings ', ' screening ', ' Isotopes ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Discipline ', ' Individual ', ' Linguistics ', ' Linguistic ', ' Numbers ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Michigan ', ' Molecular Weight ', ' Letters ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Noise ', ' Liquid substance ', ' liquid ', ' fluid ', ' Patients ', ' Peptides ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Staging ', ' outcome forecast ', ' Prognosis ', ' tool ', ' Proteins ', ' gene product ', ' public health medicine (field) ', ' Public Health ', ' radius bone structure ', ' Radius Bone ', ' Radial Bone ', ' instrument ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Running ', ' Sampling Studies ', ' Shoulder ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Knowledge ', ' Disease Management ', ' Disorder Management ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' Thailand ', ' Time ', ' United States ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Spectrometry ', ' Complex ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Biological Markers ', ' Biologic Marker ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Medical center ', ' Early Diagnosis ', ' early detection ', ' tandem mass spectrometry ', ' Calibration ', ' simulation ', ' Participant ', ' member ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' disease classification ', ' nosology ', ' disorder classification ', ' Screening for Hepatocellular Cancer ', ' screening for liver cancer ', ' liver cancer detection ', ' early liver cancer detection ', ' Code ', ' Coding System ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Morphologic artifacts ', ' Artifacts ', ' Diagnostic tests ', ' Population Heterogeneity ', ' heterogeneous population ', ' diverse populations ', ' Sampling ', ' desire ', ' Proteomics ', ' liquid chromatography mass spectrometry ', ' LC/MS ', ' Accounting ', ' design ', ' designing ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' open source ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCI,GEORGETOWN UNIVERSITY,R21,2008,172688,0.21447280264737498
"Computational approaches to protein identification and quantification using MS/MS    DESCRIPTION (provided by applicant): Shotgun proteomics is one of the most commonly used approaches to MS-based biomarker discovery, due to its high throughput and sensitivity. The general strategy involves simultaneous protease digestion of all proteins in a mixture, liquid chromatography-based separation of peptides and analysis by tandem mass spectrometry (MS/MS) to produce fragmentation spectra of each peptide. Each experimental spectrum is searched against a protein database. Sequences that best match the experimental spectra are considered identified, while a set of reliably identified peptides from the same protein is necessary for a reliable protein identification. The main goal in the proposed work is to generate and interrogate MS/MS data from several proteomics platforms, including ESI/MS, MALDI/TOF/TOF, LC-IMS/TOF and MALDI-PID/TOF to develop customized computational tools that address several challenging problems in shotgun proteomics data analysis: peptide identification, protein identification and label-free protein quantification. Our proposed approach is data-driven. At its core is the application of machine learning methods to the prediction of peptide fragmentation spectra as well as the likelihood of peptide detection in a typical proteomics experiment. Improved peptide identification coupled with the predicted peptide delectability will then be used to develop new methods for improved protein identification and quantification. The methods proposed herein will be extensively evaluated and software will be made public both as web-based tools and open-source deliverables. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies might entail disease diagnosis (biomarker discovery), disease progression (tissue profiling), or effects of treatment (drug-induced proteome changes). These studies will enhance understanding of diseases and hasten the development of effective treatments and cures. In addition, these tools will be useful in characterizing new analytical tools for proteome analysis. Here we propose to develop and extensively evaluate computational methodology that will be used to improve the interpretation of tandem mass spectrometry data. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies that might entail disease diagnosis, disease progression, or effects of treatment, will enhance understanding of diseases and hasten the development of effective treatments and cures.          ",Computational approaches to protein identification and quantification using MS/MS,7387128,R01RR024236,"['Data Analyses ', ' Data Analysis ', ' Diagnosis ', ' Digestion ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data Set ', ' Dataset ', ' Caring ', ' Data ', ' Detection ', ' Scheme ', ' Numerical value ', ' Development ', ' developmental ', ' Output ', ' Standards of Weights and Measures ', ' base ', ' concept ', ' Goals ', ' Label ', ' improved ', ' Health ', ' Algorithms ', ' Ions ', ' Chemicals ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Disease Progression ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Methods ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Peptide Hydrolases ', ' Proteolytic Enzymes ', ' Proteinases ', ' Proteases ', ' Peptidases ', ' Esteroproteases ', ' Endopeptidases ', ' Peptide Peptidohydrolases ', ' Peptides ', ' Probability ', ' Problem Formulations ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Condition ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Shotguns ', ' Computer software ', ' computer program/software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Peptide Library ', ' Knowledge ', ' programs ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Trypsin ', ' Tripcellim ', ' Work ', ' Score ', ' Techniques ', ' Biological Markers ', ' Biologic Marker ', ' tandem mass spectrometry ', ' Informatics ', ' Structure ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Disease regression ', ' Peptide Sequence Determination ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Proteome ', ' Measures ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Relative (related person) ', ' Relative ', ' Liquid Chromatography ', ' Sampling ', ' Protein Databases ', ' Proteomics ', ' Accounting ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' Coupled ', ' analytical tool ', ' treatment effect ', ' open source ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCRR,INDIANA UNIVERSITY BLOOMINGTON,R01,2008,267731,0.15867204632033174
"Novel Machine Learning Methods for Analysis of MALDI-TOF Mass Spectrometry Data    DESCRIPTION (provided by applicant):       Hepatocellular carcinoma (HCC) is a common cancer worldwide with as many as 500,000 new cases each year. Between 1981 to 1998, the 5-year patient survival rate with HCC only rose from 2% to 5%. This poor survival rate is in part related to the diagnosis of HCC at advanced stages, where effective therapies are lacking. Early detection of HCC improves patient survival. Patients with cirrhosis are typically the ones to develop HCC. Hence, monitoring cirrhotic patients can potentially decrease the cancer-related mortality rate. The poor sensitivity and specificity of currently available tools has prevented widespread implementation of HCC surveillance. Therefore, additional serum markers that provide higher sensitivity and specificity are needed to improve the detection rate of early HCC. The goal of this collaborative project is to identify a panel of serum biomarkers for early diagnosis of HCC. The long-term goal is to find and validate markers that would help identify HCC at a treatable stage in high-risk population of cirrhotic patients. This project will lead to the development of innovative mass spectral data preprocessing and biomarker selection methods that for the identification of candidate biomarkers specific to HCC by using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (MS) of low-molecular-weight (LMW) enriched sera. The specific aims of the project are the following: Aim 1: To develop algorithms for improved MALDI-TOF mass spectral data preprocessing including outlier screening, binning, smoothing, baseline correction, normalization, peak detection, and peak calibration. The proposed algorithms will enable us to reduce run-to-run variability in replicate spectra of a standard serum and to enhance the prediction accuracy in distinguishing HCC patients from cirrhotic patients or healthy individuals. Aim 2: To develop a novel algorithm that is superior to currently used biomarker selection methods by combining two popular machine learning methods, particle swarm optimization (PSO) and support vector machines (SVMs). The proposed algorithm will be used to identify HCC-specific markers from the preprocessed MALDI-TOF spectra. To avoid confounding effects, peaks will be removed prior to biomarker selection if they are associated with viral infection or covariates such as age, gender, smoking status, drinking status, and residency (urban or rural). From the remaining peaks, a small set of candidate biomarkers that accurately distinguishes HCC patients from cirrhotic patients will be identified. The capability of the algorithm to identify a small set of markers with high sensitivity and specificity is critical for establishment of clinical tests. Additionally, the algorithm will identify markers that distinguish various pairs (normal vs. cirrhosis, normal vs. HCC, cirrhosis vs. early-stage HCC, and cirrhosis vs. late-stage HCC). This will enable us to isolate HCC- specific markers and identify disease progression markers. Furthermore, the peptides represented by the selected candidate biomarkers will be identified. Finally, the performance of the algorithm will be compared with existing methods.           ",Novel Machine Learning Methods for Analysis of MALDI-TOF Mass Spectrometry Data,7367013,R03CA119313,"['Bioinformatics ', ' Bio-Informatics ', ' Inflammatory Response ', ' Diagnosis ', ' prevent ', ' preventing ', ' Data ', ' Detection ', ' Analytical Biochemistry ', ' Collection ', ' MALDI-TOF Mass Spectrometry ', ' Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry ', ' Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS ', ' Newly Diagnosed ', ' Smoking Status ', ' Monitor ', ' Preparation ', ' Rate ', ' Development ', ' developmental ', ' Cirrhosis ', ' Serum Markers ', ' Standards of Weights and Measures ', ' Age ', ' base ', ' Goals ', ' improved ', ' Primary carcinoma of the liver cells ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Algorithms ', ' Clinical ', ' Variant ', ' Variation ', ' Logistic Regressions ', ' Ensure ', ' Screening procedure ', ' screenings ', ' screening ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Rural ', ' Disease Progression ', ' Methods ', ' Molecular Weight ', ' Mortality Vital Statistics ', ' Mortality ', ' oncology ', ' Oncology Cancer ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Patient Monitoring ', ' Patients ', ' Peptides ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Figs - dietary ', ' Figs ', ' Research ', ' Residencies ', ' Risk ', ' Rosa ', ' Rose ', ' Running ', ' Sensitivity and Specificity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Survival Rate ', ' Testing ', ' Time ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Spectrometry ', ' Viral ', ' Biological Markers ', ' Biologic Marker ', ' Early Diagnosis ', ' early detection ', ' particle ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' drinking ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' Gender ', ' Generations ', ' Measures ', ' Code ', ' Coding System ', ' Liquid Chromatography ', ' Modeling ', ' Sampling ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' mass spectrometer ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCI,GEORGETOWN UNIVERSITY,R03,2008,77600,0.12884144199284772
"Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses    DESCRIPTION (provided by applicant): Digital tomosynthesis mammography (DTM) is a new modality that holds the promise of improving mammographic sensitivity of breast cancer detection and diagnosis, especially for dense breasts. The main goals of the proposed research are (1) to develop a computer-aided detection (CADd) system for breast masses in DTM, (2) to develop a computer-aided diagnosis (CADx) system for classification of malignant and benign masses in DTM, and (3) to evaluate the effects of CAD (either CADd or CADx) on radiologists' interpretation of DTMs. Previous CAD systems are developed for regular projection mammograms (PMs).The proposed CAD system makes use of the 3-dimensional (3D) information in DTM to improve mass detection and characterization. The innovations in the proposed project include: (1) development of new computer-vision techniques to exploit the 3D volumetric information in DTMs, (2) evaluation of the dependence of CAD performance on reconstruction algorithms, and (3) comparison of computerized mass detection and characterization in DTMs, projection view mammograms (PVs) (the non-reconstructed mammograms taken at multiple angles during tomosynthesis imaging), and PMs. We hypothesize that detection and characterization of masses on DTMs will be more accurate than corresponding tasks on regular PMs, and that the CAD systems can improve radiologists' accuracy. 3D breast phantoms with test objects will be designed and imaged with a prototype DTM system. The dependence of DTM image quality on reconstruction algorithms and their parameters, and on image acquisition techniques will be studied. The appropriate reconstruction techniques will be selected based on phantom and patient studies. A database of DTMs and corresponding PMs with malignant and benign masses and a set of normal cases will be collected with patient informed consent. CAD systems for detection and classification of masses will be developed. Two approaches will be compared: one uses the reconstructed DTM slices and the other uses the PVs as input to the CAD systems. For the DTMs, new techniques for 3D preprocessing, image segmentation, feature extraction, and feature classification will be designed. For the PVs, our previous techniques developed for regular PMs will be adapted to these low- dose images, and information fusion methods using techniques such as neural networks or support vector machines will be developed to merge the multiple-PV information. To test our hypotheses, we will compare the CAD system performances from these two approaches and that from the corresponding regular PMs, and conduct observer ROC studies to evaluate effects of the CAD systems on radiologists' performance. CAD will be an important tool that can help accelerate the implementation of DTM in clinical practice. DTM with CAD is expected to help fully utilize the potential of this new modality to improve breast cancer detection.           ",Digital Tomosynthesis Mammography: Computer-Aided Analysis of Masses,7668403,R33CA120234,"['Database Management Systems ', ' relational database management systems ', ' Data Base Management Systems ', ' Diagnosis ', ' Computer-Assisted Diagnosis ', ' Computer aided diagnosis ', ' imaging modality ', ' imaging method ', ' Dose ', ' TimeLine ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Collection ', ' Slice ', ' Process ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Benign ', ' Malignant - descriptor ', ' Malignant ', ' Specific qualifier value ', ' Specified ', ' Phase ', ' Image Reconstructions ', ' Informed Consent ', ' Evaluation ', ' Training ', ' Lesion ', ' Mass in breast ', ' Breast Nodule ', ' Breast Lump ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Mammography ', ' Mammogram ', ' Methods ', ' radiologist ', ' RDST ', ' Imaging Phantoms ', ' Patients ', ' Staging ', ' tool ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Dependence ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' 3-Dimensional ', ' 3-D ', ' experience ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' Breast ', ' Modality ', ' Abbreviations ', ' Classification ', ' Systematics ', ' reconstruction ', ' digital ', ' computerized ', ' Computer Assisted ', ' computer aided ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' imaging Segmentation ', ' graphical user interface ', ' graphic user interface ', ' Graphical interface ', ' prototype ', ' clinical practice ', ' Computer Vision Systems ', ' computer vision ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R33,2009,389926,0.07479768660762637
"Computational approaches to protein identification and quantification using MS/MS    DESCRIPTION (provided by applicant): Shotgun proteomics is one of the most commonly used approaches to MS-based biomarker discovery, due to its high throughput and sensitivity. The general strategy involves simultaneous protease digestion of all proteins in a mixture, liquid chromatography-based separation of peptides and analysis by tandem mass spectrometry (MS/MS) to produce fragmentation spectra of each peptide. Each experimental spectrum is searched against a protein database. Sequences that best match the experimental spectra are considered identified, while a set of reliably identified peptides from the same protein is necessary for a reliable protein identification. The main goal in the proposed work is to generate and interrogate MS/MS data from several proteomics platforms, including ESI/MS, MALDI/TOF/TOF, LC-IMS/TOF and MALDI-PID/TOF to develop customized computational tools that address several challenging problems in shotgun proteomics data analysis: peptide identification, protein identification and label-free protein quantification. Our proposed approach is data-driven. At its core is the application of machine learning methods to the prediction of peptide fragmentation spectra as well as the likelihood of peptide detection in a typical proteomics experiment. Improved peptide identification coupled with the predicted peptide delectability will then be used to develop new methods for improved protein identification and quantification. The methods proposed herein will be extensively evaluated and software will be made public both as web-based tools and open-source deliverables. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies might entail disease diagnosis (biomarker discovery), disease progression (tissue profiling), or effects of treatment (drug-induced proteome changes). These studies will enhance understanding of diseases and hasten the development of effective treatments and cures. In addition, these tools will be useful in characterizing new analytical tools for proteome analysis. Here we propose to develop and extensively evaluate computational methodology that will be used to improve the interpretation of tandem mass spectrometry data. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies that might entail disease diagnosis, disease progression, or effects of treatment, will enhance understanding of diseases and hasten the development of effective treatments and cures.          ",Computational approaches to protein identification and quantification using MS/MS,7683963,R01RR024236,"['Data Analyses ', ' Data Analysis ', ' Digestion ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data Set ', ' Dataset ', ' Caring ', ' Data ', ' Detection ', ' Scheme ', ' Numerical value ', ' Development ', ' developmental ', ' Output ', ' base ', ' Goals ', ' Label ', ' improved ', ' Health ', ' Algorithms ', ' Ions ', ' Chemicals ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Disease Progression ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Methods ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Peptide Hydrolases ', ' Proteolytic Enzymes ', ' Proteinases ', ' Proteases ', ' Peptidases ', ' Esteroproteases ', ' Peptides ', ' Probability ', ' Problem Formulations ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Shotguns ', ' Computer software ', ' computer program/software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Peptide Library ', ' Knowledge ', ' programs ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Trypsin ', ' Tripcellim ', ' Work ', ' Techniques ', ' tandem mass spectrometry ', ' Informatics ', ' Structure ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Peptide Sequence Determination ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Proteome ', ' Measures ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Relative (related person) ', ' Relative ', ' Liquid Chromatography ', ' Sampling ', ' Protein Databases ', ' Proteomics ', ' Accounting ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' Coupled ', ' analytical tool ', ' treatment effect ', ' open source ', ' effective therapy ', ' effective treatment ', ' biomarker ', ' disease diagnosis ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCRR,INDIANA UNIVERSITY BLOOMINGTON,R01,2009,268677,0.15867204632033174
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Project summary: Mass spectrometry, the core technology in the field of proteomics, promises to enable scientists to identify and quantify the entire complement of molecules that comprise a complex biological sample. In the biological and health sciences, mass spectrometry is commonly used in a nigh-throughput fashion to identify proteins in a mixture. Currently, the primary bottleneck in this type of experiment is computational. Existing algorithms for interpreting mass spectra are slow and fail to identify a large proportion of the given spectra. We propose to apply techniques and tools from the field of machine learning to the analysis of mass spectrometry data. We will build computational models of peptide fragmentation within the mass spectrometer, as well as larger-scale models of the entire mass spectrometry process. Using these models, we will design and validate algorithms for identifying the set of proteins that best explain an observed set of spectra. Software implementations for all of the methods will be made publicly available in a user-friendly form. In practical terms, this software will enable scientists to more easily, efficiently and accurately analyze and understand their mass spectrometry data. Relevance: The applications of mass spectrometry and its promises for improvements of human health are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens.           ",Machine learning analysis of tandem mass spectra,7581004,R01EB007057,"['Complex Mixtures ', ' small molecule ', ' FOLH1 gene ', ' PSM ', ' NAALAD1 ', ' FOLH1 ', ' FOLH ', ' Data ', ' Health Sciences ', ' Protein Biochemistry ', ' Protein/Amino Acid Biochemistry ', ' Collection ', ' Preparation ', ' Principal Investigator ', ' Molecular ', ' Process ', ' Set protein ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Source Code ', ' improved ', ' Procedures ', ' Hand ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Area ', ' Biological ', ' Biochemical ', ' prognostic ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Peptide Fragments ', ' Peptides ', ' Staging ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' tool ', ' Proteins ', ' gene product ', ' Receiver Operating Characteristics ', ' Diagnostic ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Running ', ' Blast Cell ', ' Hemohistioblast ', ' Hemocytoblast ', ' Hematohistioblast ', ' Ferrata cell ', ' Blasts ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Scientist ', ' Time ', ' Work ', ' Authorship ', ' Hour ', ' Complex ', ' Techniques ', ' interest ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' expectation ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Devices ', ' Carbonyl Cyanide m-Chlorophenyl Hydrazone ', ' Propanedinitrile, ((3-chlorophenyl)hydrazono)- ', ' Carbonyl Cyanide meta-Chlorophenyl Hydrazone ', ' CCCP ', ' Abbreviations ', ' Dissociation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model design ', ' Complement ', ' Complement Proteins ', ' disease phenotype ', ' mass spectrometer ', ' computer based statistical methods ', ' Bayesian Networks ', ' markov model ', ' design ', ' designing ', ' user-friendly ', ' task analysis ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' ']",NIBIB,UNIVERSITY OF WASHINGTON,R01,2009,607717,0.31162898417224394
"A Proteomic Approach to Biomarker Discovery in Prion Disease    DESCRIPTION (provided by applicant): Transmissible spongiform encephalopathies (TSEs) are a unique family of neurodegenerative diseases of the central nervous system that are always fatal. Of the various forms of prion disease, those with the most impact upon human and animal health are Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (BSE), scrapie and chronic wasting disease (CWD). The outbreaks of BSE and variant CJD (vCJD) in the United Kingdom and worldwide, including the United States, has prompted the need for rapid, reliable and inexpensive screening methods that detect TSE infection in humans and live animals. Current diagnostic tests for prion disease have, thus far, focused on detection of the causal agent of the disease, the abnormal prion protein, or individual proteins that correlate with the neurological disease. These tests are inadequate because they are post-mortem, low throughput and not sufficiently sensitive to detect infection early in the pre-clinical period. Clearly, there is an urgent need for the development of a reliable, sensitive, and specific ante-mortem diagnostic test for the pre-clinical identification of TSE-infected animals or individuals. Herein we propose the development of a new highly-sensitive mass spectrometry (MS)-based analytical platform in combination with a suite of bioinformatics tools to identify a panel of biomarkers of prion disease in body fluids collected from live animals infected with prion disease during the preclinical incubation period. The guiding hypotheses of the proposed research are: (1) The pathophysiological changes associated with prion infection will result in an altered protein profile of the cerebrospinal fluids (CSF) and/or serum proteome. (2) The combination of accurate mass measurements, isotopic labeling strategy for quantitative analyses, tandem mass spectrometry, and a suite of machine-learning algorithms will provide a unique and integrated platform to identify and characterize these diagnostic protein markers with unprecedented sensitivity and specificity. (3) Characterization of these diagnostic protein biomarkers will provide a basis for the development of an ante-mortem antibody-based screening test for prion diseases in suspected animals. To investigate these hypotheses, we propose the following specific aims: (1) To identify a panel of candidate biomarkers in the CSF and serum of animals infected with prion diseases using MS and classification algorithms. (2) To determine the identities of the candidate biomarkers by tandem MS and to obtain global quantitative changes of putative biomarkers via isotopic labeling. (3) To validate the biomarkers in blind diagnostic trials. Collectively, the proposed study will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample and it will also further our understanding of prion disease progression and pathology. This proposal explores a novel proteomic approach combining high sensitivity mass spectrometric profiling and sequencing with a set of bioinformatics tools to discover, identify, and quantify biomarkers that are indicative of prion infection. These putative biomarkers may also serve as targets for therapeutic intervention. Collectively, the proposed research will provide a basis for the development of a rapid and sensitive diagnosis of prion disease in an ante-mortem sample, enhancing our ability to secure food and blood supplies, and it will also further our understanding of prion disease progression and pathology.          ",A Proteomic Approach to Biomarker Discovery in Prion Disease,7846704,R21AI072588,"['Chronic Wasting Disease ', ' Bioinformatics ', ' Bio-Informatics ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Disease Outbreaks ', ' Outbreaks ', ' Detection ', ' Diagnostic Trial ', ' Predictive Value ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Family ', ' Prion Diseases ', ' spongiform encephalopathy ', ' spongiform degeneration ', ' Transmissible Spongiform Encephalopathies ', ' Transmissible Dementias ', ' Prion-Induced Disorder ', ' Prion Protein Diseases ', ' Prion Disease Pathway ', ' Food ', ' Formaldehyde ', ' Oxomethane ', ' Methyl Aldehyde ', ' Methanal ', ' Formic Aldehyde ', ' pre-clinical ', ' preclinical ', ' base ', ' Label ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Variant ', ' Variation ', ' Immunoassay ', ' Infection ', ' Screening procedure ', ' screenings ', ' screening ', ' Creutzfeldt-Jakob Syndrome ', ' Subacute Spongiform Encephalopathy ', ' Jakob-Creutzfeldt Disease ', ' Creutzfeldt-Jakob Disease ', ' Creutzfeldt-Jacob Disease ', ' CJDs (Creutzfeldt-Jakob Disease) ', ' CJD ', ' Serum ', ' Blood Serum ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Methods ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Animals ', ' Pathology ', ' Antibodies ', ' Prions ', ' Prion Proteins ', ' PrP Proteins ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Diagnostic ', ' Research ', ' Scrapie ', ' Rida ', ' Sensitivity and Specificity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' United Kingdom ', ' United States ', ' protein profiling ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Body Fluids ', ' Early Diagnosis ', ' early detection ', ' tandem mass spectrometry ', ' cohort ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Secure ', ' novel ', ' new technology ', ' novel technologies ', ' Proteome ', ' Cerebrospinal Fluid ', ' spinal fluid ', ' cerebral spinal fluid ', ' Therapeutic Intervention ', ' intervention therapy ', ' Bovine Spongiform Encephalopathy ', ' Mad Cow Disease ', ' Bovine Spongiform Encephalitis ', ' Diagnostic tests ', ' Sampling ', ' Proteomics ', ' Classification ', ' Systematics ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Vascular blood supply ', ' vascular supply ', ' blood supply ', ' Neuraxis ', ' Central Nervous System ', ' CNS Nervous System ', ' blind ', ' candidate marker ', ' biomarker ', ' Control Groups ', ' ']",NIAID,UNIVERSITY OF WISCONSIN-MADISON,R21,2009,19341,0.10936234579879688
"Improving Breast Cancer Detection and Diagnosis with CAD    DESCRIPTION (provided by applicant): Computer-aided detection (CAD) of breast cancer is rapidly becoming a well accepted clinical practice. Studies have found that radiologists' attitude toward and acceptance of CAD-cued micro-calcification clusters and masses were substantially different. Due to the high sensitivity, radiologists heavily rely on CAD-cued results while searching for micro-calcifications. However, the lower CAD sensitivity for mass detection (including a fraction of subtle masses being cued only on one view) and the higher false-positive detection (FP) rates reduce radiologists' confidence in CAD-cued masses. As a result, radiologists frequently discard CAD-cued subtle masses in the clinical practice. To improve CAD performance and increase radiologists' confidence in using CAD-cued masses in their decision making, we propose two observer-focused innovative approaches to develop and optimize CAD schemes. By maintaining a comparable FP rate to current commercial CAD systems, the new approaches aim to either increase the number of masses being cued on both ipsilateral (CC and MLO) views or cue more subtle masses by eliminating a fraction of other regions that can be easily identified and classified by radiologists without using CAD. To test these approaches, we propose three specific tasks. First, we will develop a unique multi-view based CAD scheme. To more sensitively detect and better match subtle mass regions, we introduce a concept of limited viewing of specific regions into the arena of CAD development. After detecting a matching strip on the ipsolateral view, the scheme applies a second highly sensitive detection scheme only to this strip to identify matched regions. To control for and reduce FP rates, the scheme limits the number of possible matched candidates to less than one per image. Second, we will develop an integrated CAD scheme that includes a combined score for both detection and classification. To improve direct use of features computed by the detection module in the classification task, we will apply a new dual active contour algorithm that should improve mass region segmentation. We will separately optimize two machine learning classifiers to generate a detection score (the likelihood of being a true-positive mass) and a classification score (the likelihood of each detected mass for malignancy) for each segmented region. We will then develop a fusion method to combine these two scores and generate a new summary index that is more heavily weighted for subtle masses. Using this scheme, we can change the current mass detection based cuing method to a new cancer-based cueing method. Third, we will conduct a pilot observer performance study to investigate radiologists' performance under three CADcueing modes (using the current commercial single-image based, the new multi-view based, and the new integrated CAD schemes). The reading results will be compared and analyzed using both ROC and JAFROC methodologies. We note that the approach is substantially different than focusing on incremental improvements in image based detection schemes in that the observer's actual use (or not) of the CADcued regions drives our objectives in this project, resulting in a targeted development effort.          ",Improving Breast Cancer Detection and Diagnosis with CAD,7617655,R01CA077850,"['radiologist ', ' RDST ', ' Perception ', ' Play ', ' Reading ', ' Diagnostic ', ' Research ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Time ', ' Attention ', ' Attitude ', ' Investigation ', ' Weight ', ' Work ', ' Ipsilateral ', ' System ', ' LOINC Axis 4 System ', ' Performance ', ' Breast ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Reporting ', ' visual search ', ' Classification ', ' Systematics ', ' Computer Assisted ', ' computer aided ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' innovation ', ' innovative ', ' innovate ', ' clinical practice ', ' Cues ', ' Data Analyses ', ' Data Analysis ', ' Decision Making ', ' Diagnosis ', ' Environment ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Detection ', ' Cancer Detection ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scheme ', ' Process ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Eye ', ' Eyeball ', ' Image ', ' imaging ', ' calcification ', ' base ', ' improved ', ' Hybrids ', ' Algorithms ', ' Area ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Specific qualifier value ', ' Specified ', ' indexing ', ' Lesion ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' ']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2009,246949,0.24752795390064436
"Peptide Biomarker Discovery by Mass Spectrometry for Early Detection of Liver Can    DESCRIPTION (provided by applicant):  Mass spectrometry (MS) has the promise to provide a noninvasive screening mechanism on easily accessible fluids such as plasma, serum, and urine. The characterization of peptides in these biological fluids is one of the promising strategies for biomarker discovery. However, peptide profiles obtained through current mass spectrometric methods are characterized by their high dimensionality and complex patterns with substantial amount of noise. The presence of biological variability and disease heterogeneity in human samples from diverse populations adds to the complexity of the problem. Thus, in addition to innovative analytical methods desired for sample preparation, peptide identification, and validation, robust computational methods are needed for optimal selection of useful peptidic markers. This collaborative project brings together experts in bioinformatics, biostatistics, proteomics, and mass spectrometry to develop analytical tools that address the above challenges. The specific aims are the following: (1) To develop fuzzy logic based methods to detect and calibrate MS peaks. Our peak detection method will identify peaks in a way that is consistent with peaks detected manually by MS experts. Peaks will be calibrated to accommodate isotopic distributions and machine drifts. (2) To investigate machine learning- based peak selection methods that take into account biological variability and disease heterogeneity of the human population. Spike-in and simulation studies will be conducted to obtain spectra whose true inputs are known. The spectra from these studies will be used to optimize our peak detection/calibration and selection methods, and compare the methods with other existing solutions. The optimized analytical tools will be applied to find and validate markers that detect hepatocellular carcinoma (HCC) at a treatable stage. Serum samples collected from cirrhotic and HCC patients as well as healthy controls in Egypt, United States, and Thailand will be used in this study. Mass spectra will be generated using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS of enriched low molecular weight (LMW) serum fractions of the samples. From these spectra, the most useful panel of peaks will be identified using the proposed peak detection, calibration, and selection methods. The selected peaks will be sequenced to identify the peptides they represent. Finally, the identity of the peptides and their ability to detect HCC will be examined using isotope dilution by synthesizing 13C-labeled peptide standards. The synergetic interaction of diverse disciplines contributes to the intellectual merit of this project, leading to analytical tools that will make scientific knowledge discovery more efficient. Analytical tools developed in this project will be useful for other biomarker discovery studies, where the analysis of high-dimensional mass spectral data is needed. The tools will be freely available (open source) to mass spectrometry users. PUBLIC HEALTH RELEVANCE:  Development of a diagnostic test would be of great benefit for detection of hepatocellular carcinoma (HCC) at a treatable stage. In particular, defining clinically applicable biomarkers that detect early-stage HCC in a high-risk population of cirrhotic patients has potentially far-reaching consequences for disease management and patient health. This project is important because most HCC patients present with advanced-stage disease and poor prognosis. There is a pressing need to identify biomarkers of HCC that could be used for early detection and more accurate classification of disease. This project will lead to the development of analytical tools to find and validate early-diagnosis candidate peptide biomarkers from high- dimensional MALDI-TOF spectra of low-molecular-weight serum fractions. In addition to screening high-risk populations for early signs of disease, the resulting biomarkers could be used to design and test improved treatment strategies.          ",Peptide Biomarker Discovery by Mass Spectrometry for Early Detection of Liver Can,7640849,R21CA130837,"['Bioinformatics ', ' Bio-Informatics ', ' Commit ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Egypt ', ' Address ', ' Data ', ' Detection ', ' Early Detection Research Network ', ' National Detection Research Network ', ' EDRN ', ' Information Resources ', ' knowledge resources ', ' knowledge resource ', ' information resource ', ' Resolution ', ' Subgroup ', ' Comprehensive Cancer Center ', ' MALDI-TOF Mass Spectrometry ', ' Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry ', ' Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS ', ' Newly Diagnosed ', ' Validation ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Cirrhosis ', ' Fuzzy Logic ', ' analytical method ', ' base ', ' Goals ', ' Label ', ' improved ', ' Health ', ' Primary carcinoma of the liver cells ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Clinical ', ' Biological ', ' Ensure ', ' Screening procedure ', ' screenings ', ' screening ', ' Isotopes ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Discipline ', ' Individual ', ' Linguistics ', ' Linguistic ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Michigan ', ' Molecular Weight ', ' Letters ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Noise ', ' Liquid substance ', ' liquid ', ' fluid ', ' Patients ', ' Peptides ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Staging ', ' outcome forecast ', ' Prognosis ', ' tool ', ' Proteins ', ' gene product ', ' instrument ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Running ', ' Sampling Studies ', ' Shoulder ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Knowledge ', ' Disease Management ', ' Disorder Management ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' Thailand ', ' Time ', ' United States ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Complex ', ' Radial ', ' Radius ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Medical center ', ' Early Diagnosis ', ' early detection ', ' tandem mass spectrometry ', ' Calibration ', ' simulation ', ' Participant ', ' member ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' disease classification ', ' nosology ', ' disorder classification ', ' Screening for Hepatocellular Cancer ', ' screening for liver cancer ', ' liver cancer detection ', ' early liver cancer detection ', ' Code ', ' Coding System ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Morphologic artifacts ', ' Artifacts ', ' Diagnostic tests ', ' Population Heterogeneity ', ' heterogeneous population ', ' diverse populations ', ' Sampling ', ' Proteomics ', ' liquid chromatography mass spectrometry ', ' LC/MS ', ' Accounting ', ' design ', ' designing ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' open source ', ' high risk ', ' public health relevance ', ' treatment strategy ', ' biomarker ', ' candidate identification ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NCI,GEORGETOWN UNIVERSITY,R21,2009,207225,0.21447280264737498
"High-throughput annotation of glycan mass spectra     DESCRIPTION (provided by applicant): The correct functioning of many proteins depends on glycosylation, the addition of sugar molecules (glycans) to selected amino acids in the protein. For example, cancer cells have different glycosylation patterns than ordinary cells, and there is strong evidence that glycoproteins on the surface of egg cells play an essential role in sperm binding. Despite the importance of glycosylation, there are as yet no reliable, high-throughput methods for determining the identity and location of glycans. Glycan identification is currently a manual procedure for experts, involving a combination of chemical assays and mass spectrometry. The automation of the process would have a significant impact on our understanding of this important biological process. The proposed project aims to invent chemical procedures, algorithms, and software for high-throughput analysis of glycan mass spectrometry data. The goal is to bring glycan analysis up to the level of peptide analysis within 3 years. In contrast to peptide analysis, which can leverage genomics data, glycan analysis requires the incorporation of expert knowledge of synthetic pathways, in order to limit the huge number of theoretical combinations of monosaccharides to the much smaller number that are actually synthesized in nature. The project will have to develop novel representations for the evolving expert knowledge, because an exhaustive list- analogous to the human genome- is not currently known. Along with expert knowledge, the project will develop and validate machine learning and statistical techniques for glycan identification. In particular, the project will develop methods for internally calibrating spectra, and will learn fragmentation patterns that can statistically distinguish different types of glycosidic linkages.         ",High-throughput annotation of glycan mass spectra,7628516,R01GM074128,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Disclosure ', ' Information Disclosure ', ' Disease ', ' disease/disorder ', ' Disorder ', ' immune function ', ' Cellular Immune Function ', ' Address ', ' Data ', ' Resolution ', ' Process ', ' Modification ', ' Development ', ' developmental ', ' Expert Systems ', ' Intelligent systems ', ' Pathway interactions ', ' pathway ', ' Human Genome ', ' human whole genome ', ' Age ', ' Glycoproteins ', ' glycosylation ', ' Metabolic Glycosylation ', ' Goals ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Algorithms ', ' Site ', ' Area ', ' Surface ', ' Specific qualifier value ', ' Specified ', ' Biological ', ' Link ', ' Chemicals ', ' Training ', ' Isomerism ', ' isomer ', ' Learning ', ' Libraries ', ' sugar ', ' enzyme activity ', ' Mammals ', ' Mammalia ', ' Manuals ', ' Amino Acids ', ' aminoacid ', ' Methods ', ' Monosaccharides ', ' Biological Process ', ' Biological Function ', ' Occupations ', ' Professional Postions ', ' Jobs ', ' Organism ', ' living system ', ' Peptides ', ' Play ', ' Polymers ', ' Polysaccharides ', ' Glycans ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Proteins ', ' gene product ', ' Nature ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Technology ', ' Work ', ' Automation ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' Speed (motion) ', ' Speed ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' C element ', ' Cartoons ', ' Cells ', ' glycosyltransferase ', ' Glycoside Transferases ', ' EC 2.4 ', ' Sampling ', ' Specialist ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Communities ', ' egg ', ' prototype ', ' ']",NIGMS,PALO ALTO RESEARCH CENTER,R01,2009,329306,0.11564226398340649
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Project summary: Mass spectrometry, the core technology in the field of proteomics, promises to enable scientists to identify and quantify the entire complement of molecules that comprise a complex biological sample. In the biological and health sciences, mass spectrometry is commonly used in a nigh-throughput fashion to identify proteins in a mixture. Currently, the primary bottleneck in this type of experiment is computational. Existing algorithms for interpreting mass spectra are slow and fail to identify a large proportion of the given spectra. We propose to apply techniques and tools from the field of machine learning to the analysis of mass spectrometry data. We will build computational models of peptide fragmentation within the mass spectrometer, as well as larger-scale models of the entire mass spectrometry process. Using these models, we will design and validate algorithms for identifying the set of proteins that best explain an observed set of spectra. Software implementations for all of the methods will be made publicly available in a user-friendly form. In practical terms, this software will enable scientists to more easily, efficiently and accurately analyze and understand their mass spectrometry data. Relevance: The applications of mass spectrometry and its promises for improvements of human health are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens.           ",Machine learning analysis of tandem mass spectra,7797540,R01EB007057,"['Complex Mixtures ', ' small molecule ', ' FOLH1 gene ', ' PSM ', ' NAALAD1 ', ' FOLH1 ', ' FOLH ', ' Data ', ' Health Sciences ', ' Protein Biochemistry ', ' Protein/Amino Acid Biochemistry ', ' Collection ', ' Preparation ', ' Principal Investigator ', ' Molecular ', ' Process ', ' Set protein ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Source Code ', ' improved ', ' Procedures ', ' Hand ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Area ', ' Biological ', ' Biochemical ', ' prognostic ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Maps ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Peptide Fragments ', ' Peptides ', ' Staging ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' tool ', ' Proteins ', ' gene product ', ' Receiver Operating Characteristics ', ' Diagnostic ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Running ', ' Blast Cell ', ' Hemohistioblast ', ' Hemocytoblast ', ' Hematohistioblast ', ' Ferrata cell ', ' Blasts ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Scientist ', ' Time ', ' Work ', ' Authorship ', ' Hour ', ' Complex ', ' Techniques ', ' interest ', ' Performance ', ' tandem mass spectrometry ', ' Calibration ', ' expectation ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Devices ', ' Carbonyl Cyanide m-Chlorophenyl Hydrazone ', ' Propanedinitrile, ((3-chlorophenyl)hydrazono)- ', ' Carbonyl Cyanide meta-Chlorophenyl Hydrazone ', ' CCCP ', ' Abbreviations ', ' Dissociation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model design ', ' Complement ', ' Complement Proteins ', ' disease phenotype ', ' mass spectrometer ', ' computer based statistical methods ', ' Bayesian Networks ', ' markov model ', ' design ', ' designing ', ' user-friendly ', ' task analysis ', ' computer cluster ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' ']",NIBIB,UNIVERSITY OF WASHINGTON,R01,2010,593600,0.31162898417224394
"Improving Breast Cancer Detection and Diagnosis with CAD    DESCRIPTION (provided by applicant): Computer-aided detection (CAD) of breast cancer is rapidly becoming a well accepted clinical practice. Studies have found that radiologists' attitude toward and acceptance of CAD-cued micro-calcification clusters and masses were substantially different. Due to the high sensitivity, radiologists heavily rely on CAD-cued results while searching for micro-calcifications. However, the lower CAD sensitivity for mass detection (including a fraction of subtle masses being cued only on one view) and the higher false-positive detection (FP) rates reduce radiologists' confidence in CAD-cued masses. As a result, radiologists frequently discard CAD-cued subtle masses in the clinical practice. To improve CAD performance and increase radiologists' confidence in using CAD-cued masses in their decision making, we propose two observer-focused innovative approaches to develop and optimize CAD schemes. By maintaining a comparable FP rate to current commercial CAD systems, the new approaches aim to either increase the number of masses being cued on both ipsilateral (CC and MLO) views or cue more subtle masses by eliminating a fraction of other regions that can be easily identified and classified by radiologists without using CAD. To test these approaches, we propose three specific tasks. First, we will develop a unique multi-view based CAD scheme. To more sensitively detect and better match subtle mass regions, we introduce a concept of limited viewing of specific regions into the arena of CAD development. After detecting a matching strip on the ipsolateral view, the scheme applies a second highly sensitive detection scheme only to this strip to identify matched regions. To control for and reduce FP rates, the scheme limits the number of possible matched candidates to less than one per image. Second, we will develop an integrated CAD scheme that includes a combined score for both detection and classification. To improve direct use of features computed by the detection module in the classification task, we will apply a new dual active contour algorithm that should improve mass region segmentation. We will separately optimize two machine learning classifiers to generate a detection score (the likelihood of being a true-positive mass) and a classification score (the likelihood of each detected mass for malignancy) for each segmented region. We will then develop a fusion method to combine these two scores and generate a new summary index that is more heavily weighted for subtle masses. Using this scheme, we can change the current mass detection based cuing method to a new cancer-based cueing method. Third, we will conduct a pilot observer performance study to investigate radiologists' performance under three CADcueing modes (using the current commercial single-image based, the new multi-view based, and the new integrated CAD schemes). The reading results will be compared and analyzed using both ROC and JAFROC methodologies. We note that the approach is substantially different than focusing on incremental improvements in image based detection schemes in that the observer's actual use (or not) of the CADcued regions drives our objectives in this project, resulting in a targeted development effort.          ",Improving Breast Cancer Detection and Diagnosis with CAD,7797472,R01CA077850,"['Cues ', ' Data Analyses ', ' Data Analysis ', ' Decision Making ', ' Diagnosis ', ' Environment ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Detection ', ' Cancer Detection ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scheme ', ' Process ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Eye ', ' Eyeball ', ' Image ', ' imaging ', ' calcification ', ' base ', ' improved ', ' Hybrids ', ' Algorithms ', ' Area ', ' Benign ', ' Clinical ', ' Malignant - descriptor ', ' Malignant ', ' Specific qualifier value ', ' Specified ', ' indexing ', ' Lesion ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' radiologist ', ' RDST ', ' Perception ', ' Play ', ' Reading ', ' Diagnostic ', ' Research ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Time ', ' Attention ', ' Attitude ', ' Investigation ', ' Weight ', ' Work ', ' Ipsilateral ', ' System ', ' LOINC Axis 4 System ', ' Performance ', ' Breast ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Reporting ', ' visual search ', ' Classification ', ' Systematics ', ' Computer Assisted ', ' computer aided ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' innovation ', ' innovative ', ' innovate ', ' clinical practice ', ' ']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2010,278249,0.24752795390064436
"Computational approaches to protein identification and quantification using MS/MS    DESCRIPTION (provided by applicant): Shotgun proteomics is one of the most commonly used approaches to MS-based biomarker discovery, due to its high throughput and sensitivity. The general strategy involves simultaneous protease digestion of all proteins in a mixture, liquid chromatography-based separation of peptides and analysis by tandem mass spectrometry (MS/MS) to produce fragmentation spectra of each peptide. Each experimental spectrum is searched against a protein database. Sequences that best match the experimental spectra are considered identified, while a set of reliably identified peptides from the same protein is necessary for a reliable protein identification. The main goal in the proposed work is to generate and interrogate MS/MS data from several proteomics platforms, including ESI/MS, MALDI/TOF/TOF, LC-IMS/TOF and MALDI-PID/TOF to develop customized computational tools that address several challenging problems in shotgun proteomics data analysis: peptide identification, protein identification and label-free protein quantification. Our proposed approach is data-driven. At its core is the application of machine learning methods to the prediction of peptide fragmentation spectra as well as the likelihood of peptide detection in a typical proteomics experiment. Improved peptide identification coupled with the predicted peptide delectability will then be used to develop new methods for improved protein identification and quantification. The methods proposed herein will be extensively evaluated and software will be made public both as web-based tools and open-source deliverables. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies might entail disease diagnosis (biomarker discovery), disease progression (tissue profiling), or effects of treatment (drug-induced proteome changes). These studies will enhance understanding of diseases and hasten the development of effective treatments and cures. In addition, these tools will be useful in characterizing new analytical tools for proteome analysis. Here we propose to develop and extensively evaluate computational methodology that will be used to improve the interpretation of tandem mass spectrometry data. These software tools will enable researchers using proteomics technologies to more effectively and efficiently study a variety of health related conditions. Such studies that might entail disease diagnosis, disease progression, or effects of treatment, will enhance understanding of diseases and hasten the development of effective treatments and cures.          ",Computational approaches to protein identification and quantification using MS/MS,7916503,R01RR024236,"['Knowledge ', ' programs ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Trypsin ', ' Tripcellim ', ' Work ', ' Techniques ', ' tandem mass spectrometry ', ' Informatics ', ' Structure ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Peptide Sequence Determination ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Proteome ', ' Measures ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Relative (related person) ', ' Relative ', ' Liquid Chromatography ', ' Sampling ', ' Protein Databases ', ' Proteomics ', ' Accounting ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' Coupled ', ' analytical tool ', ' treatment effect ', ' open source ', ' effective therapy ', ' effective treatment ', ' biomarker ', ' disease diagnosis ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' Data Analysis ', ' Digestion ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data Set ', ' Dataset ', ' Caring ', ' Data ', ' Detection ', ' Scheme ', ' Numerical value ', ' Development ', ' developmental ', ' Output ', ' base ', ' Goals ', ' Label ', ' improved ', ' Health ', ' Algorithms ', ' Ions ', ' Chemicals ', ' Training ', ' Learning ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Disease Progression ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Methods ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Peptide Hydrolases ', ' Proteolytic Enzymes ', ' Proteinases ', ' Proteases ', ' Peptidases ', ' Esteroproteases ', ' Peptides ', ' Probability ', ' Problem Formulations ', ' Staging ', ' tool ', ' Proteins ', ' gene product ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Shotguns ', ' Computer software ', ' computer program/software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Peptide Library ', ' ']",NCRR,INDIANA UNIVERSITY BLOOMINGTON,R01,2010,273971,0.15867204632033174
"A New Model of Peptide Fragmentation for Improved Protein Identification and Targ    DESCRIPTION (provided by applicant): Mass spectrometry (MS) based proteomics has emerged as a key technology in the search for disease- associated biomarkers. State-of-the-art instruments can identify thousands of proteins in a single sample by 'shotgun' proteomic analysis, where protein mixtures are proteolyzed into peptides, separated by one or more chromatographic steps, and analyzed by peptide dissociation using tandem mass spectrometry (MS/MS). The goal of this approach is to create new technologies for the accurate detection of proteins within complex samples. Achieving this target is currently limited by the major problem of inferring the peptide sequence from MS/MS spectra by sequence database searching: spectra are compared to ""model spectra"" generated from database sequences. Current algorithms suffer from poor accuracy and discrimination due to the use of simple models for predicting spectra, which ignores the rich information contained in the relative intensities of peaks in a typical MS/MS. Consequently, there is a vital need for more accurate models to predict MS/MS spectrum intensities from peptide sequences. In this proposal, we will develop a new and innovative kinetic model for predicting peptide fragmentation MS/MS spectra, and use the model to develop MS/MS identification algorithms with high discrimatory power. Spectra simulated by the kinetic model will then be used to design selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies. This will solve a bottleneck for widespread adoption of SRM methods for biomarker discovery, which is currently hindered by the slow process of identifying and optimizing SRM transitions for the assays. The following specific aims are (1) Develop an optimized kinetic model of gas-phase peptide fragmentation which predicts MS/MS spectra for any peptide sequence. Model parameters will be fit using the Levenberg- Marquardt algorithm, a robust method for non-linear least squares. (2) Extend the model to predict MS/MS fragmentation of phosphopeptides. The approaches developed in this aim can be extended to other disease- relevant post-translational modifications which profoundly alter peptide fragmentation and interfere with MS/MS identification. (3) Develop a route to successful implementation of spectrum-to-spectrum matching algorithms, an entirely new approach for large scale identification of proteins, in which MS/MS are searched directly against libraries of predicted spectra, simulated using our prototype kinetic model. We use predicted spectra to bypass the need for sequence databases, and spectrum-to-sequence strategies altogether. (4) Develop an algorithm for de novo prediction of selected reaction monitoring (SRM) assays for highly multiplexed quantitative measurement of proteins in complex mixtures.      PUBLIC HEALTH RELEVANCE:    PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.              PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.         ",A New Model of Peptide Fragmentation for Improved Protein Identification and Targ,8026467,R01CA155453,"['protein profiling ', ' Complex Mixtures ', ' Sensitivity and Specificity ', ' Adoption ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' peptide sequence ', ' peptide aminoacid sequence ', ' protein aminoacid sequence ', ' Phosphopeptides ', ' Shotguns ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Kinetics ', ' Technology ', ' Health ', ' Detection ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Chemicals ', ' instrument ', ' Address ', ' Measurement ', ' Reaction ', ' Molecular Target ', ' Relative ', ' Relative (related person) ', ' Phase ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Simulate ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Work ', ' Route ', ' base ', ' novel technologies ', ' new technology ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' chemotherapy ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Goals ', ' Monitor ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' designing ', ' design ', ' Methods ', ' Measures ', ' gene product ', ' Proteins ', ' Techniques ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Modeling ', ' Process ', ' preventing ', ' prevent ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Proteomics ', ' Complex ', ' interest ', ' Sampling ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' improved ', ' Scanning ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Peptides ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' innovative ', ' innovate ', ' innovation ', ' Libraries ', ' Bypass ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' Algorithms ', ' prototype ', ' Ions ', ' early detection ', ' Early Diagnosis ', ' Probabilistic Models ', ' Statistical Models ', ' tandem mass spectrometry ', ' instrumentation ', ' Dissociation ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' Gases ', ' drug efficacy ', ' Protein Analysis ', ' Protein Sequence Analyses ', ' Peptide Sequence Analysis ', ' Peptide Sequence Analyses ', ' Amino Acid Sequence Analysis ', ' Amino Acid Sequence Analyses ', ' Protein Sequence Analysis ', ' ']",NCI,UNIVERSITY OF COLORADO,R01,2011,314363,0.17345378648469237
"Improving Breast Cancer Detection and Diagnosis with CAD    DESCRIPTION (provided by applicant): Computer-aided detection (CAD) of breast cancer is rapidly becoming a well accepted clinical practice. Studies have found that radiologists' attitude toward and acceptance of CAD-cued micro-calcification clusters and masses were substantially different. Due to the high sensitivity, radiologists heavily rely on CAD-cued results while searching for micro-calcifications. However, the lower CAD sensitivity for mass detection (including a fraction of subtle masses being cued only on one view) and the higher false-positive detection (FP) rates reduce radiologists' confidence in CAD-cued masses. As a result, radiologists frequently discard CAD-cued subtle masses in the clinical practice. To improve CAD performance and increase radiologists' confidence in using CAD-cued masses in their decision making, we propose two observer-focused innovative approaches to develop and optimize CAD schemes. By maintaining a comparable FP rate to current commercial CAD systems, the new approaches aim to either increase the number of masses being cued on both ipsilateral (CC and MLO) views or cue more subtle masses by eliminating a fraction of other regions that can be easily identified and classified by radiologists without using CAD. To test these approaches, we propose three specific tasks. First, we will develop a unique multi-view based CAD scheme. To more sensitively detect and better match subtle mass regions, we introduce a concept of limited viewing of specific regions into the arena of CAD development. After detecting a matching strip on the ipsolateral view, the scheme applies a second highly sensitive detection scheme only to this strip to identify matched regions. To control for and reduce FP rates, the scheme limits the number of possible matched candidates to less than one per image. Second, we will develop an integrated CAD scheme that includes a combined score for both detection and classification. To improve direct use of features computed by the detection module in the classification task, we will apply a new dual active contour algorithm that should improve mass region segmentation. We will separately optimize two machine learning classifiers to generate a detection score (the likelihood of being a true-positive mass) and a classification score (the likelihood of each detected mass for malignancy) for each segmented region. We will then develop a fusion method to combine these two scores and generate a new summary index that is more heavily weighted for subtle masses. Using this scheme, we can change the current mass detection based cuing method to a new cancer-based cueing method. Third, we will conduct a pilot observer performance study to investigate radiologists' performance under three CADcueing modes (using the current commercial single-image based, the new multi-view based, and the new integrated CAD schemes). The reading results will be compared and analyzed using both ROC and JAFROC methodologies. We note that the approach is substantially different than focusing on incremental improvements in image based detection schemes in that the observer's actual use (or not) of the CADcued regions drives our objectives in this project, resulting in a targeted development effort.          ",Improving Breast Cancer Detection and Diagnosis with CAD,8065906,R01CA077850,"['Malignant - descriptor ', ' Malignant ', ' Hybrids ', ' Breast ', ' Decision Making ', ' cancer diagnosis ', ' Data Analyses ', ' Data Analysis ', ' Scheme ', ' Lesion ', ' Reading ', ' Computer Assisted ', ' computer aided ', ' Attitude ', ' Eye ', ' Eyeball ', ' Ipsilateral ', ' indexing ', ' Diagnostic ', ' clinical practice ', ' Investigation ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Environment ', ' Image ', ' imaging ', ' Algorithms ', ' Testing ', ' Weight ', ' Perception ', ' Research ', ' improved ', ' Specific qualifier value ', ' Specified ', ' Play ', ' Performance ', ' Methods ', ' Process ', ' Methodology ', ' Method LOINC Axis 6 ', ' Clinical ', ' innovation ', ' innovative ', ' innovate ', ' Role ', ' social role ', ' base ', ' Detection ', ' Attention ', ' Work ', ' Time ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cues ', ' Development ', ' developmental ', ' Reporting ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Area ', ' System ', ' LOINC Axis 4 System ', ' Genetic Programming ', ' Genetic Algorithm ', ' calcification ', ' radiologist ', ' RDST ', ' Classification ', ' Systematics ', ' Cancer Detection ', ' visual search ', ' Breast Cancer Detection ', ' mammary cancer detection ', ' Breast cancer screening ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Benign ', ' ']",NCI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2011,269902,0.24752795390064436
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efficient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the fields of machine learning, statistics and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets.  The core of the proposal is a type of probabilistic model, known as a dynamic Bayesian network that allows us to reason efficiently and accurately about complex sequential data sets. This modeling framework leverages a large body of related work from the fields of natural language processing and speech recognition. Much of this prior work has not yet been exploited by computational biologists, so the proposal represents a valuable cross-fertilization across disciplines.  More specifically, this project employs a collection of cooperating dynamic Bayesian networks to model jointly an entire mass spectrometry experiment. Relative to most existing methods for analyzing mass spectrometry data, which tend to divide the analysis of an experiment into a series of small independent subtasks, the proposed unified model jointly, considers all of the available data. This approach can thus exploit valuable dependencies among spectra and along various dimensions of the data. Dynamic Bayesian networks also provide a rigorous framework for performing inference from a combination of observed data and qualitative expert knowledge.  The project is divided into five aims, each of which concerns a particular type of mass spectrometry experiment. These experiments involve (1) identifying all of the proteins in a given complex biological sample using a standard mass spectrometry protocol; (2) identifying proteins using a modified protocol in which the mass spectrometer samples the data in a systematic, rather than data-dependent, fashion, with the goal of identifying lower abundance proteins; (3) quantifying the relative abundance of proteins within or between biological samples; (4) identifying post-translational modified proteins or proteins that contain sequence variation; and (5) performing targeted quantification of a specified set of proteins, such as proteins in a pathway of interest or protein biomarkers.  The methods described in this proposal have the potential to dramatically improve our ability to draw conclusions from and formulate hypotheses on the basis of high-throughput shotgun proteomics experiments. Experiments like the ones described above can, for example, identify proteins involved in fundamental disease processes, identify previously unknown protein isoforms, or quantify the re- sponses of proteins to environmental stressors or disease states.      PUBLIC HEALTH RELEVANCE: The applications of mass spectrometry and its promises for improvements of human health are nu- merous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens. How- ever, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.           The applications of mass spectrometry and its promises for improvements of human health are nu- merous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens. How- ever, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.         ",Machine learning analysis of tandem mass spectra,8038072,R01GM096306,"['Fertility/Fertilization ', ' Fertilization ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Peptide Sequence Determination ', ' Complex Mixtures ', ' protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' speech recognition ', ' Shotguns ', ' environmental stressor ', ' natural language understanding ', ' Natural Language Processing ', ' Graph ', ' Isoforms ', ' Protein Isoforms ', ' Discipline ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' computational tools ', ' computerized tools ', ' computer program/software ', ' Software ', ' Computer software ', ' Dataset ', ' Data Set ', ' prognostic ', ' Dimensions ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteomics ', ' Bayesian Networks ', ' computer based statistical methods ', ' Probability ', ' Liquid Chromatography ', ' Connecting Peptide ', ' C-Peptide ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' disease phenotype ', ' Probabilistic Models ', ' Statistical Models ', ' tandem mass spectrometry ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' Reproducibility ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Cells ', ' Sampling ', ' Diagnostic ', ' Protocol ', ' Protocols documentation ', ' Monitor ', ' Health ', ' Scanning ', ' interest ', ' Reaction ', ' Complex ', ' Knowledge ', ' Variation ', ' Variant ', ' Biological ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' Life ', ' improved ', ' Peptides ', ' gene product ', ' Proteins ', ' pathway ', ' Pathway interactions ', ' Modeling ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Specified ', ' Specific qualifier value ', ' Collection ', ' Ions ', ' Molecular ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Methods ', ' designing ', ' design ', ' Area ', ' disease/disorder ', ' Disorder ', ' Disease ', ' mass spectrometer ', ' Series ', ' Relative ', ' Relative (related person) ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' Clinical ', ' Process ', ' Goals ', ' Time ', ' Work ', ' statistics ', ' response ', ' base ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' tool ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Phase ', ' Data ', ' novel ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2011,627642,0.29499527542110854
"A photographic method for human body composition assessment     DESCRIPTION (provided by applicant): The assessment of body composition, particularly fat and fat free mass, is vital to understanding many health-related conditions including obesity and sarcopenia, whose very definitions depend on assessment of fat and fat free mass, but also cachexia induced by HIV, cancer, and other diseases; multiple sclerosis; wasting in neurological disorders such as Parkinson's, Alzheimer's, muscular dystrophy; eating disorders; proper growth in children; and yet others still. Nevertheless, challenges remain in measuring body composition. Existing methods beyond height, weight, and very simple anthropometry are still not the norm in large-scale epidemiologic studies and clinical studies. This is because of concerns, depending on method, about cost, portability, time, radiation exposure, and accuracy. Calculation of body mass index (BMI; kg/m2) is a commonly used alternative, but is limited in that it is an assessment of body weight relative to height and not of body fatness per se. A hand-held device that could be carried by any individual, accurately assess fat mass and skeletal muscle mass, and be utilized without any discomfort to the subject, inexpensively, and without radiation exposure would be highly desirable. Evidence suggests that highly experienced trained observers can accurately estimate percentage of body fat by visual examination of subjects, but concerns about accuracy and subjectivity predominate. We hypothesize that we can develop a computer algorithm which can perform as or more accurately when analyzing photographic imagery data, will require no repeated retraining, and eliminate subjectivity. Our first specific aim is to develop a computer image analysis algorithm to accurately estimate adiposity and skeletal muscle mass from standardized photographic images in a bi-ethnic sample of men, women, and children. Our second specific aim is to validate the algorithm in a large diverse sample of men, women, and children.        PUBLIC HEALTH RELEVANCE: Obesity, loss of skeletal muscle with aging, and other body composition alterations are of profound public health importance. We propose a novel method for measuring the quantity of fat and skeletal muscle mass in humans quickly, painlessly, safely, accurately, and inexpensively that can subsequently be used in many large scale and remote studies.                  Obesity, loss of skeletal muscle with aging, and other body composition alterations are of profound public health importance. We propose a novel method for measuring the quantity of fat and skeletal muscle mass in humans quickly, painlessly, safely, accurately, and inexpensively that can subsequently be used in many large scale and remote studies.                ",A photographic method for human body composition assessment,8295495,R01HL107916,"['Body Size ', ' Body Weight ', ' Cachexia ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Body Composition ', ' Aging ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Abbreviations ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Algorithms ', ' Air ', ' Anthropometry ', ' Age ', ' Eating Disorders ', ' Fats ', ' Fatty acid glycerol esters ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Hand ', ' Physical Exercise ', ' Exercise ', ' Health ', ' Equipment ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' disease/disorder ', ' Disorder ', ' Disease ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' Methods ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', "" men's "", ' men ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Laboratories ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Public Health ', ' public health medicine (field) ', ' Technology ', ' Research ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Persons ', ' muscle dystrophy ', ' Myodystrophy ', ' Myodystrophica ', ' Muscular Dystrophies ', ' Plethysmography ', ' Measures ', ' Visualization ', ' Imagery ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Relative ', ' Relative (related person) ', ' Weight ', ' Clinical ', ' improved ', ' Task Forces ', ' Advisory Committees ', ' Woman ', ' Time ', ' Writing ', ' Work ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Testing ', ' frailty ', ' Home ', ' Home environment ', ' Techniques ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Body fat ', ' Training ', ' Individual ', ' light (weight) ', ' not painful ', ' non-painful ', ' Painless ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' wasting ', ' Human Figure ', ' Human body ', ' Measurement ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Visual ', ' portability ', ' Sampling ', ' Categories ', ' Laboratory Study ', ' sarcopenia ', ' ray (radiation) ', ' Radiation ', ' Devices ', ' response ', ' novel ', ' field study ', ' Participant ', ' LOINC Axis 4 System ', ' System ', ' computer imaging ', ' digital imaging ', ' interest ', ' experience ', ' waist circumference ', ' Height ', ' imaging ', ' Image ', ' sex ', ' cost ', ' Validation ', ' digital ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' Skin ', ' Strategic Planning ', ' Data ', ' DXA ', ' Dual-Energy X-Ray Absorptiometry ', ' primary outcome ', ' computer algorithm ', ' Computational algorithm ', ' Population ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,R01,2012,504654,0.16043072264896296
"A New Model of Peptide Fragmentation for Improved Protein Identification and Targ    DESCRIPTION (provided by applicant): Mass spectrometry (MS) based proteomics has emerged as a key technology in the search for disease- associated biomarkers. State-of-the-art instruments can identify thousands of proteins in a single sample by 'shotgun' proteomic analysis, where protein mixtures are proteolyzed into peptides, separated by one or more chromatographic steps, and analyzed by peptide dissociation using tandem mass spectrometry (MS/MS). The goal of this approach is to create new technologies for the accurate detection of proteins within complex samples. Achieving this target is currently limited by the major problem of inferring the peptide sequence from MS/MS spectra by sequence database searching: spectra are compared to ""model spectra"" generated from database sequences. Current algorithms suffer from poor accuracy and discrimination due to the use of simple models for predicting spectra, which ignores the rich information contained in the relative intensities of peaks in a typical MS/MS. Consequently, there is a vital need for more accurate models to predict MS/MS spectrum intensities from peptide sequences. In this proposal, we will develop a new and innovative kinetic model for predicting peptide fragmentation MS/MS spectra, and use the model to develop MS/MS identification algorithms with high discrimatory power. Spectra simulated by the kinetic model will then be used to design selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies. This will solve a bottleneck for widespread adoption of SRM methods for biomarker discovery, which is currently hindered by the slow process of identifying and optimizing SRM transitions for the assays. The following specific aims are (1) Develop an optimized kinetic model of gas-phase peptide fragmentation which predicts MS/MS spectra for any peptide sequence. Model parameters will be fit using the Levenberg- Marquardt algorithm, a robust method for non-linear least squares. (2) Extend the model to predict MS/MS fragmentation of phosphopeptides. The approaches developed in this aim can be extended to other disease- relevant post-translational modifications which profoundly alter peptide fragmentation and interfere with MS/MS identification. (3) Develop a route to successful implementation of spectrum-to-spectrum matching algorithms, an entirely new approach for large scale identification of proteins, in which MS/MS are searched directly against libraries of predicted spectra, simulated using our prototype kinetic model. We use predicted spectra to bypass the need for sequence databases, and spectrum-to-sequence strategies altogether. (4) Develop an algorithm for de novo prediction of selected reaction monitoring (SRM) assays for highly multiplexed quantitative measurement of proteins in complex mixtures.           PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.         ",A New Model of Peptide Fragmentation for Improved Protein Identification and Targ,8323866,R01CA155453,"['Adoption ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Gases ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' instrumentation ', ' Ions ', ' Kinetics ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' Libraries ', ' Methods ', ' Probabilistic Models ', ' Statistical Models ', ' Peptides ', ' Phosphopeptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Sensitivity and Specificity ', ' Shotguns ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dissociation ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Phase ', ' Chemicals ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Simulate ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Scanning ', ' Reaction ', ' protein profiling ', ' Route ', ' Techniques ', ' interest ', ' early detection ', ' Early Diagnosis ', ' drug efficacy ', ' tandem mass spectrometry ', ' novel technologies ', ' new technology ', ' Bypass ', ' Protein Sequence Analyses ', ' Peptide Sequence Analysis ', ' Peptide Sequence Analyses ', ' Amino Acid Sequence Analysis ', ' Amino Acid Sequence Analyses ', ' Protein Sequence Analysis ', ' Modeling ', ' Sampling ', ' Proteomics ', ' peptide sequence ', ' peptide aminoacid sequence ', ' protein aminoacid sequence ', ' Complex Mixtures ', ' preventing ', ' prevent ', ' Address ', ' Detection ', ' Molecular Target ', ' Protein Analysis ', ' Monitor ', ' Process ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' innovative ', ' innovate ', ' innovation ', ' chemotherapy ', ' prototype ', ' biomarker ', ' ']",NCI,UNIVERSITY OF COLORADO,R01,2012,314363,0.16116800926157937
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efficient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the fields of machine learning, statistics and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets.  The core of the proposal is a type of probabilistic model, known as a dynamic Bayesian network that allows us to reason efficiently and accurately about complex sequential data sets. This modeling framework leverages a large body of related work from the fields of natural language processing and speech recognition. Much of this prior work has not yet been exploited by computational biologists, so the proposal represents a valuable cross-fertilization across disciplines.  More specifically, this project employs a collection of cooperating dynamic Bayesian networks to model jointly an entire mass spectrometry experiment. Relative to most existing methods for analyzing mass spectrometry data, which tend to divide the analysis of an experiment into a series of small independent subtasks, the proposed unified model jointly, considers all of the available data. This approach can thus exploit valuable dependencies among spectra and along various dimensions of the data. Dynamic Bayesian networks also provide a rigorous framework for performing inference from a combination of observed data and qualitative expert knowledge.  The project is divided into five aims, each of which concerns a particular type of mass spectrometry experiment. These experiments involve (1) identifying all of the proteins in a given complex biological sample using a standard mass spectrometry protocol; (2) identifying proteins using a modified protocol in which the mass spectrometer samples the data in a systematic, rather than data-dependent, fashion, with the goal of identifying lower abundance proteins; (3) quantifying the relative abundance of proteins within or between biological samples; (4) identifying post-translational modified proteins or proteins that contain sequence variation; and (5) performing targeted quantification of a specified set of proteins, such as proteins in a pathway of interest or protein biomarkers.  The methods described in this proposal have the potential to dramatically improve our ability to draw conclusions from and formulate hypotheses on the basis of high-throughput shotgun proteomics experiments. Experiments like the ones described above can, for example, identify proteins involved in fundamental disease processes, identify previously unknown protein isoforms, or quantify the re- sponses of proteins to environmental stressors or disease states.        The applications of mass spectrometry and its promises for improvements of human health are nu- merous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens. How- ever, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.         ",Machine learning analysis of tandem mass spectra,8288063,R01GM096306,"['protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' Connecting Peptide ', ' C-Peptide ', ' Cells ', ' Liquid Chromatography ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fertility/Fertilization ', ' Fertilization ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Ions ', ' Methods ', ' Probabilistic Models ', ' Statistical Models ', ' natural language understanding ', ' Natural Language Processing ', ' Peptides ', ' Probability ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Shotguns ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' prognostic ', ' Discipline ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Dimensions ', ' Complex ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' interest ', ' environmental stressor ', ' Isoforms ', ' Protein Isoforms ', ' speech recognition ', ' tandem mass spectrometry ', ' novel ', ' Graph ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Peptide Sequence Determination ', ' Modeling ', ' Sampling ', ' response ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Complex Mixtures ', ' Data ', ' Reproducibility ', ' Collection ', ' Monitor ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' mass spectrometer ', ' Bayesian Networks ', ' computer based statistical methods ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' biomarker ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2012,621711,0.2854977525196606
"Computational approaches to protein identification and quantification using MS/MS (Not modified) Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) is a widely used platform for high-throughput identification and quantification of proteins in biological samples. In addition to experimental steps in the pipeline, computational and statistical procedures play important roles in determining the content of the mixture. However, even with the best analytical platforms and modern software, only a small fraction of spectra are typically identified, thus directly impacting the quality of the biological sample analysis. If high- throughput proteomics techniques are to become routinely used in biomedical applications on the population scale, it is critical to address analytical and computational factors that contribute to the inadequate identification coverage and sensitivity. Over the past several years, we and others have spent a significant amount of research activity to understand and model analytical platforms and subsequently improve computational methods for the analyses of complex biological mixtures. While our original grant application has resulted in methods and programs already accepted by the community, there is a need and significant room for further key contributions. We see many of these contributions being related to the analyses of dynamic changes in cells and tissues, and involving changes in protein quantities, protein post-translational modifications (PTMs) and transient protein-protein interactions. Mass spectrometry-based proteomics provides an excellent platform to address each of these challenges. Thus, we plan to continue to develop novel methods for label-free quantification and remain close to our core strengths, but also strongly focus on PTMs and protein-protein interactions as new directions of this renewal application. This application includes a considerably closer collaboration between computational (Dr. Radivojac, Dr. Tang) and experimental (Dr. Arnold, Dr. Clemmer, Dr. Reilly) scientists than did our original application. The investigators bring complementary expertise and experience in a range of disciplines involving protein bioinformatics, algorithms, machine learning, as well as analytical chemistry and instrumentation. Overall, we believe that this proposal will result in significant advances for mass spectrometry-based proteomics. (Not modified) We propose to develop novel and theoretically sound methodology for several important yet challenging problems in mass spectrometry-based proteomics, including the identification of peptides containing post- translational modifications and cross-linked peptides, and the absolute quantification of proteins in complex samples.",Computational approaches to protein identification and quantification using MS/MS,8373375,R01GM103725,"['Play ', ' Data Set ', ' Peptides ', ' Post-Translational Protein Processing ', ' Proteins ', ' Custom ', ' Gases ', ' Goals ', ' Research Personnel ', ' Algorithms ', ' Role ', ' Computer software ', ' sound ', ' Indiana ', ' instrumentation ', ' Ions ', ' Mass Spectrum Analysis ', ' Tissues ', ' Measures ', ' Learning ', ' Cells ', ' Analytical Chemistry ', ' Relative (related person) ', ' Liquid Chromatography ', ' Universities ', ' Work ', ' Communities ', ' Computing Methodologies ', ' Methods ', ' Methodology ', ' Bioinformatics ', ' Occupations ', ' Collaborations ', ' experience ', ' protein protein interaction ', ' Proteomics ', ' base ', ' Modeling ', ' Sampling ', ' response ', ' Procedures ', ' Site ', ' Area ', ' Phase ', ' Biological ', ' crosslink ', ' Label ', ' improved ', ' Staging ', ' tandem mass spectrometry ', ' model development ', ' instrument ', ' Machine Learning ', ' Chemicals ', ' Training ', ' Synthetic Peptide Libraries ', ' Peptide Library ', ' Discipline ', ' Scientist ', ' Reproducibility ', ' programs ', ' Research Activity ', ' Spectrometry ', ' ion mobility ', ' Complex ', ' Synthesis Chemistry ', ' Method LOINC Axis 6 ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Techniques ', ' Population ', ' novel ', ' Coupled ', ' research study ', ' Process ', ' Funding ', ' Development ', ' Data ', ' Applications Grants ', ' Analytic Chemistry ', ' Computational Technique ', ' Address ', ' Body Tissues ', ' Relative ', ' Jobs ', ' Professional Postions ', ' computational methodology ', ' computational methods ', ' computer methods ', ' Post-Translational Modification Site ', ' Synthetic Chemistry ', ' Researchers ', ' social role ', ' Bio-Informatics ', ' developmental ', ' Software ', ' computer program/software ', ' experiment ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Modifications ', ' Post-Translational Protein Modification ', ' Posttranslational Modifications ', ' Posttranslational Protein Processing ', ' Protein Modification ', ' experimental research ', ' experimental study ', ' gene product ', ' cross-link ', ' kernel methods ', ' statistical learning ', ' support vector machine ', ' Dataset ', ' Grant Proposals ', ' Investigators ', ' ']",NIGMS,INDIANA UNIVERSITY BLOOMINGTON,R01,2012,448534,0.2242818409386892
"Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul    DESCRIPTION (provided by applicant): Early detection of cancer improves patient survival. Characterizing the association of peptides and glycans with cancer is one of the most promising strategies to discover early-diagnosis cancer biomarkers. This study evaluates peptide and glycan expression profiles in the progression of chronic liver disease (CLD) to hepatocellular carcinoma (HCC) by using the liquid chromatography-mass spectrometry (LC-MS) technology. The goal is to find and validate peptide and glycan biomarkers for detection of HCC at a treatable stage in a high-risk population of patients with CLD. Label-free LC-MS quantification allows comparison of peptides and glycans with good throughput which allows us to compare a large population of patients. However, such quantification is not addressed adequately in the instrument-specific software packages. In particular, alignment and normalization of LC-MS data present a significant challenge in label-free quantification and comparison of biomolecules. This challenge coupled with biological variability and disease heterogeneity in human populations has restricted recent advances in LC-MS-based biomarker discovery studies. This project brings together experts in bioinformatics, biostatistics, biochemistry, and mass spectrometry to develop a suite of novel analytical tools for LC-MS-based label-free quantification and comparison of peptides and glycans in serum and plasma. Specifically, a novel Bayesian hierarchical model will be investigated for simultaneous alignment and normalization of LC-MS data and for identification of patient subgroups. The Bayesian framework involves fixed and random effects to account for subpopulation homogeneous behavior (fixed systematic changes), while allowing for modeling heterogeneity within a group (random effects). A spike-in study will be conducted to obtain replicate LC-MS runs with known peptide and glycan concentrations. The data will be utilized to develop and optimize the proposed Bayesian framework and to compare its performance with other existing solutions. The optimized framework and a machine learning-based feature selection method will be applied to identify an integrated set of peptide and glycan candidate biomarkers for early detection of HCC. LC-MS analysis of integrated peptides and glycans in both serum and plasma of patients with HCC is to our knowledge unprecedented. Blood samples from patients with HCC and CLD controls in Egypt and United States will be used. The biomarkers will be validated using isotope dilution mass spectrometric assays.       PUBLIC HEALTH RELEVANCE: This project will lead to the development of a suite of novel open source analytical tools for label-free quantification of peptides and glycans in serum and plasma using liquid chromatography-mass spectrometry (LC-MS) technologies. The availability of such tools will assist the research community in advancing the promising LC-MS-based biomarker discovery research. The proposed tools will be utilized to find and validate early-diagnosis biomarkers of hepatocellular carcinoma (HCC). Defining clinically applicable biomarkers that detect early-stage HCC in a high-risk population of patients with chronic liver disease has potentially far-reaching consequences for disease management and patient health. This project is important because most HCC patients are diagnosed at a late stage, where the treatment options are limited. There is a pressing need to identify biomarkers of HCC that could be used for early detection and more accurate classification of disease. In addition to screening high-risk populations for early signs of disease, the resulting biomarkers could be used to design and test improved treatment strategies.            ",Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul,8468922,R01CA143420,"['Accounting ', ' Behavior ', ' Biological Chemistry ', ' Biochemistry ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Egypt ', ' Exhibits ', ' Fibrosis ', ' Goals ', ' Health ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Primary carcinoma of the liver cells ', ' Heterogeneity ', ' University Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Isotopes ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Michigan ', ' Patients ', ' Peptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Glycans ', ' Polysaccharides ', ' gene product ', ' Proteins ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Running ', ' computer program/software ', ' Software ', ' Computer software ', ' Solutions ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' United States ', ' Universities ', ' Work ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Label ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' specimen collection ', ' sample collection ', ' Biological ', ' Ensure ', ' Blood Serum ', ' Serum ', ' Individual ', ' Collaborations ', ' Staging ', ' tool ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' chronic liver disease ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Disorder Management ', ' Disease Management ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' synthetic peptide ', ' novel ', ' nosology ', ' disorder classification ', ' disease classification ', ' Metric ', ' Modeling ', ' Sampling ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' disease control ', ' disorder control ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Data ', ' Detection ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Subgroup ', ' Newly Diagnosed ', ' Process ', ' developmental ', ' Development ', ' cirrhotic ', ' Cirrhosis ', ' mass spectrometer ', ' designing ', ' design ', ' Population ', ' Coupled ', ' analytical tool ', ' open source ', ' comparative ', ' stem ', ' high risk ', ' public health relevance ', ' patient population ', ' treatment strategy ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' multiple reaction monitoring ', ' screening ', ' ']",NCI,GEORGETOWN UNIVERSITY,R01,2013,261371,0.09017819989312975
"A photographic method for human body composition assessment     DESCRIPTION (provided by applicant): The assessment of body composition, particularly fat and fat free mass, is vital to understanding many health-related conditions including obesity and sarcopenia, whose very definitions depend on assessment of fat and fat free mass, but also cachexia induced by HIV, cancer, and other diseases; multiple sclerosis; wasting in neurological disorders such as Parkinson's, Alzheimer's, muscular dystrophy; eating disorders; proper growth in children; and yet others still. Nevertheless, challenges remain in measuring body composition. Existing methods beyond height, weight, and very simple anthropometry are still not the norm in large-scale epidemiologic studies and clinical studies. This is because of concerns, depending on method, about cost, portability, time, radiation exposure, and accuracy. Calculation of body mass index (BMI; kg/m2) is a commonly used alternative, but is limited in that it is an assessment of body weight relative to height and not of body fatness per se. A hand-held device that could be carried by any individual, accurately assess fat mass and skeletal muscle mass, and be utilized without any discomfort to the subject, inexpensively, and without radiation exposure would be highly desirable. Evidence suggests that highly experienced trained observers can accurately estimate percentage of body fat by visual examination of subjects, but concerns about accuracy and subjectivity predominate. We hypothesize that we can develop a computer algorithm which can perform as or more accurately when analyzing photographic imagery data, will require no repeated retraining, and eliminate subjectivity. Our first specific aim is to develop a computer image analysis algorithm to accurately estimate adiposity and skeletal muscle mass from standardized photographic images in a bi-ethnic sample of men, women, and children. Our second specific aim is to validate the algorithm in a large diverse sample of men, women, and children.          Obesity, loss of skeletal muscle with aging, and other body composition alterations are of profound public health importance. We propose a novel method for measuring the quantity of fat and skeletal muscle mass in humans quickly, painlessly, safely, accurately, and inexpensively that can subsequently be used in many large scale and remote studies.                ",A photographic method for human body composition assessment,8468734,R01HL107916,"['Abbreviations ', ' Age ', ' Aging ', ' Air ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Anthropometry ', ' Body Composition ', ' Body Size ', ' Body Weight ', ' Cachexia ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Eating Disorders ', ' Equipment ', ' Physical Exercise ', ' Exercise ', ' Fats ', ' Fatty acid glycerol esters ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Hand ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', "" men's "", ' men ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' muscle dystrophy ', ' Myodystrophy ', ' Myodystrophica ', ' Muscular Dystrophies ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Plethysmography ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Technology ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Weight ', ' Woman ', ' Work ', ' Writing ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Task Forces ', ' Advisory Committees ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Visualization ', ' Imagery ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Training ', ' not painful ', ' non-painful ', ' Painless ', ' Visual ', ' wasting ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Measurement ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' Human Figure ', ' Human body ', ' light (weight) ', ' Body fat ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' frailty ', ' Home ', ' Home environment ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' waist circumference ', ' Height ', ' interest ', ' computer imaging ', ' digital imaging ', ' experience ', ' field study ', ' novel ', ' Participant ', ' Laboratory Study ', ' Categories ', ' Devices ', ' ray (radiation) ', ' Radiation ', ' Sampling ', ' response ', ' sarcopenia ', ' portability ', ' Skin ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' DXA ', ' Dual-Energy X-Ray Absorptiometry ', ' Data ', ' Strategic Planning ', ' Validation ', ' sex ', ' imaging ', ' Image ', ' cost ', ' digital ', ' Population ', ' computer algorithm ', ' Computational algorithm ', ' primary outcome ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,R01,2013,522750,0.1573394519826196
"A New Model of Peptide Fragmentation for Improved Protein Identification and Targ    DESCRIPTION (provided by applicant): Mass spectrometry (MS) based proteomics has emerged as a key technology in the search for disease- associated biomarkers. State-of-the-art instruments can identify thousands of proteins in a single sample by 'shotgun' proteomic analysis, where protein mixtures are proteolyzed into peptides, separated by one or more chromatographic steps, and analyzed by peptide dissociation using tandem mass spectrometry (MS/MS). The goal of this approach is to create new technologies for the accurate detection of proteins within complex samples. Achieving this target is currently limited by the major problem of inferring the peptide sequence from MS/MS spectra by sequence database searching: spectra are compared to ""model spectra"" generated from database sequences. Current algorithms suffer from poor accuracy and discrimination due to the use of simple models for predicting spectra, which ignores the rich information contained in the relative intensities of peaks in a typical MS/MS. Consequently, there is a vital need for more accurate models to predict MS/MS spectrum intensities from peptide sequences. In this proposal, we will develop a new and innovative kinetic model for predicting peptide fragmentation MS/MS spectra, and use the model to develop MS/MS identification algorithms with high discrimatory power. Spectra simulated by the kinetic model will then be used to design selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies. This will solve a bottleneck for widespread adoption of SRM methods for biomarker discovery, which is currently hindered by the slow process of identifying and optimizing SRM transitions for the assays. The following specific aims are (1) Develop an optimized kinetic model of gas-phase peptide fragmentation which predicts MS/MS spectra for any peptide sequence. Model parameters will be fit using the Levenberg- Marquardt algorithm, a robust method for non-linear least squares. (2) Extend the model to predict MS/MS fragmentation of phosphopeptides. The approaches developed in this aim can be extended to other disease- relevant post-translational modifications which profoundly alter peptide fragmentation and interfere with MS/MS identification. (3) Develop a route to successful implementation of spectrum-to-spectrum matching algorithms, an entirely new approach for large scale identification of proteins, in which MS/MS are searched directly against libraries of predicted spectra, simulated using our prototype kinetic model. We use predicted spectra to bypass the need for sequence databases, and spectrum-to-sequence strategies altogether. (4) Develop an algorithm for de novo prediction of selected reaction monitoring (SRM) assays for highly multiplexed quantitative measurement of proteins in complex mixtures.           PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.         ",A New Model of Peptide Fragmentation for Improved Protein Identification and Targ,8504800,R01CA155453,"['Adoption ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Gases ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' instrumentation ', ' Ions ', ' Kinetics ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' Libraries ', ' Methods ', ' Probabilistic Models ', ' Statistical Models ', ' Peptides ', ' Phosphopeptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Sensitivity and Specificity ', ' Shotguns ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dissociation ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Phase ', ' Chemicals ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Simulate ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Scanning ', ' Reaction ', ' protein profiling ', ' Route ', ' Techniques ', ' interest ', ' early detection ', ' Early Diagnosis ', ' drug efficacy ', ' tandem mass spectrometry ', ' novel technologies ', ' new technology ', ' Bypass ', ' Protein Sequence Analyses ', ' Peptide Sequence Analysis ', ' Peptide Sequence Analyses ', ' Amino Acid Sequence Analysis ', ' Amino Acid Sequence Analyses ', ' Protein Sequence Analysis ', ' Modeling ', ' Sampling ', ' Proteomics ', ' peptide sequence ', ' peptide aminoacid sequence ', ' protein aminoacid sequence ', ' Complex Mixtures ', ' preventing ', ' prevent ', ' Address ', ' Detection ', ' Molecular Target ', ' Protein Analysis ', ' Monitor ', ' Process ', ' designing ', ' design ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' innovative ', ' innovate ', ' innovation ', ' chemotherapy ', ' prototype ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' ']",NCI,UNIVERSITY OF COLORADO,R01,2013,295501,0.16116800926157937
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efficient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the fields of machine learning, statistics and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets.  The core of the proposal is a type of probabilistic model, known as a dynamic Bayesian network that allows us to reason efficiently and accurately about complex sequential data sets. This modeling framework leverages a large body of related work from the fields of natural language processing and speech recognition. Much of this prior work has not yet been exploited by computational biologists, so the proposal represents a valuable cross-fertilization across disciplines.  More specifically, this project employs a collection of cooperating dynamic Bayesian networks to model jointly an entire mass spectrometry experiment. Relative to most existing methods for analyzing mass spectrometry data, which tend to divide the analysis of an experiment into a series of small independent subtasks, the proposed unified model jointly, considers all of the available data. This approach can thus exploit valuable dependencies among spectra and along various dimensions of the data. Dynamic Bayesian networks also provide a rigorous framework for performing inference from a combination of observed data and qualitative expert knowledge.  The project is divided into five aims, each of which concerns a particular type of mass spectrometry experiment. These experiments involve (1) identifying all of the proteins in a given complex biological sample using a standard mass spectrometry protocol; (2) identifying proteins using a modified protocol in which the mass spectrometer samples the data in a systematic, rather than data-dependent, fashion, with the goal of identifying lower abundance proteins; (3) quantifying the relative abundance of proteins within or between biological samples; (4) identifying post-translational modified proteins or proteins that contain sequence variation; and (5) performing targeted quantification of a specified set of proteins, such as proteins in a pathway of interest or protein biomarkers.  The methods described in this proposal have the potential to dramatically improve our ability to draw conclusions from and formulate hypotheses on the basis of high-throughput shotgun proteomics experiments. Experiments like the ones described above can, for example, identify proteins involved in fundamental disease processes, identify previously unknown protein isoforms, or quantify the re- sponses of proteins to environmental stressors or disease states.        The applications of mass spectrometry and its promises for improvements of human health are nu- merous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens. How- ever, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.         ",Machine learning analysis of tandem mass spectra,8470188,R01GM096306,"['protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' Connecting Peptide ', ' C-Peptide ', ' Cells ', ' Liquid Chromatography ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fertility/Fertilization ', ' Fertilization ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Ions ', ' Methods ', ' Probabilistic Models ', ' Statistical Models ', ' natural language understanding ', ' Natural Language Processing ', ' Peptides ', ' Probability ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Shotguns ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' prognostic ', ' Discipline ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Dimensions ', ' Complex ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' interest ', ' environmental stressor ', ' Isoforms ', ' Protein Isoforms ', ' speech recognition ', ' tandem mass spectrometry ', ' novel ', ' Graph ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Peptide Sequence Determination ', ' Modeling ', ' Sampling ', ' response ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Complex Mixtures ', ' Data ', ' Reproducibility ', ' Collection ', ' Monitor ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' mass spectrometer ', ' Bayesian Networks ', ' computer based statistical methods ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2013,602213,0.2854977525196606
"Computational approaches to protein identification and quantification using MS/MS (Not modified) Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) is a widely used platform for high-throughput identification and quantification of proteins in biological samples. In addition to experimental steps in the pipeline, computational and statistical procedures play important roles in determining the content of the mixture. However, even with the best analytical platforms and modern software, only a small fraction of spectra are typically identified, thus directly impacting the quality of the biological sample analysis. If high- throughput proteomics techniques are to become routinely used in biomedical applications on the population scale, it is critical to address analytical and computational factors that contribute to the inadequate identification coverage and sensitivity. Over the past several years, we and others have spent a significant amount of research activity to understand and model analytical platforms and subsequently improve computational methods for the analyses of complex biological mixtures. While our original grant application has resulted in methods and programs already accepted by the community, there is a need and significant room for further key contributions. We see many of these contributions being related to the analyses of dynamic changes in cells and tissues, and involving changes in protein quantities, protein post-translational modifications (PTMs) and transient protein-protein interactions. Mass spectrometry-based proteomics provides an excellent platform to address each of these challenges. Thus, we plan to continue to develop novel methods for label-free quantification and remain close to our core strengths, but also strongly focus on PTMs and protein-protein interactions as new directions of this renewal application. This application includes a considerably closer collaboration between computational (Dr. Radivojac, Dr. Tang) and experimental (Dr. Arnold, Dr. Clemmer, Dr. Reilly) scientists than did our original application. The investigators bring complementary expertise and experience in a range of disciplines involving protein bioinformatics, algorithms, machine learning, as well as analytical chemistry and instrumentation. Overall, we believe that this proposal will result in significant advances for mass spectrometry-based proteomics. (Not modified) We propose to develop novel and theoretically sound methodology for several important yet challenging problems in mass spectrometry-based proteomics, including the identification of peptides containing post- translational modifications and cross-linked peptides, and the absolute quantification of proteins in complex samples.",Computational approaches to protein identification and quantification using MS/MS,8549841,R01GM103725,"['Algorithms ', ' Cells ', ' Analytic Chemistry ', ' Analytical Chemistry ', ' Liquid Chromatography ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Gases ', ' Goals ', ' Indiana ', ' instrumentation ', ' Ions ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Professional Postions ', ' Jobs ', ' Occupations ', ' Peptides ', ' Play ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' sound ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Body Tissues ', ' Tissues ', ' Universities ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' cross-link ', ' crosslink ', ' Label ', ' improved ', ' Procedures ', ' Site ', ' Area ', ' Phase ', ' Biological ', ' Chemicals ', ' Training ', ' Discipline ', ' Research Activity ', ' Funding ', ' Collaborations ', ' Staging ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Synthetic Peptide Libraries ', ' Peptide Library ', ' programs ', ' Scientist ', ' Spectrometry ', ' Complex ', ' Techniques ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Modeling ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' model development ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Post-Translational Modification Site ', ' Reproducibility ', ' Synthetic Chemistry ', ' Synthesis Chemistry ', ' Computational Technique ', ' Process ', ' developmental ', ' Development ', ' ion mobility ', ' Population ', ' Coupled ', ' ']",NIGMS,INDIANA UNIVERSITY BLOOMINGTON,R01,2013,396933,0.2242818409386892
"Self Correcting Nanoflow LC-MS for Clinical Proteomics     DESCRIPTION (provided by applicant): The overall goal of this proposal is to improve the quality, reliability, and interlaboratory comparability of peptide mass spectrometry data. Mass spectrometry (MS) has become a fundamental technology for the identification and quantitative analysis of proteins, protein interactions, and protein post-translational modifications. These analyses are an important part of solving biological problems that involve changes in protein abundance in response to disease, drug treatment, and genetic or environmental perturbations. Unfortunately, the application of protein mass spectrometry measurements in the clinical laboratory has been limited. Unlike most clinical assays by mass spectrometry, which use microflow liquid chromatography, peptide measurements are commonly performed using a nanoflow liquid chromatograph interface to the mass spectrometer (nanoflow LC-MS). Despite their analytical power, these nanoflow LC-MS methods have been difficult to apply robustly in quantitative assays involving large numbers of samples from a challenging sample matrix. The successful completion of our project will result in a peptide analysis platform that can automatically assess problems with the nanoflow LC-MS system and correct the problem during an analytical run and will significantly improve the robustness and reproducibility of peptide mass spectrometry measurements.         PUBLIC HEALTH RELEVANCE: Mass spectrometry has been a fundamental technology for the analysis of proteins in health and disease. However, despite the analytical power of conventional mass spectrometry methods, they have not been well-suited for the comparative analysis of very large numbers of samples acquired under a large number of conditions. Thus, the continued development of novel mass spectrometry technology is essential to understanding complex biological systems so that can be characterized that have a change in abundance in response to disease, drug treatment, and genetic or environmental perturbation.            ",Self Correcting Nanoflow LC-MS for Clinical Proteomics,8558710,R01GM107142,"['Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Liquid Chromatography ', ' Communities ', ' Couples ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Goals ', ' Health ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Laboratories ', ' Medicine ', ' Methods ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Quality Control ', ' Research ', ' Robotics ', ' Running ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Universities ', ' Washington ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Training ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Data Quality ', ' Measurement ', ' liquid ', ' fluid ', ' Liquid substance ', ' Genetic ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' experience ', ' Performance ', ' novel ', ' Metric ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' Process ', ' developmental ', ' Development ', ' mass spectrometer ', ' Outcome ', ' open source ', ' comparative ', ' public health relevance ', ' complex biological systems ', ' operation ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2013,355930,0.27932609388434526
"Pharmaco Response Signatures and Disease Mechanism     DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals.         PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.            ",Pharmaco Response Signatures and Disease Mechanism,8787853,U54HL127365,"['Accounting ', ' Antibodies ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Extracts ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Genome ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Pharmacology ', ' Phenotype ', ' Transphosphorylases ', ' Kinases ', ' EC 2.7 ', ' Phosphotransferases ', ' Production ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' mRNA ', ' Messenger RNA ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' Measures ', ' Tumor Cell Line ', ' forest ', ' Dataset ', ' Data Set ', ' Fuzzy Logic ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' Visualization ', ' Imagery ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' immunoresponse ', ' host response ', ' Immune response ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' programs ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Immune ', ' Complex ', ' cell type ', ' Gray ', ' Gray unit of radiation dose ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Metric ', ' Proteome ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' Genomics ', ' cell fixing ', ' drug discovery ', ' Sentinel ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Dose ', ' Data ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Education and Outreach ', ' Collection ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' usability ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' network models ', ' senescent ', ' senescence ', ' public health relevance ', ' operation ', ' epigenome ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2014,2145458,0.09579543721714887
"Self Correcting Nanoflow LC-MS for Clinical Proteomics     DESCRIPTION (provided by applicant): The overall goal of this proposal is to improve the quality, reliability, and interlaboratory comparability of peptide mass spectrometry data. Mass spectrometry (MS) has become a fundamental technology for the identification and quantitative analysis of proteins, protein interactions, and protein post-translational modifications. These analyses are an important part of solving biological problems that involve changes in protein abundance in response to disease, drug treatment, and genetic or environmental perturbations. Unfortunately, the application of protein mass spectrometry measurements in the clinical laboratory has been limited. Unlike most clinical assays by mass spectrometry, which use microflow liquid chromatography, peptide measurements are commonly performed using a nanoflow liquid chromatograph interface to the mass spectrometer (nanoflow LC-MS). Despite their analytical power, these nanoflow LC-MS methods have been difficult to apply robustly in quantitative assays involving large numbers of samples from a challenging sample matrix. The successful completion of our project will result in a peptide analysis platform that can automatically assess problems with the nanoflow LC-MS system and correct the problem during an analytical run and will significantly improve the robustness and reproducibility of peptide mass spectrometry measurements.         PUBLIC HEALTH RELEVANCE: Mass spectrometry has been a fundamental technology for the analysis of proteins in health and disease. However, despite the analytical power of conventional mass spectrometry methods, they have not been well-suited for the comparative analysis of very large numbers of samples acquired under a large number of conditions. Thus, the continued development of novel mass spectrometry technology is essential to understanding complex biological systems so that can be characterized that have a change in abundance in response to disease, drug treatment, and genetic or environmental perturbation.",Self Correcting Nanoflow LC-MS for Clinical Proteomics,8727640,R01GM107142,"['Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Liquid Chromatography ', ' Communities ', ' Couples ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Goals ', ' Health ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Laboratories ', ' Medicine ', ' Methods ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Quality Control ', ' Research ', ' Robotics ', ' Running ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Universities ', ' Washington ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Training ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Data Quality ', ' Measurement ', ' liquid ', ' fluid ', ' Liquid substance ', ' Genetic ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' experience ', ' Performance ', ' novel ', ' Metric ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' Process ', ' developmental ', ' Development ', ' mass spectrometer ', ' Outcome ', ' open source ', ' comparative ', ' public health relevance ', ' complex biological systems ', ' operation ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2014,371177,0.27932609388434526
"A photographic method for human body composition assessment     DESCRIPTION (provided by applicant): The assessment of body composition, particularly fat and fat free mass, is vital to understanding many health-related conditions including obesity and sarcopenia, whose very definitions depend on assessment of fat and fat free mass, but also cachexia induced by HIV, cancer, and other diseases; multiple sclerosis; wasting in neurological disorders such as Parkinson's, Alzheimer's, muscular dystrophy; eating disorders; proper growth in children; and yet others still. Nevertheless, challenges remain in measuring body composition. Existing methods beyond height, weight, and very simple anthropometry are still not the norm in large-scale epidemiologic studies and clinical studies. This is because of concerns, depending on method, about cost, portability, time, radiation exposure, and accuracy. Calculation of body mass index (BMI; kg/m2) is a commonly used alternative, but is limited in that it is an assessment of body weight relative to height and not of body fatness per se. A hand-held device that could be carried by any individual, accurately assess fat mass and skeletal muscle mass, and be utilized without any discomfort to the subject, inexpensively, and without radiation exposure would be highly desirable. Evidence suggests that highly experienced trained observers can accurately estimate percentage of body fat by visual examination of subjects, but concerns about accuracy and subjectivity predominate. We hypothesize that we can develop a computer algorithm which can perform as or more accurately when analyzing photographic imagery data, will require no repeated retraining, and eliminate subjectivity. Our first specific aim is to develop a computer image analysis algorithm to accurately estimate adiposity and skeletal muscle mass from standardized photographic images in a bi-ethnic sample of men, women, and children. Our second specific aim is to validate the algorithm in a large diverse sample of men, women, and children.          Obesity, loss of skeletal muscle with aging, and other body composition alterations are of profound public health importance. We propose a novel method for measuring the quantity of fat and skeletal muscle mass in humans quickly, painlessly, safely, accurately, and inexpensively that can subsequently be used in many large scale and remote studies.                ",A photographic method for human body composition assessment,8656408,R01HL107916,"['Abbreviations ', ' Age ', ' Aging ', ' Air ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Anthropometry ', ' Body Composition ', ' Body Size ', ' Body Weight ', ' Cachexia ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Eating Disorders ', ' Equipment ', ' Physical Exercise ', ' Exercise ', ' Fats ', ' Fatty acid glycerol esters ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Hand ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', "" men's "", ' men ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' muscle dystrophy ', ' Myodystrophy ', ' Myodystrophica ', ' Muscular Dystrophies ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Plethysmography ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Technology ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Weight ', ' Woman ', ' Work ', ' Writing ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Task Forces ', ' Advisory Committees ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Visualization ', ' Imagery ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Training ', ' not painful ', ' non-painful ', ' Painless ', ' Visual ', ' wasting ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Measurement ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' Human Figure ', ' Human body ', ' light (weight) ', ' Body fat ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' frailty ', ' Home ', ' Home environment ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' waist circumference ', ' Height ', ' interest ', ' computer imaging ', ' digital imaging ', ' experience ', ' field study ', ' novel ', ' Participant ', ' Laboratory Study ', ' Categories ', ' Devices ', ' ray (radiation) ', ' Radiation ', ' Sampling ', ' response ', ' sarcopenia ', ' portability ', ' Skin ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' DXA ', ' Dual-Energy X-Ray Absorptiometry ', ' Data ', ' Strategic Planning ', ' Validation ', ' sex ', ' imaging ', ' Image ', ' cost ', ' digital ', ' Population ', ' computer algorithm ', ' Computational algorithm ', ' primary outcome ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,R01,2014,515730,0.1573394519826196
"Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul    DESCRIPTION (provided by applicant): Early detection of cancer improves patient survival. Characterizing the association of peptides and glycans with cancer is one of the most promising strategies to discover early-diagnosis cancer biomarkers. This study evaluates peptide and glycan expression profiles in the progression of chronic liver disease (CLD) to hepatocellular carcinoma (HCC) by using the liquid chromatography-mass spectrometry (LC-MS) technology. The goal is to find and validate peptide and glycan biomarkers for detection of HCC at a treatable stage in a high-risk population of patients with CLD. Label-free LC-MS quantification allows comparison of peptides and glycans with good throughput which allows us to compare a large population of patients. However, such quantification is not addressed adequately in the instrument-specific software packages. In particular, alignment and normalization of LC-MS data present a significant challenge in label-free quantification and comparison of biomolecules. This challenge coupled with biological variability and disease heterogeneity in human populations has restricted recent advances in LC-MS-based biomarker discovery studies. This project brings together experts in bioinformatics, biostatistics, biochemistry, and mass spectrometry to develop a suite of novel analytical tools for LC-MS-based label-free quantification and comparison of peptides and glycans in serum and plasma. Specifically, a novel Bayesian hierarchical model will be investigated for simultaneous alignment and normalization of LC-MS data and for identification of patient subgroups. The Bayesian framework involves fixed and random effects to account for subpopulation homogeneous behavior (fixed systematic changes), while allowing for modeling heterogeneity within a group (random effects). A spike-in study will be conducted to obtain replicate LC-MS runs with known peptide and glycan concentrations. The data will be utilized to develop and optimize the proposed Bayesian framework and to compare its performance with other existing solutions. The optimized framework and a machine learning-based feature selection method will be applied to identify an integrated set of peptide and glycan candidate biomarkers for early detection of HCC. LC-MS analysis of integrated peptides and glycans in both serum and plasma of patients with HCC is to our knowledge unprecedented. Blood samples from patients with HCC and CLD controls in Egypt and United States will be used. The biomarkers will be validated using isotope dilution mass spectrometric assays.       PUBLIC HEALTH RELEVANCE: This project will lead to the development of a suite of novel open source analytical tools for label-free quantification of peptides and glycans in serum and plasma using liquid chromatography-mass spectrometry (LC-MS) technologies. The availability of such tools will assist the research community in advancing the promising LC-MS-based biomarker discovery research. The proposed tools will be utilized to find and validate early-diagnosis biomarkers of hepatocellular carcinoma (HCC). Defining clinically applicable biomarkers that detect early-stage HCC in a high-risk population of patients with chronic liver disease has potentially far-reaching consequences for disease management and patient health. This project is important because most HCC patients are diagnosed at a late stage, where the treatment options are limited. There is a pressing need to identify biomarkers of HCC that could be used for early detection and more accurate classification of disease. In addition to screening high-risk populations for early signs of disease, the resulting biomarkers could be used to design and test improved treatment strategies.            ",Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul,8658019,R01CA143420,"['Accounting ', ' Behavior ', ' Biological Chemistry ', ' Biochemistry ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Egypt ', ' Exhibits ', ' Fibrosis ', ' Goals ', ' Health ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Primary carcinoma of the liver cells ', ' Heterogeneity ', ' University Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Isotopes ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Michigan ', ' Patients ', ' Peptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Glycans ', ' Polysaccharides ', ' gene product ', ' Proteins ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Running ', ' computer program/software ', ' Software ', ' Computer software ', ' Solutions ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' United States ', ' Universities ', ' Work ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Label ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' specimen collection ', ' sample collection ', ' Biological ', ' Ensure ', ' Blood Serum ', ' Serum ', ' Individual ', ' Collaborations ', ' Staging ', ' tool ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' chronic liver disease ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Disorder Management ', ' Disease Management ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' synthetic peptide ', ' novel ', ' nosology ', ' disorder classification ', ' disease classification ', ' Metric ', ' Modeling ', ' Sampling ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' disease control ', ' disorder control ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Data ', ' Detection ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Subgroup ', ' Newly Diagnosed ', ' Process ', ' developmental ', ' Development ', ' cirrhotic ', ' Cirrhosis ', ' mass spectrometer ', ' designing ', ' design ', ' Population ', ' Coupled ', ' analytical tool ', ' open source ', ' comparative ', ' stem ', ' high risk ', ' public health relevance ', ' patient population ', ' treatment strategy ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' multiple reaction monitoring ', ' screening ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' ']",NCI,GEORGETOWN UNIVERSITY,R01,2014,269721,0.09017819989312975
"Computational approaches to protein identification and quantification using MS/MS (Not modified) Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) is a widely used platform for high-throughput identification and quantification of proteins in biological samples. In addition to experimental steps in the pipeline, computational and statistical procedures play important roles in determining the content of the mixture. However, even with the best analytical platforms and modern software, only a small fraction of spectra are typically identified, thus directly impacting the quality of the biological sample analysis. If high- throughput proteomics techniques are to become routinely used in biomedical applications on the population scale, it is critical to address analytical and computational factors that contribute to the inadequate identification coverage and sensitivity. Over the past several years, we and others have spent a significant amount of research activity to understand and model analytical platforms and subsequently improve computational methods for the analyses of complex biological mixtures. While our original grant application has resulted in methods and programs already accepted by the community, there is a need and significant room for further key contributions. We see many of these contributions being related to the analyses of dynamic changes in cells and tissues, and involving changes in protein quantities, protein post-translational modifications (PTMs) and transient protein-protein interactions. Mass spectrometry-based proteomics provides an excellent platform to address each of these challenges. Thus, we plan to continue to develop novel methods for label-free quantification and remain close to our core strengths, but also strongly focus on PTMs and protein-protein interactions as new directions of this renewal application. This application includes a considerably closer collaboration between computational (Dr. Radivojac, Dr. Tang) and experimental (Dr. Arnold, Dr. Clemmer, Dr. Reilly) scientists than did our original application. The investigators bring complementary expertise and experience in a range of disciplines involving protein bioinformatics, algorithms, machine learning, as well as analytical chemistry and instrumentation. Overall, we believe that this proposal will result in significant advances for mass spectrometry-based proteomics. (Not modified) We propose to develop novel and theoretically sound methodology for several important yet challenging problems in mass spectrometry-based proteomics, including the identification of peptides containing post- translational modifications and cross-linked peptides, and the absolute quantification of proteins in complex samples.",Computational approaches to protein identification and quantification using MS/MS,8728956,R01GM103725,"['Algorithms ', ' Cells ', ' Analytic Chemistry ', ' Analytical Chemistry ', ' Liquid Chromatography ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Gases ', ' Goals ', ' Indiana ', ' instrumentation ', ' Ions ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Professional Positions ', ' Jobs ', ' Occupations ', ' Peptides ', ' Play ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' sound ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Body Tissues ', ' Tissues ', ' Universities ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' cross-link ', ' crosslink ', ' Label ', ' improved ', ' Procedures ', ' Site ', ' Area ', ' Phase ', ' Biological ', ' Chemicals ', ' Training ', ' Discipline ', ' Research Activity ', ' Funding ', ' Collaborations ', ' Staging ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Synthetic Peptide Libraries ', ' Peptide Library ', ' programs ', ' Scientist ', ' Spectrometry ', ' Complex ', ' Techniques ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Modeling ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' model development ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Post-Translational Modification Site ', ' Reproducibility ', ' Synthetic Chemistry ', ' Synthesis Chemistry ', ' Computational Technique ', ' Process ', ' developmental ', ' Development ', ' ion mobility ', ' Population ', ' Coupled ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' ']",NIGMS,INDIANA UNIVERSITY BLOOMINGTON,R01,2014,411329,0.2242818409386892
"Machine learning analysis of tandem mass spectra    DESCRIPTION (provided by applicant): Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efficient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the fields of machine learning, statistics and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets.  The core of the proposal is a type of probabilistic model, known as a dynamic Bayesian network that allows us to reason efficiently and accurately about complex sequential data sets. This modeling framework leverages a large body of related work from the fields of natural language processing and speech recognition. Much of this prior work has not yet been exploited by computational biologists, so the proposal represents a valuable cross-fertilization across disciplines.  More specifically, this project employs a collection of cooperating dynamic Bayesian networks to model jointly an entire mass spectrometry experiment. Relative to most existing methods for analyzing mass spectrometry data, which tend to divide the analysis of an experiment into a series of small independent subtasks, the proposed unified model jointly, considers all of the available data. This approach can thus exploit valuable dependencies among spectra and along various dimensions of the data. Dynamic Bayesian networks also provide a rigorous framework for performing inference from a combination of observed data and qualitative expert knowledge.  The project is divided into five aims, each of which concerns a particular type of mass spectrometry experiment. These experiments involve (1) identifying all of the proteins in a given complex biological sample using a standard mass spectrometry protocol; (2) identifying proteins using a modified protocol in which the mass spectrometer samples the data in a systematic, rather than data-dependent, fashion, with the goal of identifying lower abundance proteins; (3) quantifying the relative abundance of proteins within or between biological samples; (4) identifying post-translational modified proteins or proteins that contain sequence variation; and (5) performing targeted quantification of a specified set of proteins, such as proteins in a pathway of interest or protein biomarkers.  The methods described in this proposal have the potential to dramatically improve our ability to draw conclusions from and formulate hypotheses on the basis of high-throughput shotgun proteomics experiments. Experiments like the ones described above can, for example, identify proteins involved in fundamental disease processes, identify previously unknown protein isoforms, or quantify the re- sponses of proteins to environmental stressors or disease states.        The applications of mass spectrometry and its promises for improvements of human health are nu- merous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specific diagnostic and prognostic screens. How- ever, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.         ",Machine learning analysis of tandem mass spectra,8660698,R01GM096306,"['protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' Connecting Peptide ', ' C-Peptide ', ' Cells ', ' Liquid Chromatography ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Fertility/Fertilization ', ' Fertilization ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Ions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' natural language understanding ', ' Natural Language Processing ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Shotguns ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' prognostic ', ' Discipline ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Dimensions ', ' Complex ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' interest ', ' environmental stressor ', ' Isoforms ', ' Protein Isoforms ', ' speech recognition ', ' tandem mass spectrometry ', ' novel ', ' Graph ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Protein Sequencing Molecular Biology ', ' Protein Sequencing ', ' Protein Sequence Determinations ', ' Amino Acid Sequence Determinations ', ' Peptide Sequence Determination ', ' Modeling ', ' Sampling ', ' response ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Complex Mixtures ', ' Data ', ' Reproducibility ', ' Collection ', ' Monitor ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' mass spectrometer ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2014,617496,0.2854977525196606
"A New Model of Peptide Fragmentation for Improved Protein Identification and Targ    DESCRIPTION (provided by applicant): Mass spectrometry (MS) based proteomics has emerged as a key technology in the search for disease- associated biomarkers. State-of-the-art instruments can identify thousands of proteins in a single sample by 'shotgun' proteomic analysis, where protein mixtures are proteolyzed into peptides, separated by one or more chromatographic steps, and analyzed by peptide dissociation using tandem mass spectrometry (MS/MS). The goal of this approach is to create new technologies for the accurate detection of proteins within complex samples. Achieving this target is currently limited by the major problem of inferring the peptide sequence from MS/MS spectra by sequence database searching: spectra are compared to ""model spectra"" generated from database sequences. Current algorithms suffer from poor accuracy and discrimination due to the use of simple models for predicting spectra, which ignores the rich information contained in the relative intensities of peaks in a typical MS/MS. Consequently, there is a vital need for more accurate models to predict MS/MS spectrum intensities from peptide sequences. In this proposal, we will develop a new and innovative kinetic model for predicting peptide fragmentation MS/MS spectra, and use the model to develop MS/MS identification algorithms with high discrimatory power. Spectra simulated by the kinetic model will then be used to design selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies. This will solve a bottleneck for widespread adoption of SRM methods for biomarker discovery, which is currently hindered by the slow process of identifying and optimizing SRM transitions for the assays. The following specific aims are (1) Develop an optimized kinetic model of gas-phase peptide fragmentation which predicts MS/MS spectra for any peptide sequence. Model parameters will be fit using the Levenberg- Marquardt algorithm, a robust method for non-linear least squares. (2) Extend the model to predict MS/MS fragmentation of phosphopeptides. The approaches developed in this aim can be extended to other disease- relevant post-translational modifications which profoundly alter peptide fragmentation and interfere with MS/MS identification. (3) Develop a route to successful implementation of spectrum-to-spectrum matching algorithms, an entirely new approach for large scale identification of proteins, in which MS/MS are searched directly against libraries of predicted spectra, simulated using our prototype kinetic model. We use predicted spectra to bypass the need for sequence databases, and spectrum-to-sequence strategies altogether. (4) Develop an algorithm for de novo prediction of selected reaction monitoring (SRM) assays for highly multiplexed quantitative measurement of proteins in complex mixtures.           PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.         ",A New Model of Peptide Fragmentation for Improved Protein Identification and Targ,8701249,R01CA155453,"['Adoption ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Gases ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' instrumentation ', ' Ions ', ' Kinetics ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' Libraries ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Peptides ', ' Phosphopeptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Sensitivity and Specificity ', ' Shotguns ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dissociation ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Set protein ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Phase ', ' Chemicals ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Simulate ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Scanning ', ' Reaction ', ' protein profiling ', ' Route ', ' Techniques ', ' interest ', ' early detection ', ' Early Diagnosis ', ' drug efficacy ', ' tandem mass spectrometry ', ' novel technologies ', ' new technology ', ' Bypass ', ' Protein Sequence Analyses ', ' Peptide Sequence Analysis ', ' Peptide Sequence Analyses ', ' Amino Acid Sequence Analysis ', ' Amino Acid Sequence Analyses ', ' Protein Sequence Analysis ', ' Modeling ', ' Sampling ', ' Proteomics ', ' peptide sequence ', ' peptide aminoacid sequence ', ' protein aminoacid sequence ', ' Complex Mixtures ', ' preventing ', ' prevent ', ' Address ', ' Detection ', ' Molecular Target ', ' Protein Analysis ', ' Monitor ', ' Process ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' innovative ', ' innovate ', ' innovation ', ' chemotherapy ', ' prototype ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' ']",NCI,UNIVERSITY OF COLORADO,R01,2014,304932,0.16116800926157937
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,8926239,U54HL127365,"['Accounting ', ' Antibodies ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Extracts ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Genome ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Pharmacology ', ' Phenotype ', ' Transphosphorylases ', ' Kinases ', ' EC 2.7 ', ' Phosphotransferases ', ' Production ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' mRNA ', ' Messenger RNA ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' Measures ', ' Tumor Cell Line ', ' forest ', ' Dataset ', ' Data Set ', ' Fuzzy Logic ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' immunoresponse ', ' host response ', ' Immune response ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' programs ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Immune ', ' Complex ', ' cell type ', ' Gray ', ' Gray unit of radiation dose ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' Genomics ', ' cell fixing ', ' drug discovery ', ' Sentinel ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Dose ', ' Data ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Education and Outreach ', ' Collection ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' usability ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' network models ', ' senescent ', ' senescence ', ' operation ', ' epigenome ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2015,2313698,0.09579543721714887
"A New Model of Peptide Fragmentation for Improved Protein Identification and Targ    DESCRIPTION (provided by applicant): Mass spectrometry (MS) based proteomics has emerged as a key technology in the search for disease- associated biomarkers. State-of-the-art instruments can identify thousands of proteins in a single sample by 'shotgun' proteomic analysis, where protein mixtures are proteolyzed into peptides, separated by one or more chromatographic steps, and analyzed by peptide dissociation using tandem mass spectrometry (MS/MS). The goal of this approach is to create new technologies for the accurate detection of proteins within complex samples. Achieving this target is currently limited by the major problem of inferring the peptide sequence from MS/MS spectra by sequence database searching: spectra are compared to ""model spectra"" generated from database sequences. Current algorithms suffer from poor accuracy and discrimination due to the use of simple models for predicting spectra, which ignores the rich information contained in the relative intensities of peaks in a typical MS/MS. Consequently, there is a vital need for more accurate models to predict MS/MS spectrum intensities from peptide sequences. In this proposal, we will develop a new and innovative kinetic model for predicting peptide fragmentation MS/MS spectra, and use the model to develop MS/MS identification algorithms with high discrimatory power. Spectra simulated by the kinetic model will then be used to design selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies. This will solve a bottleneck for widespread adoption of SRM methods for biomarker discovery, which is currently hindered by the slow process of identifying and optimizing SRM transitions for the assays. The following specific aims are (1) Develop an optimized kinetic model of gas-phase peptide fragmentation which predicts MS/MS spectra for any peptide sequence. Model parameters will be fit using the Levenberg- Marquardt algorithm, a robust method for non-linear least squares. (2) Extend the model to predict MS/MS fragmentation of phosphopeptides. The approaches developed in this aim can be extended to other disease- relevant post-translational modifications which profoundly alter peptide fragmentation and interfere with MS/MS identification. (3) Develop a route to successful implementation of spectrum-to-spectrum matching algorithms, an entirely new approach for large scale identification of proteins, in which MS/MS are searched directly against libraries of predicted spectra, simulated using our prototype kinetic model. We use predicted spectra to bypass the need for sequence databases, and spectrum-to-sequence strategies altogether. (4) Develop an algorithm for de novo prediction of selected reaction monitoring (SRM) assays for highly multiplexed quantitative measurement of proteins in complex mixtures.           PROJECT NARRATIVE Mass spectrometry-based proteomics has emerged as a key technology in the search for useful protein biomarkers, and holds many promises for early detection of disease, prediction of drug efficacy and resistance, and targeted molecular therapies. The field is currently limited by the major problem of inferring the peptide sequence from a fragmentation mass spectrum - until this problem is solved, many potential applications of proteomics to human health will not be achieved. We will develop a kinetic model to predict peptide fragmentation spectra for any peptide sequence; a method that will enable comprehensive protein profiling in human biofluids, and the rapid design of selected reaction monitoring (SRM) assays, which have become a critically important technique for measuring targeted sets of proteins in human biomarker studies.         ",A New Model of Peptide Fragmentation for Improved Protein Identification and Targ,8895275,R01CA155453,"['Adoption ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Gases ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' instrumentation ', ' Ions ', ' Kinetics ', ' Least-Squares Analyses ', ' Least Squares ', ' Least-Squares Analysis ', ' Libraries ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Peptides ', ' Phosphopeptides ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Sensitivity and Specificity ', ' Shotguns ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dissociation ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Template Activating Factor I Beta ', ' Set protein ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Phase ', ' Chemicals ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Scanning ', ' Reaction ', ' protein profiling ', ' Route ', ' Techniques ', ' interest ', ' early detection ', ' Early Diagnosis ', ' drug efficacy ', ' tandem mass spectrometry ', ' novel technologies ', ' new technology ', ' Bypass ', ' Protein Sequence Analyses ', ' Peptide Sequence Analysis ', ' Peptide Sequence Analyses ', ' Amino Acid Sequence Analysis ', ' Amino Acid Sequence Analyses ', ' Protein Sequence Analysis ', ' Modeling ', ' Sampling ', ' Proteomics ', ' peptide sequence ', ' peptide aminoacid sequence ', ' protein aminoacid sequence ', ' Complex Mixtures ', ' preventing ', ' prevent ', ' Address ', ' Detection ', ' Molecular Target ', ' Protein Analysis ', ' Monitor ', ' Process ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' innovative ', ' innovate ', ' innovation ', ' chemotherapy ', ' prototype ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' ']",NCI,UNIVERSITY OF COLORADO,R01,2015,314363,0.16116800926157937
"A photographic method for human body composition assessment DESCRIPTION (provided by applicant): The assessment of body composition, particularly fat and fat free mass, is vital to understanding many health-related conditions including obesity and sarcopenia, whose very definitions depend on assessment of fat and fat free mass, but also cachexia induced by HIV, cancer, and other diseases; multiple sclerosis; wasting in neurological disorders such as Parkinson's, Alzheimer's, muscular dystrophy; eating disorders; proper growth in children; and yet others still. Nevertheless, challenges remain in measuring body composition. Existing methods beyond height, weight, and very simple anthropometry are still not the norm in large-scale epidemiologic studies and clinical studies. This is because of concerns, depending on method, about cost, portability, time, radiation exposure, and accuracy. Calculation of body mass index (BMI; kg/m2) is a commonly used alternative, but is limited in that it is an assessment of body weight relative to height and not of body fatness per se. A hand-held device that could be carried by any individual, accurately assess fat mass and skeletal muscle mass, and be utilized without any discomfort to the subject, inexpensively, and without radiation exposure would be highly desirable. Evidence suggests that highly experienced trained observers can accurately estimate percentage of body fat by visual examination of subjects, but concerns about accuracy and subjectivity predominate. We hypothesize that we can develop a computer algorithm which can perform as or more accurately when analyzing photographic imagery data, will require no repeated retraining, and eliminate subjectivity. Our first specific aim is to develop a computer image analysis algorithm to accurately estimate adiposity and skeletal muscle mass from standardized photographic images in a bi-ethnic sample of men, women, and children. Our second specific aim is to validate the algorithm in a large diverse sample of men, women, and children. Obesity, loss of skeletal muscle with aging, and other body composition alterations are of profound public health importance. We propose a novel method for measuring the quantity of fat and skeletal muscle mass in humans quickly, painlessly, safely, accurately, and inexpensively that can subsequently be used in many large scale and remote studies.",A photographic method for human body composition assessment,8835138,R01HL107916,"['Abbreviations ', ' Age ', ' Aging ', ' Air ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Anthropometry ', ' Body Composition ', ' Body Size ', ' Body Weight ', ' Cachexia ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Eating Disorders ', ' Equipment ', ' Physical Exercise ', ' Exercise ', ' Fats ', ' Fatty acid glycerol esters ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Hand ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', "" men's "", ' men ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' muscle dystrophy ', ' Myodystrophy ', ' Myodystrophica ', ' Muscular Dystrophies ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Primary Parkinsonism ', ' Parkinsons disease ', "" Parkinson's disease "", "" Parkinson's "", ' Parkinson ', ' Paralysis Agitans ', ' Lewy Body Parkinson Disease ', ' Idiopathic Parkinson Disease ', ' Parkinson Disease ', ' Plethysmography ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Technology ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computerized Axial Tomography (Computerized Tomography) ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Weight ', ' Woman ', ' Work ', ' Writing ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Task Forces ', ' Advisory Committees ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Visualization ', ' Imagery ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Training ', ' not painful ', ' non-painful ', ' Painless ', ' Visual ', ' wasting ', ' Individual ', ' muscle mass ', ' muscle bulk ', ' muscle form ', ' Measurement ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' Human Figure ', ' Human body ', ' light (weight) ', ' Body fat ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' frailty ', ' Home ', ' Home environment ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' waist circumference ', ' Height ', ' interest ', ' computer imaging ', ' digital imaging ', ' experience ', ' field study ', ' novel ', ' Participant ', ' Laboratory Study ', ' Categories ', ' Devices ', ' ray (radiation) ', ' Radiation ', ' Sampling ', ' response ', ' sarcopenia ', ' portability ', ' Skin ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' DXA ', ' Dual-Energy X-Ray Absorptiometry ', ' Data ', ' Strategic Planning ', ' Validation ', ' sex ', ' imaging ', ' Image ', ' cost ', ' digital ', ' Population ', ' computer algorithm ', ' Computational algorithm ', ' primary outcome ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,R01,2015,515384,0.1573394519826196
"Computational approaches to protein identification and quantification using MS/MS (Not modified) Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) is a widely used platform for high-throughput identification and quantification of proteins in biological samples. In addition to experimental steps in the pipeline, computational and statistical procedures play important roles in determining the content of the mixture. However, even with the best analytical platforms and modern software, only a small fraction of spectra are typically identified, thus directly impacting the quality of the biological sample analysis. If high- throughput proteomics techniques are to become routinely used in biomedical applications on the population scale, it is critical to address analytical and computational factors that contribute to the inadequate identification coverage and sensitivity. Over the past several years, we and others have spent a significant amount of research activity to understand and model analytical platforms and subsequently improve computational methods for the analyses of complex biological mixtures. While our original grant application has resulted in methods and programs already accepted by the community, there is a need and significant room for further key contributions. We see many of these contributions being related to the analyses of dynamic changes in cells and tissues, and involving changes in protein quantities, protein post-translational modifications (PTMs) and transient protein-protein interactions. Mass spectrometry-based proteomics provides an excellent platform to address each of these challenges. Thus, we plan to continue to develop novel methods for label-free quantification and remain close to our core strengths, but also strongly focus on PTMs and protein-protein interactions as new directions of this renewal application. This application includes a considerably closer collaboration between computational (Dr. Radivojac, Dr. Tang) and experimental (Dr. Arnold, Dr. Clemmer, Dr. Reilly) scientists than did our original application. The investigators bring complementary expertise and experience in a range of disciplines involving protein bioinformatics, algorithms, machine learning, as well as analytical chemistry and instrumentation. Overall, we believe that this proposal will result in significant advances for mass spectrometry-based proteomics. (Not modified) We propose to develop novel and theoretically sound methodology for several important yet challenging problems in mass spectrometry-based proteomics, including the identification of peptides containing post- translational modifications and cross-linked peptides, and the absolute quantification of proteins in complex samples.",Computational approaches to protein identification and quantification using MS/MS,8902210,R01GM103725,"['Algorithms ', ' Cells ', ' Analytic Chemistry ', ' Analytical Chemistry ', ' Liquid Chromatography ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Gases ', ' Goals ', ' Indiana ', ' instrumentation ', ' Ions ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Professional Positions ', ' Jobs ', ' Occupations ', ' Peptides ', ' Play ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' sound ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Body Tissues ', ' Tissues ', ' Universities ', ' Work ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' cross-link ', ' crosslink ', ' Label ', ' improved ', ' Procedures ', ' Site ', ' Area ', ' Phase ', ' Biological ', ' Chemicals ', ' Training ', ' Discipline ', ' Research Activity ', ' Funding ', ' Collaborations ', ' Staging ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Synthetic Peptide Libraries ', ' Peptide Library ', ' programs ', ' Scientist ', ' Spectrometry ', ' Complex ', ' Techniques ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Modeling ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' model development ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Post-Translational Modification Site ', ' Reproducibility ', ' Synthetic Chemistry ', ' Synthesis Chemistry ', ' Computational Technique ', ' Process ', ' developmental ', ' Development ', ' ion mobility ', ' Population ', ' Coupled ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' ']",NIGMS,INDIANA UNIVERSITY BLOOMINGTON,R01,2015,411329,0.2242818409386892
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,9126651,U54HL127365,"['Accounting ', ' Antibodies ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Extracts ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Genome ', ' Goals ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' Growth Factor ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Pharmacology ', ' Phenotype ', ' Transphosphorylases ', ' Kinases ', ' EC 2.7 ', ' Phosphotransferases ', ' Production ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' mRNA ', ' Messenger RNA ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' Measures ', ' Tumor Cell Line ', ' forest ', ' Dataset ', ' Data Set ', ' Fuzzy Logic ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' immunoresponse ', ' host response ', ' Immune response ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' programs ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Immune ', ' Complex ', ' cell type ', ' Gray ', ' Gray unit of radiation dose ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' Genomics ', ' cell fixing ', ' drug discovery ', ' Sentinel ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Dose ', ' Data ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Education and Outreach ', ' Collection ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' usability ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' network models ', ' senescent ', ' senescence ', ' operation ', ' epigenome ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2015,192983,0.09579543721714887
"Self Correcting Nanoflow LC-MS for Clinical Proteomics DESCRIPTION (provided by applicant): The overall goal of this proposal is to improve the quality, reliability, and interlaboratory comparability of peptide mass spectrometry data. Mass spectrometry (MS) has become a fundamental technology for the identification and quantitative analysis of proteins, protein interactions, and protein post-translational modifications. These analyses are an important part of solving biological problems that involve changes in protein abundance in response to disease, drug treatment, and genetic or environmental perturbations. Unfortunately, the application of protein mass spectrometry measurements in the clinical laboratory has been limited. Unlike most clinical assays by mass spectrometry, which use microflow liquid chromatography, peptide measurements are commonly performed using a nanoflow liquid chromatograph interface to the mass spectrometer (nanoflow LC-MS). Despite their analytical power, these nanoflow LC-MS methods have been difficult to apply robustly in quantitative assays involving large numbers of samples from a challenging sample matrix. The successful completion of our project will result in a peptide analysis platform that can automatically assess problems with the nanoflow LC-MS system and correct the problem during an analytical run and will significantly improve the robustness and reproducibility of peptide mass spectrometry measurements. PUBLIC HEALTH RELEVANCE: Mass spectrometry has been a fundamental technology for the analysis of proteins in health and disease. However, despite the analytical power of conventional mass spectrometry methods, they have not been well-suited for the comparative analysis of very large numbers of samples acquired under a large number of conditions. Thus, the continued development of novel mass spectrometry technology is essential to understanding complex biological systems so that can be characterized that have a change in abundance in response to disease, drug treatment, and genetic or environmental perturbation.",Self Correcting Nanoflow LC-MS for Clinical Proteomics,8840976,R01GM107142,"['Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Liquid Chromatography ', ' Communities ', ' Couples ', ' Data Collection ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Goals ', ' Health ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Laboratories ', ' Medicine ', ' Methods ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Quality Control ', ' Robotics ', ' Running ', ' computer program/software ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Universities ', ' Washington ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Training ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Data Quality ', ' Measurement ', ' liquid ', ' fluid ', ' Liquid substance ', ' Genetic ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' experience ', ' Performance ', ' novel ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' Process ', ' developmental ', ' Development ', ' mass spectrometer ', ' Outcome ', ' open source ', ' comparative ', ' complex biological systems ', ' operation ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2015,374279,0.27932609388434526
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,9098801,U54HL127365,"['Accounting ', ' Antibodies ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Extracts ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Modern Man ', ' Human ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Pharmacology ', ' Phenotype ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Phosphotransferases ', ' Production ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' mRNA ', ' Messenger RNA ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence Immunologic ', ' Immunofluorescence ', ' Measures ', ' Tumor Cell Line ', ' forest ', ' Data Set ', ' Dataset ', ' Fuzzy Logic ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Collaborations ', ' immunoresponse ', ' host response ', ' Immune response ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' programs ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Immune ', ' Complex ', ' cell type ', ' Gray ', ' Gray unit of radiation dose ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' cell fixing ', ' drug discovery ', ' Sentinel ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' Signaling Protein ', ' Dose ', ' Data ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Education and Outreach ', ' Collection ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Computational algorithm ', ' computer algorithm ', ' usability ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' network models ', ' senescence ', ' senescent ', ' operation ', ' epigenome ', ' data visualization ', ' learning strategy ', ' learning method ', ' learning activity ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' live cell imaging ', ' live cellular imaging ', ' live cellular image ', ' live cell image ', ' phenotypic data ', ' genome browser ', ' genomic data ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2016,2155917,0.09579543721714887
"Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways     DESCRIPTION (provided by applicant): This project aims to develop new statistical machine learning methods for metabolomics data from diverse platforms, including targeted and unbiased/global mass spectrometry (MS), labeled MS experiments for measuring metabolic ux and Nuclear Magnetic Resonance (NMR) platforms. Unbiased MS and NMR proling studies result in identifying a large number of unnamed spectra, which cannot be directly matched to known metabolites and are hence often discarded in downstream analyses. The rst aim develops a novel kernel penalized regression method for analysis of data from unbiased proling studies. It provides a systematic framework for extracting the relevant information from unnamed spectra through a kernel that highlights the similarities and differences between samples, and in turn boosts the signal from named metabolites. This results in improved power in identication of named metabolites associated with the phenotype of interest, as well as improved prediction accuracy. An extension of this kernel-based framework is also proposed to allow for systematic integration of metabolomics data from diverse proling studies, e.g. targeted and unbiased MS proling technologies. The second aim pro- vides a formal inference framework for kernel penalized regression and thus complements the discovery phase of the rst aim. The third aim focuses on metabolic pathway enrichment analysis that tests both orchestrated changes in activities of steady state metabolites in a given pathway, as well as aberrations in the mechanisms of metabolic reactions. The fourth aim of the project provides a unied framework for network-based integrative analysis of static (based on mass spectrometry) and dynamic (based on metabolic ux) metabolomics measurements, thus providing an integrated view of the metabolome and the uxome. Finally, the last aim implements the pro- posed methods in easy-to-use open-source software leveraging the R language, the capabilities of the Cytoscape platform and the Galaxy workow system, thus providing an expandable platform for further developments in the area of metabolomics. The proposed software tool will also provide a plug-in to the Data Repository and Coordination Center (DRCC) data sets, where all regional metabolomics centers supported by the NIH Common Funds Metabolomics Program deposit curated data.         PUBLIC HEALTH RELEVANCE: Metabolomics, i.e. the study of small molecules involved in metabolism, provides a dynamic view into processes that reect the actual physiology of the cell, and hence offers vast potential for detection of novel biomarkers and targeted therapies for complex diseases. However, despite this potential, the development of computational methods for analysis of metabolomics data lags the rapid growth of metabolomics proling technologies. The current application addresses this need by developing novel statistical machine learning methods for integrative analysis of static and dynamic metabolomics measurements, as well as easy-to-use open-source software to facilitate the application of these methods.            ",Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways,9104589,R01GM114029,"['Accounting ', ' Adoption ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Environment ', ' balance function ', ' balance ', ' Equilibrium ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Language ', ' Linear Models ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' Names ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Nuclear Magnetic Resonance ', ' Phenotype ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' Work ', ' Measures ', ' Data Set ', ' Dataset ', ' Visualization ', ' Imagery ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Area ', ' Phase ', ' Biological ', ' biosynthesis ', ' Anabolism ', ' insight ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Funding ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Galaxy ', ' Letters ', ' Metabolic ', ' Staging ', ' Deposit ', ' Deposition ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Dimensions ', ' Complex ', ' Reaction ', ' System ', ' interest ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' novel technologies ', ' new technology ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Coding System ', ' Code ', ' Sampling ', ' response ', ' Proteomics ', ' Metabolic Pathway ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' Address ', ' Enzymatic Reaction ', ' Biochemical Reaction ', ' Data ', ' Detection ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' rapid growth ', ' designing ', ' design ', ' transcriptomics ', ' Plug-in ', ' open source ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' public health relevance ', ' novel marker ', ' novel biomarker ', ' new marker ', ' biological systems ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' diagnostic biomarker ', ' diagnostic marker ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2016,359776,0.09527853519809468
"Self Correcting Nanoflow LC-MS for Clinical Proteomics DESCRIPTION (provided by applicant): The overall goal of this proposal is to improve the quality, reliability, and interlaboratory comparability of peptide mass spectrometry data. Mass spectrometry (MS) has become a fundamental technology for the identification and quantitative analysis of proteins, protein interactions, and protein post-translational modifications. These analyses are an important part of solving biological problems that involve changes in protein abundance in response to disease, drug treatment, and genetic or environmental perturbations. Unfortunately, the application of protein mass spectrometry measurements in the clinical laboratory has been limited. Unlike most clinical assays by mass spectrometry, which use microflow liquid chromatography, peptide measurements are commonly performed using a nanoflow liquid chromatograph interface to the mass spectrometer (nanoflow LC-MS). Despite their analytical power, these nanoflow LC-MS methods have been difficult to apply robustly in quantitative assays involving large numbers of samples from a challenging sample matrix. The successful completion of our project will result in a peptide analysis platform that can automatically assess problems with the nanoflow LC-MS system and correct the problem during an analytical run and will significantly improve the robustness and reproducibility of peptide mass spectrometry measurements. PUBLIC HEALTH RELEVANCE: Mass spectrometry has been a fundamental technology for the analysis of proteins in health and disease. However, despite the analytical power of conventional mass spectrometry methods, they have not been well-suited for the comparative analysis of very large numbers of samples acquired under a large number of conditions. Thus, the continued development of novel mass spectrometry technology is essential to understanding complex biological systems so that can be characterized that have a change in abundance in response to disease, drug treatment, and genetic or environmental perturbation.",Self Correcting Nanoflow LC-MS for Clinical Proteomics,9060365,R01GM107142,"['Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Liquid Chromatography ', ' Communities ', ' Couples ', ' Data Collection ', ' Disorder ', ' Disease ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Environment ', ' Goals ', ' Health ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Laboratories ', ' Medicine ', ' Methods ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteins ', ' Quality Control ', ' Robotics ', ' Running ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Universities ', ' Washington ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Training ', ' Failure ', ' Data Quality ', ' Measurement ', ' liquid ', ' fluid ', ' Liquid substance ', ' Genetic ', ' tool ', ' instrument ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' System ', ' experience ', ' Performance ', ' novel ', ' Sampling ', ' response ', ' protein protein interaction ', ' Proteomics ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' Process ', ' developmental ', ' Development ', ' mass spectrometer ', ' Outcome ', ' open source ', ' comparative ', ' complex biological systems ', ' operation ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2016,359848,0.27932609388434526
"Deep-radiomics-learning for mass detection in CT colonography Project Summary/Abstract Colon cancer is the second leading cause of cancer deaths for men and women in the United States. However, it would be prevented by early detection and removal of its precursor lesions. The use of CT colonography (CTC) would substantially increase the access, capacity, safety, cost-effectiveness, and patient compliance of colorectal examinations. The interpretation of CTC examinations would be most effective by use of a first-reader computer- aided detection (FR-CADe) paradigm, where a radiologist reviews only the lesion candidates detected automatically by a computer-aided detection (CADe) system. However, because CADe systems can miss large masses, radiologists still need to perform an additional two-dimensional (2D) review of the CT images of the colon, which increases reading time over 40% on average. Furthermore, also radiologists can occasionally miss some types of masses on CTC images. The goal of this project is to develop a DEep RAdiomics LEarning (DERALE) scheme for the detection of large masses on CTC images. The scheme will be used to integrate deep learning methods and radiomic biomarkers to perform a complete automated review of CTC images for reliable detection of colorectal masses. We hypothesize that the DERALE scheme will be able to detect colorectal masses at a sensitivity comparable to that of unaided expert radiologists and that it can be used to reduce the interpretation time of FR- CADe without degrading diagnostic accuracy in CTC. We will evaluate and compare the classification performance of DERALE with that of unaided expert radiologists and conduct an observer performance study to compare the detection accuracy of the use of DERALE in the FR-CADe paradigm with that of unaided expert radiologists in the detection of masses from CTC images. Successful development and broad adoption of DERALE in the FR-CADe paradigm will facilitate early, accurate, and cost-effective diagnoses, and thus it will reduce the mortality rate from colon cancer, one of the largest threats of cancer deaths in the United States. Project Narrative Successful development and validation of DERALE will substantially advance the clinical implementation of CTC and the FR-CADe paradigm in large populations to facilitate early, accurate, and cost-effective diagnoses, and thus it will reduce mortality from colon cancer, the second leading cause of cancer deaths in both men and women in the United States. The research is innovative in that robust mass detection has not been developed for CTC and FR- CADe, and that there have been no attempts to use deep learning for mass detection in CTC.",Deep-radiomics-learning for mass detection in CT colonography,9167836,R21EB022747,"['Abdominal ', ' Abdomen ', ' abstracting ', ' Adoption ', ' American Cancer Society ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Systematics ', ' Classification ', ' Colon ', ' Colonoscopy ', ' cost effectiveness ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Lack of Energy ', ' Fatigue ', ' Goals ', ' Heating ', ' Learning ', ' Maps ', "" men's "", ' men ', ' Methods ', ' mortality ', ' Polyps ', ' Reading ', ' Research ', ' Safety ', ' Societies ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Woman ', ' Advisory Committees ', ' advisory team ', ' Task Forces ', ' Guidelines ', ' base ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Evaluation ', ' Lesion ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' RDST ', ' radiologist ', ' System ', ' Location ', ' colorectum ', ' colo-rectal ', ' Colon or Rectum ', ' Colorectal ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' Accuracy of Diagnosis ', ' diagnostic accuracy ', ' neural network ', ' Biological Neural Networks ', ' novel ', ' Categories ', ' Prevention ', ' Colonic Carcinoma ', ' Colon Cancer ', ' Colon Carcinoma ', ' Reporting ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' computed tomography colography ', ' Virtual Colonoscopy ', ' Computed Tomography Colonography ', ' CT Colonography ', ' Computed Tomographic Colonography ', ' preventing ', ' prevent ', ' therapy cooperation ', ' therapy compliance ', ' patient adherence ', ' compliance cooperation ', ' Treatment Compliance ', ' Patient Cooperation ', ' Patient Compliance ', ' Compliance behavior ', ' Detection ', ' Reader ', ' American College of Radiology ', ' Cancer Cause ', ' Cancer Etiology ', ' Collection ', ' Scheme ', ' Validation ', ' Characteristics ', ' developmental ', ' Development ', ' Colo-rectal Cancer ', ' Colorectal Cancer ', ' imaging ', ' Image ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' two-dimensional ', ' 2-dimensional ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' computer aided detection ', ' computer assisted detection ', ' screening ', ' accurate diagnosis ', ' learning strategy ', ' learning method ', ' learning activity ', ' radiomics ', ' ']",NIBIB,MASSACHUSETTS GENERAL HOSPITAL,R21,2016,256500,0.20473895349327276
"Deep-radiomics-learning for mass detection in CT colonography Project Summary/Abstract Colon cancer is the second leading cause of cancer deaths for men and women in the United States. However, it would be prevented by early detection and removal of its precursor lesions. The use of CT colonography (CTC) would substantially increase the access, capacity, safety, cost-effectiveness, and patient compliance of colorectal examinations. The interpretation of CTC examinations would be most effective by use of a first-reader computer- aided detection (FR-CADe) paradigm, where a radiologist reviews only the lesion candidates detected automatically by a computer-aided detection (CADe) system. However, because CADe systems can miss large masses, radiologists still need to perform an additional two-dimensional (2D) review of the CT images of the colon, which increases reading time over 40% on average. Furthermore, also radiologists can occasionally miss some types of masses on CTC images. The goal of this project is to develop a DEep RAdiomics LEarning (DERALE) scheme for the detection of large masses on CTC images. The scheme will be used to integrate deep learning methods and radiomic biomarkers to perform a complete automated review of CTC images for reliable detection of colorectal masses. We hypothesize that the DERALE scheme will be able to detect colorectal masses at a sensitivity comparable to that of unaided expert radiologists and that it can be used to reduce the interpretation time of FR- CADe without degrading diagnostic accuracy in CTC. We will evaluate and compare the classification performance of DERALE with that of unaided expert radiologists and conduct an observer performance study to compare the detection accuracy of the use of DERALE in the FR-CADe paradigm with that of unaided expert radiologists in the detection of masses from CTC images. Successful development and broad adoption of DERALE in the FR-CADe paradigm will facilitate early, accurate, and cost-effective diagnoses, and thus it will reduce the mortality rate from colon cancer, one of the largest threats of cancer deaths in the United States. Project Narrative Successful development and validation of DERALE will substantially advance the clinical implementation of CTC and the FR-CADe paradigm in large populations to facilitate early, accurate, and cost-effective diagnoses, and thus it will reduce mortality from colon cancer, the second leading cause of cancer deaths in both men and women in the United States. The research is innovative in that robust mass detection has not been developed for CTC and FR- CADe, and that there have been no attempts to use deep learning for mass detection in CTC.",Deep-radiomics-learning for mass detection in CT colonography,9316607,R21EB022747,"['Abdominal ', ' Abdomen ', ' Adoption ', ' American Cancer Society ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Systematics ', ' Classification ', ' Colon ', ' Colonoscopy ', ' cost effectiveness ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Lack of Energy ', ' Fatigue ', ' Goals ', ' Learning ', ' Maps ', ' men ', "" men's "", ' Methods ', ' mortality ', ' Phenotype ', ' Polyps ', ' Reading ', ' Research ', ' Safety ', ' Societies ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Woman ', ' advisory team ', ' Task Forces ', ' Advisory Committees ', ' Guidelines ', ' base ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Clinical ', ' Evaluation ', ' Lesion ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' RDST ', ' radiologist ', ' System ', ' Location ', ' Colorectal ', ' colorectum ', ' colo-rectal ', ' Colon or Rectum ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' diagnostic accuracy ', ' Accuracy of Diagnosis ', ' Biological Neural Networks ', ' neural network ', ' novel ', ' Categories ', ' Prevention ', ' Colon Carcinoma ', ' cancer in the colon ', ' Colonic Carcinoma ', ' Colon Cancer ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Computed Tomographic Colonography ', ' computed tomography colography ', ' Virtual Colonoscopy ', ' Computed Tomography Colonography ', ' CT Colonography ', ' prevent ', ' preventing ', ' Compliance behavior ', ' therapy cooperation ', ' therapy compliance ', ' patient adherence ', ' compliance cooperation ', ' Treatment Compliance ', ' Patient Cooperation ', ' Patient Compliance ', ' Detection ', ' Reader ', ' American College of Radiology ', ' Cancer Cause ', ' Cancer Etiology ', ' Collection ', ' Scheme ', ' Validation ', ' Characteristics ', ' developmental ', ' Development ', ' Colo-rectal Cancer ', ' Colorectal Cancer ', ' imaging ', ' Image ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' two-dimensional ', ' 2-dimensional ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' computer aided detection ', ' computer assisted detection ', ' screening ', ' accurate diagnosis ', ' learning strategy ', ' learning method ', ' learning activity ', ' radiomics ', ' ']",NIBIB,MASSACHUSETTS GENERAL HOSPITAL,R21,2017,213750,0.20473895349327276
"Optimization and joint modeling for peptide detection by tandem mass spectrometry Project Summary/Abstract Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efcient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the elds of machine learning, statistics, and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets. Our project will focus on three key problems in the analysis of such data: 1. facilitating the use of previously annotated spectra to improve our ability to annotate new spectra by creating  a hybrid search scheme that compares an observed spectrum to a database comprised of theoretical spectra  and previously annotated spectra, 2. enabling the efcient and accurate detection of peptides containing post-translational modications and  sequence variants, and 3. detecting sets of peptide species that are co-fragmented in the mass spectrometer and hence give rise to  complex, mixture spectra. Each of these aims will improve the ability of mass spectrometrists to efciently and accurately identify and quantify proteins in complex mixtures. To increase the impact of our work, we will continue to make all of our tools available as free software. Project narrative The applications of mass spectrometry, and its promises for improvements of human health, are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specic diagnostic and prognostic screens. However, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.",Optimization and joint modeling for peptide detection by tandem mass spectrometry,9214942,R01GM121818,"['Algorithms ', ' protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' driving ', ' Automobile Driving ', ' Cell Body ', ' Cells ', ' Liquid Chromatography ', ' Communities ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Economics ', ' Fertility/Fertilization ', ' Fertilization ', ' Game Theory ', ' Health ', ' Modern Man ', ' Human ', ' Hybrids ', ' Joints ', ' Libraries ', ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Natural Language Processing ', ' natural language understanding ', ' Operations Research ', ' Peptides ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Shotguns ', ' Computer software ', ' Software ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' prognostic ', ' Discipline ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' speech recognition ', ' tandem mass spectrometry ', ' Speed ', ' novel ', ' Column Chromatography ', ' Modeling ', ' Sampling ', ' theories ', ' Proteomics ', ' liquid chromatography mass spectrometry ', ' LC/MS ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Complex Mixtures ', ' Data ', ' Detection ', ' Collection ', ' Scheme ', ' Molecular ', ' disease phenotype ', ' cost ', ' mass spectrometer ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' computational tools ', ' computerized tools ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' mathematical theory ', ' mathematics theory ', ' mathematics reasoning ', ' mathematics logic ', ' mathematic theory ', ' math theory ', ' Mathematical Reasoning ', ' Mathematical Logic ', ' learning strategy ', ' learning method ', ' learning activity ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2017,332329,0.27967696839716344
"Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways     DESCRIPTION (provided by applicant): This project aims to develop new statistical machine learning methods for metabolomics data from diverse platforms, including targeted and unbiased/global mass spectrometry (MS), labeled MS experiments for measuring metabolic ux and Nuclear Magnetic Resonance (NMR) platforms. Unbiased MS and NMR proling studies result in identifying a large number of unnamed spectra, which cannot be directly matched to known metabolites and are hence often discarded in downstream analyses. The rst aim develops a novel kernel penalized regression method for analysis of data from unbiased proling studies. It provides a systematic framework for extracting the relevant information from unnamed spectra through a kernel that highlights the similarities and differences between samples, and in turn boosts the signal from named metabolites. This results in improved power in identication of named metabolites associated with the phenotype of interest, as well as improved prediction accuracy. An extension of this kernel-based framework is also proposed to allow for systematic integration of metabolomics data from diverse proling studies, e.g. targeted and unbiased MS proling technologies. The second aim pro- vides a formal inference framework for kernel penalized regression and thus complements the discovery phase of the rst aim. The third aim focuses on metabolic pathway enrichment analysis that tests both orchestrated changes in activities of steady state metabolites in a given pathway, as well as aberrations in the mechanisms of metabolic reactions. The fourth aim of the project provides a unied framework for network-based integrative analysis of static (based on mass spectrometry) and dynamic (based on metabolic ux) metabolomics measurements, thus providing an integrated view of the metabolome and the uxome. Finally, the last aim implements the pro- posed methods in easy-to-use open-source software leveraging the R language, the capabilities of the Cytoscape platform and the Galaxy workow system, thus providing an expandable platform for further developments in the area of metabolomics. The proposed software tool will also provide a plug-in to the Data Repository and Coordination Center (DRCC) data sets, where all regional metabolomics centers supported by the NIH Common Funds Metabolomics Program deposit curated data. PUBLIC HEALTH RELEVANCE: Metabolomics, i.e. the study of small molecules involved in metabolism, provides a dynamic view into processes that reect the actual physiology of the cell, and hence offers vast potential for detection of novel biomarkers and targeted therapies for complex diseases. However, despite this potential, the development of computational methods for analysis of metabolomics data lags the rapid growth of metabolomics proling technologies. The current application addresses this need by developing novel statistical machine learning methods for integrative analysis of static and dynamic metabolomics measurements, as well as easy-to-use open-source software to facilitate the application of these methods.",Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways,9250169,R01GM114029,"['Adoption ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Environment ', ' balance function ', ' balance ', ' Equilibrium ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Language ', ' Linear Models ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Names ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Nuclear Magnetic Resonance ', ' Phenotype ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' Visualization ', ' Imagery ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Area ', ' Phase ', ' Biological ', ' biosynthesis ', ' Anabolism ', ' insight ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Funding ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Galaxy ', ' Letters ', ' Metabolic ', ' Deposition ', ' Deposit ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Complex ', ' Reaction ', ' System ', ' interest ', ' novel ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Code ', ' Coding System ', ' Sampling ', ' response ', ' Proteomics ', ' Metabolic Pathway ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Address ', ' Biochemical Reaction ', ' Enzymatic Reaction ', ' Data ', ' Detection ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' rapid growth ', ' Data Coordination Center ', ' Data Coordinating Center ', ' transcriptomics ', ' Plug-in ', ' open source ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' public health relevance ', ' novel marker ', ' novel biomarker ', ' new marker ', ' biological systems ', ' flexibility ', ' flexible ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' diagnostic biomarker ', ' diagnostic marker ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' experimental study ', ' experimental research ', ' experiment ', ' high dimensionality ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2017,339051,0.09527853519809468
"Ion mobility based informatics and visualization strategies in support of metabolomics Project Summary  Metabolites are building blocks of cellular function, thus understanding the mechanisms that underlie various physiological conditions and processes will provide insight into disease or aberrant states. Innovative developments in high-throughput analytical technologies and data analysis have allowed for systems-level metabolomics analyses to be performed, many of these technologies have centered around mass spectrometry. The diverse chemical structures in the human metabolome exhibit a wide range of concentration, solubility, polarity and volatility with highly diverse structural forms and physiochemical properties as well as a high number of isomers, therefore the need for as many orthogonal separations as possible is necessary for metabolomics experiments (i.e., multidimensional data sets). Mass spectrometry approaches incorporating liquid chromatography ion mobility mass spectrometry (LC-IM-MS/MS) analyses have shown utility for global untargeted metabolic profiling experiments. Since ion mobility coupled to mass spectrometry (IM-MS) is a relatively new commercially available technology, the incorporation of the ion mobility measurement (via collision cross section, CCS) into current metabolomics data analysis identification strategies is minimal. The typical analytical use of ion mobility is as a quick chemical separation (which allows for noise reduction, increase in peak capacity, etc.), however IM can also be used to increase the confidence in identification and characterization because CCS provides structure specific information about individual metabolites. The long term objectives of this proposal are all centered around incorporating IM measurements into metabolomics based chemoinformatic and bioinformatics pipelines. These include: (1) determining the extent at which the ion mobility dimension can address molecular specificity of isomeric metabolites, (2) developing an IM-based library using CCS values as a descriptor to screen and assign identities to unknown metabolites and lastly, (3) incorporating visualization tools for navigating multidimensional datasets which will allow scientists to better uncover relationships between metabolites and human health. Molecular specificity of the IM dimension will be addressed by analyzing previously generated IM-MS data from a commercially available metabolite library (>600 primary metabolites, of which >20% are isomeric). Individual metabolites in the metabolite library will also be interrogated for curation of the CCS library and these values will be used in the molecular identification pipeline for global untargeted metabolite studies generated previously. Lastly, multidimensional self-organizing maps will be utilized to visualize and navigate various dimensions of data (LC, CCS, m/z, etc.) and ultimately allow the user to prioritize and identify with high confidence metabolites indicative of disease state. Accomplishing the aims outlined in this proposal will be seen as overcoming several critical barriers which have so far hindered the routine and widespread use of ion mobility in MS-based metabolomics workflows. Project Narrative  The innovative developments described in the proposal incorporate high-throughput metabolomics technologies, big data informatics, and multidimensional visualization strategies which will allow scientists to uncover relationships between metabolites and human health using systems-level metabolomics analyses. Specifically, we believe these goals can be accomplished by overcoming several critical barriers to adopting new technologies based on multidimensional mass spectrometry which hold promise for furthering our knowledge about the nature and behavior of living systems. Strategies outlined in this proposal include, providing a highly annotated library incorporating empirical ion mobility based collision cross section values (inclusive also of exact mass, fragment ion data, and retention time) and developing novel big data and visualization strategies to improve throughput and confidence in metabolite annotations.",Ion mobility based informatics and visualization strategies in support of metabolomics,9433378,R03CA222452,"['Adoption ', ' Algorithms ', ' Behavior ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Chemistry ', ' Liquid Chromatography ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Disorder ', ' Disease ', ' electronic communication ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Exhibits ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Ions ', ' Isomerism ', ' isomer ', ' Laboratories ', ' Libraries ', ' Lipids ', ' Manuals ', ' Maps ', ' Noise ', ' Organism ', ' living system ', ' Phonation ', ' Play ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Solubility ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Telephone ', ' Phone ', ' Time ', ' Universities ', ' Work ', ' Dataset ', ' Data Set ', ' Visualization ', ' Imagery ', ' base ', ' improved ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Chemicals ', ' Chemical Structure ', ' insight ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Descriptor ', ' Metabolic ', ' tool ', ' instrument ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Adopted ', ' Dimensions ', ' Techniques ', ' System ', ' interest ', ' innovative technologies ', ' professor ', ' tandem mass spectrometry ', ' Informatics ', ' Structure ', ' novel ', ' new technology ', ' novel technologies ', ' Reporting ', ' Property ', ' Bioinformatics ', ' Bio-Informatics ', ' cheminformatics ', ' chemical informatics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Defect ', ' Data ', ' Reproducibility ', ' Research Infrastructure ', ' Infrastructure ', ' Funding Opportunities ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' ion mobility ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' visualization tool ', ' Visualization software ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' Big Data ', ' BigData ', ' data visualization ', ' metabolic profile ', ' metabolome ', ' metabonome ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NCI,VANDERBILT UNIVERSITY,R03,2017,151533,0.14993461112666798
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,9316354,U54HL127365,"['inhibitor ', ' inhibitor/antagonist ', ' Antibodies ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Extracts ', ' Cell Body ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Goals ', ' Modern Man ', ' Human ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Pharmacology ', ' Phenotype ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Production ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Messenger RNA ', ' mRNA ', ' Semantics ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Stem cells ', ' Progenitor Cells ', ' Technology ', ' Testing ', ' Thromboplastin ', ' Urothromboplastin ', ' Tissue Thromboplastin ', ' Tissue Factor Procoagulant ', ' Tissue Factor ', ' Prothrombinase ', ' Glomerular Procoagulant Activity ', ' Factor III ', ' Coagulin ', ' Coagulation Factor III ', ' CD142 Antigens ', ' Blood Coagulation Factor III ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' Measures ', ' forest ', ' Dataset ', ' Data Set ', ' Fuzzy Logic ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Data Quality ', ' Measurement ', ' Collaborations ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Immune ', ' Immunes ', ' Complex ', ' cell type ', ' Gray unit of radiation dose ', ' Gray ', ' single cell analysis ', ' novel ', ' member ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' drug discovery ', ' Sentinel ', ' Molecular Computations ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' Dose ', ' Data ', ' Education and Outreach ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Collection ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web-based service ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Computational algorithm ', ' computer algorithm ', ' usability ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' network models ', ' tumor ', ' senescence ', ' senescent ', ' public health relevance ', ' operation ', ' epigenome ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' data visualization ', ' learning strategy ', ' learning method ', ' learning activity ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' live cell imaging ', ' live cellular imaging ', ' live cellular image ', ' live cell image ', ' phenotypic data ', ' genome browser ', ' genomic data ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' experimental study ', ' experimental research ', ' experiment ', ' translational impact ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2017,2287000,0.09579543721714887
"Advanced Computational Approaches for NMR Data-mining ABSTRACT Nuclear magnetic resonance spectroscopy (NMR)-based metabolomics is a powerful method for identifying metabolic perturbations that report on different biological states and sample types. Compared to mass spectrometry, NMR provides robust and highly reproducible quantitative data in a matter of minutes, which makes it very suitable for first-line clinical diagnostics. Although the metabolome is known to provide an instantaneous snap-shot of the biological status of a cell, tissue, and organism, the utilization of NMR in clinical practice is hindered by cumbersome data analysis. Major challenges include high-dimensionality of the data, overlapping signals, variability of resonance frequencies (chemical shift), non-ideal shapes of signals, and low signal-to-noise ratio (SNR) for low concentration metabolites. Existing approaches fail to address these challenges and sample analysis is time-consuming, manually done, and requires considerable knowledge of NMR spectroscopy. Recent developments in the field of sparse methods for machine learning and accelerated convex optimization for high dimensional problems, as well as kernel-based spatial clustering show promise at enabling us to overcome these challenges and achieve fully automated, operator-independent analysis. We are developing two novel, powerful, and automated algorithms that capitalize on these recent developments in machine learning. In Aim 1, we describe NMRQuant for automated identification and quantification of annotated metabolites irrespective of the chemical shift, low SNR, and signal shape variability. In Aim 2, we describe SPA-STOCSY for automated de-novo identification of molecular fragments of unknown, non- annotated metabolites. Based on substantial preliminary data, we propose to evaluate these algorithms' sensitivity, specificity, stability, and resistance to noise on phantom, biological, and clinical samples, comparing them to current methods. We will validate the accuracy of analyses by experimental 2D NMR, spike-in, and mass spectrometry. The proposed efforts will produce new NMR analytical software for discovery of both annotated and non-annotated metabolites, substantially improving accuracy and reproducibility of NMR analysis. Such analytical ability would change the existing paradigm of NMR-based metabolomics and provide an even stronger complement to current mass spectrometry-based methods. This approach, once thoroughly validated, will enable NMR to reach wide network of applications in biomedical, pharmaceutical, and nutritional research and clinical medicine. NARRATIVE This project seeks to develop an advanced and automated platform for identifying NMR metabolomics biomarkers of diseases and for fundamental studies of biological systems. When fully developed, these approaches could be used to detect small molecules in the blood or urine, indicative of the onset of various diseases, drug toxicity, or environmental effects on the organism.",Advanced Computational Approaches for NMR Data-mining,9260548,R01GM120033,"['Algorithms ', ' Blood Reticuloendothelial System ', ' Blood ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Animal Disease Models ', ' Drug toxicity ', ' Health ', ' Modern Man ', ' Human ', ' Libraries ', ' Manuals ', ' Methods ', ' Noise ', ' Nuclear Magnetic Resonance ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' Plague ', ' Yersinia pestis disease ', ' Relaxation ', ' Research ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Societies ', ' Sodium Chloride ', ' salt ', ' Computer software ', ' Software ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Temperature ', ' Time ', ' Tissues ', ' Body Tissues ', ' Urine Urinary System ', ' Urine ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Left ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Link ', ' Chemicals ', ' infantile ', ' infancy ', ' Metabolic ', ' Shapes ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' Early Diagnosis ', ' early detection ', ' novel ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Alpha Cell ', ' -cell ', ' Glucagon Secreting Cell ', ' Glucagon Cell ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Reproducibility ', ' Cancer Cause ', ' Cancer Etiology ', ' nutritious ', ' Nutritional ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' Outcome ', ' Resistance ', ' resistant ', ' experimental analysis ', ' stem ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' clinical practice ', ' biological systems ', ' Statistical Algorithm ', ' Statistics Algorithm ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' phenotypic biomarker ', ' phenotypic marker ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' clinical diagnostics ', ' experimental study ', ' experimental research ', ' experiment ', ' high dimensionality ', ' ']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2017,356625,0.08385061490508142
"Feature Learning For Improved Multiplex Disease Diagnosis Abstract This proposal is for CATTS, a feature learning technique optimized for use in multiplex mass spectrometry (MS) fingerprinting assays. MS fingerprints consist of a large number of chemical species, leading to very high dimensional feature spaces, and subsequent high false-discovery rates. CATTS aims to reduce the size of this space, by using knowledge of the underlying biochemistry, as well as general-purpose clustering algorithms. Our preliminary results demonstrate that, when used as a feature-learning technique for a variety of classification methods, CATTS significantly improves assay sensitivity. This proposal takes our existing implementation of CATTS and extends it to support additional feature learning algorithms and classification methods. Additionally, its performance as a multiplex assay strategy will be tested on both protein and lipid MS fingerprint libraries, with an eye towards commercialization.. Relevance to public health: The detection of pathogens via mass spectroscopy fingerprinting is rapidly becoming a standard technique for clinical microbiology. However, high false detection rates and conflicting multiple identifications limit applicability, and make interpretation of results difficult. Our work on CATTS aims to improve the statistical performance of these assays. Preliminary results from studies on one dataset we intend to apply CATTS to suggest that UTIs and, in some cases antimicrobial resistance, can be detected, directly from patient samples. However, the statistical methods currently employed aren't reliable enough - the further development of CATTS will accelerate the development of this, and other mass-spectroscopy-based assays..",Feature Learning For Improved Multiplex Disease Diagnosis,9559527,R43GM128538,"['Algorithms ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Classification ', ' Systematics ', ' Conflict (Psychology) ', ' Conflict ', ' Decision Trees ', ' Eye ', ' Eyeball ', ' Fingerprint ', ' Protein Fingerprints ', ' Protein Fingerprinting ', ' Learning ', ' Libraries ', ' Lipids ', ' Methods ', ' Noise ', ' Organism ', ' living system ', ' Patients ', ' Proteins ', ' Public Health ', ' Research ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Testing ', ' Work ', ' Measures ', ' forest ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Chemicals ', ' Biological Diversity ', ' Biodiversity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dimensions ', ' Immune ', ' Immunes ', ' Techniques ', ' System ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Clinical Microbiology ', ' Antimicrobial Resistance ', ' resistant to antimicrobial ', ' resistant to anti-microbial ', ' resistance to anti-microbial ', ' anti-microbial resistant ', ' anti-microbial resistance ', ' Resistance to antimicrobial ', ' Antimicrobial resistant ', ' Detection ', ' Process ', ' developmental ', ' Development ', ' vector ', ' feeding ', ' Pathogen detection ', ' commercialization ', ' disease diagnosis ', ' learning method ', ' learning activity ', ' learning strategy ', ' high dimensionality ', ' ']",NIGMS,"DEURION, LLC",R43,2018,177191,0.07081390602731841
"Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets PROJECT SUMMARY/ABSTRACT Recent advances in high-resolution mass spectrometry (HRMS) instrumentation have not been fully leveraged to upgrade the information content of metabolomics datasets obtained from stable isotope labeling studies. This is primarily due to lack of validated software tools for extracting and interpreting isotope enrichments from HRMS datasets. The overall objective of the current application is to develop tools that enable the metabolomics community to fully leverage stable isotopes to profile metabolic network dynamics. Two new tools will be implemented within the open-source OpenMS software library, which provides an infrastructure for rapid development and dissemination of mass spectrometry software. The first tool will automate tasks required for extracting isotope enrichment information from HRMS datasets, and the second tool will use this information to group ion peaks into interaction networks based on similar patterns of isotope labeling. The tools will be validated using in-house datasets derived from metabolic flux studies of animal and plant systems, as well as through feedback from the metabolomics community. The rationale for the research is that the software tools will enable metabolomics investigators to address important questions about pathway dynamics and regulation that cannot be answered without the use of stable isotopes. The first aim is to develop a software tool to automate data extraction and quantification of isotopologue distributions from HRMS datasets. The software will provide several key features not included in currently available metabolomics software: i) a graphical, interactive user interface that is appropriate for non-expert users, ii) support for native instrument file formats, iii) support for samples that are labeled with multiple stable isotopes, iv) support for tandem mass spectra, and v) support for multi-group or time-series comparisons. The second aim is to develop a companion software that applies machine learning and correlation-based algorithms to group unknown metabolites into modules and pathways based on similarities in isotope labeling. The third aim is to validate the tools through comparative analysis of stable isotope labeling in test standards and samples from animal and plant tissues, including time-series and dual-tracer experiments. A variety of collaborators and professional working groups will be engaged to test and validate the software, and the tools will be refined based on their feedback. The proposed research is exceptionally innovative because it will provide the advanced software capabilities required for both targeted and untargeted analysis of isotopically labeled metabolites, but in a flexible and user-friendly environment. The research is significant because it will contribute software tools that automate and standardize the data processing steps required to extract and utilize isotope enrichment information from large-scale metabolomics datasets. This work will have an important positive impact on the ability of metabolomics investigators to leverage information from stable isotopes to identify unknown metabolic interactions and quantify flux within metabolic networks. In addition, it will enable entirely new approaches to study metabolic dynamics within biological systems. PROJECT NARRATIVE The proposed research is relevant to public health because it will develop novel software tools to quantify and interpret data from stable isotope labeling experiments, which can be used to uncover relationships between metabolites and biochemical pathways. These tools have potential to accelerate progress toward identifying the causes and cures of many important diseases that impact metabolism.",Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets,9589711,U01CA235508,"['Algorithms ', ' Animals ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Environment ', ' Feedback ', ' instrumentation ', ' Ions ', ' Isotope Labeling ', ' Isotopes ', ' Libraries ', ' Manuals ', ' Maps ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Plants ', ' Public Health ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Work ', ' Measures ', ' Data Set ', ' Dataset ', ' base ', ' Label ', ' improved ', ' Biological ', ' Series ', ' Measurement ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' metabolic abnormality assessment ', ' Letters ', ' stable isotope ', ' Metabolic ', ' Companions ', ' tool ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Pattern ', ' System ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' Regulation ', ' Modeling ', ' Sampling ', ' computerized data processing ', ' data processing ', ' Stable Isotope Labeling ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Detection ', ' Research Infrastructure ', ' Infrastructure ', ' Resolution ', ' Validation ', ' Process ', ' Tracer ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' file format ', ' user-friendly ', ' open source ', ' Network-based ', ' comparative ', ' biological systems ', ' flexible ', ' flexibility ', ' operation ', ' metabotype ', ' metabolic phenotype ', ' metabolic profile ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NCI,VANDERBILT UNIVERSITY,U01,2018,439996,0.0908120303695696
"Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry PROJECT SUMMARY  Cellular interactions with the environment form the basis of health and disease for all organisms. Exposure to nutrients, toxins, and neighboring cells trigger coordinated molecular responses that impact cell function and metabolism in a beneficial, adaptive, or detrimental manner. Although the benefits of multicellularity for the formation of complex tissue structures or the function of entire organ systems has been long appreciated, it has only recently been understood that microbial inhabitants of vertebrates also have a tremendous impact on host cell function and dysfunction. Despite this, an understanding of these interactions has not moved beyond simple associations, and there are virtually no molecular technologies available that adequately define how a complex microbial ecosystem impacts host cell function, or how the host response to microbial colonization affects the bacterial community. This gap in knowledge is striking when one considers the broad and significant impact that microbes have on human health. In this application, we propose to expressly fill this knowledge gap through development of a novel multimodal imaging pipeline that will provide 3-dimensional information on the molecular heterogeneity of microbial communities and the immune response at the host-pathogen interface.  This proposal combines our expertise in immunology, infection biology, mass spectrometry, small animal imaging, machine learning, and computer vision to develop an integrated multimodal visualization method for studying infectious disease. Our unique approach will computationally combine ultra-high speed (~50px/s) MALDI-TOF images, ultra-high mass resolution (>200,000 resolving power) MALDI FTICR IMS, metal imaging by LA-ICP-IMS, high-spatial resolution optical microscopy, and MR imaging using data-driven image fusion. This strategy will enable 3-D molecular images to be generated for thousands of elements, metabolites, lipids, and proteins with an unprecedented combination of chemical specificity and spatial fidelity more than 50x faster than is currently possible. We will use this next-generation imaging capability to (i) define the heterogeneous microbial subpopulations throughout the 3-D volume of a S. aureus community, (ii) uncover the host molecules that form the abscess and accumulate to restrict microbial growth in murine models, and (iii) elucidate molecular markers that differentiate in vivo biofilms at the host-pathogen interface, between abscesses at various stages of progression, and under distinct degrees of nutrient stress. These studies will uncover new targets for therapeutic intervention and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research. PROJECT NARRATIVE This proposal will enable detailed views of the molecular components of infectious disease with unprecedented resolution through the development of a multimodal, 3-dimensional imaging platform. The proposed technologies will improve throughput and molecular specificity, enable automated high-precision and high-accuracy image alignment, and allow for descriptions of molecular signals in 3-D through the fusion of multi-modal imaging data. These studies will uncover targets for therapeutic intervention and antibiotic development and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research.",Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry,9659850,R01AI138581,"['Abscess ', ' Affect ', ' Animals ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Antibodies ', ' Differentiation Antigens ', ' Marker Antigens ', ' Differentiation Markers ', ' Differentation Markers ', ' Architecture ', ' Engineering / Architecture ', ' Awareness ', ' Bacteria ', ' Bacterial Infections ', ' bacterial disease ', ' Bacterial Proteins ', ' Bacterial Gene Proteins ', ' Bacterial Gene Products ', ' Behavior ', ' Biology ', ' Biomedical Research ', ' Cell Differentiation process ', ' Cell Differentiation ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Computer Vision Systems ', ' computer vision ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Elements ', ' Environment ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Health ', ' Health Promotion ', ' promoting health ', ' Salutogenesis ', ' Heterogeneity ', ' Histology ', ' Human ', ' Modern Man ', ' Infection ', ' Lipids ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maps ', ' Metals ', ' Methods ', ' Methodology ', ' neutrophil ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Heterophil Granulocyte ', ' Blood Segmented Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' Optics ', ' optical ', ' Organism ', ' living system ', ' Proteins ', ' Reagent ', ' Research ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Spatial Distribution ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Staphylococcus aureus ', ' Staph aureus ', ' S.aureus ', ' S. aureus ', ' S aureus ', ' Stress ', ' Supervision ', ' Technology ', ' Tissues ', ' Body Tissues ', ' Toxin ', ' Vertebrates ', ' vertebrata ', ' Vertebrate Animals ', ' Work ', ' Microbial Biofilms ', ' biofilm ', ' Glean ', ' Immunology ', ' Custom ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' Visualization ', ' Imagery ', ' base ', ' Label ', ' improved ', ' Site ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Physiologic ', ' Physiological ', ' Chemicals ', ' Lesion ', ' Individual ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' Host Factor Protein ', ' Host Factor ', ' Integration Host Factors ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dimensions ', ' Immune ', ' Immunes ', ' Complex ', ' Source ', ' Techniques ', ' 3-Dimensional ', ' 3-D ', ' body system ', ' Organ System ', ' interest ', ' Anterior nares ', ' Nostril ', ' External Nare ', ' microbial colonization ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' microbial ', ' Speed ', ' Structure ', ' Nutrient ', ' novel ', ' Modality ', ' Pathogenesis ', ' Therapeutic Intervention ', ' intervention therapy ', ' Modeling ', ' Sampling ', ' response ', ' Three-Dimensional Imaging ', ' Three Dimensional Medical Imaging ', ' 3D imaging ', ' 3-D Imaging ', ' protein expression ', ' imaging modality ', ' imaging method ', ' image-based method ', ' Data ', ' Infectious Diseases Research ', ' Infectious Diseases / Laboratory ', ' Multimodal Imaging ', ' multimodality imaging ', ' multi-modality imaging ', ' Resolution ', ' in vivo ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Computer Analysis ', ' Molecular ', ' Process ', ' cellular metabaolism ', ' cell metabolism ', ' Cellular Metabolic Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' virtual ', ' next generation ', ' 3D analysis ', ' 3-dimensional analysis ', ' 3-D analysis ', ' Three-dimensional analysis ', ' pathogen ', ' Imaging technology ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' community microbes ', ' microbial community ', ' Microbe ', ' murine model ', ' mouse model ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' multimodality ', ' molecular biomarker ', ' molecular marker ', ' FTICR ', ' Fourier transform ion cyclotron resonance ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' animal imaging ', ' imaging platform ', ' microscopy imaging ', ' microscope imaging ', ' microscopic imaging ', ' imaging-based disease detection ', ' imaging-based detection ', ' imaging detection ', ' experimental research ', ' experiment ', ' experimental study ', ' imaging capabilities ', ' commensal bacterial species ', ' commensal bacteria ', ' bacterial community ', ' host colonization ', ' ']",NIAID,VANDERBILT UNIVERSITY MEDICAL CENTER,R01,2018,593526,0.07908084283376025
"Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Mass spectrometry imaging (MSI) is a powerful technique that enables label-free spatial mapping of different classes of biomolecules in biological systems. Because it does not require any special sample pretreatment, ambient MSI is particularly attractive for high throughput automated imaging applications. The throughput of ambient MSI experiments is typically limited by the inherently slow microprobe-type sampling from surfaces, which is a characteristic shortcoming of many chemical imaging modalities. This project will combine several highly innovative approaches to address challenges associated with the high-throughput high- resolution ambient MSI of lipids and metabolites using nanospray desorption electrospray ionization (nano-DESI). Nano-DESI is an ambient ionization technique, which relies on gentle localized liquid extraction of molecules from tissue sections into a flowing solvent confined between two glass capillaries. The extracted molecules are efficiently delivered to a mass spectrometer inlet and ionized by soft electrospray ionization. Nano-DESI MSI enables detection of hundreds of metabolites, lipids, and peptides in tissue sections with high sensitivity, high spatial resolution, and without special sample pretreatment. Furthermore, on-the-fly quantification of lipids and metabolites in tissue sections during nano-DESI imaging experiments is achieved by doping the working solvent with appropriate standards of known concentration. This project will extend these powerful capabilities of nano-DESI MSI to enable high-throughput imaging of large tissue sections of interest to the HubMAP Consortium. This will be achieved using a combination of a conceptually different nano-DESI probe design optimized for robustness, ease of fabrication, and spatial resolution and a suite of advanced machine learning and compressed sensing computational approaches. These developments will be applicable to different types of human tissues and will transform quantitative molecular imaging of multiple classes of biomolecules in tissue sections. Although the capabilities of the new imaging platform will be demonstrated using non-diseased tissue, these developments will be broadly applicable to scientific problems associated with understanding health and disease Project Narrative This research is focused on the development of a transformative technology for rapid, quantitative, and robust imaging of different classes of biomolecules in human tissues using mass spectrometry. This new technology will contribute to understanding complex processes in biological tissues that play a role in both health and disease.",Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry,9659552,UG3HL145593,"['Automation ', ' Blood capillaries ', ' capillary ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Glass ', ' Health ', ' Histology ', ' Ions ', ' Lipids ', ' Maps ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oligosaccharides ', ' Optics ', ' optical ', ' Peptides ', ' Play ', ' Proteins ', ' Research ', ' Role ', ' social role ', ' Sensitivity and Specificity ', ' Computer software ', ' Software ', ' Solvents ', ' Spatial Distribution ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Imaging Techniques ', ' Imaging Technics ', ' Imaging Procedures ', ' Label ', ' Microscope ', ' Surface ', ' Phase ', ' Biological ', ' Ensure ', ' Chemicals ', ' Measurement ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' human tissue ', ' Slide ', ' Techniques ', ' interest ', ' Spectrometry, Mass, Electrospray Ionization ', ' ESI Mass Spectrometry ', ' Performance ', ' Structure ', ' novel ', ' member ', ' new technology ', ' novel technologies ', ' Sampling ', ' Proteomics ', ' Microfluidics ', ' Microfluidic ', ' imaging modality ', ' imaging method ', ' image-based method ', ' Tissue Sample ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Detection ', ' Resolution ', ' Electrospray Ionization ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' nano ', ' imaging ', ' Image ', ' ionization method ', ' ionization technique ', ' mass spectrometer ', ' reconstruction ', ' designing ', ' design ', ' nano probe ', ' nanoprobe ', ' scale up ', ' innovative ', ' innovate ', ' innovation ', ' data acquisition ', ' biological systems ', ' operation ', ' quantitative imaging ', ' imaging platform ', ' human imaging ', ' experimental research ', ' experiment ', ' experimental study ', ' imaging capabilities ', ' ']",NHLBI,PURDUE UNIVERSITY,UG3,2018,375000,0.14318785766211636
"Deep Ovarian Cancer Metabolomics PROJECT SUMMARY  Ovarian cancer (OC) is the 5th leading cause of cancer-related deaths for U.S. women and the deadliest gynecological disease. Lack of symptoms in addition to the deficiency of highly specific biomarkers for detection typically result in only 25% of OC cases being diagnosed at FIGO stage I. High-grade serous carcinoma (HGSC) is the most prevalent form of OC, but three rarer histological subtypes also exist endometrioid, clear cell, and mucinous. An effective screening strategy for early diagnosis would be particularly advantageous since 5-year OC survival rates can be as high as 90%. Unfortunately, protein biomarkers such as CA-125 do not have sufficient positive predictive value to be useful from a clinical perspective. We hypothesize that useful information regarding early stage HGSC and other ovarian cancers can be found in the serum metabolome. Our pilot studies in both humans and OC models, such as the double-knockout Dicer-Pten mouse recently developed by our team members, show great promise in this regard average sensitivity and specificity for early detection have reached 97.8% and 99.0% in banked human serum samples, and up to100% in mice. These results have prompted us to perform a much deeper investigation of metabolome alterations associated with early stage ovarian cancers in larger serum sample sets, and over time. We will perform metabolomics experiments in mice and banked de-identified human serum samples with much higher coverage than before by data fusing various modes of ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) and nuclear magnetic resonance (NMR), coupled with pathway-centric data analysis. We also propose supplementing serum-level metabolomics experiments with deep-coverage tissue mass spectrometry imaging (MSI) in both 2-D and 3-D, using a combination of matrix-assisted laser desorption/ionization (MALDI) and desorption electrospray ionization (DESI), which have complementary ionization mechanisms. Furthermore, we propose to depart from the commonly used approach of tentatively identifying spectral features by only using accurate masses, and implement a deep metabolite annotation approach that uses both fused high-resolution techniques (high field Orbitrap MS, MS/MS, 2-D NMR) and a new technology based on collisional cross section predictions for both travelling wave and drift tube ion mobility-MS. High-grade serous ovarian cancer is the most common and deadliest type of ovarian cancer; it is diagnosed mostly at an advanced stage at which the cancer has already spread beyond the ovary or the fallopian tube, to the abdominal cavity. This advanced-stage diagnosis inevitably causes high mortality. In this project, we propose to study molecular changes associated with early disease both in mouse models that closely mimic human disease and in banked de-identified human serum samples, with the aim of ultimately designing a robust diagnostic panel.",Deep Ovarian Cancer Metabolomics,9470426,R01CA218664,"['Age ', ' ages ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' CA-125 Antigen ', ' Carbohydrate Antigen 125 ', ' Cancer Antigen 125 ', ' CA125 ', ' CA-125 ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carcinoma ', ' epithelial carcinoma ', ' Malignant Epithelial Tumors ', ' Malignant Epithelial Neoplasms ', ' Epithelial cancer ', ' Liquid Chromatography ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Evolution ', ' Exhibits ', ' Mammalian Oviducts ', ' oviduct ', ' Uterine Tubes ', ' Salpinx ', ' Fallopian Tubes ', ' Genes ', ' Female Genital Diseases ', ' Gynecologic Diseases ', ' Human ', ' Modern Man ', ' Logic ', ' mortality ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Nuclear Magnetic Resonance ', ' Ovary ', ' Patients ', ' Greater sac of peritoneum ', ' Peritoneal Cavity ', ' Pilot Projects ', ' pilot study ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Survival Rate ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Travel ', ' Woman ', ' TP53 gene ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' low malignant potential neoplasm ', ' borderline malignancy neoplasm ', ' Borderline tumor ', ' Borderline Neoplasm ', ' uncertain malignant potential neoplasm ', ' Tube ', ' base ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' tumor progression ', ' Ovarian ', ' Benign ', ' Clinical ', ' Phase ', ' Histologically ', ' Histologic ', ' Null Mouse ', ' Knock-out Mice ', ' KO mice ', ' Knockout Mice ', ' Lesion ', ' Clear Cell ', ' Blood Serum ', ' Serum ', ' Cavitas abdominis ', ' Abdominal Cavity ', ' Measurement ', ' Disease Progression ', ' ovarian cancer early screening ', ' ovarian cancer early detection ', ' ovarian cancer detection ', ' Screening for Ovarian Cancer ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' Metabolic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Serous ', ' Techniques ', ' 3-Dimensional ', ' 3-D ', ' Penetrance ', ' Early Diagnosis ', ' early detection ', ' ionization ', ' mutant ', ' hydrophilicity ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Primary Neoplasm ', ' Primary Tumor ', ' member ', ' new technology ', ' novel technologies ', ' Sampling ', ' liquid chromatography mass spectrometry ', ' LC/MS ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' cancer diagnosis ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Reproductive system ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Mucinous ', ' Predictive Value ', ' Premalignant ', ' precancerous ', ' Pre-Malignant ', ' Resolution ', ' Cancer Cause ', ' Cancer Etiology ', ' CancerModel ', ' Cancer Model ', ' Cancer Patient ', ' Electrospray Ionization ', ' Characteristics ', ' Molecular ', ' genetically engineered murine model ', ' genetically engineered mouse model ', ' GEM model ', ' Genetically Engineered Mouse ', ' Knockout ', ' Knock-out ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' ion mobility ', ' designing ', ' design ', ' Coupled ', ' human disease ', ' murine model ', ' mouse model ', ' tumor ', ' multimodality ', ' screening ', ' diagnostic panel ', ' cancer markers ', ' cancer biomarkers ', ' specific biomarkers ', ' protein markers ', ' protein biomarkers ', ' metabotype ', ' metabolic phenotype ', ' metabonome ', ' metabolome ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NCI,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2018,410432,0.08240623922129495
"Optimization and joint modeling for peptide detection by tandem mass spectrometry Project Summary/Abstract Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efcient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the elds of machine learning, statistics, and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets. Our project will focus on three key problems in the analysis of such data: 1. facilitating the use of previously annotated spectra to improve our ability to annotate new spectra by creating  a hybrid search scheme that compares an observed spectrum to a database comprised of theoretical spectra  and previously annotated spectra, 2. enabling the efcient and accurate detection of peptides containing post-translational modications and  sequence variants, and 3. detecting sets of peptide species that are co-fragmented in the mass spectrometer and hence give rise to  complex, mixture spectra. Each of these aims will improve the ability of mass spectrometrists to efciently and accurately identify and quantify proteins in complex mixtures. To increase the impact of our work, we will continue to make all of our tools available as free software. Project narrative The applications of mass spectrometry, and its promises for improvements of human health, are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specic diagnostic and prognostic screens. However, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.",Optimization and joint modeling for peptide detection by tandem mass spectrometry,9419312,R01GM121818,"['Algorithms ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Automobile Driving ', ' driving ', ' Cells ', ' Cell Body ', ' Liquid Chromatography ', ' Communities ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Economics ', ' Fertilization ', ' Fertility/Fertilization ', ' Game Theory ', ' Health ', ' Human ', ' Modern Man ', ' Hybrids ', ' Joints ', ' Libraries ', ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Natural Language Processing ', ' natural language understanding ', ' Operations Research ', ' Peptides ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Shotguns ', ' shot gun ', ' Computer software ', ' Software ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Data Set ', ' Dataset ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' prognostic ', ' Discipline ', ' data base ', ' Data Bases ', ' Databases ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' speech recognition ', ' tandem mass spectrometry ', ' Speed ', ' novel ', ' Column Chromatography ', ' Modeling ', ' Sampling ', ' theories ', ' Proteomics ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Complex Mixtures ', ' Data ', ' Detection ', ' Collection ', ' Scheme ', ' Molecular ', ' disease phenotype ', ' cost ', ' mass spectrometer ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' computational tools ', ' computerized tools ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' mathematics theory ', ' mathematics reasoning ', ' mathematics logic ', ' mathematic theory ', ' math theory ', ' Mathematical Reasoning ', ' Mathematical Logic ', ' mathematical theory ', ' learning method ', ' learning activity ', ' learning strategy ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2018,315421,0.27967696839716344
"Advanced Computational Approaches for NMR Data-mining ABSTRACT Nuclear magnetic resonance spectroscopy (NMR)-based metabolomics is a powerful method for identifying metabolic perturbations that report on different biological states and sample types. Compared to mass spectrometry, NMR provides robust and highly reproducible quantitative data in a matter of minutes, which makes it very suitable for first-line clinical diagnostics. Although the metabolome is known to provide an instantaneous snap-shot of the biological status of a cell, tissue, and organism, the utilization of NMR in clinical practice is hindered by cumbersome data analysis. Major challenges include high-dimensionality of the data, overlapping signals, variability of resonance frequencies (chemical shift), non-ideal shapes of signals, and low signal-to-noise ratio (SNR) for low concentration metabolites. Existing approaches fail to address these challenges and sample analysis is time-consuming, manually done, and requires considerable knowledge of NMR spectroscopy. Recent developments in the field of sparse methods for machine learning and accelerated convex optimization for high dimensional problems, as well as kernel-based spatial clustering show promise at enabling us to overcome these challenges and achieve fully automated, operator-independent analysis. We are developing two novel, powerful, and automated algorithms that capitalize on these recent developments in machine learning. In Aim 1, we describe NMRQuant for automated identification and quantification of annotated metabolites irrespective of the chemical shift, low SNR, and signal shape variability. In Aim 2, we describe SPA-STOCSY for automated de-novo identification of molecular fragments of unknown, non- annotated metabolites. Based on substantial preliminary data, we propose to evaluate these algorithms' sensitivity, specificity, stability, and resistance to noise on phantom, biological, and clinical samples, comparing them to current methods. We will validate the accuracy of analyses by experimental 2D NMR, spike-in, and mass spectrometry. The proposed efforts will produce new NMR analytical software for discovery of both annotated and non-annotated metabolites, substantially improving accuracy and reproducibility of NMR analysis. Such analytical ability would change the existing paradigm of NMR-based metabolomics and provide an even stronger complement to current mass spectrometry-based methods. This approach, once thoroughly validated, will enable NMR to reach wide network of applications in biomedical, pharmaceutical, and nutritional research and clinical medicine. NARRATIVE This project seeks to develop an advanced and automated platform for identifying NMR metabolomics biomarkers of diseases and for fundamental studies of biological systems. When fully developed, these approaches could be used to detect small molecules in the blood or urine, indicative of the onset of various diseases, drug toxicity, or environmental effects on the organism.",Advanced Computational Approaches for NMR Data-mining,9406318,R01GM120033,"['Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cells ', ' Cell Body ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Animal Disease Models ', ' Drug toxicity ', ' Health ', ' Human ', ' Modern Man ', ' Libraries ', ' Manuals ', ' Methods ', ' Noise ', ' Nuclear Magnetic Resonance ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' Plague ', ' Yersinia pestis disease ', ' Relaxation ', ' Research ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Societies ', ' Sodium Chloride ', ' salt ', ' Computer software ', ' Software ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Temperature ', ' Time ', ' Tissues ', ' Body Tissues ', ' Urine ', ' Urine Urinary System ', ' Measures ', ' Treatment outcome ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Left ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Link ', ' Chemicals ', ' infantile ', ' infancy ', ' Metabolic ', ' Shapes ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Early Diagnosis ', ' early detection ', ' novel ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Reproducibility ', ' Cancer Cause ', ' Cancer Etiology ', ' nutritious ', ' Nutritional ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' Outcome ', ' resistant ', ' Resistance ', ' experimental analysis ', ' stem ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' clinical practice ', ' biological systems ', ' Statistics Algorithm ', ' Statistical Algorithm ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' phenotypic marker ', ' phenotypic biomarker ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' clinical diagnostics ', ' experimental research ', ' experiment ', ' experimental study ', ' high dimensionality ', ' clinical implementation ', ' ']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2018,356625,0.08385061490508142
"Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways     DESCRIPTION (provided by applicant): This project aims to develop new statistical machine learning methods for metabolomics data from diverse platforms, including targeted and unbiased/global mass spectrometry (MS), labeled MS experiments for measuring metabolic ux and Nuclear Magnetic Resonance (NMR) platforms. Unbiased MS and NMR proling studies result in identifying a large number of unnamed spectra, which cannot be directly matched to known metabolites and are hence often discarded in downstream analyses. The rst aim develops a novel kernel penalized regression method for analysis of data from unbiased proling studies. It provides a systematic framework for extracting the relevant information from unnamed spectra through a kernel that highlights the similarities and differences between samples, and in turn boosts the signal from named metabolites. This results in improved power in identication of named metabolites associated with the phenotype of interest, as well as improved prediction accuracy. An extension of this kernel-based framework is also proposed to allow for systematic integration of metabolomics data from diverse proling studies, e.g. targeted and unbiased MS proling technologies. The second aim pro- vides a formal inference framework for kernel penalized regression and thus complements the discovery phase of the rst aim. The third aim focuses on metabolic pathway enrichment analysis that tests both orchestrated changes in activities of steady state metabolites in a given pathway, as well as aberrations in the mechanisms of metabolic reactions. The fourth aim of the project provides a unied framework for network-based integrative analysis of static (based on mass spectrometry) and dynamic (based on metabolic ux) metabolomics measurements, thus providing an integrated view of the metabolome and the uxome. Finally, the last aim implements the pro- posed methods in easy-to-use open-source software leveraging the R language, the capabilities of the Cytoscape platform and the Galaxy workow system, thus providing an expandable platform for further developments in the area of metabolomics. The proposed software tool will also provide a plug-in to the Data Repository and Coordination Center (DRCC) data sets, where all regional metabolomics centers supported by the NIH Common Funds Metabolomics Program deposit curated data. PUBLIC HEALTH RELEVANCE: Metabolomics, i.e. the study of small molecules involved in metabolism, provides a dynamic view into processes that reect the actual physiology of the cell, and hence offers vast potential for detection of novel biomarkers and targeted therapies for complex diseases. However, despite this potential, the development of computational methods for analysis of metabolomics data lags the rapid growth of metabolomics proling technologies. The current application addresses this need by developing novel statistical machine learning methods for integrative analysis of static and dynamic metabolomics measurements, as well as easy-to-use open-source software to facilitate the application of these methods.",Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways,9462161,R01GM114029,"['Adoption ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Environment ', ' Equilibrium ', ' balance function ', ' balance ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Language ', ' Linear Models ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Names ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Nuclear Magnetic Resonance ', ' Phenotype ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Work ', ' Measures ', ' Data Set ', ' Dataset ', ' Visualization ', ' Imagery ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Area ', ' Phase ', ' Biological ', ' biosynthesis ', ' Anabolism ', ' insight ', ' Measurement ', ' Funding ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Galaxy ', ' Letters ', ' Metabolic ', ' Deposition ', ' Deposit ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Complex ', ' Reaction ', ' System ', ' interest ', ' novel ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Code ', ' Coding System ', ' Sampling ', ' response ', ' Proteomics ', ' Metabolic Pathway ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Address ', ' Biochemical Reaction ', ' Enzymatic Reaction ', ' Data ', ' Detection ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' rapid growth ', ' Data Coordination Center ', ' Data Coordinating Center ', ' transcriptomics ', ' Plug-in ', ' open source ', ' Network-based ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' public health relevance ', ' novel biomarker ', ' new marker ', ' novel marker ', ' biological systems ', ' flexible ', ' flexibility ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' learning method ', ' learning activity ', ' learning strategy ', ' diagnostic marker ', ' diagnostic biomarker ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' experimental research ', ' experiment ', ' experimental study ', ' high dimensionality ', ' data repository ', ' Databanks ', ' Data Banks ', ' data warehouse ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2018,338393,0.09527853519809468
"Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease Abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide and is rising in incidence in the US. 90% of patients in the US with liver cancer have underlying cirrhosis, thus guideline recommendations recommend surveillance in all patients with cirrhosis to facilitate early detection. Unfortunately, only 20-30% of patients are detected with early detection and are thus eligible for potentially curative treatments. There is an unmet need for reliable biomarkers for HCC to facilitate adherence to screening and for early detection. In the proposed work we will develop early detection strategies for HCC based on glycoproteomic profiles. Unique changes in glycosylation in proteins, which involve structural changes in glycan groups, have been shown to be important serum biomarkers for early cancer detection. Importantly, the subtle changes may only involve minor structures but they can be very specific in differentiating cirrhosis versus early versus late stage HCC. In addition, these changes may be specific to the etiology of liver disease. These glycan structural changes will be detected and monitored quantitatively using a mass spectrometry approach which has proven to be an accurate way to characterize even minor changes in structure which may be significant as biomarkers based on our previous mass analysis, tandem mass spectrometry measurements and databases which have been developed for glycan and glycopeptide analysis. This will be demonstrated for both glycan and glycopeptide screening from serum using novel extraction and separation methods coupled to mass spectrometry which can ultimately be used to distinguish early stage HCC from cirrhosis. The proposed work will deliver separations and mass spec methods enabling isomeric separation of glycans and glycopeptides, permitting unequivocal assignment of protein glycosylation related to disease state. We will be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. Novel software will be developed and used to assign these glycan structures. The markers will be discovered for specific etiologies of HCV-related, alcohol-related and NAFLD-related etiologies of HCC. This will be a multisite study to include all components required for a tumor biomarker lab including samples and sample preparation, separations and mass spec analysis, bioinformatics evaluation and statistical analysis. Ultimately, we will develop methods for discovery of glycan/glycopeptide markers from patient serum, the identification of potential markers and the development of new assays to provide a limited confirmation of these markers. Project Narrative: The proposed work will use new separations and mass spec methods to provide isomeric separation of glycans and glycopeptides, resulting in detailed assignment of protein glycosylation related to disease state. We expect to be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. The markers will be discovered for specific etiologies of HCV- related, alcohol-related and NAFLD-related etiologies of HCC. Ultimately, we will develop new assays to provide a limited confirmation of these markers.",Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease,9495790,U01CA225753,"['Alcohols ', ' Alcohol Chemical Class ', ' alpha-Fetoproteins ', ' -Fetoproteins ', ' Fetuins ', ' Alpha-Fetoglobulin ', ' Alpha-1-Fetoprotein ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' Statistical Data Interpretation ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Europe ', ' Glycopeptides ', ' Glycoproteins ', ' glycosylation ', ' Metabolic Glycosylation ', ' Primary carcinoma of the liver cells ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Incidence ', ' Isomerism ', ' isomer ', ' Japan ', ' Lectin ', ' Liver Cirrhosis ', ' Hepatic Cirrhosis ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Methods ', ' Minor ', ' Patients ', ' Peptides ', ' Polysaccharides ', ' Glycans ', ' Proteins ', ' Recommendation ', ' Risk ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Survival Rate ', ' Testing ', ' Time ', ' Tumor Markers ', ' tumor specific biomarker ', ' tumor biomarker ', ' TM-MKR ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Work ', ' Serum Markers ', ' Guidelines ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Site ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' data base ', ' Data Bases ', ' Databases ', ' Measurement ', ' Natural graphite ', ' Graphite ', ' Malignant neoplasm of liver ', ' malignant liver tumor ', ' liver cancer ', ' Hepatic Cancer ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Protein Glycosylation ', ' Frequencies ', ' Complex ', ' Pattern ', ' carbohydrate structure ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' Protein Isoforms ', ' Isoforms ', ' tandem mass spectrometry ', ' Structure ', ' novel ', ' Proteome ', ' Sampling ', ' sialylation ', ' Bioinformatics ', ' Bio-Informatics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Alcohol-Related Hepatocellular Carcinoma ', ' Adherence ', ' Cancer Cause ', ' Cancer Etiology ', ' Monitor ', ' Preparation ', ' developmental ', ' Development ', ' cirrhotic ', ' Cirrhosis ', ' early onset ', ' Coupled ', ' tumor ', ' nonalcoholic steato-hepatitis ', ' non-alcoholic steatohepatitis ', ' non-alcoholic steato-hepatitis ', ' non-alcohol induced steatohepatitis ', ' NASH ', ' nonalcoholic steatohepatitis ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' screening ', ' precision-based medicine ', ' precision medicine ', ' stratified patient ', ' patient stratification ', ' early detection markers ', ' early biomarkers ', ' early detection biomarkers ', ' curative therapy ', ' curative therapeutic ', ' curative intervention ', ' curative treatments ', ' glycoproteomics ', ' diagnostic screening ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis B Virus ', ' HCV ', ' Hepatitis C virus ', ' nonalcoholic fatty liver disease ', ' non-alcoholic liver disease ', ' non-alcohol fatty liver disease ', ' NAFLD ', ' non-alcoholic fatty liver disease ', ' patient screening ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2018,529478,0.15832598644319476
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,9536551,U54HL127365,"['inhibitor/antagonist ', ' inhibitor ', ' Antibodies ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cell Extracts ', ' Cells ', ' Cell Body ', ' Pharmaceutical Chemistry ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Clinical Investigator ', ' Communities ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Data Collection ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Extracellular Matrix ', ' ECM ', ' Cell-Extracellular Matrix ', ' Goals ', ' Human ', ' Modern Man ', ' Immunoassay ', ' Learning ', ' Linear Regressions ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Pharmacology ', ' Phenotype ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Production ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Messenger RNA ', ' mRNA ', ' Semantics ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Stem cells ', ' Progenitor Cells ', ' Technology ', ' Testing ', ' Thromboplastin ', ' Urothromboplastin ', ' Tissue Thromboplastin ', ' Tissue Factor Procoagulant ', ' Tissue Factor ', ' Prothrombinase ', ' Glomerular Procoagulant Activity ', ' Factor III ', ' Coagulin ', ' Coagulation Factor III ', ' CD142 Antigens ', ' Blood Coagulation Factor III ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence Immunologic ', ' Immunofluorescence ', ' Measures ', ' forest ', ' Data Set ', ' Dataset ', ' Fuzzy Logic ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Data Quality ', ' Measurement ', ' Collaborations ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Immune ', ' Immunes ', ' Complex ', ' cell type ', ' Gray unit of radiation dose ', ' Gray ', ' single cell analysis ', ' novel ', ' member ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' drug discovery ', ' Sentinel ', ' Molecular Computations ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' Dose ', ' Data ', ' Education and Outreach ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Collection ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' web-based service ', ' web services ', ' website ', ' web site ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' usability ', ' iPSCs ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' network models ', ' tumor ', ' senescent ', ' senescence ', ' public health relevance ', ' operation ', ' epigenome ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' data visualization ', ' learning method ', ' learning activity ', ' learning strategy ', ' response prediction ', ' predictor of response ', ' predictive response ', ' prediction of response ', ' predicting response ', ' live cellular imaging ', ' live cellular image ', ' live cell image ', ' live cell imaging ', ' phenotypic data ', ' genome browser ', ' genomic data ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' Growth Factor ', ' experimental research ', ' experiment ', ' experimental study ', ' translational impact ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2018,2167304,0.09579543721714887
"Advanced Computational Approaches for NMR Data-mining ABSTRACT Nuclear magnetic resonance spectroscopy (NMR)-based metabolomics is a powerful method for identifying metabolic perturbations that report on different biological states and sample types. Compared to mass spectrometry, NMR provides robust and highly reproducible quantitative data in a matter of minutes, which makes it very suitable for first-line clinical diagnostics. Although the metabolome is known to provide an instantaneous snap-shot of the biological status of a cell, tissue, and organism, the utilization of NMR in clinical practice is hindered by cumbersome data analysis. Major challenges include high-dimensionality of the data, overlapping signals, variability of resonance frequencies (chemical shift), non-ideal shapes of signals, and low signal-to-noise ratio (SNR) for low concentration metabolites. Existing approaches fail to address these challenges and sample analysis is time-consuming, manually done, and requires considerable knowledge of NMR spectroscopy. Recent developments in the field of sparse methods for machine learning and accelerated convex optimization for high dimensional problems, as well as kernel-based spatial clustering show promise at enabling us to overcome these challenges and achieve fully automated, operator-independent analysis. We are developing two novel, powerful, and automated algorithms that capitalize on these recent developments in machine learning. In Aim 1, we describe NMRQuant for automated identification and quantification of annotated metabolites irrespective of the chemical shift, low SNR, and signal shape variability. In Aim 2, we describe SPA-STOCSY for automated de-novo identification of molecular fragments of unknown, non- annotated metabolites. Based on substantial preliminary data, we propose to evaluate these algorithms' sensitivity, specificity, stability, and resistance to noise on phantom, biological, and clinical samples, comparing them to current methods. We will validate the accuracy of analyses by experimental 2D NMR, spike-in, and mass spectrometry. The proposed efforts will produce new NMR analytical software for discovery of both annotated and non-annotated metabolites, substantially improving accuracy and reproducibility of NMR analysis. Such analytical ability would change the existing paradigm of NMR-based metabolomics and provide an even stronger complement to current mass spectrometry-based methods. This approach, once thoroughly validated, will enable NMR to reach wide network of applications in biomedical, pharmaceutical, and nutritional research and clinical medicine. NARRATIVE This project seeks to develop an advanced and automated platform for identifying NMR metabolomics biomarkers of diseases and for fundamental studies of biological systems. When fully developed, these approaches could be used to detect small molecules in the blood or urine, indicative of the onset of various diseases, drug toxicity, or environmental effects on the organism.",Advanced Computational Approaches for NMR Data-mining,9608754,R01GM120033,"['Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cell Body ', ' Cells ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Animal Disease Models ', ' Drug toxicity ', ' Health ', ' Modern Man ', ' Human ', ' Libraries ', ' Manuals ', ' Methods ', ' Noise ', ' Nuclear Magnetic Resonance ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' living system ', ' Organism ', ' Patients ', ' Phenotype ', ' Yersinia pestis disease ', ' Plague ', ' Relaxation ', ' Research ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Societies ', ' salt ', ' Sodium Chloride ', ' Software ', ' Computer software ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Temperature ', ' Time ', ' Body Tissues ', ' Tissues ', ' Urine Urinary System ', ' Urine ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Left ', ' Clinical ', ' Residual state ', ' Residual ', ' Variant ', ' Variation ', ' Biological ', ' Medical ', ' Link ', ' Chemicals ', ' infancy ', ' infantile ', ' Metabolic ', ' Shapes ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Early Diagnosis ', ' early detection ', ' Structure ', ' novel ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' Reproducibility ', ' Nutritional ', ' nutritious ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Outcome ', ' Consumption ', ' Resistance ', ' resistant ', ' experimental analysis ', ' stem ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' clinical practice ', ' biological systems ', ' Statistical Algorithm ', ' Statistics Algorithm ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' phenotypic biomarker ', ' phenotypic marker ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' clinical diagnostics ', ' experimental study ', ' experimental research ', ' experiment ', ' high dimensionality ', ' clinical implementation ', ' multidimensional data ', ' high dimensional data ', ' automated analysis ', ' computational suite ', ' ']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2019,356625,0.08385061490508142
"Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Mass spectrometry imaging (MSI) is a powerful technique that enables label-free spatial mapping of different classes of biomolecules in biological systems. Because it does not require any special sample pretreatment, ambient MSI is particularly attractive for high throughput automated imaging applications. The throughput of ambient MSI experiments is typically limited by the inherently slow microprobe-type sampling from surfaces, which is a characteristic shortcoming of many chemical imaging modalities. This project will combine several highly innovative approaches to address challenges associated with the high-throughput high- resolution ambient MSI of lipids and metabolites using nanospray desorption electrospray ionization (nano-DESI). Nano-DESI is an ambient ionization technique, which relies on gentle localized liquid extraction of molecules from tissue sections into a flowing solvent confined between two glass capillaries. The extracted molecules are efficiently delivered to a mass spectrometer inlet and ionized by soft electrospray ionization. Nano-DESI MSI enables detection of hundreds of metabolites, lipids, and peptides in tissue sections with high sensitivity, high spatial resolution, and without special sample pretreatment. Furthermore, on-the-fly quantification of lipids and metabolites in tissue sections during nano-DESI imaging experiments is achieved by doping the working solvent with appropriate standards of known concentration. This project will extend these powerful capabilities of nano-DESI MSI to enable high-throughput imaging of large tissue sections of interest to the HubMAP Consortium. This will be achieved using a combination of a conceptually different nano-DESI probe design optimized for robustness, ease of fabrication, and spatial resolution and a suite of advanced machine learning and compressed sensing computational approaches. These developments will be applicable to different types of human tissues and will transform quantitative molecular imaging of multiple classes of biomolecules in tissue sections. Although the capabilities of the new imaging platform will be demonstrated using non-diseased tissue, these developments will be broadly applicable to scientific problems associated with understanding health and disease Project Narrative This research is focused on the development of a transformative technology for rapid, quantitative, and robust imaging of different classes of biomolecules in human tissues using mass spectrometry. This new technology will contribute to understanding complex processes in biological tissues that play a role in both health and disease.",Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry,9782980,UG3HL145593,"['Automation ', ' Blood capillaries ', ' capillary ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Glass ', ' Health ', ' Histology ', ' Ions ', ' Lipids ', ' Maps ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Oligosaccharides ', ' optical ', ' Optics ', ' Peptides ', ' Play ', ' Proteins ', ' Research ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Sensitivity and Specificity ', ' Software ', ' Computer software ', ' Solvents ', ' Spatial Distribution ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Body Tissues ', ' Tissues ', ' Imaging Technics ', ' Imaging Procedures ', ' Imaging Techniques ', ' Label ', ' Microscope ', ' Surface ', ' Phase ', ' Biological ', ' Ensure ', ' Chemicals ', ' Measurement ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' human tissue ', ' Slide ', ' Techniques ', ' interest ', ' Spectrometry, Mass, Electrospray Ionization ', ' ESI Mass Spectrometry ', ' Performance ', ' Structure ', ' novel ', ' member ', ' new technology ', ' novel technologies ', ' Sampling ', ' Proteomics ', ' fluidic ', ' Microfluidics ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Tissue Sample ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Data ', ' Detection ', ' Resolution ', ' Electrospray Ionization ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' molecular imaging ', ' molecule imaging ', ' nano ', ' Image ', ' imaging ', ' ionization technique ', ' ionization method ', ' mass spectrometer ', ' reconstruction ', ' design ', ' designing ', ' nanoprobe ', ' nano probe ', ' scale up ', ' innovation ', ' innovative ', ' innovate ', ' data acquisition ', ' biological systems ', ' operation ', ' quantitative imaging ', ' imaging platform ', ' human imaging ', ' experimental study ', ' experimental research ', ' experiment ', ' imaging capabilities ', ' preservation ', ' automated analysis ', ' ']",NHLBI,PURDUE UNIVERSITY,UG3,2019,400342,0.14318785766211636
"Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets PROJECT SUMMARY/ABSTRACT Recent advances in high-resolution mass spectrometry (HRMS) instrumentation have not been fully leveraged to upgrade the information content of metabolomics datasets obtained from stable isotope labeling studies. This is primarily due to lack of validated software tools for extracting and interpreting isotope enrichments from HRMS datasets. The overall objective of the current application is to develop tools that enable the metabolomics community to fully leverage stable isotopes to profile metabolic network dynamics. Two new tools will be implemented within the open-source OpenMS software library, which provides an infrastructure for rapid development and dissemination of mass spectrometry software. The first tool will automate tasks required for extracting isotope enrichment information from HRMS datasets, and the second tool will use this information to group ion peaks into interaction networks based on similar patterns of isotope labeling. The tools will be validated using in-house datasets derived from metabolic flux studies of animal and plant systems, as well as through feedback from the metabolomics community. The rationale for the research is that the software tools will enable metabolomics investigators to address important questions about pathway dynamics and regulation that cannot be answered without the use of stable isotopes. The first aim is to develop a software tool to automate data extraction and quantification of isotopologue distributions from HRMS datasets. The software will provide several key features not included in currently available metabolomics software: i) a graphical, interactive user interface that is appropriate for non-expert users, ii) support for native instrument file formats, iii) support for samples that are labeled with multiple stable isotopes, iv) support for tandem mass spectra, and v) support for multi-group or time-series comparisons. The second aim is to develop a companion software that applies machine learning and correlation-based algorithms to group unknown metabolites into modules and pathways based on similarities in isotope labeling. The third aim is to validate the tools through comparative analysis of stable isotope labeling in test standards and samples from animal and plant tissues, including time-series and dual-tracer experiments. A variety of collaborators and professional working groups will be engaged to test and validate the software, and the tools will be refined based on their feedback. The proposed research is exceptionally innovative because it will provide the advanced software capabilities required for both targeted and untargeted analysis of isotopically labeled metabolites, but in a flexible and user-friendly environment. The research is significant because it will contribute software tools that automate and standardize the data processing steps required to extract and utilize isotope enrichment information from large-scale metabolomics datasets. This work will have an important positive impact on the ability of metabolomics investigators to leverage information from stable isotopes to identify unknown metabolic interactions and quantify flux within metabolic networks. In addition, it will enable entirely new approaches to study metabolic dynamics within biological systems. PROJECT NARRATIVE The proposed research is relevant to public health because it will develop novel software tools to quantify and interpret data from stable isotope labeling experiments, which can be used to uncover relationships between metabolites and biochemical pathways. These tools have potential to accelerate progress toward identifying the causes and cures of many important diseases that impact metabolism.",Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets,9786702,U01CA235508,"['Algorithms ', ' Animals ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' Environment ', ' Feedback ', ' instrumentation ', ' Ions ', ' Isotope Labeling ', ' Isotopes ', ' Libraries ', ' Manuals ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Plants ', ' Public Health ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' Label ', ' improved ', ' Biological ', ' Series ', ' Measurement ', ' Biochemical Pathway ', ' Metabolic Networks ', ' metabolic abnormality assessment ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' Letters ', ' stable isotope ', ' Metabolic ', ' Companions ', ' tool ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Pattern ', ' System ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' Regulation ', ' Modeling ', ' Sampling ', ' data processing ', ' computerized data processing ', ' Stable Isotope Labeling ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Data ', ' Detection ', ' Resolution ', ' Validation ', ' Process ', ' Tracer ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' working group ', ' work group ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' file format ', ' user-friendly ', ' open source ', ' Network-based ', ' comparative ', ' biological systems ', ' flexibility ', ' flexible ', ' operation ', ' metabolic phenotype ', ' metabotype ', ' metabolic profile ', ' experimental study ', ' experimental research ', ' experiment ', ' Infrastructure ', ' ']",NCI,VANDERBILT UNIVERSITY,U01,2019,659173,0.0908120303695696
"Feature Learning For Improved Multiplex Disease Diagnosis Abstract This proposal is for CATTS, a feature learning technique optimized for use in multiplex mass spectrometry (MS) fingerprinting assays. MS fingerprints consist of a large number of chemical species, leading to very high dimensional feature spaces, and subsequent high false-discovery rates. CATTS aims to reduce the size of this space, by using knowledge of the underlying biochemistry, as well as general-purpose clustering algorithms. Our preliminary results demonstrate that, when used as a feature-learning technique for a variety of classification methods, CATTS significantly improves assay sensitivity. This proposal takes our existing implementation of CATTS and extends it to support additional feature learning algorithms and classification methods. Additionally, its performance as a multiplex assay strategy will be tested on both protein and lipid MS fingerprint libraries, with an eye towards commercialization.. Relevance to public health: The detection of pathogens via mass spectroscopy fingerprinting is rapidly becoming a standard technique for clinical microbiology. However, high false detection rates and conflicting multiple identifications limit applicability, and make interpretation of results difficult. Our work on CATTS aims to improve the statistical performance of these assays. Preliminary results from studies on one dataset we intend to apply CATTS to suggest that UTIs and, in some cases antimicrobial resistance, can be detected, directly from patient samples. However, the statistical methods currently employed aren't reliable enough - the further development of CATTS will accelerate the development of this, and other mass-spectroscopy-based assays..",Feature Learning For Improved Multiplex Disease Diagnosis,9813280,R43GM128538,"['Algorithms ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Systematics ', ' Classification ', ' Conflict ', ' Conflict (Psychology) ', ' Decision Trees ', ' Eyeball ', ' Eye ', ' Fingerprint ', ' Protein Fingerprinting ', ' Protein Fingerprints ', ' Learning ', ' Libraries ', ' Lipids ', ' Methods ', ' Noise ', ' living system ', ' Organism ', ' Patients ', ' Proteins ', ' Public Health ', ' Research ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Testing ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Chemicals ', ' Biodiversity ', ' Biological Diversity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dimensions ', ' Immune ', ' Immunes ', ' Techniques ', ' System ', ' Performance ', ' Structure ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Clinical Microbiology ', ' Antimicrobial Resistance ', ' resistant to antimicrobial ', ' resistant to anti-microbial ', ' resistance to anti-microbial ', ' anti-microbial resistant ', ' anti-microbial resistance ', ' Resistance to antimicrobial ', ' Antimicrobial resistant ', ' Detection ', ' Process ', ' Development ', ' developmental ', ' vector ', ' feeding ', ' Pathogen detection ', ' commercialization ', ' disease diagnosis ', ' learning strategy ', ' learning method ', ' learning activity ', ' high dimensionality ', ' neural network ', ' random forest ', ' learning algorithm ', ' ']",NIGMS,"DEURION, LLC",R43,2019,14770,0.07081390602731841
"Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways     DESCRIPTION (provided by applicant): This project aims to develop new statistical machine learning methods for metabolomics data from diverse platforms, including targeted and unbiased/global mass spectrometry (MS), labeled MS experiments for measuring metabolic ux and Nuclear Magnetic Resonance (NMR) platforms. Unbiased MS and NMR proling studies result in identifying a large number of unnamed spectra, which cannot be directly matched to known metabolites and are hence often discarded in downstream analyses. The rst aim develops a novel kernel penalized regression method for analysis of data from unbiased proling studies. It provides a systematic framework for extracting the relevant information from unnamed spectra through a kernel that highlights the similarities and differences between samples, and in turn boosts the signal from named metabolites. This results in improved power in identication of named metabolites associated with the phenotype of interest, as well as improved prediction accuracy. An extension of this kernel-based framework is also proposed to allow for systematic integration of metabolomics data from diverse proling studies, e.g. targeted and unbiased MS proling technologies. The second aim pro- vides a formal inference framework for kernel penalized regression and thus complements the discovery phase of the rst aim. The third aim focuses on metabolic pathway enrichment analysis that tests both orchestrated changes in activities of steady state metabolites in a given pathway, as well as aberrations in the mechanisms of metabolic reactions. The fourth aim of the project provides a unied framework for network-based integrative analysis of static (based on mass spectrometry) and dynamic (based on metabolic ux) metabolomics measurements, thus providing an integrated view of the metabolome and the uxome. Finally, the last aim implements the pro- posed methods in easy-to-use open-source software leveraging the R language, the capabilities of the Cytoscape platform and the Galaxy workow system, thus providing an expandable platform for further developments in the area of metabolomics. The proposed software tool will also provide a plug-in to the Data Repository and Coordination Center (DRCC) data sets, where all regional metabolomics centers supported by the NIH Common Funds Metabolomics Program deposit curated data. PUBLIC HEALTH RELEVANCE: Metabolomics, i.e. the study of small molecules involved in metabolism, provides a dynamic view into processes that reect the actual physiology of the cell, and hence offers vast potential for detection of novel biomarkers and targeted therapies for complex diseases. However, despite this potential, the development of computational methods for analysis of metabolomics data lags the rapid growth of metabolomics proling technologies. The current application addresses this need by developing novel statistical machine learning methods for integrative analysis of static and dynamic metabolomics measurements, as well as easy-to-use open-source software to facilitate the application of these methods.",Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways,9667435,R01GM114029,"['Adoption ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Environment ', ' balance function ', ' balance ', ' Equilibrium ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Language ', ' Linear Models ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' Names ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Nuclear Magnetic Resonance ', ' Phenotype ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' Imagery ', ' Visualization ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Area ', ' Phase ', ' Biological ', ' Anabolism ', ' biosynthesis ', ' insight ', ' Measurement ', ' Funding ', ' Biochemical Pathway ', ' Metabolic Networks ', ' Galaxy ', ' Letters ', ' Metabolic ', ' Deposition ', ' Deposit ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Complex ', ' Reaction ', ' System ', ' interest ', ' novel ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Code ', ' Coding System ', ' Sampling ', ' response ', ' Proteomics ', ' Metabolic Pathway ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' Address ', ' Biochemical Reaction ', ' Enzymatic Reaction ', ' Data ', ' Detection ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' rapid growth ', ' Data Coordinating Center ', ' Data Coordination Center ', ' transcriptomics ', ' Plug-in ', ' open source ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' public health relevance ', ' novel marker ', ' novel biomarker ', ' new marker ', ' biological systems ', ' flexibility ', ' flexible ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' diagnostic biomarker ', ' diagnostic marker ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' experimental study ', ' experimental research ', ' experiment ', ' high dimensionality ', ' data warehouse ', ' data repository ', ' Databanks ', ' Data Banks ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2019,337658,0.09527853519809468
"Optimization and joint modeling for peptide detection by tandem mass spectrometry Project Summary/Abstract Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efcient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the elds of machine learning, statistics, and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets. Our project will focus on three key problems in the analysis of such data: 1. facilitating the use of previously annotated spectra to improve our ability to annotate new spectra by creating  a hybrid search scheme that compares an observed spectrum to a database comprised of theoretical spectra  and previously annotated spectra, 2. enabling the efcient and accurate detection of peptides containing post-translational modications and  sequence variants, and 3. detecting sets of peptide species that are co-fragmented in the mass spectrometer and hence give rise to  complex, mixture spectra. Each of these aims will improve the ability of mass spectrometrists to efciently and accurately identify and quantify proteins in complex mixtures. To increase the impact of our work, we will continue to make all of our tools available as free software. Project narrative The applications of mass spectrometry, and its promises for improvements of human health, are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specic diagnostic and prognostic screens. However, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.",Optimization and joint modeling for peptide detection by tandem mass spectrometry,9627997,R01GM121818,"['Algorithms ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Automobile Driving ', ' driving ', ' Cell Body ', ' Cells ', ' Liquid Chromatography ', ' Communities ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Economics ', ' Fertility/Fertilization ', ' Fertilization ', ' Game Theory ', ' Health ', ' Modern Man ', ' Human ', ' Hybrids ', ' Joints ', ' Libraries ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' natural language understanding ', ' Natural Language Processing ', ' Operations Research ', ' Peptides ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteins ', ' shot gun ', ' Shotguns ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' statistics ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' improved ', ' Variant ', ' Variation ', ' Biological ', ' prognostic ', ' Discipline ', ' Databases ', ' data base ', ' Data Bases ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' speech recognition ', ' tandem mass spectrometry ', ' Speed ', ' novel ', ' Column Chromatography ', ' Modeling ', ' Sampling ', ' theories ', ' Proteomics ', ' protein aminoacid sequence ', ' peptide sequence ', ' peptide aminoacid sequence ', ' Complex Mixtures ', ' Data ', ' Detection ', ' Collection ', ' Scheme ', ' Molecular ', ' disease phenotype ', ' cost ', ' mass spectrometer ', ' computerized tools ', ' computational tools ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' mathematical theory ', ' mathematics theory ', ' mathematics reasoning ', ' mathematics logic ', ' mathematic theory ', ' math theory ', ' Mathematical Reasoning ', ' Mathematical Logic ', ' learning strategy ', ' learning method ', ' learning activity ', ' experimental study ', ' experimental research ', ' experiment ', ' Bayesian Network ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2019,315830,0.27967696839716344
"High-Throughput De Novo Glycan Sequencing Glycosylation fulfills important physiological functions, including protein folding, embryogenesis, cell adhesion, pathogen recognition, and immune response. The multifaceted roles glycosylation plays derive from the presence of a range of glycan epitopes, where a small structural variation can have a profound impact on functions. Further, a glycome consists of many closely related structures, with their relative amounts determined by metabolic conditions in a cell- and growth-specific manner. Altered glycosylation is linked to many diseases, including cardiovascular, pulmonary, neurological and autoimmune disorders, and cancer. Thus, there is a clear need for analytical methods that can rapidly identify and quantify the many glycoforms in a glycome from different health and disease states. Finally, no genome-predicted glycan database exists due to the unscripted nature of glycan biosynthesis, and discovery of new glycan structures must be achieved by de novo methods. Although tandem mass spectrometry-based biopolymer sequencing has been the major catalyst to the recent rapid advance of 'omics, the prevailing collisionally activated dissociation method often fails to provide sufficient glycan structural detail at the MS2 level, whereas the MSn approach lacks the speed, sensitivity, and quantitative potential for high-throughput glycome analysis. We have recently developed an electronic excitation dissociation (EED) method that can yield rich structural information in a single stage of MS/MS analysis. However, the impact of EED on glycomics research is currently limited by its poor accessibility, insufficient coupling to on-line glycan separation methods, and difficulty in interpretation of complex glycan EED tandem mass spectra. Here, we propose to develop an integrated approach that combines EED with on-line liquid chromatography (LC) separation and a novel bioinformatics tool to achieve high-throughput, de novo, and comprehensive glycome characterization. We will explore the potential of EED for analysis of glycans in various derivatized forms, study their fragmentation behaviors, and establish fragmentation rules for the development of bioinformatics software. We will optimize conditions for efficient coupling of EED to reversed-phase, and porous graphitic carbon LC, and develop an LC-EED-MS/MS approach for simultaneous characterization and quantitation of glycan mixtures. We will implement EED on a Q-TOF instrument to improve its access to the glycoscience community. Finally, we will develop and rigorously test the performance of a novel bioinformatics software that can rapidly and accurately determine each glycan's structure from its tandem MS spectra. The proposed algorithm is fundamentally different from most existing software, in that it no longer relies solely on glycosidic and cross-ring fragments for topology and linkage analysis, but rather adopts a machine learning approach that considers the contexts of various types of fragment peaks, and the spectral features associated with different linkage configurations and structural motifs. The availability of such a high-throughput, de novo glycan sequencing tool will have an immense impact on many biomedical research fields, as glycosylation plays critical roles in almost all biological pathways. High-Throughput De Novo Glycan Sequencing Project narrative Characterization of glycans from biological sources requires sensitive and high-throughput analytical methods that can separate and identify each glycoform in a complex mixture. We propose to develop an HPLC-EED- MS/MS method for comprehensive glycome characterization. We will also develop a novel bioinformatics program that can accurately determine the glycan structure from its EED tandem mass spectrum de novo.",High-Throughput De Novo Glycan Sequencing,9713593,R01GM132675,"['tool ', ' instrument ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Adopted ', ' Complex ', ' Source ', ' Pattern ', ' tandem mass spectrometry ', ' Speed ', ' Structure ', ' novel ', ' genetic linkage analysis ', ' linkage analyses ', ' genetic linkage analyses ', ' family based linkage study ', ' Linkage Analysis ', ' Sampling ', ' performance tests ', ' Bioinformatics ', ' Bio-Informatics ', ' Molecular Interaction ', ' Binding ', ' Complex Mixtures ', ' Effectiveness ', ' Address ', ' Data ', ' Scheme ', ' Development ', ' developmental ', ' ultraviolet ', ' Pathway interactions ', ' pathway ', ' mass spectrometer ', ' reconstruction ', ' design ', ' designing ', ' pathogen ', ' Coupling ', ' Impairment ', ' therapeutic target ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Fourier transform ion cyclotron resonance ', ' FTICR ', ' Algorithm Design ', ' algorithmic composition ', ' algorithm engineering ', ' Algorithmic Engineering ', ' Algorithmic Design ', ' bioinformatics tool ', ' bio-informatics tool ', ' Algorithms ', ' Epitopes ', ' Binding Determinants ', ' Antigenic Determinants ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Behavior ', ' Biomedical Research ', ' Biopolymers ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cellular Adhesion ', ' Cell Adhesion ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' High Speed Liquid Chromatography ', ' High Performance Liquid Chromatography ', ' HPLC ', ' High Pressure Liquid Chromatography ', ' Liquid Chromatography ', ' Communities ', ' Disorder ', ' Disease ', ' electron transfer ', ' Electron Transport ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Genome ', ' Glycoconjugates ', ' Glycosides ', ' Metabolic Glycosylation ', ' glycosylation ', ' Health ', ' isomer ', ' Isomerism ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Methods ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' Pathological Processes ', ' Pathologic Processes ', ' Physiology ', ' Physiologic Processes ', ' Organismal Process ', ' Organism-Level Process ', ' Physiological Processes ', ' Play ', ' Glycans ', ' Polysaccharides ', ' Research ', ' social role ', ' Role ', ' Software ', ' Computer software ', ' Specificity ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' structure function relationship ', ' chemical structure function ', ' Structure-Activity Relationship ', ' Vacuum ', ' Dissociation ', ' Dataset ', ' Data Set ', ' protein folding ', ' catalyst ', ' analytical method ', ' base ', ' improved ', ' Surface ', ' Phase ', ' Variant ', ' Variation ', ' Biological ', ' Physiological ', ' Physiologic ', ' Link ', ' Anabolism ', ' biosynthesis ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Liquid substance ', ' liquid ', ' fluid ', ' Natural graphite ', ' Graphite ', ' Metabolic ', ' ']",NIGMS,BOSTON UNIVERSITY MEDICAL CAMPUS,R01,2019,462286,0.11519076242926818
"Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods PROJECT SUMMARY / ABSTRACT Title: Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods The project seeks to improve reliability and speed up the development of life-saving and life-enhancing, precision, protein therapeutics and magnify the positive impact of biomedical research and education worldwide, leading to a quantum leap in our understanding of the molecular and cellular pathways and mechanisms involved in healthy and diseased biological systems. The development of biologics is bottlenecked across the entire drug development process, from discovery to early stage candidate selection, process development and manufacturing, due to manual intervention in the mass spectrometry data analysis pipeline. Similarly, the proteomics research community is hindered as it moves from analysis of complex mixtures to more in-depth characterization of proteins and their modifications. Novel machine learning methods will be added to MassMatrixs (LC-MS/MS software) proven analytical engine and visualization platform to minimize the loss of true positive peptide spectral matches. An innovative approach for efficient accountability of experimental data at the chromatogram level will also be researched, developed and added. The latter providing for easy traceability of each peaks status in the chromatogram as soon as possible, thus providing convenient high-level assessment. Together, these aims are expected to improve the reliability and accuracy of results as well as to significantly reduce the mass spec bottleneck for the pharmaceutical industry and the research community. Deeper understanding and better decision making will follow, both having a potentially dramatic positive impact on downstream processes and resource deployment, including improved drug safety and efficacy. PROJECT NARRATIVE Title: Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods The project seeks to speed up and improve reliability in the development of life-saving and life-enhancing, precision, protein therapeutics and magnify the positive impact of biomedical research and life science education worldwide. Due to manual intervention in a critical, mass spectrometry data analysis pipeline, progress in drug development and protein research is bottlenecked and compromised. Through novel machine learning methods and an innovative visualization approach for validating experimental data, the project is expected to improve the accuracy and reliability of results and alleviate the bottleneck, thereby deepening understanding of proteins and biological systems and improving resource allocation through better decision making, including improved drug safety and efficacy. 1",Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods,9680373,R44GM131484,"['Monoclonal Antibodies ', ' mAbs ', ' Clinical Treatment Moab ', ' Biological Sciences ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biomedical Research ', ' Communication ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Decision Making ', ' Disorder ', ' Disease ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Drug Industry ', ' Educational aspects ', ' Education ', ' Manuals ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Peptide Fingerprinting ', ' Peptide Mapping ', ' Peptides ', ' Proteins ', ' Reliability of Results ', ' Research ', ' Research Resources ', ' Resources ', ' Savings ', ' shot gun ', ' Shotguns ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Testing ', ' Time ', ' Accountability ', ' Resource Allocation ', ' Imagery ', ' Visualization ', ' base ', ' improved ', ' Site ', ' Phase ', ' Variant ', ' Variation ', ' Biological ', ' Pythons ', ' Ensure ', ' Databases ', ' data base ', ' Data Bases ', ' Systems Integration ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' light weight ', ' lightweight ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Event ', ' Protocols documentation ', ' Protocol ', ' Source ', ' System ', ' Location ', ' science education ', ' drug efficacy ', ' Speed ', ' Biologic Development ', ' novel ', ' Code ', ' Coding System ', ' Sampling ', ' drug development ', ' Protein Databases ', ' Proteomics ', ' repository ', ' therapeutic protein ', ' protein drug agent ', ' pharmaceutical protein ', ' native protein drug ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Directories ', ' Published Directory ', ' Complex Mixtures ', ' Preparedness ', ' Readiness ', ' FOLH1 gene ', ' Prostate-Specific Membrane Antigen ', ' PSMA ', ' PSM ', ' NAALADase I ', ' NAALAD1 ', ' N-Acetylated Alpha-Linked Acidic Dipeptidase 1 ', ' Glutamate Carboxypeptidase II ', ' GCP2 ', ' Folate Hydrolase 1 ', ' FOLH1 ', ' FOLH ', ' Address ', ' Data ', ' Security ', ' Molecular ', ' Process ', ' Modification ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' Output ', ' cost ', ' design ', ' designing ', ' quantum ', ' blind ', ' innovation ', ' innovative ', ' innovate ', ' interoperability ', ' comparative ', ' prototype ', ' commercialization ', ' candidate selection ', ' biological systems ', ' Secure ', ' learning strategy ', ' learning method ', ' learning activity ', ' experimental study ', ' experimental research ', ' experiment ', ' lead candidate ', ' analysis pipeline ', ' feature detection ', ' feature recognition ', ' medication safety ', ' pharmaceutical safety ', ' drug safety ', ' ']",NIGMS,"MASSMATRIX, INC.",R44,2019,132515,0.10503431754490973
"Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease Abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide and is rising in incidence in the US. 90% of patients in the US with liver cancer have underlying cirrhosis, thus guideline recommendations recommend surveillance in all patients with cirrhosis to facilitate early detection. Unfortunately, only 20-30% of patients are detected with early detection and are thus eligible for potentially curative treatments. There is an unmet need for reliable biomarkers for HCC to facilitate adherence to screening and for early detection. In the proposed work we will develop early detection strategies for HCC based on glycoproteomic profiles. Unique changes in glycosylation in proteins, which involve structural changes in glycan groups, have been shown to be important serum biomarkers for early cancer detection. Importantly, the subtle changes may only involve minor structures but they can be very specific in differentiating cirrhosis versus early versus late stage HCC. In addition, these changes may be specific to the etiology of liver disease. These glycan structural changes will be detected and monitored quantitatively using a mass spectrometry approach which has proven to be an accurate way to characterize even minor changes in structure which may be significant as biomarkers based on our previous mass analysis, tandem mass spectrometry measurements and databases which have been developed for glycan and glycopeptide analysis. This will be demonstrated for both glycan and glycopeptide screening from serum using novel extraction and separation methods coupled to mass spectrometry which can ultimately be used to distinguish early stage HCC from cirrhosis. The proposed work will deliver separations and mass spec methods enabling isomeric separation of glycans and glycopeptides, permitting unequivocal assignment of protein glycosylation related to disease state. We will be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. Novel software will be developed and used to assign these glycan structures. The markers will be discovered for specific etiologies of HCV-related, alcohol-related and NAFLD-related etiologies of HCC. This will be a multisite study to include all components required for a tumor biomarker lab including samples and sample preparation, separations and mass spec analysis, bioinformatics evaluation and statistical analysis. Ultimately, we will develop methods for discovery of glycan/glycopeptide markers from patient serum, the identification of potential markers and the development of new assays to provide a limited confirmation of these markers. Project Narrative: The proposed work will use new separations and mass spec methods to provide isomeric separation of glycans and glycopeptides, resulting in detailed assignment of protein glycosylation related to disease state. We expect to be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. The markers will be discovered for specific etiologies of HCV- related, alcohol-related and NAFLD-related etiologies of HCC. Ultimately, we will develop new assays to provide a limited confirmation of these markers.",Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease,9696355,U01CA225753,"['sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Work ', ' Serum Markers ', ' Guidelines ', ' base ', ' improved ', ' Screening for cancer ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Site ', ' Evaluation ', ' Serum ', ' Blood Serum ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Natural graphite ', ' Graphite ', ' Malignant neoplasm of liver ', ' malignant liver tumor ', ' liver cancer ', ' Hepatic Cancer ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Protein Glycosylation ', ' Frequencies ', ' Complex ', ' Pattern ', ' carbohydrate structure ', ' Early Diagnosis ', ' early detection ', ' Performance ', ' Protein Isoforms ', ' Isoforms ', ' tandem mass spectrometry ', ' Structure ', ' novel ', ' Proteome ', ' Sampling ', ' sialylation ', ' Bioinformatics ', ' Bio-Informatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Alcohol-Related Hepatocellular Carcinoma ', ' Adherence ', ' Cancer Etiology ', ' Cancer Cause ', ' Monitor ', ' Preparation ', ' Development ', ' developmental ', ' Cirrhosis ', ' cirrhotic ', ' early onset ', ' Coupled ', ' tumor ', ' nonalcoholic steatohepatitis ', ' nonalcoholic steato-hepatitis ', ' non-alcoholic steatohepatitis ', ' non-alcoholic steato-hepatitis ', ' non-alcohol induced steatohepatitis ', ' NASH ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' screening ', ' precision medicine ', ' precision-based medicine ', ' patient stratification ', ' stratified patient ', ' early detection biomarkers ', ' early detection markers ', ' early biomarkers ', ' curative treatments ', ' curative therapy ', ' curative therapeutic ', ' curative intervention ', ' glycoproteomics ', ' diagnostic screening ', ' Hepatitis B Virus ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis C virus ', ' HCV ', ' non-alcoholic fatty liver disease ', ' nonalcoholic fatty liver disease ', ' non-alcoholic liver disease ', ' non-alcohol fatty liver disease ', ' NAFLD ', ' patient screening ', ' Alcohols ', ' Alcohol Chemical Class ', ' alpha-Fetoproteins ', ' -Fetoproteins ', ' Fetuins ', ' Alpha-Fetoglobulin ', ' Alpha-1-Fetoprotein ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbon ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Europe ', ' Glycopeptides ', ' Glycoproteins ', ' Metabolic Glycosylation ', ' glycosylation ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Primary carcinoma of the liver cells ', ' Incidence ', ' isomer ', ' Isomerism ', ' Japan ', ' Lectin ', ' Hepatic Cirrhosis ', ' Liver Cirrhosis ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Methods ', ' Minor ', ' Patients ', ' Peptides ', ' Glycans ', ' Polysaccharides ', ' Proteins ', ' Recommendation ', ' Risk ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Specificity ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Survival Rate ', ' Testing ', ' Time ', ' tumor specific biomarker ', ' tumor biomarker ', ' TM-MKR ', ' Tumor Markers ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2019,584481,0.15832598644319476
"Pharmaco Response Signatures and Disease Mechanism DESCRIPTION (provided by applicant): The overall goal of the HMS LINCS Center is to delineate the fundamental principles of cellular response to perturbagens at the level of single-cells and cell populations and to make response data routinely available via web-based browse, query and programmatic interfaces. This will involve the development and testing of new measurement methods, computational algorithms, and response signatures for diverse human cell types exposed to perturbations individually and in combination. We will emphasize the systematic collection of data not currently available in existing public databases including live and fixed-cell imaging, biochemical data on signaling proteins and multi-factorial drug-response phenotypes. A focus on diverse transformed and primary cells, including those derived from healthy and diseased donors, and on clinical grade small molecules (kinase inhibitors and epigenome drugs) will increase the translational impact of our work. The proposed LINCS Center represents a continuation of a program in operation for ~3.5 years under a LINCS pilot phase U54 award. We will expand the scope and sophistication of our Center, devoting  significant effort to (i) improving the quality of data analysis and visualization, particularly wih respect to the  complexities of perturbagen polypharmacy (ii) accelerating the release of perturbagen-response signatures  using methods that have been demonstrated to yield reliable and informative data, with a particular  emphasis on primary and non-transformed cells (iii) developing and applying new measurement methods,  particularly mass spectrometry for analysis of cell populations and live-cell imaging for analysis of single cells.  The work will involve nine complementary but independent aims. In Data Generation, Aim 1 will perform systematic analysis of perturbagen responses at a single-cell level. Aim 2 will collect multiplex protein and mRNA data on perturbagen response using a set of complementary imaging, mass spectrometry and bead-based assays. Aim 3 will apply LINCS methods to non-transformed immune cells and induced pluripotent stem cells, and explore if signatures can guide a detailed medicinal chemistry campaign. In Data Analysis, Aim 4 will construct perturbagen-response signatures using statistical modeling, network inference and machine learning methods. Aim 5 will develop new approaches to understanding and analyzing drug interactions on multiple phenotypes in single cells. Aim 6 will develop a novel compressed sensing framework for analyzing the poly-pharmacology of kinase inhibitors. Aim 7 will enhance the query, browse and explore functions of the HMS LINCS website and database and its integration with the UCSC Genome Browser. In Community Interaction and Outreach, Aim 8 will implement diverse training and outreach activities, including collaboration with LINCS and non-LINCS research groups. In Administration, Aim 9 will ensure effective management of the Center, sustained access to tools and data produced within the LINCS Project, and compliance with program goals. PUBLIC HEALTH RELEVANCE: Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.",Pharmaco Response Signatures and Disease Mechanism,9754857,U54HL127365,"['inhibitor/antagonist ', ' inhibitor ', ' Antibodies ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cell Extracts ', ' Cell Body ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Investigator ', ' Communities ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ECM ', ' Cell-Extracellular Matrix ', ' Extracellular Matrix ', ' Goals ', ' Modern Man ', ' Human ', ' Immunoassay ', ' Linear Regressions ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Pharmacology ', ' Phenotype ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Phosphotransferases ', ' Production ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteins ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' mRNA ', ' Messenger RNA ', ' Semantics ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Urothromboplastin ', ' Tissue Thromboplastin ', ' Tissue Factor Procoagulant ', ' Tissue Factor ', ' Prothrombinase ', ' Glomerular Procoagulant Activity ', ' Factor III ', ' Coagulin ', ' Coagulation Factor III ', ' CD142 Antigens ', ' Blood Coagulation Factor III ', ' Thromboplastin ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytokine ', ' Generations ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' Measures ', ' Dataset ', ' Data Set ', ' Fuzzy Logic ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' analytical method ', ' base ', ' improved ', ' Polypharmacy ', ' Clinical ', ' Phase ', ' Biochemical ', ' Ensure ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Data Quality ', ' Measurement ', ' Collaborations ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Immune ', ' Immunes ', ' Complex ', ' cell type ', ' single cell analysis ', ' Structure ', ' novel ', ' member ', ' outreach ', ' Drug Interactions ', ' Cell surface ', ' Proteome ', ' Statistical Methods ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' Proteomics ', ' drug discovery ', ' Sentinel ', ' Molecular Computations ', ' Cell Cycle Arrest ', ' kinase inhibitor ', ' small molecule ', ' Signaling Protein ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' Dose ', ' Data ', ' Education and Outreach ', ' Tutoring and Outreach ', ' Training and Outreach ', ' Instruction and Outreach ', ' Collection ', ' Development ', ' developmental ', ' cellular imaging ', ' cell imaging ', ' Image ', ' imaging ', ' web services ', ' web-based service ', ' web site ', ' website ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Computational algorithm ', ' computer algorithm ', ' usability ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' network models ', ' tumor ', ' senescence ', ' senescent ', ' public health relevance ', ' operation ', ' epigenome ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' data visualization ', ' learning strategy ', ' learning method ', ' learning activity ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' prediction of response ', ' live cell imaging ', ' live cellular imaging ', ' live cellular image ', ' live cell image ', ' phenotypic data ', ' genome browser ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' experimental study ', ' experimental research ', ' experiment ', ' translational impact ', ' random forest ', ' Bayesian learning ', ' Bayesian machine learning ', ' ']",NHLBI,HARVARD MEDICAL SCHOOL,U54,2019,2176377,0.09579543721714887
"Feature Learning For Improved Multiplex Disease Diagnosis Abstract This proposal is for CATTS, a feature learning technique optimized for use in multiplex mass spectrometry (MS) fingerprinting assays. MS fingerprints consist of a large number of chemical species, leading to very high dimensional feature spaces, and subsequent high false-discovery rates. CATTS aims to reduce the size of this space, by using knowledge of the underlying biochemistry, as well as general-purpose clustering algorithms. Our preliminary results demonstrate that, when used as a feature-learning technique for a variety of classification methods, CATTS significantly improves assay sensitivity. This proposal takes our existing implementation of CATTS and extends it to support additional feature learning algorithms and classification methods. Additionally, its performance as a multiplex assay strategy will be tested on both protein and lipid MS fingerprint libraries, with an eye towards commercialization.. Relevance to public health: The detection of pathogens via mass spectroscopy fingerprinting is rapidly becoming a standard technique for clinical microbiology. However, high false detection rates and conflicting multiple identifications limit applicability, and make interpretation of results difficult. Our work on CATTS aims to improve the statistical performance of these assays. Preliminary results from studies on one dataset we intend to apply CATTS to suggest that UTIs and, in some cases antimicrobial resistance, can be detected, directly from patient samples. However, the statistical methods currently employed aren't reliable enough - the further development of CATTS will accelerate the development of this, and other mass-spectroscopy-based assays..",Feature Learning For Improved Multiplex Disease Diagnosis,9813275,R43GM128538,"['Algorithms ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Systematics ', ' Classification ', ' Conflict ', ' Conflict (Psychology) ', ' Decision Trees ', ' Eyeball ', ' Eye ', ' Fingerprint ', ' Protein Fingerprinting ', ' Protein Fingerprints ', ' Learning ', ' Libraries ', ' Lipids ', ' Methods ', ' Noise ', ' living system ', ' Organism ', ' Patients ', ' Proteins ', ' Public Health ', ' Research ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Testing ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Chemicals ', ' Biodiversity ', ' Biological Diversity ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dimensions ', ' Immune ', ' Immunes ', ' Techniques ', ' System ', ' Performance ', ' Structure ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Clinical Microbiology ', ' Antimicrobial Resistance ', ' resistant to antimicrobial ', ' resistant to anti-microbial ', ' resistance to anti-microbial ', ' anti-microbial resistant ', ' anti-microbial resistance ', ' Resistance to antimicrobial ', ' Antimicrobial resistant ', ' Detection ', ' Process ', ' Development ', ' developmental ', ' vector ', ' feeding ', ' Pathogen detection ', ' commercialization ', ' disease diagnosis ', ' learning strategy ', ' learning method ', ' learning activity ', ' high dimensionality ', ' neural network ', ' random forest ', ' learning algorithm ', ' ']",NIGMS,"DEURION, LLC",R43,2019,25298,0.07081390602731841
"Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry PROJECT SUMMARY  Cellular interactions with the environment form the basis of health and disease for all organisms. Exposure to nutrients, toxins, and neighboring cells trigger coordinated molecular responses that impact cell function and metabolism in a beneficial, adaptive, or detrimental manner. Although the benefits of multicellularity for the formation of complex tissue structures or the function of entire organ systems has been long appreciated, it has only recently been understood that microbial inhabitants of vertebrates also have a tremendous impact on host cell function and dysfunction. Despite this, an understanding of these interactions has not moved beyond simple associations, and there are virtually no molecular technologies available that adequately define how a complex microbial ecosystem impacts host cell function, or how the host response to microbial colonization affects the bacterial community. This gap in knowledge is striking when one considers the broad and significant impact that microbes have on human health. In this application, we propose to expressly fill this knowledge gap through development of a novel multimodal imaging pipeline that will provide 3-dimensional information on the molecular heterogeneity of microbial communities and the immune response at the host-pathogen interface.  This proposal combines our expertise in immunology, infection biology, mass spectrometry, small animal imaging, machine learning, and computer vision to develop an integrated multimodal visualization method for studying infectious disease. Our unique approach will computationally combine ultra-high speed (~50px/s) MALDI-TOF images, ultra-high mass resolution (>200,000 resolving power) MALDI FTICR IMS, metal imaging by LA-ICP-IMS, high-spatial resolution optical microscopy, and MR imaging using data-driven image fusion. This strategy will enable 3-D molecular images to be generated for thousands of elements, metabolites, lipids, and proteins with an unprecedented combination of chemical specificity and spatial fidelity more than 50x faster than is currently possible. We will use this next-generation imaging capability to (i) define the heterogeneous microbial subpopulations throughout the 3-D volume of a S. aureus community, (ii) uncover the host molecules that form the abscess and accumulate to restrict microbial growth in murine models, and (iii) elucidate molecular markers that differentiate in vivo biofilms at the host-pathogen interface, between abscesses at various stages of progression, and under distinct degrees of nutrient stress. These studies will uncover new targets for therapeutic intervention and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research. PROJECT NARRATIVE This proposal will enable detailed views of the molecular components of infectious disease with unprecedented resolution through the development of a multimodal, 3-dimensional imaging platform. The proposed technologies will improve throughput and molecular specificity, enable automated high-precision and high-accuracy image alignment, and allow for descriptions of molecular signals in 3-D through the fusion of multi-modal imaging data. These studies will uncover targets for therapeutic intervention and antibiotic development and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research.",Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry,9788239,R01AI138581,"['Abscess ', ' Affect ', ' Animals ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Antibodies ', ' Differentiation Antigens ', ' Marker Antigens ', ' Differentiation Markers ', ' Differentation Markers ', ' Architecture ', ' Engineering / Architecture ', ' Awareness ', ' Bacteria ', ' Bacterial Infections ', ' bacterial disease ', ' bacteria infection ', ' Bacterial Proteins ', ' Bacterial Gene Proteins ', ' Bacterial Gene Products ', ' Behavior ', ' Biology ', ' Biomedical Research ', ' Cell Differentiation ', ' Cell Differentiation process ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Complement Proteins ', ' Complement ', ' computer vision ', ' Computer Vision Systems ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Elements ', ' Environment ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' promoting health ', ' Salutogenesis ', ' Health Promotion ', ' Heterogeneity ', ' Histology ', ' Modern Man ', ' Human ', ' Infection ', ' Lipids ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maps ', ' Metals ', ' Methods ', ' Methodology ', ' Polymorphonuclear Neutrophils ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Cell ', ' Neutrophilic Leukocyte ', ' Neutrophilic Granulocyte ', ' Marrow Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Blood Neutrophil ', ' neutrophil ', ' optical ', ' Optics ', ' living system ', ' Organism ', ' Proteins ', ' Reagent ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Spatial Distribution ', ' Specificity ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Staphylococcus ', ' Genus staphylococcus ', ' Staph aureus ', ' S.aureus ', ' S. aureus ', ' S aureus ', ' Staphylococcus aureus ', ' Stress ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Toxin ', ' vertebrata ', ' Vertebrate Animals ', ' Vertebrates ', ' Work ', ' biofilm ', ' Microbial Biofilms ', ' Glean ', ' Immunology ', ' Custom ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' Imagery ', ' Visualization ', ' base ', ' Label ', ' improved ', ' Site ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Physiological ', ' Physiologic ', ' Chemicals ', ' Lesion ', ' Individual ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Integration Host Factors ', ' Host Factor Protein ', ' Host Factor ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dimensions ', ' Immune ', ' Immunes ', ' Complex ', ' Source ', ' Techniques ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' body system ', ' Organ System ', ' interest ', ' Anterior nares ', ' Nostril ', ' External Nare ', ' microbial colonization ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' microbial ', ' Speed ', ' Structure ', ' Nutrient ', ' novel ', ' Modality ', ' Pathogenesis ', ' Therapeutic Intervention ', ' intervention therapy ', ' Modeling ', ' Sampling ', ' response ', ' Three-Dimensional Imaging ', ' 3D imaging ', ' 3-D Imaging ', ' protein expression ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Data ', ' Infectious Diseases Research ', ' Infectious Diseases / Laboratory ', ' Multimodal Imaging ', ' multimodality imaging ', ' multi-modality imaging ', ' multi-modal imaging ', ' Resolution ', ' in vivo ', ' Computer Analysis ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Molecular ', ' Process ', ' Cellular Metabolic Process ', ' cellular metabaolism ', ' cell metabolism ', ' Development ', ' developmental ', ' molecular imaging ', ' molecule imaging ', ' Image ', ' imaging ', ' virtual ', ' next generation ', ' Three-dimensional analysis ', ' 3D analysis ', ' 3-dimensional analysis ', ' 3-D analysis ', ' pathogen ', ' Imaging technology ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' microbial community ', ' community microbes ', ' Microbe ', ' mouse model ', ' murine model ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' multimodality ', ' multi-modality ', ' molecular marker ', ' molecular biomarker ', ' Fourier transform ion cyclotron resonance ', ' FTICR ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' animal imaging ', ' imaging platform ', ' microscopic imaging ', ' microscopy imaging ', ' microscope imaging ', ' imaging detection ', ' imaging-based disease detection ', ' imaging-based detection ', ' experimental study ', ' experimental research ', ' experiment ', ' imaging capabilities ', ' commensal bacteria ', ' commensal bacterial species ', ' bacterial community ', ' host colonization ', ' supervised learning ', ' supervised machine learning ', ' ']",NIAID,VANDERBILT UNIVERSITY MEDICAL CENTER,R01,2019,562232,0.07908084283376025
"Deep Ovarian Cancer Metabolomics PROJECT SUMMARY  Ovarian cancer (OC) is the 5th leading cause of cancer-related deaths for U.S. women and the deadliest gynecological disease. Lack of symptoms in addition to the deficiency of highly specific biomarkers for detection typically result in only 25% of OC cases being diagnosed at FIGO stage I. High-grade serous carcinoma (HGSC) is the most prevalent form of OC, but three rarer histological subtypes also exist endometrioid, clear cell, and mucinous. An effective screening strategy for early diagnosis would be particularly advantageous since 5-year OC survival rates can be as high as 90%. Unfortunately, protein biomarkers such as CA-125 do not have sufficient positive predictive value to be useful from a clinical perspective. We hypothesize that useful information regarding early stage HGSC and other ovarian cancers can be found in the serum metabolome. Our pilot studies in both humans and OC models, such as the double-knockout Dicer-Pten mouse recently developed by our team members, show great promise in this regard average sensitivity and specificity for early detection have reached 97.8% and 99.0% in banked human serum samples, and up to100% in mice. These results have prompted us to perform a much deeper investigation of metabolome alterations associated with early stage ovarian cancers in larger serum sample sets, and over time. We will perform metabolomics experiments in mice and banked de-identified human serum samples with much higher coverage than before by data fusing various modes of ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) and nuclear magnetic resonance (NMR), coupled with pathway-centric data analysis. We also propose supplementing serum-level metabolomics experiments with deep-coverage tissue mass spectrometry imaging (MSI) in both 2-D and 3-D, using a combination of matrix-assisted laser desorption/ionization (MALDI) and desorption electrospray ionization (DESI), which have complementary ionization mechanisms. Furthermore, we propose to depart from the commonly used approach of tentatively identifying spectral features by only using accurate masses, and implement a deep metabolite annotation approach that uses both fused high-resolution techniques (high field Orbitrap MS, MS/MS, 2-D NMR) and a new technology based on collisional cross section predictions for both travelling wave and drift tube ion mobility-MS. High-grade serous ovarian cancer is the most common and deadliest type of ovarian cancer; it is diagnosed mostly at an advanced stage at which the cancer has already spread beyond the ovary or the fallopian tube, to the abdominal cavity. This advanced-stage diagnosis inevitably causes high mortality. In this project, we propose to study molecular changes associated with early disease both in mouse models that closely mimic human disease and in banked de-identified human serum samples, with the aim of ultimately designing a robust diagnostic panel.",Deep Ovarian Cancer Metabolomics,9789208,R01CA218664,"['Age ', ' ages ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' CA-125 Antigen ', ' Carbohydrate Antigen 125 ', ' Cancer Antigen 125 ', ' CA125 ', ' CA-125 ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carcinoma ', ' epithelial carcinoma ', ' Malignant Epithelial Tumors ', ' Malignant Epithelial Neoplasms ', ' Epithelial cancer ', ' Liquid Chromatography ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Evolution ', ' Exhibits ', ' oviduct ', ' Uterine Tubes ', ' Salpinx ', ' Fallopian Tubes ', ' Mammalian Oviducts ', ' Genes ', ' Gynecologic Diseases ', ' Female Genital Diseases ', ' Modern Man ', ' Human ', ' Logic ', ' mortality ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Neoplasm Metastasis ', ' Nuclear Magnetic Resonance ', ' Ovary ', ' Patients ', ' Peritoneal Cavity ', ' Greater sac of peritoneum ', ' pilot study ', ' Pilot Projects ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Survival Rate ', ' Technology ', ' Time ', ' Body Tissues ', ' Tissues ', ' Travel ', ' Woman ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' TP53 gene ', ' uncertain malignant potential neoplasm ', ' low malignant potential neoplasm ', ' borderline malignancy neoplasm ', ' Borderline tumor ', ' Borderline Neoplasm ', ' Tube ', ' base ', ' tumor progression ', ' neoplastic progression ', ' neoplasm progression ', ' cancer progression ', ' Ovarian ', ' Benign ', ' Clinical ', ' Phase ', ' Histologic ', ' Histologically ', ' Knockout Mice ', ' Null Mouse ', ' Knock-out Mice ', ' KO mice ', ' Lesion ', ' Clear Cell ', ' Serum ', ' Blood Serum ', ' Abdominal Cavity ', ' Cavitas abdominis ', ' Measurement ', ' Disease Progression ', ' Screening for Ovarian Cancer ', ' ovarian cancer early screening ', ' ovarian cancer early detection ', ' ovarian cancer detection ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' MALDI-MS ', ' MALDI ', ' MALD-MS ', ' Metabolic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Serous ', ' Techniques ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' Penetrance ', ' Early Diagnosis ', ' early detection ', ' ionization ', ' mutant ', ' hydrophilicity ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Primary Neoplasm ', ' Primary Tumor ', ' member ', ' new technology ', ' novel technologies ', ' Sampling ', ' liquid chromatography mass spectrometry ', ' LC/MS ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' cancer diagnosis ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Reproductive system ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Mucinous ', ' Predictive Value ', ' Premalignant ', ' precancerous ', ' Pre-Malignant ', ' Resolution ', ' Cancer Etiology ', ' Cancer Cause ', ' Cancer Model ', ' CancerModel ', ' Cancer Patient ', ' Electrospray Ionization ', ' Characteristics ', ' Molecular ', ' Genetically Engineered Mouse ', ' genetically engineered murine model ', ' genetically engineered mouse model ', ' GEM model ', ' Knock-out ', ' Knockout ', ' Image ', ' imaging ', ' Pathway interactions ', ' pathway ', ' ion mobility ', ' design ', ' designing ', ' Coupled ', ' human disease ', ' mouse model ', ' murine model ', ' tumor ', ' multimodality ', ' multi-modality ', ' screening ', ' diagnostic panel ', ' cancer biomarkers ', ' cancer markers ', ' specific biomarkers ', ' protein biomarkers ', ' protein markers ', ' metabolic phenotype ', ' metabotype ', ' metabolome ', ' metabonome ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NCI,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2019,398117,0.08240623922129495
"Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods PROJECT SUMMARY / ABSTRACT Title: Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods The project seeks to improve reliability and speed up the development of life-saving and life-enhancing, precision, protein therapeutics and magnify the positive impact of biomedical research and education worldwide, leading to a quantum leap in our understanding of the molecular and cellular pathways and mechanisms involved in healthy and diseased biological systems. The development of biologics is bottlenecked across the entire drug development process, from discovery to early stage candidate selection, process development and manufacturing, due to manual intervention in the mass spectrometry data analysis pipeline. Similarly, the proteomics research community is hindered as it moves from analysis of complex mixtures to more in-depth characterization of proteins and their modifications. Novel machine learning methods will be added to MassMatrixs (LC-MS/MS software) proven analytical engine and visualization platform to minimize the loss of true positive peptide spectral matches. An innovative approach for efficient accountability of experimental data at the chromatogram level will also be researched, developed and added. The latter providing for easy traceability of each peaks status in the chromatogram as soon as possible, thus providing convenient high-level assessment. Together, these aims are expected to improve the reliability and accuracy of results as well as to significantly reduce the mass spec bottleneck for the pharmaceutical industry and the research community. Deeper understanding and better decision making will follow, both having a potentially dramatic positive impact on downstream processes and resource deployment, including improved drug safety and efficacy. PROJECT NARRATIVE Title: Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods The project seeks to speed up and improve reliability in the development of life-saving and life-enhancing, precision, protein therapeutics and magnify the positive impact of biomedical research and life science education worldwide. Due to manual intervention in a critical, mass spectrometry data analysis pipeline, progress in drug development and protein research is bottlenecked and compromised. Through novel machine learning methods and an innovative visualization approach for validating experimental data, the project is expected to improve the accuracy and reliability of results and alleviate the bottleneck, thereby deepening understanding of proteins and biological systems and improving resource allocation through better decision making, including improved drug safety and efficacy. 1",Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods,9927740,R44GM131484,"['Monoclonal Antibodies ', ' Clinical Treatment Moab ', ' mAbs ', ' Biological Sciences ', ' Biologic Sciences ', ' Bioscience ', ' Life Sciences ', ' Biomedical Research ', ' Communication ', ' Communities ', ' Decision Making ', ' Disease ', ' Disorder ', ' Drug Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Industry ', ' Education ', ' Educational aspects ', ' Manuals ', ' Methods ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Peptide Mapping ', ' Peptide Fingerprinting ', ' Peptides ', ' Proteins ', ' Reliability of Results ', ' Research ', ' Resources ', ' Research Resources ', ' Savings ', ' Shotguns ', ' shot gun ', ' Computer software ', ' Software ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Testing ', ' Time ', ' Accountability ', ' Resource Allocation ', ' base ', ' improved ', ' Site ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Pythons ', ' Ensure ', ' Data Bases ', ' data base ', ' Databases ', ' Systems Integration ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' lightweight ', ' light weight ', ' machine learned ', ' Machine Learning ', ' Life ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' System ', ' Location ', ' science education ', ' drug efficacy ', ' Speed ', ' Biologic Development ', ' novel ', ' Coding System ', ' Code ', ' Sampling ', ' drug development ', ' Protein Databases ', ' Proteomics ', ' depository ', ' repository ', ' native protein drug ', ' pharmaceutical protein ', ' protein drug agent ', ' therapeutic protein ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Published Directory ', ' Directories ', ' Complex Mixtures ', ' Preparedness ', ' Readiness ', ' FOLH ', ' FOLH1 ', ' Folate Hydrolase 1 ', ' GCP2 ', ' Glutamate Carboxypeptidase II ', ' N-Acetylated Alpha-Linked Acidic Dipeptidase 1 ', ' NAALAD1 ', ' NAALADase I ', ' PSM ', ' PSMA ', ' Prostate-Specific Membrane Antigen ', ' FOLH1 gene ', ' Address ', ' Data ', ' Security ', ' Molecular ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Output ', ' cost ', ' designing ', ' design ', ' quantum ', ' blind ', ' innovate ', ' innovative ', ' innovation ', ' interoperability ', ' encryption ', ' comparative ', ' prototype ', ' commercialization ', ' candidate selection ', ' biological systems ', ' Secure ', ' experiment ', ' experimental research ', ' experimental study ', ' lead candidate ', ' feature recognition ', ' feature detection ', ' drug safety ', ' pharmaceutical safety ', ' medication safety ', ' Visualization ', ' data processing pipeline ', ' data analysis pipeline ', ' machine learning method ', ' ']",NIGMS,"MASSMATRIX, INC.",R44,2020,453564,0.10503431754490973
"Imaging Mass Spectrometry for metabolome mapping SUMMARY In response to NOT-GM-20-013, we are requesting a supplement to our R01 5R01GM120033-04 for an MALDI imaging source unit to be attached to an existing Q ExactiveMass Spectrometer (Ultra-High Mass Range Hybrid Quadrupole-Orbitrap) for spatial mapping of metabolites in thin tissue sections. Within our R01 award, to analyze NMR metabolome data we are developing two novel, powerful, and automated algorithms that capitalize on recent developments in machine learning. We have coded these algorithms and tested their sensitivity and specificity on both synthesized and real data. We then applied these methods to human disease models and identified putative biomarkers. To validate these biomarkers, we have developed methods to analyze animal tissues and human brain organoids using imaging mass spectrometry (IMS), which permits spatial localization of metabolites without labeling. This targeted IMS metabolic phenotyping approach complements our untargeted NMR methods: it allows us to determine whether the individual metabolites identified by NMR represent bona fide biomarkers and to develop metabolic hypotheses for their association with disease. We submit this request for imaging mass spectrometer hardware because a nearby IMS facility on which we have relied has closed and no other IMS facility exists in greater Houston area. Performing the IMS studies ourselves, with the help of collaborators, will accelerate our discovery about the role small molecules and metabolites play in health and disease. This instrument will help us better i) perform metabolome screens to identify the effects of SARS-CoV-2 on neural cell types in human brain organoid models; ii) perform high-throughput drug screening to stimulate neural stem cells to produce new neurons in the brain organoid models to regenerate damaged tissue; and iii) use our NMR algorithms to develop a protocol for quantitative imaging. None of these studies will be possible without the imaging mass spectrometer. Given our access to state-of-the-art equipment, data-collection expertise, and new analytical algorithms that are especially sensitive and specific to NMR spectral data, we are uniquely positioned to advance biomarker and diagnostics tools and screening methods for metabolites and synthetic small molecules. Using an imaging mass spectrometer to map metabolite distribution may help us discover diagnostic and prognostic biomarkers not only for SARS-CoV-2, but for a broad spectrum of brain disorders that lead to neurodegeneration. Such broad usage of our platform would be transformative for neuroscientists, neurologists, and their patients. NARRATIVE The metabolome is a dynamic and sensitive biological system that reflects both innate processes and environmental influences, and can therefore tell us much about an organism's health and homeostasis. In our R01, we are developing two novel, powerful, and automated algorithms to analyze NMR metabolome data. We are requesting an MALDI imaging source unit to attach to an existing Q ExactiveMass Spectrometer (Ultra- High Mass Range Hybrid Quadrupole-Orbitrap) to validate our ongoing NMR studies and accelerate the translation of our biomarker discoveries to the clinical realm.",Imaging Mass Spectrometry for metabolome mapping,10175695,R01GM120033,"['Algorithms ', ' Award ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Brain Diseases ', ' Brain Disorders ', ' Encephalon Diseases ', ' Intracranial CNS Disorders ', ' Intracranial Central Nervous System Disorders ', ' Complement ', ' Complement Proteins ', ' Data Collection ', ' Disease ', ' Disorder ', ' Equipment ', ' Health ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Human ', ' Modern Man ', ' Hybrids ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Maps ', ' Methods ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Organism ', ' living system ', ' Organoids ', ' Patients ', ' Play ', ' Role ', ' social role ', ' Sensitivity and Specificity ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Testing ', ' Thinness ', ' Leanness ', ' Tissues ', ' Body Tissues ', ' Translations ', ' Label ', ' Area ', ' Clinical ', ' animal tissue ', ' Individual ', ' Neurologist ', ' MALD-MS ', ' MALDI ', ' MALDI-MS ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' Metabolic ', ' tool ', ' instrument ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Protocol ', ' Protocols documentation ', ' Source ', ' cell type ', ' novel ', ' disorder model ', ' Disease model ', ' Position ', ' Positioning Attribute ', ' Coding System ', ' Code ', ' Modeling ', ' response ', ' Neural Stem Cell ', ' neural precursor ', ' neural precursor cell ', ' neural progenitor ', ' neural progenitor cells ', ' neuron progenitors ', ' neuronal progenitor ', ' neuronal progenitor cells ', ' neuronal stem cells ', ' neuroprogenitor ', ' nerve stem cell ', ' small molecule ', ' Data ', ' Molecular Marker of Prognosis ', ' Prognosis Marker ', ' prognostic biomarker ', ' prognostic indicator ', ' Prognostic Marker ', ' Process ', ' developmental ', ' Development ', ' regenerate new tissue ', ' regenerating damaged tissue ', ' tissue renewal ', ' tissue regeneration ', ' imaging ', ' Image ', ' mass spectrometer ', ' human disease ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biological systems ', ' screening ', ' quantitative imaging ', ' targeted imaging ', ' diagnostic marker ', ' diagnostic biomarker ', ' biomarker discovery ', ' metabotype ', ' metabolic phenotype ', ' metabonome ', ' metabolome ', ' 2019 novel coronavirus ', ' SARS-CoV-2 ', ' SARS-CoV2 ', ' SARS-associated coronavirus 2 ', ' SARS-coronavirus-2 ', ' SARS-related coronavirus 2 ', ' Severe acute respiratory syndrome coronavirus 2 ', ' Wuhan coronavirus ', ' 2019-nCoV ', ' automatic algorithm ', ' automated algorithm ', ' high-throughput drug screening ', ' ']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2020,209619,0.19909617096800056
"Skyline Targeted Proteomics Environment Development on Skyline started in 2008 to fill a critical need for a software tool that enabled targeted proteomics experiments. Since then, Skyline has grown into an entire ecosystem of tools, expanding well beyond targeted proteomics. The Skyline software ecosystem is one of the most widely used software platforms in all of mass spectrometry, supporting thousands of investigators in their research. The synergy between Skyline software development and its vast and thriving user community uniquely generate exciting new opportunities for quantitative mass spectrometry. Skyline has been a key factor in the success and growth of this new field, with Skyline itself becoming one of the most significant software tools in mass spectrometry. Since 2015, we have expanded Skyline software, from just the traditional targeted proteomics experiments that used selected reaction monitoring (SRM) with triple quadrupole (QQQ) mass spectrometers, to broadly encompass ALL types of quantitative proteomics experiments, including data dependent acquisition (DDA) experiments using MS1 peak areas (aka MS1 filtering), targeted tandem mass spectrometry (aka parallel reaction monitoring or PRM) experiments and data independent acquisition (DIA). As of Oct 2019, Skyline has been installed >97,500 times (117% increase since 2015), has over 14,000 registered users (122% increase since 2015) on its website (http://skyline.ms) and is booted up >9,000 times per week (exceeding 17,500 bootups in a single week). The Skyline project has grown beyond the bounds of a single tool. Currently, there are 14 Skyline external tools (55% increase since 2015) that rely on a formalized framework in Skyline and available through its tool store, with more still in development. The prior grant cycle has greatly expanded a community of users and developers working with a common set of tools to analyze quantitative data from all six major mass spectrometry vendors. Specifically, our proposal has five aims. 1) Improve Skylines analysis of DDA data, 2) Improve Skylines analysis of DIA data, 3) Expand support of new molecule types within Skyline, 4) Support for new quantitative data types, and 5) Provide continued support and training for the Skyline ecosystem. Mass spectrometry has been a fundamental technology for the analysis diverse molecule types in health and disease. Targeted mass spectrometry measurements offer a promising alternative to immunological based assays that are the standard for quantitative protein measurements in clinical and basic research laboratories. Critical to these experiments is our software, Skyline and the associated ecosystem of tools, which have been developed to handle the generation of instrument methods and the subsequent analysis of the resulting data.",Skyline Targeted Proteomics Environment,10049625,R01GM103551,"['Algorithms ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Disease ', ' Disorder ', ' Engineering ', ' Environment ', ' Grant ', ' Health ', ' Laboratory Research ', ' Lipids ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Peptides ', ' Polysaccharides ', ' Glycans ', ' Proteins ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Running ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Time ', ' Vendor ', ' Generations ', ' Flow Injection Analysis ', ' Flow Injection Analyses ', ' Ecologic Systems ', ' Ecological Systems ', ' Ecosystem ', ' base ', ' cross-link ', ' crosslink ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Training ', ' Workshop ', ' Educational workshop ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' tool ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Reaction ', ' meetings ', ' success ', ' biomedical scientist ', ' synergism ', ' tandem mass spectrometry ', ' Basic Research ', ' Basic Science ', ' Sampling ', ' Proteomics ', ' develop software ', ' developing computer software ', ' software development ', ' data processing ', ' computerized data processing ', ' small molecule ', ' Data ', ' Collection ', ' Validation ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Monitor ', ' Modification ', ' developmental ', ' Development ', ' website ', ' web site ', ' mass spectrometer ', ' ion mobility ', ' innovate ', ' innovative ', ' innovation ', ' data acquisition ', ' open source ', ' new growth ', ' webinar ', ' Data Discovery ', ' search engine ', ' experiment ', ' experimental research ', ' experimental study ', ' Infrastructure ', ' Data Scientist ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2020,258335,0.21996002993013844
"Multimodal mass spectrometry imaging of mouse and human liver We propose to develop a multimodal mass spectrometry imaging pipeline with novel desorption sources and data integration that will enable simultaneously mapping of biomolecule abundance in 3-dimensions in biological tissues at high spatial resolution (micron to submicron) and high speed (>10 ms/pixel) in a near-native environment. This would provide previously inaccessible information on cellular and tissue organization, and how homeostasis and disease intersect at the level of tissue physiology. A major challenge for performing multi- omics using mass spectrometry imaging has been the (i) lack of universal ionization methods, (ii) limited sample preparation protocols for preserving chemical gradients, (iii) low sensitivity, and (iv) limited tools for integration of large quantities of data. Our laboratories are developing systematic MS imaging for high sensitivity and high resolution analysis of diverse tissues. We discovered that water-based gas cluster ion beams (H2O-GCIB) operating at high energy yield ionization enhancements of multiple biomolecules (e.g., metabolites, lipids, and peptides/protein fragments) with high sensitivity at 1 m lateral resolution and without labeling or complicated sample preparation. Coupled with unique Secondary Ion Mass Spectrometry (SIMS) instrumentation and cryogenic sample handling, we have imaged biomolecules directly in cells and tissues in a near-native state (i.e., frozen-hydration) with feature resolution of 1-10 m. Low concentration biomolecules (e.g. cardiolipin and metabolites) that were impossible to localize in single cells previously are now visible with 3-dimensional localization. Moreover, the sufficient signal per pixel, we can use automated data analysis to characterize biologically active functional sites within 1 m2 and areas of interest in single cells. We further developed data integration methods to combine imaging data from adjacent sections to create a multi-model imaging data sets. We propose to develop a pipeline for MS imaging analysis of biomolecules, and to elucidate molecular heterogeneity in tissues using multimodal imaging. To support the multi-modal analysis pipeline, we will develop an integrated data analysis platform. Integration of multiomics remains challenging, particularly spatially localize multiple biomolecules at single cell level. The direct visualization of cellular contents provides information on biomolecular composition, interactions and functions. This network of biomolecules is the driving force of specific behavior of cells in physiological states. Despite this, a comprehensive grasp of these interactions at cellular level has not moved beyond segregated methods. Our efforts will result in an integrated multimodal imaging platform to summon the best characteristics of each image form, acquiring a complete picture the biomolecular network at spatial resolution of 1 m. With this direct visualization, we will address how metabolism links with functional biomarkers that stem from metabolism-associated protein complexes and phase-separated membrane-less organelles at the subcellular level, and how this drive different cell death modalities, including different modes of cell death. We propose to develop a new mass spectrometry imaging pipeline that will enable mapping of biomolecules in in biological tissues at high spatial resolution. This will provide previously inaccessible information on cellular and tissue organization, and how homeostasis and disease intersect at the level of tissue physiology.",Multimodal mass spectrometry imaging of mouse and human liver,10118811,UG3CA256962,"['Age ', ' ages ', ' Algorithms ', ' Atlases ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cardiolipins ', ' Cell Death ', ' necrocytosis ', ' Cells ', ' Cell Body ', ' Chemistry ', ' Computer Vision Systems ', ' computer vision ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Eosine Yellowish ', ' Eosin ', ' Tetrabromofluorescein ', ' Freezing ', ' Gases ', ' Health ', ' Heart ', ' Primary carcinoma of the liver cells ', ' Hepatocarcinoma ', ' Hepatocellular Carcinoma ', ' Hepatocellular cancer ', ' Hepatoma ', ' Liver Cells Carcinoma ', ' liver carcinoma ', ' Heterogeneity ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Human ', ' Modern Man ', ' image reconstruction ', ' image construction ', ' image generation ', ' Immunohistochemistry ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry Staining Method ', ' instrumentation ', ' Ions ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Laboratories ', ' Lipids ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Optics ', ' optical ', ' Organelles ', ' Peptides ', ' Phenotype ', ' Physiology ', ' Messenger RNA ', ' mRNA ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Spatial Distribution ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Water ', ' Hydrogen Oxide ', ' Dataset ', ' Data Set ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' base ', ' Label ', ' improved ', ' Lateral ', ' Site ', ' Area ', ' Phase ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Active Sites ', ' Link ', ' Chemicals ', ' Grips ', ' grasp ', ' insight ', ' Individual ', ' fibrotic liver ', ' hepatic fibrosis ', ' Liver Fibrosis ', ' SIMS Microscopy ', ' Secondary Ion Mass Spectrometry Microscopy ', ' Secondary Ion Mass Spectroscopy Microscopy ', ' Spectroscopy, Mass, Secondary Ion ', ' Spectrometry, Mass, Secondary Ion ', ' Morphology ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' human tissue ', ' Protocol ', ' Protocols documentation ', ' Source ', ' cell type ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' interest ', ' ESI Mass Spectrometry ', ' Spectrometry, Mass, Electrospray Ionization ', ' ionization ', ' membrane structure ', ' Membrane ', ' cryogenics ', ' Speed ', ' novel ', ' Modality ', ' Cytometry ', ' Modeling ', ' Sampling ', ' protein complex ', ' Hydration ', ' Hydration status ', ' Oncogenesis ', ' tumorigenesis ', ' datamining ', ' data mining ', ' Protein Fragment ', ' Address ', ' Data ', ' Metabolic Marker ', ' multi-modal imaging ', ' multi-modality imaging ', ' multimodality imaging ', ' Multimodal Imaging ', ' Resolution ', ' Electrospray Ionization ', ' Transcript ', ' Preparation ', ' Characteristics ', ' Molecular ', ' Modification ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' ionization method ', ' ionization technique ', ' reconstruction ', ' data integration ', ' sub micron ', ' submicron ', ' Coupled ', ' driving force ', ' cellular behavior ', ' cell behavior ', ' stem ', ' multi-modality ', ' multimodality ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' imaging platform ', ' data visualization ', ' multiomics ', ' multiple omics ', ' Tissue imaging ', ' high resolution imaging ', ' experiment ', ' experimental research ', ' experimental study ', ' preservation ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' analysis pipeline ', ' Visualization ', ' data processing pipeline ', ' data analysis pipeline ', ' ']",NCI,COLUMBIA UNIV NEW YORK MORNINGSIDE,UG3,2020,300000,0.12191940575856201
"Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry PROJECT SUMMARY  Cellular interactions with the environment form the basis of health and disease for all organisms. Exposure to nutrients, toxins, and neighboring cells trigger coordinated molecular responses that impact cell function and metabolism in a beneficial, adaptive, or detrimental manner. Although the benefits of multicellularity for the formation of complex tissue structures or the function of entire organ systems has been long appreciated, it has only recently been understood that microbial inhabitants of vertebrates also have a tremendous impact on host cell function and dysfunction. Despite this, an understanding of these interactions has not moved beyond simple associations, and there are virtually no molecular technologies available that adequately define how a complex microbial ecosystem impacts host cell function, or how the host response to microbial colonization affects the bacterial community. This gap in knowledge is striking when one considers the broad and significant impact that microbes have on human health. In this application, we propose to expressly fill this knowledge gap through development of a novel multimodal imaging pipeline that will provide 3-dimensional information on the molecular heterogeneity of microbial communities and the immune response at the host-pathogen interface.  This proposal combines our expertise in immunology, infection biology, mass spectrometry, small animal imaging, machine learning, and computer vision to develop an integrated multimodal visualization method for studying infectious disease. Our unique approach will computationally combine ultra-high speed (~50px/s) MALDI-TOF images, ultra-high mass resolution (>200,000 resolving power) MALDI FTICR IMS, metal imaging by LA-ICP-IMS, high-spatial resolution optical microscopy, and MR imaging using data-driven image fusion. This strategy will enable 3-D molecular images to be generated for thousands of elements, metabolites, lipids, and proteins with an unprecedented combination of chemical specificity and spatial fidelity more than 50x faster than is currently possible. We will use this next-generation imaging capability to (i) define the heterogeneous microbial subpopulations throughout the 3-D volume of a S. aureus community, (ii) uncover the host molecules that form the abscess and accumulate to restrict microbial growth in murine models, and (iii) elucidate molecular markers that differentiate in vivo biofilms at the host-pathogen interface, between abscesses at various stages of progression, and under distinct degrees of nutrient stress. These studies will uncover new targets for therapeutic intervention and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research. PROJECT NARRATIVE This proposal will enable detailed views of the molecular components of infectious disease with unprecedented resolution through the development of a multimodal, 3-dimensional imaging platform. The proposed technologies will improve throughput and molecular specificity, enable automated high-precision and high-accuracy image alignment, and allow for descriptions of molecular signals in 3-D through the fusion of multi-modal imaging data. These studies will uncover targets for therapeutic intervention and antibiotic development and the techniques developed as a result of this proposal will be broadly applicable to all physiologically relevant processes, profoundly impacting biomedical research.",Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry,9989025,R01AI138581,"['Abscess ', ' Affect ', ' Animals ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Antibodies ', ' Differentiation Antigens ', ' Differentation Markers ', ' Differentiation Markers ', ' Marker Antigens ', ' Architecture ', ' Engineering / Architecture ', ' Awareness ', ' Bacteria ', ' Bacterial Infections ', ' bacteria infection ', ' bacterial disease ', ' Bacterial Proteins ', ' Bacterial Gene Products ', ' Bacterial Gene Proteins ', ' Behavior ', ' Biology ', ' Biomedical Research ', ' Cell Differentiation process ', ' Cell Differentiation ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Computer Vision Systems ', ' computer vision ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Elements ', ' Environment ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Heterogeneity ', ' Histology ', ' Human ', ' Modern Man ', ' Infection ', ' Lipids ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Maps ', ' Metals ', ' Methods ', ' Methodology ', ' neutrophil ', ' Blood Neutrophil ', ' Blood Polymorphonuclear Neutrophil ', ' Marrow Neutrophil ', ' Neutrophilic Granulocyte ', ' Neutrophilic Leukocyte ', ' Polymorphonuclear Cell ', ' Polymorphonuclear Leukocytes ', ' Polymorphonuclear Neutrophils ', ' Optics ', ' optical ', ' Organism ', ' living system ', ' Proteins ', ' Reagent ', ' Research ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Spatial Distribution ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Genus staphylococcus ', ' Staphylococcus ', ' Staphylococcus aureus ', ' S aureus ', ' S. aureus ', ' Staph aureus ', ' Stress ', ' Technology ', ' Tissues ', ' Body Tissues ', ' Toxin ', ' Vertebrates ', ' Vertebrate Animals ', ' vertebrata ', ' Work ', ' Microbial Biofilms ', ' biofilm ', ' Glean ', ' Immunology ', ' Custom ', ' Ecologic Systems ', ' Ecological Systems ', ' Ecosystem ', ' base ', ' Label ', ' improved ', ' Site ', ' incarcerated ', ' incarceration ', ' Imprisonment ', ' Physiologic ', ' Physiological ', ' Chemicals ', ' Lesion ', ' Individual ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' MALD-MS ', ' MALDI ', ' MALDI-MS ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' Host Factor ', ' Host Factor Protein ', ' Integration Host Factors ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Dimensions ', ' Immunes ', ' Immune ', ' Complex ', ' Source ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Organ System ', ' body system ', ' interest ', ' External Nare ', ' Nostril ', ' Anterior nares ', ' microbial colonization ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' microbial ', ' Speed ', ' Structure ', ' Nutrient ', ' novel ', ' Modality ', ' Pathogenesis ', ' intervention therapy ', ' Therapeutic Intervention ', ' Modeling ', ' Sampling ', ' response ', ' 3-D Imaging ', ' 3D imaging ', ' Three-Dimensional Imaging ', ' protein expression ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Data ', ' Infectious Diseases / Laboratory ', ' Infectious Diseases Research ', ' multi-modal imaging ', ' multi-modality imaging ', ' multimodality imaging ', ' Multimodal Imaging ', ' Resolution ', ' in vivo ', ' computational analyses ', ' computational analysis ', ' computer analyses ', ' Computer Analysis ', ' Molecular ', ' Process ', ' cell metabolism ', ' cellular metabaolism ', ' Cellular Metabolic Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' virtual ', ' next generation ', ' 3-D analysis ', ' 3-dimensional analysis ', ' 3D analysis ', ' Three-dimensional analysis ', ' pathogen ', ' Imaging technology ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' community microbes ', ' microbial community ', ' Microbe ', ' murine model ', ' mouse model ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' multi-modality ', ' multimodality ', ' molecular biomarker ', ' molecular marker ', ' FTICR ', ' Fourier transform ion cyclotron resonance ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' animal imaging ', ' imaging platform ', ' microscope imaging ', ' microscopy imaging ', ' microscopic imaging ', ' imaging-based detection ', ' imaging-based disease detection ', ' imaging detection ', ' experiment ', ' experimental research ', ' experimental study ', ' imaging capabilities ', ' commensal bacterial species ', ' commensal bacteria ', ' bacterial community ', ' host colonization ', ' supervised machine learning ', ' supervised learning ', ' Visualization ', ' ']",NIAID,VANDERBILT UNIVERSITY MEDICAL CENTER,R01,2020,612684,0.07908084283376025
"Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease Abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide and is rising in incidence in the US. 90% of patients in the US with liver cancer have underlying cirrhosis, thus guideline recommendations recommend surveillance in all patients with cirrhosis to facilitate early detection. Unfortunately, only 20-30% of patients are detected with early detection and are thus eligible for potentially curative treatments. There is an unmet need for reliable biomarkers for HCC to facilitate adherence to screening and for early detection. In the proposed work we will develop early detection strategies for HCC based on glycoproteomic profiles. Unique changes in glycosylation in proteins, which involve structural changes in glycan groups, have been shown to be important serum biomarkers for early cancer detection. Importantly, the subtle changes may only involve minor structures but they can be very specific in differentiating cirrhosis versus early versus late stage HCC. In addition, these changes may be specific to the etiology of liver disease. These glycan structural changes will be detected and monitored quantitatively using a mass spectrometry approach which has proven to be an accurate way to characterize even minor changes in structure which may be significant as biomarkers based on our previous mass analysis, tandem mass spectrometry measurements and databases which have been developed for glycan and glycopeptide analysis. This will be demonstrated for both glycan and glycopeptide screening from serum using novel extraction and separation methods coupled to mass spectrometry which can ultimately be used to distinguish early stage HCC from cirrhosis. The proposed work will deliver separations and mass spec methods enabling isomeric separation of glycans and glycopeptides, permitting unequivocal assignment of protein glycosylation related to disease state. We will be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. Novel software will be developed and used to assign these glycan structures. The markers will be discovered for specific etiologies of HCV-related, alcohol-related and NAFLD-related etiologies of HCC. This will be a multisite study to include all components required for a tumor biomarker lab including samples and sample preparation, separations and mass spec analysis, bioinformatics evaluation and statistical analysis. Ultimately, we will develop methods for discovery of glycan/glycopeptide markers from patient serum, the identification of potential markers and the development of new assays to provide a limited confirmation of these markers. Project Narrative: The proposed work will use new separations and mass spec methods to provide isomeric separation of glycans and glycopeptides, resulting in detailed assignment of protein glycosylation related to disease state. We expect to be able to distinguish different isomeric forms of fucosylation and sialylation which may contain important disease related markers. The markers will be discovered for specific etiologies of HCV- related, alcohol-related and NAFLD-related etiologies of HCC. Ultimately, we will develop new assays to provide a limited confirmation of these markers.",Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease,9893836,U01CA225753,"['Alcohols ', ' Alcohol Chemical Class ', ' alpha-Fetoproteins ', ' Alpha-1-Fetoprotein ', ' Alpha-Fetoglobulin ', ' Fetuins ', ' -Fetoproteins ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Carbon ', ' Statistical Data Interpretation ', ' Statistical Data Analyses ', ' Statistical Data Analysis ', ' statistical analysis ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Europe ', ' Glycopeptides ', ' Glycoproteins ', ' glycosylation ', ' Metabolic Glycosylation ', ' Primary carcinoma of the liver cells ', ' Hepatocarcinoma ', ' Hepatocellular Carcinoma ', ' Hepatocellular cancer ', ' Hepatoma ', ' Liver Cells Carcinoma ', ' liver carcinoma ', ' Incidence ', ' Isomerism ', ' isomer ', ' Japan ', ' Lectin ', ' Liver Cirrhosis ', ' Hepatic Cirrhosis ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Methods ', ' Minor ', ' Patients ', ' Peptides ', ' Polysaccharides ', ' Glycans ', ' Proteins ', ' Recommendation ', ' Risk ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Survival Rate ', ' Testing ', ' Time ', ' Tumor Markers ', ' TM-MKR ', ' tumor biomarker ', ' tumor specific biomarker ', ' Ultrasonography ', ' Echography ', ' Echotomography ', ' Medical Ultrasound ', ' Ultrasonic Imaging ', ' Ultrasonogram ', ' Ultrasound Diagnosis ', ' Ultrasound Medical Imaging ', ' Ultrasound Test ', ' diagnostic ultrasound ', ' sonogram ', ' sonography ', ' sound measurement ', ' ultrasound ', ' ultrasound imaging ', ' ultrasound scanning ', ' Work ', ' Serum Markers ', ' Guidelines ', ' base ', ' improved ', ' Cancer Screening for Patients ', ' early cancer detection ', ' Screening for cancer ', ' Site ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Graphite ', ' Natural graphite ', ' Hepatic Cancer ', ' liver cancer ', ' malignant liver tumor ', ' Malignant neoplasm of liver ', ' machine learned ', ' Machine Learning ', ' Protein Glycosylation ', ' Frequencies ', ' Complex ', ' Pattern ', ' carbohydrate structure ', ' early detection ', ' Early Diagnosis ', ' Performance ', ' Isoforms ', ' Protein Isoforms ', ' tandem mass spectrometry ', ' Structure ', ' novel ', ' Proteome ', ' Sampling ', ' sialylation ', ' Bio-Informatics ', ' Bioinformatics ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Alcohol-Related Hepatocellular Carcinoma ', ' Adherence ', ' Cancer Cause ', ' Cancer Etiology ', ' Monitor ', ' Preparation ', ' developmental ', ' Development ', ' cirrhotic ', ' Cirrhosis ', ' early onset ', ' Coupled ', ' tumor ', ' NASH ', ' non-alcohol induced steatohepatitis ', ' non-alcoholic steato-hepatitis ', ' non-alcoholic steatohepatitis ', ' nonalcoholic steato-hepatitis ', ' nonalcoholic steatohepatitis ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' screening ', ' precision-based medicine ', ' precision medicine ', ' stratified patient ', ' patient stratification ', ' early biomarkers ', ' early detection markers ', ' early detection biomarkers ', ' curative intervention ', ' curative therapeutic ', ' curative therapy ', ' curative treatments ', ' glycoproteomics ', ' diagnostic screening ', ' HBV ', ' Homologous Serum Hepatitis Virus ', ' Hepatitis B Virus ', ' HCV ', ' Hepatitis C virus ', ' NAFLD ', ' non-alcohol fatty liver disease ', ' non-alcoholic liver disease ', ' nonalcoholic fatty liver disease ', ' non-alcoholic fatty liver disease ', ' patient screening ', ' ']",NCI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U01,2020,581988,0.15832598644319476
"Identification of Biomarkers and Novel Pathways of Alcoholic Liver Disease by Leveraging Metabolomics, Tissue Imaging Mass Spectrometry, and Integrative Machine Learning ABSTRACT Alcoholic liver disease (ALD) is a serious global health problem. It encompasses a spectrum of pathological conditions, ranging from simple hepatic steatosis, steatohepatitis, fibrosis, alcoholic hepatitis, to liver cirrhosis. Unfortunately, no definitive diagnostic markers exist for ALD (or its different phases), and diagnosis requires a liver biopsy which itself carries significant risk. As a result, management of ALD is frequently empiric. In recent years, some progress has been made using metabolomics to identify potential biomarkers of ALD in animal models and human cohorts. However, global metabolomic profiling of ALD in humans has proceeded slowly and as of today, no studies have been performed that relate metabolomic profiles with pathological changes occurring during the development of ALD. Our working hypothesis predicts that biomarkers specific to ALD may be more effectively identified by applying integrative machine learning to the analysis of data from two state-of-the-art analytical approaches, i.e., metabolomics and imaging mass spectrometry (IMS). As such, we propose to use plasma metabolomics (Specific Aim 1), and histological analysis and liver tissue IMS (Specific Aim 2) in three mouse models of ALD (alcohol-induced steatosis, hepatitis or mild fibrosis) to gain unique insights into the feasibility of using these approaches to identify pathogenic markers of ALD. Ethanol-induced damage to the liver results in alterations in cellular function that can be documented as changes in the metabolome of biological fluids (plasma) and hepatic cells. Metabolomics, the analysis of low molecular metabolites (e.g., lipids and small molecules) in a sample, can be used to directly investigate changes in biochemical pathways induced by alcohol in the liver, such as occurs during ALD. Tissue IMS maps molecules in a tissue section, thereby allowing the quantitation of lipids, proteins and metabolites within a tissue in unprecedented detail. When interfaced with histological analysis of a paired adjacent tissue section, the cellular source of the mapped molecules may be identified. We strongly believe that the integration of metabolomics, IMS and histology (Specific Aim 3) using integrative machine learning will greatly enhance our understanding of the biochemical basis of ALD pathophysiology, and in so doing, allow the development of diagnostic tools that can be used to detect biomarkers in other forms of ALD, thereby improving early diagnosis and treatment of ALD. The management and interpretation of large metabolomics and proteomic data generated as part of the project (10-100GB of raw IMS data per single tissue section) require advanced data-analytics solutions. We will capitalize on our recently published bespoke machine learning solution (BASIS) for interrogation of large -omics data to identify metabolic/signaling pathways and their downstream metabolites disrupted in ALD. The novelty of this proposal relies on the use of cutting-edge approaches that will allow identification of novel biomarkers and their cellular sources in predictable animal models of ALD. Such information will form a basis for more effective diagnosis and prediction of the progression of ALD. Successful completion of the proposed studies will form a foundation upon which studies in human biological fluids will be conducted in the future. In addition, it is anticipated that our studies will also lay the foundation for examination of the molecular mechanisms associated with other forms of alcohol-induced tissue injury. Such knowledge will facilitate the development of more effective treatments of alcohol abuse. NARRATIVE Excessive alcohol consumption induces alcoholic liver disease (ALD). Unfortunately, no definitive diagnostic markers exist for ALD (or its different phases), and diagnosis requires a liver biopsy which itself carries significant risk. Because the early stages of ALD can potentially be reversed by sobriety, regular screening of the general population and early diagnosis are essential. The overarching goal of this application is to establish metabolomic analyses and tissue imaging mass spectrometry coupled with integrative machine learning to identify novel pathways in and biomarkers for ALD that will be applied in humans.","Identification of Biomarkers and Novel Pathways of Alcoholic Liver Disease by Leveraging Metabolomics, Tissue Imaging Mass Spectrometry, and Integrative Machine Learning",9995686,R21AA028432,"['alcohol-induced liver dysfunction ', ' alcohol-mediated liver dysfunction ', ' alcohol-mediated liver injury ', ' alcoholic liver injury ', ' ethanol induced hepatic injury ', ' ethanol induced liver disorder ', ' ethanol induced liver injury ', ' ethanol-induced hepatic dysfunction ', ' ethanol-induced liver disease ', ' ethanol-induced liver dysfunction ', ' ethanol-mediated liver dysfunction ', ' ethanol-mediated liver injury ', ' Maps ', ' Molecular Structure ', ' Macromolecular Structure ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Publishing ', ' Resources ', ' Research Resources ', ' Risk ', ' Signal Pathway ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Drug or chemical Tissue Distribution ', ' Tissue Distribution ', ' Tissues ', ' Body Tissues ', ' human subject ', ' Label ', ' improved ', ' Liver lesion biopsy ', ' liver biopsy ', ' liver scanning ', ' liver imaging ', ' Chronic ', ' Phase ', ' Biological ', ' Histologically ', ' Histologic ', ' Biochemical ', ' Link ', ' Hepatic Cells ', ' Hepatic Parenchymal Cell ', ' Liver Cells ', ' Hepatocyte ', ' insight ', ' alcohol induced injury ', ' alcohol-induced damage ', ' ethanol induced injury ', ' ethanol-induced disorder ', ' Alcohol-Induced Disorders ', ' Individual ', ' Recovery ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' MoAb R24 ', ' R-24 Monoclonal Antibody ', ' R24 ', ' Monoclonal Antibody R24 ', ' MALD-MS ', ' MALDI ', ' MALDI-MS ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Investigation ', ' Complex ', ' Source ', ' Pattern ', ' System ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Structure ', ' novel ', ' sober ', ' sobriety ', ' General Public ', ' General Population ', ' drink heavily ', ' excessive alcohol consumption ', ' excessive alcohol ingestion ', ' excessive alcohol intake ', ' excessive drinking ', ' excessive ethanol ingestion ', ' extreme drinking ', ' heavy alcohol use ', ' Heavy Drinking ', ' Sampling ', ' Proteomics ', ' alcohol abuse treatment ', ' alcohol treatment ', ' alcohol abuse therapy ', ' Pathogenicity ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' alcohol liver damage ', ' alcohol-induced hepatic damage ', ' alcohol-induced liver damage ', ' ethanol-induced hepatic damage ', ' ethanol-induced liver damage ', ' Alcoholic liver damage ', ' global health ', ' Data ', ' Detection ', ' intrahepatic ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' Pathologic ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' protein metabolite ', ' Steatohepatitis ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' Coupled ', ' early therapy ', ' Early treatment ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' alcohol related research ', ' ethanol research ', ' alcohol research ', ' murine model ', ' mouse model ', ' candidate biomarker ', ' candidate marker ', ' effective treatment ', ' effective therapy ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' screening ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' Data Analytics ', ' potential biological marker ', ' potential biomarker ', ' diagnostic marker ', ' diagnostic biomarker ', ' specific biomarkers ', ' metabonome ', ' metabolome ', ' Tissue imaging ', ' marker identification ', ' biomarker identification ', ' injury to tissue ', ' tissue injury ', ' Ethanol ', ' Absolute ethanol ', ' ETOH ', ' Ethyl Alcohol ', ' Grain Alcohol ', ' Methylcarbinol ', ' Alcohols ', ' Alcohol Chemical Class ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diagnosis ', ' Fatty Liver ', ' Liver Steatosis ', ' hepatic steatosis ', ' Fibrosis ', ' Foundations ', ' Future ', ' Goals ', ' Hepatitis ', ' Alcoholic Hepatitis ', ' Ethanol-induced hepatitis ', ' Histology ', ' Human ', ' Modern Man ', ' Hybrids ', ' Inflammation ', ' Lipids ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Liver Cirrhosis ', ' Hepatic Cirrhosis ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Alcoholic Liver Diseases ', ' alcohol induced hepatic injury ', ' alcohol induced liver disorder ', ' alcohol induced liver injury ', ' alcohol-induced hepatic dysfunction ', ' alcohol-induced liver disease ', ' ']",NIAAA,YALE UNIVERSITY,R21,2020,178842,0.014592790923721342
"Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets PROJECT SUMMARY/ABSTRACT Recent advances in high-resolution mass spectrometry (HRMS) instrumentation have not been fully leveraged to upgrade the information content of metabolomics datasets obtained from stable isotope labeling studies. This is primarily due to lack of validated software tools for extracting and interpreting isotope enrichments from HRMS datasets. The overall objective of the current application is to develop tools that enable the metabolomics community to fully leverage stable isotopes to profile metabolic network dynamics. Two new tools will be implemented within the open-source OpenMS software library, which provides an infrastructure for rapid development and dissemination of mass spectrometry software. The first tool will automate tasks required for extracting isotope enrichment information from HRMS datasets, and the second tool will use this information to group ion peaks into interaction networks based on similar patterns of isotope labeling. The tools will be validated using in-house datasets derived from metabolic flux studies of animal and plant systems, as well as through feedback from the metabolomics community. The rationale for the research is that the software tools will enable metabolomics investigators to address important questions about pathway dynamics and regulation that cannot be answered without the use of stable isotopes. The first aim is to develop a software tool to automate data extraction and quantification of isotopologue distributions from HRMS datasets. The software will provide several key features not included in currently available metabolomics software: i) a graphical, interactive user interface that is appropriate for non-expert users, ii) support for native instrument file formats, iii) support for samples that are labeled with multiple stable isotopes, iv) support for tandem mass spectra, and v) support for multi-group or time-series comparisons. The second aim is to develop a companion software that applies machine learning and correlation-based algorithms to group unknown metabolites into modules and pathways based on similarities in isotope labeling. The third aim is to validate the tools through comparative analysis of stable isotope labeling in test standards and samples from animal and plant tissues, including time-series and dual-tracer experiments. A variety of collaborators and professional working groups will be engaged to test and validate the software, and the tools will be refined based on their feedback. The proposed research is exceptionally innovative because it will provide the advanced software capabilities required for both targeted and untargeted analysis of isotopically labeled metabolites, but in a flexible and user-friendly environment. The research is significant because it will contribute software tools that automate and standardize the data processing steps required to extract and utilize isotope enrichment information from large-scale metabolomics datasets. This work will have an important positive impact on the ability of metabolomics investigators to leverage information from stable isotopes to identify unknown metabolic interactions and quantify flux within metabolic networks. In addition, it will enable entirely new approaches to study metabolic dynamics within biological systems. PROJECT NARRATIVE The proposed research is relevant to public health because it will develop novel software tools to quantify and interpret data from stable isotope labeling experiments, which can be used to uncover relationships between metabolites and biochemical pathways. These tools have potential to accelerate progress toward identifying the causes and cures of many important diseases that impact metabolism.",Tools for Leveraging High-Resolution MS Detection of Stable Isotope Enrichments to Upgrade the Information Content of Metabolomics Datasets,10002192,U01CA235508,"['Algorithms ', ' Animals ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Environment ', ' Feedback ', ' instrumentation ', ' Ions ', ' Isotope Labeling ', ' Isotopes ', ' Libraries ', ' Manuals ', ' Maps ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Plants ', ' Public Health ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' Label ', ' improved ', ' Biological ', ' Series ', ' Measurement ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Abnormal Assessment of Metabolism ', ' Metabolic Studies ', ' Metabolism Studies ', ' metabolic abnormality assessment ', ' Letters ', ' stable isotope ', ' Metabolic ', ' Companions ', ' tool ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Pattern ', ' System ', ' experience ', ' tandem mass spectrometry ', ' novel ', ' Regulation ', ' Modeling ', ' Sampling ', ' data processing ', ' computerized data processing ', ' Stable Isotope Labeling ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' Data ', ' Detection ', ' Resolution ', ' Validation ', ' Process ', ' Tracer ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' file format ', ' user-friendly ', ' open source ', ' Network-based ', ' comparative ', ' biological systems ', ' flexible ', ' flexibility ', ' operation ', ' metabotype ', ' metabolic phenotype ', ' metabolic profile ', ' experiment ', ' experimental research ', ' experimental study ', ' Infrastructure ', ' data standardization ', ' data standards ', ' ']",NCI,VANDERBILT UNIVERSITY,U01,2020,617714,0.0908120303695696
"High-Throughput De Novo Glycan Sequencing Glycosylation fulfills important physiological functions, including protein folding, embryogenesis, cell adhesion, pathogen recognition, and immune response. The multifaceted roles glycosylation plays derive from the presence of a range of glycan epitopes, where a small structural variation can have a profound impact on functions. Further, a glycome consists of many closely related structures, with their relative amounts determined by metabolic conditions in a cell- and growth-specific manner. Altered glycosylation is linked to many diseases, including cardiovascular, pulmonary, neurological and autoimmune disorders, and cancer. Thus, there is a clear need for analytical methods that can rapidly identify and quantify the many glycoforms in a glycome from different health and disease states. Finally, no genome-predicted glycan database exists due to the unscripted nature of glycan biosynthesis, and discovery of new glycan structures must be achieved by de novo methods. Although tandem mass spectrometry-based biopolymer sequencing has been the major catalyst to the recent rapid advance of 'omics, the prevailing collisionally activated dissociation method often fails to provide sufficient glycan structural detail at the MS2 level, whereas the MSn approach lacks the speed, sensitivity, and quantitative potential for high-throughput glycome analysis. We have recently developed an electronic excitation dissociation (EED) method that can yield rich structural information in a single stage of MS/MS analysis. However, the impact of EED on glycomics research is currently limited by its poor accessibility, insufficient coupling to on-line glycan separation methods, and difficulty in interpretation of complex glycan EED tandem mass spectra. Here, we propose to develop an integrated approach that combines EED with on-line liquid chromatography (LC) separation and a novel bioinformatics tool to achieve high-throughput, de novo, and comprehensive glycome characterization. We will explore the potential of EED for analysis of glycans in various derivatized forms, study their fragmentation behaviors, and establish fragmentation rules for the development of bioinformatics software. We will optimize conditions for efficient coupling of EED to reversed-phase, and porous graphitic carbon LC, and develop an LC-EED-MS/MS approach for simultaneous characterization and quantitation of glycan mixtures. We will implement EED on a Q-TOF instrument to improve its access to the glycoscience community. Finally, we will develop and rigorously test the performance of a novel bioinformatics software that can rapidly and accurately determine each glycan's structure from its tandem MS spectra. The proposed algorithm is fundamentally different from most existing software, in that it no longer relies solely on glycosidic and cross-ring fragments for topology and linkage analysis, but rather adopts a machine learning approach that considers the contexts of various types of fragment peaks, and the spectral features associated with different linkage configurations and structural motifs. The availability of such a high-throughput, de novo glycan sequencing tool will have an immense impact on many biomedical research fields, as glycosylation plays critical roles in almost all biological pathways. High-Throughput De Novo Glycan Sequencing Project narrative Characterization of glycans from biological sources requires sensitive and high-throughput analytical methods that can separate and identify each glycoform in a complex mixture. We propose to develop an HPLC-EED- MS/MS method for comprehensive glycome characterization. We will also develop a novel bioinformatics program that can accurately determine the glycan structure from its EED tandem mass spectrum de novo.",High-Throughput De Novo Glycan Sequencing,10000171,R01GM132675,"['Algorithms ', ' Epitopes ', ' Antigenic Determinants ', ' Binding Determinants ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Behavior ', ' Biomedical Research ', ' Biopolymers ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Carbon ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cell Adhesion ', ' Cellular Adhesion ', ' cell growth ', ' Cellular Expansion ', ' Cellular Growth ', ' High Pressure Liquid Chromatography ', ' HPLC ', ' High Performance Liquid Chromatography ', ' High Speed Liquid Chromatography ', ' Liquid Chromatography ', ' Communities ', ' Disease ', ' Disorder ', ' Electron Transport ', ' electron transfer ', ' Embryonic Development ', ' Embryo Development ', ' Embryogenesis ', ' Genome ', ' Glycoconjugates ', ' Glycosides ', ' glycosylation ', ' Metabolic Glycosylation ', ' Health ', ' Isomerism ', ' isomer ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Methods ', ' nervous system disorder ', ' Nervous System Diseases ', ' Neurologic Disorders ', ' Neurological Disorders ', ' neurological disease ', ' Pathologic Processes ', ' Pathological Processes ', ' Physiology ', ' Physiological Processes ', ' Organism-Level Process ', ' Organismal Process ', ' Physiologic Processes ', ' Play ', ' Polysaccharides ', ' Glycans ', ' Research ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Specificity ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Structure-Activity Relationship ', ' chemical structure function ', ' structure function relationship ', ' Vacuum ', ' Dissociation ', ' Dataset ', ' Data Set ', ' protein folding ', ' catalyst ', ' analytical method ', ' base ', ' improved ', ' Surface ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' biosynthesis ', ' Anabolism ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' fluid ', ' liquid ', ' Liquid substance ', ' Graphite ', ' Natural graphite ', ' Metabolic ', ' tool ', ' instrument ', ' Nature ', ' machine learned ', ' Machine Learning ', ' programs ', ' Adopted ', ' Complex ', ' Source ', ' Pattern ', ' tandem mass spectrometry ', ' Speed ', ' Structure ', ' novel ', ' Linkage Analysis ', ' family based linkage study ', ' genetic linkage analyses ', ' linkage analyses ', ' genetic linkage analysis ', ' Sampling ', ' performance tests ', ' Bio-Informatics ', ' Bioinformatics ', ' Molecular Interaction ', ' Binding ', ' Complex Mixtures ', ' Effectiveness ', ' Address ', ' Data ', ' Scheme ', ' developmental ', ' Development ', ' ultraviolet ', ' pathway ', ' Pathway interactions ', ' mass spectrometer ', ' reconstruction ', ' designing ', ' design ', ' pathogen ', ' Coupling ', ' Impairment ', ' therapeutic target ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' FTICR ', ' Fourier transform ion cyclotron resonance ', ' Algorithmic Design ', ' Algorithmic Engineering ', ' algorithm engineering ', ' algorithmic composition ', ' Algorithm Design ', ' bio-informatics tool ', ' bioinformatics tool ', ' ']",NIGMS,BOSTON UNIVERSITY MEDICAL CAMPUS,R01,2020,447308,0.11519076242926818
"Optimization and joint modeling for peptide detection by tandem mass spectrometry Project Summary/Abstract Proteins are the primary functional molecules in living cells, and tandem mass spectrometry provides the most efcient means of studying proteins in a high-throughput fashion. The proposal aims to use state-of-the-art methods from the elds of machine learning, statistics, and natural language processing to improve our ability to make sense of large tandem mass spectrometry data sets. Our project will focus on three key problems in the analysis of such data: 1. facilitating the use of previously annotated spectra to improve our ability to annotate new spectra by creating  a hybrid search scheme that compares an observed spectrum to a database comprised of theoretical spectra  and previously annotated spectra, 2. enabling the efcient and accurate detection of peptides containing post-translational modications and  sequence variants, and 3. detecting sets of peptide species that are co-fragmented in the mass spectrometer and hence give rise to  complex, mixture spectra. Each of these aims will improve the ability of mass spectrometrists to efciently and accurately identify and quantify proteins in complex mixtures. To increase the impact of our work, we will continue to make all of our tools available as free software. Project narrative The applications of mass spectrometry, and its promises for improvements of human health, are numerous, including an increased understanding of disease phenotypes and the molecular mechanisms that underlie them, and vastly more sensitive and specic diagnostic and prognostic screens. However, making optimal use of mass spectrometry data requires sophisticated computational methods. This project will develop and apply novel statistical and machine learning methods for interpreting mass spectra.",Optimization and joint modeling for peptide detection by tandem mass spectrometry,9856476,R01GM121818,"['Algorithms ', ' Amino Acid Sequence ', ' Primary Protein Structure ', ' protein sequence ', ' Automobile Driving ', ' driving ', ' Cells ', ' Cell Body ', ' Liquid Chromatography ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Economics ', ' Fertilization ', ' Fertility/Fertilization ', ' Game Theory ', ' Health ', ' Human ', ' Modern Man ', ' Hybrids ', ' Joints ', ' Libraries ', ' Methods ', ' Methodology ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Natural Language Processing ', ' natural language understanding ', ' Operations Research ', ' Peptides ', ' Post-Translational Protein Processing ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Modifications ', ' Post-Translational Protein Modification ', ' Posttranslational Modifications ', ' Posttranslational Protein Processing ', ' Protein Modification ', ' Proteins ', ' Shotguns ', ' shot gun ', ' Computer software ', ' Software ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' statistics ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' prognostic ', ' Discipline ', ' Data Bases ', ' data base ', ' Databases ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' speech recognition ', ' tandem mass spectrometry ', ' Speed ', ' novel ', ' Column Chromatography ', ' Modeling ', ' Sampling ', ' theories ', ' Proteomics ', ' peptide aminoacid sequence ', ' peptide sequence ', ' protein aminoacid sequence ', ' Complex Mixtures ', ' Data ', ' Detection ', ' Collection ', ' Scheme ', ' Molecular ', ' disease phenotype ', ' cost ', ' mass spectrometer ', ' computational tools ', ' computerized tools ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Mathematical Logic ', ' Mathematical Reasoning ', ' math theory ', ' mathematic theory ', ' mathematics logic ', ' mathematics reasoning ', ' mathematics theory ', ' mathematical theory ', ' experiment ', ' experimental research ', ' experimental study ', ' Bayesian Network ', ' complex data  ', ' statistical and machine learning ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2020,315830,0.27967696839716344
"COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWN DATA INDEPENDENT ACQUISITION MASS SPECTROMETRY Summary Mass spectrometry-based top-down proteomics has become one of the most informative approaches in protein analysis because it provides the bird's-eye view of intact proteoforms (protein forms) generated from post-translational modifications and sequence variations. Data dependent acquisition and data independent acquisition are the two main methods in top-down mass spectrometry. The former has been the dominant one, but it has two main challenges in proteome-wide studies: low protein coverage: a regular experiment of human cells can identify only 200  400 proteins, and low reproducibility: a technical triplet shares only about one third of identified proteoforms. Top-down data independent acquisition mass spectrometry (TD-DIA-MS) has the potential to significantly increase protein coverage and improve reproducibility in proteome-wide studies. However, its application has been hampered by the complexity of the data and the lack of efficient software tools. To address this problem, we will propose new algorithms and machine learning models and develop the first software package for proteoform identification by TD-DIA-MS. The proposed research will be conducted by a group of researchers with complementary expertise. All the proposed algorithms will be implemented as user-friendly open source software tools. Narrative This project addresses the proteoform identification problem by top-down data independent acquisition mass spectrometry. We will propose new machine learning models and new algorithms for high-throughput proteome-wide identification of complex proteoforms with post-translational modifications and sequence variations by using top- down data independent acquisition mass spectrometry. The proposed methods will facilitate the study of the function of complex proteoforms and the discovery of proteome biomarkers.",COMPUTATIONAL TOOLS FOR PROTEOFORM IDENTIFICATION BY TOP-DOWN DATA INDEPENDENT ACQUISITION MASS SPECTROMETRY,10049810,R01GM118470,"['Algorithms ', ' Amino Acid Sequence ', ' Primary Protein Structure ', ' protein sequence ', ' Cells ', ' Cell Body ', ' Communities ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Insulin-Dependent Diabetes Mellitus ', ' Brittle Diabetes Mellitus ', ' IDDM ', ' Juvenile-Onset Diabetes Mellitus ', ' Ketosis-Prone Diabetes Mellitus ', ' Sudden-Onset Diabetes Mellitus ', ' T1 DM ', ' T1 diabetes ', ' T1D ', ' T1DM ', ' Type 1 Diabetes Mellitus ', ' Type 1 diabetes ', ' Type I Diabetes Mellitus ', ' insulin dependent diabetes ', ' juvenile diabetes ', ' juvenile diabetes mellitus ', ' ketosis prone diabetes ', ' type I diabetes ', ' type one diabetes ', ' Disease ', ' Disorder ', ' Escherichia coli ', ' E coli ', ' E. coli ', ' Feedback ', ' Human ', ' Modern Man ', ' insulinoma ', ' Beta Cell Neoplasm ', ' Beta Cell Neoplasm of the Pancreas ', ' Beta Cell Tumor of the Pancreas ', ' Insulin-Producing Neoplasm of the Islet Cells ', ' Insulin-Producing Tumor of the Islet Cells ', ' Insuloma ', ' Pancreatic Beta Cell Insulin Producing Neoplasm ', ' Pancreatic Beta Cell Insulin Producing Tumor ', ' Pancreatic Beta Cell Tumor ', ' beta-Cell Adenoma ', ' beta-Cell Tumor ', ' Methods ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Peptides ', ' Post-Translational Protein Processing ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Modifications ', ' Post-Translational Protein Modification ', ' Posttranslational Modifications ', ' Posttranslational Protein Processing ', ' Protein Modification ', ' Proteins ', ' Rattus ', ' Common Rat Strains ', ' Rat ', ' Rats Mammals ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Testing ', ' Time ', ' Triplet Multiple Birth ', ' Triplets ', ' Yeasts ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Evaluation ', ' insight ', ' Data Bases ', ' data base ', ' Databases ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' System ', ' Proteome ', ' Modeling ', ' Sampling ', ' Proteomics ', ' develop software ', ' developing computer software ', ' software development ', ' Address ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' migration ', ' Coupling ', ' user-friendly ', ' open source ', ' signature molecule ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' Drug Targeting ', ' Algorithmic Tools ', ' Software Algorithm ', ' Algorithmic Software ', ' experiment ', ' experimental research ', ' experimental study ', ' evaluate effectiveness ', ' effectiveness evaluation ', ' ']",NIGMS,INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,R01,2020,60245,0.1867326972390216
"Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry Mass spectrometry imaging (MSI) is a powerful technique that enables label-free spatial mapping of different classes of biomolecules in biological systems. Because it does not require any special sample pretreatment, ambient MSI is particularly attractive for high throughput automated imaging applications. The throughput of ambient MSI experiments is typically limited by the inherently slow microprobe-type sampling from surfaces, which is a characteristic shortcoming of many chemical imaging modalities. This project will combine several highly innovative approaches to address challenges associated with the high-throughput high- resolution ambient MSI of lipids and metabolites using nanospray desorption electrospray ionization (nano-DESI). Nano-DESI is an ambient ionization technique, which relies on gentle localized liquid extraction of molecules from tissue sections into a flowing solvent confined between two glass capillaries. The extracted molecules are efficiently delivered to a mass spectrometer inlet and ionized by soft electrospray ionization. Nano-DESI MSI enables detection of hundreds of metabolites, lipids, and peptides in tissue sections with high sensitivity, high spatial resolution, and without special sample pretreatment. Furthermore, on-the-fly quantification of lipids and metabolites in tissue sections during nano-DESI imaging experiments is achieved by doping the working solvent with appropriate standards of known concentration. This project will extend these powerful capabilities of nano-DESI MSI to enable high-throughput imaging of large tissue sections of interest to the HubMAP Consortium. This will be achieved using a combination of a conceptually different nano-DESI probe design optimized for robustness, ease of fabrication, and spatial resolution and a suite of advanced machine learning and compressed sensing computational approaches. These developments will be applicable to different types of human tissues and will transform quantitative molecular imaging of multiple classes of biomolecules in tissue sections. Although the capabilities of the new imaging platform will be demonstrated using non-diseased tissue, these developments will be broadly applicable to scientific problems associated with understanding health and disease Project Narrative This research is focused on the development of a transformative technology for rapid, quantitative, and robust imaging of different classes of biomolecules in human tissues using mass spectrometry. This new technology will contribute to understanding complex processes in biological tissues that play a role in both health and disease.",Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry,10026443,UH3CA255132,"['Automation ', ' Blood capillaries ', ' capillary ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Glass ', ' Health ', ' Histology ', ' Ions ', ' Lipids ', ' Maps ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Oligosaccharides ', ' Optics ', ' optical ', ' Peptides ', ' Play ', ' Proteins ', ' Research ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Role ', ' social role ', ' Sensitivity and Specificity ', ' Computer software ', ' Software ', ' Solvents ', ' Spatial Distribution ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Label ', ' Microscope ', ' Surface ', ' Phase ', ' Biological ', ' Ensure ', ' Chemicals ', ' Measurement ', ' Collaborations ', ' fluid ', ' liquid ', ' Liquid substance ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' human tissue ', ' Slide ', ' Techniques ', ' interest ', ' ESI Mass Spectrometry ', ' Spectrometry, Mass, Electrospray Ionization ', ' Performance ', ' Structure ', ' novel ', ' member ', ' novel technologies ', ' new technology ', ' Sampling ', ' Proteomics ', ' fluidic ', ' Microfluidics ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Tissue Sample ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' Data ', ' Detection ', ' Resolution ', ' Electrospray Ionization ', ' Validation ', ' Characteristics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' nano ', ' imaging ', ' Image ', ' ionization method ', ' ionization technique ', ' mass spectrometer ', ' reconstruction ', ' designing ', ' design ', ' nano probe ', ' nanoprobe ', ' scale up ', ' innovate ', ' innovative ', ' innovation ', ' data acquisition ', ' biological systems ', ' operation ', ' quantitative imaging ', ' imaging platform ', ' human imaging ', ' experiment ', ' experimental research ', ' experimental study ', ' imaging capabilities ', ' preservation ', ' automated analysis ', ' HuBMAP ', ' Human BioMolecular Atlas Program ', ' ']",NCI,PURDUE UNIVERSITY,UH3,2020,637788,0.14318785766211636
"Deep Ovarian Cancer Metabolomics PROJECT SUMMARY  Ovarian cancer (OC) is the 5th leading cause of cancer-related deaths for U.S. women and the deadliest gynecological disease. Lack of symptoms in addition to the deficiency of highly specific biomarkers for detection typically result in only 25% of OC cases being diagnosed at FIGO stage I. High-grade serous carcinoma (HGSC) is the most prevalent form of OC, but three rarer histological subtypes also exist endometrioid, clear cell, and mucinous. An effective screening strategy for early diagnosis would be particularly advantageous since 5-year OC survival rates can be as high as 90%. Unfortunately, protein biomarkers such as CA-125 do not have sufficient positive predictive value to be useful from a clinical perspective. We hypothesize that useful information regarding early stage HGSC and other ovarian cancers can be found in the serum metabolome. Our pilot studies in both humans and OC models, such as the double-knockout Dicer-Pten mouse recently developed by our team members, show great promise in this regard average sensitivity and specificity for early detection have reached 97.8% and 99.0% in banked human serum samples, and up to100% in mice. These results have prompted us to perform a much deeper investigation of metabolome alterations associated with early stage ovarian cancers in larger serum sample sets, and over time. We will perform metabolomics experiments in mice and banked de-identified human serum samples with much higher coverage than before by data fusing various modes of ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) and nuclear magnetic resonance (NMR), coupled with pathway-centric data analysis. We also propose supplementing serum-level metabolomics experiments with deep-coverage tissue mass spectrometry imaging (MSI) in both 2-D and 3-D, using a combination of matrix-assisted laser desorption/ionization (MALDI) and desorption electrospray ionization (DESI), which have complementary ionization mechanisms. Furthermore, we propose to depart from the commonly used approach of tentatively identifying spectral features by only using accurate masses, and implement a deep metabolite annotation approach that uses both fused high-resolution techniques (high field Orbitrap MS, MS/MS, 2-D NMR) and a new technology based on collisional cross section predictions for both travelling wave and drift tube ion mobility-MS. High-grade serous ovarian cancer is the most common and deadliest type of ovarian cancer; it is diagnosed mostly at an advanced stage at which the cancer has already spread beyond the ovary or the fallopian tube, to the abdominal cavity. This advanced-stage diagnosis inevitably causes high mortality. In this project, we propose to study molecular changes associated with early disease both in mouse models that closely mimic human disease and in banked de-identified human serum samples, with the aim of ultimately designing a robust diagnostic panel.",Deep Ovarian Cancer Metabolomics,9985087,R01CA218664,"['Age ', ' ages ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' CA-125 Antigen ', ' CA-125 ', ' CA125 ', ' Cancer Antigen 125 ', ' Carbohydrate Antigen 125 ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Carcinoma ', ' Epithelial cancer ', ' Malignant Epithelial Neoplasms ', ' Malignant Epithelial Tumors ', ' epithelial carcinoma ', ' Liquid Chromatography ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Evolution ', ' Exhibits ', ' Mammalian Oviducts ', ' Fallopian Tubes ', ' Salpinx ', ' Uterine Tubes ', ' oviduct ', ' Genes ', ' Female Genital Diseases ', ' Gynecologic Diseases ', ' Human ', ' Modern Man ', ' Logic ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Neoplasm Metastasis ', ' Metastasis ', ' Metastasize ', ' Metastatic Lesion ', ' Metastatic Mass ', ' Metastatic Neoplasm ', ' Metastatic Tumor ', ' Secondary Neoplasm ', ' Secondary Tumor ', ' cancer metastasis ', ' tumor cell metastasis ', ' Nuclear Magnetic Resonance ', ' Ovary ', ' Patients ', ' Greater sac of peritoneum ', ' Peritoneal Cavity ', ' Pilot Projects ', ' pilot study ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Survival Rate ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Travel ', ' Woman ', ' TP53 gene ', ' P53 ', ' TP53 ', ' TRP53 ', ' Tumor Protein p53 Gene ', ' p53 Genes ', ' Borderline Neoplasm ', ' Borderline tumor ', ' borderline malignancy neoplasm ', ' low malignant potential neoplasm ', ' uncertain malignant potential neoplasm ', ' Tube ', ' base ', ' cancer progression ', ' neoplasm progression ', ' neoplastic progression ', ' tumor progression ', ' Ovarian ', ' Benign ', ' Clinical ', ' Phase ', ' Histologically ', ' Histologic ', ' KO mice ', ' Knock-out Mice ', ' Null Mouse ', ' Knockout Mice ', ' Lesion ', ' Clear Cell ', ' Blood Serum ', ' Serum ', ' Cavitas abdominis ', ' Abdominal Cavity ', ' Measurement ', ' Disease Progression ', ' ovarian cancer detection ', ' ovarian cancer early detection ', ' ovarian cancer early screening ', ' Screening for Ovarian Cancer ', ' MALD-MS ', ' MALDI ', ' MALDI-MS ', ' Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' matrix assisted laser desorption ionization ', ' Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ', ' Metabolic ', ' machine learned ', ' Machine Learning ', ' Investigation ', ' Serous ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Penetrance ', ' early detection ', ' Early Diagnosis ', ' ionization ', ' mutant ', ' hydrophilicity ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Primary Tumor ', ' Primary Neoplasm ', ' member ', ' novel technologies ', ' new technology ', ' Sampling ', ' LC/MS ', ' liquid chromatography mass spectrometry ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cancer diagnosis ', ' Malignant Ovarian Neoplasm ', ' Malignant Ovarian Tumor ', ' Malignant Tumor of the Ovary ', ' Ovary Cancer ', ' ovarian cancer ', ' Malignant neoplasm of ovary ', ' Reproductive system ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Mucinous ', ' Predictive Value ', ' precancerous ', ' premalignant ', ' Resolution ', ' Cancer Cause ', ' Cancer Etiology ', ' CancerModel ', ' Cancer Model ', ' Cancer Patient ', ' Electrospray Ionization ', ' Characteristics ', ' Molecular ', ' GEM model ', ' genetically engineered mouse model ', ' genetically engineered murine model ', ' Genetically Engineered Mouse ', ' Knockout ', ' Knock-out ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' ion mobility ', ' designing ', ' design ', ' Coupled ', ' human disease ', ' murine model ', ' mouse model ', ' tumor ', ' multi-modality ', ' multimodality ', ' screening ', ' diagnostic panel ', ' cancer markers ', ' cancer biomarkers ', ' specific biomarkers ', ' protein markers ', ' protein biomarkers ', ' metabotype ', ' metabolic phenotype ', ' metabonome ', ' metabolome ', ' experiment ', ' experimental research ', ' experimental study ', ' data fusion ', ' ']",NCI,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2020,410432,0.08240623922129495
"A knowledge graph framework for automated gating analysis of cytometry data Project Summary / Abstract Flow and mass cytometry provide multiparametric single-cell data critical for understanding the cellular heterogeneity in various biological systems. Modern polychromatic flow cytometers simultaneously measure about 16 parameters routinely. The next-generation mass cytometry (CyTOF) technology allows for the simultaneous measurement of 50 or more parameters. Even as the cytometry technology is rapidly advancing, approaches for analyzing such complex data remain inadequate. The widely-used manual gating analysis is knowledge-driven and easy-to- interpret, but it is subjective, labor-intensive, and not scalable to handle the increasing complexity of the data. Recent developments of automated data-driven algorithms are able to address the issues of manual gating, but the results from data-driven algorithms are often not intuitive for biology experts to interpret. These limitations create a critical bottleneck for flow and mass cytometry analysis. The overall objective of this application is to develop a novel framework that combines both knowledge-driven and data-driven approaches to achieve automated gating analysis of flow cytometry and CyTOF data. The specific aims are: (1) build knowledge graphs to capture existing knowledge of manual gating analysis, (2) develop algorithms for automated gating analysis, and (3) validate the knowledge graph framework using large-scale studies in ImmPort. The proposed research is significant because it will enable efficient and reproducible gating analysis and provide visualizations that are easy-to-interpret, both of which are critically important to the research community. Such contributions will fundamentally impact single-cell analysis of cellular heterogeneity in diverse fields including immunology, infectious diseases, cancer, AIDS, among others. Project Narrative The proposed research is relevant to public health because it is expected to develop novel computational methods for automated analysis and interpretation of single-cell analysis by flow and mass cytometry. Such contributions will impact single-cell analysis of cellular heterogeneity in diverse fields such as immunology, infectious diseases, cancer, AIDS, among others.",A knowledge graph framework for automated gating analysis of cytometry data,10026829,UH2AI153028,"['Acquired Immunodeficiency Syndrome ', ' AIDS ', ' Acquired Immune Deficiency ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Adoption ', ' Algorithms ', ' Biological Sciences ', ' Biologic Sciences ', ' Bioscience ', ' Life Sciences ', ' Biology ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cells ', ' Cell Body ', ' Clinical Research ', ' Clinical Study ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Flow Cytometry ', ' Flow Cytofluorometries ', ' Flow Cytofluorometry ', ' Flow Microfluorimetry ', ' Flow Microfluorometry ', ' flow cytophotometry ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Immune system ', ' allergic/immunologic body system ', ' allergic/immunologic organ system ', ' Literature ', ' Logic ', ' Manuals ', ' Modernization ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Public Health ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Computer software ', ' Software ', ' Technology ', ' Thinking ', ' thoughts ', ' Measures ', ' Dataset ', ' Data Set ', ' Immunology ', ' base ', ' Clinical ', ' Biological ', ' Intuition ', ' Individual ', ' Measurement ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Adopted ', ' Dimensions ', ' cell type ', ' single cell analysis ', ' novel ', ' Graph ', ' Cytometry ', ' Modeling ', ' Address ', ' Data ', ' Reproducibility ', ' developmental ', ' Development ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' user-friendly ', ' Graphical interface ', ' graphic user interface ', ' software user interface ', ' graphical user interface ', ' web based interface ', ' stem ', ' biological systems ', ' Algorithmic Analyses ', ' Analyses of Algorithms ', ' Analysis of Algorithms ', ' Algorithmic Analysis ', ' Algorithmic Design ', ' Algorithmic Engineering ', ' algorithm engineering ', ' algorithmic composition ', ' Algorithm Design ', ' protein markers ', ' protein biomarkers ', ' data resource ', ' high dimensionality ', ' deep learning ', ' high dimensional data ', ' multidimensional datasets ', ' multidimensional data ', ' automated analysis ', ' informatics tool ', ' Visualization ', ' complex data  ', ' automatic algorithm ', ' automated algorithm ', ' data diversity ', ' diverse data ', ' data and analysis portal ', ' Database and Analysis Portal ', ' graph knowledge base ', ' graph knowledgebase ', ' knowledge graph ', ' ']",NIAID,GEORGIA INSTITUTE OF TECHNOLOGY,UH2,2020,211738,0.11812327124090238
"Real time optimization of electron-based fragmentation for middle and top-down proteomics in mass spectrometry The identification and quantification of biological macromolecules remains challenging despite major advances in the speed, resolution and mass accuracy of modern mass spectrometers. A key weakness with current instrumentation lies in the methods used to induce fragmentation. The reliance in particular on collision-induced dissociation (CID) has limited such analyses to bottom-up workflows of trypsin-digested peptides of 10-30 residues. At e-MSion, we have developed an efficient electron-fragmentation technology called ExD for large proteins and are now co-marketed our ExD Option with Agilent, and soon will be with Thermo and Waters instruments. What has really captured the interest of the biopharma and top-down communities in the past year is the exceptional sequence coverage of native proteins we obtain with the same ExD cell. The resulting spectra are less congested than those obtained with currently available ETD/UVPD/CID fragmentation methodologies. We have shown that our technology works faster and gives cleaner spectra with more complete dissociation with larger macromolecular protein complexes than has ever been possible before, while still preserving labile post translational modifications. In addition, fragmentation with higher energy electrons can be used to provide complementary data to improve protein and glycan identification. The challenge now has become how to optimally collect and process these data to maximize the utility of ExD fragmentation. Last summer, Xilinx released its Versal Adaptive Compute Acceleration Platform (ACAP), a massively parallel processor with 50 billion transistors targeted to transform digital signal processing, handling of big data and artificial intelligence. This ACAP technology has already accelerated Illumina DNA sequence assembly by 90-fold. Our feasibility question asks how to effectively harness this new highly parallelized technology to preprocess complex top-down mass spectra on- the-fly. This will allow us to actively optimize data acquisition by enabling adaptive operation of the ExD cell and mass spectrometer. The objective is to maximize both fragmentation and dissociation of native proteins, enabling faster and comprehensive characterization of challenging proteoforms important to the biopharmaceutical industry and biomedical researchers.  Success will offer an extremely fast, cost-effective solution to characterize complexes of macromolecules under native conditions with increased accuracy, speed, and fewer misidentifications. Our ExD technology with the Versal ACAP can be both retrofitted into existing mass spectrometers as well as being available in new generations of mass spectrometers at a price below other less-effective alternative fragmentation technologies like ETD and UVPD. Thus, it will provide new abilities for many NIH investigators to advance basic research, probe disease mechanisms and permit more sophisticated searches for both diagnostic and therapeutic biomarkers. Even with all of the scientific progress made to date, the complexity of disease-affected tissues still challenges our ability to probe what makes people sick. The goal of this Phase I SBIR project is to develop a powerful computer technology to aid in characterizing biological molecules that will improve the diagnosis and treatment of diseases ranging from arthritis, cancer, diabetes to heart disease and neurodegeneration.",Real time optimization of electron-based fragmentation for middle and top-down proteomics in mass spectrometry,10081127,R43GM139467,"['Acceleration ', ' Affect ', ' Arthritis ', ' arthritic ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Automobile Driving ', ' driving ', ' Biological Products ', ' Biologic Products ', ' Biological Agent ', ' biopharmaceutical ', ' biotherapeutic agent ', ' Biological Response Modifier Therapy ', ' Biologic Therapy ', ' Biological Therapy ', ' biological therapeutic ', ' biological treatment ', ' biotherapeutics ', ' biotherapy ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cells ', ' Cell Body ', ' Communities ', ' Computers ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Digital Signal Processing ', ' Disease ', ' Disorder ', ' Electronics ', ' electronic device ', ' Electrons ', ' Negative Beta Particle ', ' Negatrons ', ' Engineering ', ' Face ', ' faces ', ' facial ', ' Family ', ' Feasibility Studies ', ' Goals ', ' Grant ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Industrialization ', ' Industry ', ' instrumentation ', ' Ions ', ' Isoleucine ', ' Laboratories ', ' Leucine ', ' Maps ', ' Methods ', ' Methodology ', ' Modernization ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Noise ', ' Optics ', ' optical ', ' Peptides ', ' Periodicity ', ' Cyclicity ', ' Rhythmicity ', ' Polysaccharides ', ' Glycans ', ' Post-Translational Protein Processing ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Modifications ', ' Post-Translational Protein Modification ', ' Posttranslational Modifications ', ' Posttranslational Protein Processing ', ' Protein Modification ', ' Proteins ', ' Reading ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Time ', ' Tissues ', ' Body Tissues ', ' Transistors ', ' Trypsin ', ' Tripcellim ', ' Vendor ', ' Water ', ' Hydrogen Oxide ', ' Work ', ' Generations ', ' Price ', ' pricing ', ' Businesses ', ' Dissociation ', ' fragment X ', ' DNA Sequence ', ' base ', ' macromolecule ', ' improved ', ' Phase ', ' Biological ', ' Individual ', ' instrument ', ' programs ', ' Complex ', ' Continuous Infusion ', ' Techniques ', ' interest ', ' meetings ', ' disulfide bond ', ' experience ', ' success ', ' Speed ', ' Structure ', ' Basic Research ', ' Basic Science ', ' Macromolecular Complexes ', ' Macromolecular Protein Complexes ', ' Multiprotein Complexes ', ' Proteomics ', ' data processing ', ' computerized data processing ', ' protein complex ', ' Protein Fragment ', ' Data ', ' Protein Analysis ', ' Resolution ', ' Collection ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Process ', ' mass spectrometer ', ' cost effective ', ' blind ', ' data acquisition ', ' encryption ', ' operation ', ' signal processing ', ' BigData ', ' Big Data ', ' electron energy ', ' diagnostic marker ', ' diagnostic biomarker ', ' therapeutic marker ', ' therapeutic biomarker ', ' preservation ', ' computing platform ', ' computational platform ', ' ']",NIGMS,"E-MSION, INC.",R43,2020,198907,0.23876266548451786
"Advanced Computational Approaches for NMR Data-mining ABSTRACT Nuclear magnetic resonance spectroscopy (NMR)-based metabolomics is a powerful method for identifying metabolic perturbations that report on different biological states and sample types. Compared to mass spectrometry, NMR provides robust and highly reproducible quantitative data in a matter of minutes, which makes it very suitable for first-line clinical diagnostics. Although the metabolome is known to provide an instantaneous snap-shot of the biological status of a cell, tissue, and organism, the utilization of NMR in clinical practice is hindered by cumbersome data analysis. Major challenges include high-dimensionality of the data, overlapping signals, variability of resonance frequencies (chemical shift), non-ideal shapes of signals, and low signal-to-noise ratio (SNR) for low concentration metabolites. Existing approaches fail to address these challenges and sample analysis is time-consuming, manually done, and requires considerable knowledge of NMR spectroscopy. Recent developments in the field of sparse methods for machine learning and accelerated convex optimization for high dimensional problems, as well as kernel-based spatial clustering show promise at enabling us to overcome these challenges and achieve fully automated, operator-independent analysis. We are developing two novel, powerful, and automated algorithms that capitalize on these recent developments in machine learning. In Aim 1, we describe NMRQuant for automated identification and quantification of annotated metabolites irrespective of the chemical shift, low SNR, and signal shape variability. In Aim 2, we describe SPA-STOCSY for automated de-novo identification of molecular fragments of unknown, non- annotated metabolites. Based on substantial preliminary data, we propose to evaluate these algorithms' sensitivity, specificity, stability, and resistance to noise on phantom, biological, and clinical samples, comparing them to current methods. We will validate the accuracy of analyses by experimental 2D NMR, spike-in, and mass spectrometry. The proposed efforts will produce new NMR analytical software for discovery of both annotated and non-annotated metabolites, substantially improving accuracy and reproducibility of NMR analysis. Such analytical ability would change the existing paradigm of NMR-based metabolomics and provide an even stronger complement to current mass spectrometry-based methods. This approach, once thoroughly validated, will enable NMR to reach wide network of applications in biomedical, pharmaceutical, and nutritional research and clinical medicine. NARRATIVE This project seeks to develop an advanced and automated platform for identifying NMR metabolomics biomarkers of diseases and for fundamental studies of biological systems. When fully developed, these approaches could be used to detect small molecules in the blood or urine, indicative of the onset of various diseases, drug toxicity, or environmental effects on the organism.",Advanced Computational Approaches for NMR Data-mining,9889134,R01GM120033,"['Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cells ', ' Cell Body ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Animal Disease Models ', ' Drug toxicity ', ' Health ', ' Human ', ' Modern Man ', ' Libraries ', ' Manuals ', ' Methods ', ' Noise ', ' Nuclear Magnetic Resonance ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Organism ', ' living system ', ' Patients ', ' Phenotype ', ' Plague ', ' Yersinia pestis disease ', ' Relaxation ', ' Research ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Societies ', ' Sodium Chloride ', ' salt ', ' Computer software ', ' Software ', ' Spectrum Analysis ', ' Spectroscopy ', ' Spectrum Analyses ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Temperature ', ' Time ', ' Tissues ', ' Body Tissues ', ' Urine ', ' Urine Urinary System ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Left ', ' Clinical ', ' Residual ', ' Residual state ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Link ', ' Chemicals ', ' infantile ', ' infancy ', ' Metabolic ', ' Shapes ', ' Diagnostic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' Degenerative Neurologic Diseases ', ' Degenerative Neurologic Disorders ', ' Nervous System Degenerative Diseases ', ' Neural Degenerative Diseases ', ' Neural degenerative Disorders ', ' Neurodegenerative Diseases ', ' Neurologic Degenerative Conditions ', ' degenerative diseases of motor and sensory neurons ', ' degenerative neurological diseases ', ' neurodegenerative illness ', ' Neurodegenerative Disorders ', ' early detection ', ' Early Diagnosis ', ' Structure ', ' novel ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' Reproducibility ', ' nutritious ', ' Nutritional ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' Outcome ', ' Consumption ', ' resistant ', ' Resistance ', ' experimental analysis ', ' stem ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical practice ', ' biological systems ', ' Statistics Algorithm ', ' Statistical Algorithm ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' phenotypic marker ', ' phenotypic biomarker ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' clinical diagnostics ', ' experiment ', ' experimental research ', ' experimental study ', ' high dimensionality ', ' clinical implementation ', ' high dimensional data ', ' multidimensional datasets ', ' multidimensional data ', ' automated analysis ', ' computational suite ', ' automatic algorithm ', ' automated algorithm ', ' machine learning method ', ' ']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2020,356625,0.08385061490508142
"Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways     DESCRIPTION (provided by applicant): This project aims to develop new statistical machine learning methods for metabolomics data from diverse platforms, including targeted and unbiased/global mass spectrometry (MS), labeled MS experiments for measuring metabolic ux and Nuclear Magnetic Resonance (NMR) platforms. Unbiased MS and NMR proling studies result in identifying a large number of unnamed spectra, which cannot be directly matched to known metabolites and are hence often discarded in downstream analyses. The rst aim develops a novel kernel penalized regression method for analysis of data from unbiased proling studies. It provides a systematic framework for extracting the relevant information from unnamed spectra through a kernel that highlights the similarities and differences between samples, and in turn boosts the signal from named metabolites. This results in improved power in identication of named metabolites associated with the phenotype of interest, as well as improved prediction accuracy. An extension of this kernel-based framework is also proposed to allow for systematic integration of metabolomics data from diverse proling studies, e.g. targeted and unbiased MS proling technologies. The second aim pro- vides a formal inference framework for kernel penalized regression and thus complements the discovery phase of the rst aim. The third aim focuses on metabolic pathway enrichment analysis that tests both orchestrated changes in activities of steady state metabolites in a given pathway, as well as aberrations in the mechanisms of metabolic reactions. The fourth aim of the project provides a unied framework for network-based integrative analysis of static (based on mass spectrometry) and dynamic (based on metabolic ux) metabolomics measurements, thus providing an integrated view of the metabolome and the uxome. Finally, the last aim implements the pro- posed methods in easy-to-use open-source software leveraging the R language, the capabilities of the Cytoscape platform and the Galaxy workow system, thus providing an expandable platform for further developments in the area of metabolomics. The proposed software tool will also provide a plug-in to the Data Repository and Coordination Center (DRCC) data sets, where all regional metabolomics centers supported by the NIH Common Funds Metabolomics Program deposit curated data. PUBLIC HEALTH RELEVANCE: Metabolomics, i.e. the study of small molecules involved in metabolism, provides a dynamic view into processes that reect the actual physiology of the cell, and hence offers vast potential for detection of novel biomarkers and targeted therapies for complex diseases. However, despite this potential, the development of computational methods for analysis of metabolomics data lags the rapid growth of metabolomics proling technologies. The current application addresses this need by developing novel statistical machine learning methods for integrative analysis of static and dynamic metabolomics measurements, as well as easy-to-use open-source software to facilitate the application of these methods.",Machine Learning Tools for Discovery and Analysis of Active Metabolic Pathways,9899255,R01GM114029,"['Adoption ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Environment ', ' Equilibrium ', ' balance ', ' balance function ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Language ', ' Linear Models ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Methodology ', ' Names ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nuclear Magnetic Resonance ', ' Phenotype ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Testing ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Area ', ' Phase ', ' Biological ', ' biosynthesis ', ' Anabolism ', ' insight ', ' Measurement ', ' Funding ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Galaxy ', ' Letters ', ' Metabolic ', ' Deposit ', ' Deposition ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Complex ', ' Reaction ', ' System ', ' interest ', ' novel ', ' novel technologies ', ' new technology ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Coding System ', ' Code ', ' Sampling ', ' response ', ' Proteomics ', ' Metabolic Pathway ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' Address ', ' Enzymatic Reaction ', ' Biochemical Reaction ', ' Data ', ' Detection ', ' Molecular Marker of Prognosis ', ' Prognosis Marker ', ' prognostic biomarker ', ' prognostic indicator ', ' Prognostic Marker ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' rapid growth ', ' Data Coordination Center ', ' Data Coordinating Center ', ' transcriptomics ', ' Plug-in ', ' open source ', ' Network-based ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' public health relevance ', ' new marker ', ' novel biomarker ', ' novel marker ', ' biological systems ', ' flexible ', ' flexibility ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' diagnostic marker ', ' diagnostic biomarker ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' experiment ', ' experimental research ', ' experimental study ', ' high dimensionality ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' Visualization ', ' statistical and machine learning ', ' data diversity ', ' diverse data ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2020,336869,0.09527853519809468
